Pre-meeting Symposia • Sunday, June 14 Scientific Sessions • Sunday, June 14 - Thursday, June 18

Jointly sponsored by: National Lipid Association, Giovanni Lorenzini Medical Science Foundation

Hosting Organizations: Boston Atherosclerosis Society, Weill Cornell Medical College

Supporting Organization: Council on Arteriosclerosis, Thrombosis, and Vascular Biology, AHA International Atherosclerosis Society Future ISA Meeting

ISA 2012 March 25–30, 2012 Sydney, Meeting Office 15000 Commerce Parkway, Suite C Mount Laurel, NJ 08054 Telephone: 856-439-0500 Fax: 856-439-0525 Email: [email protected] Table of Contents

Address from the Presidents...... 3

International Advisory Board...... 4

Program Committees...... 5

Corporate Supporters...... 6

General Information...... 8

Exhibits...... 14

Exhibit Floor Plan...... 20

Meeting-At-A-Glance...... Insert

Scientific and Poster Sessions...... 21

Category Index...... 184

Author Index...... 186

Notes...... 211

Convention Center Map...... Inside Back Cover Address from the Presidents

Dear Colleagues,

It is our pleasure to welcome you to Boston, Massachusetts on June 14-18, 2009 for the XV International Symposium on Atherosclerosis. This Symposium, held triennially under the auspices of the International Atherosclerosis Society, offers the world’s largest and most prestigious forum for the presentation of new research and clinical findings on Antonio M. Gotto, Jr. arterial disease. Co-President Atherosclerosis is the underlying cause of heart disease and stroke, which together account for more than half of all mortality and morbidity in developed societies. Advances in the detection, prevention, and treatment of cardiovascular disease continue to emerge as knowledge about the pathogenesis and biology of atherosclerosis increases. In recent years, ongoing awareness of the importance of lifestyle and drug therapies in cardiovascular risk reduction has been enhanced by

Ernst J. Schaefer pharmacological innovations, the development of sophisticated imaging Co-President techniques, and the sequencing of the human genome. Treatment of coronary heart disease has shifted from a primary focus on LDL- C levels to the concept of global cardiometabolic risk, and there has been increased attention paid to the contributing role of other lipoprotein fractions including HDL and triglycerides and of inflammation in the development of atherosclerosis.

Leading clinicians and scientific investigators from around the world have developed and will contribute to a cutting-edge program that aims to capture the scope and depth of the exciting field of atherosclerosis research and treatment. The Symposium will provide a comprehensive update on the challenges and questions currently shaping the field, as well as a clear picture of past and present advances and a look towards future, emerging strategies for the diagnosis, treatment, and prevention of atherosclerosis.

We are delighted that you are joining us for what promises to be a stimulating professional and educational event, and we wish you a great stay in Boston.

Antonio M. Gotto, Jr., MD, DPhil Ernst J. Schaefer, MD

Co-President Co-President XV International Symposium on XV International Symposium on Atherosclerosis on Atherosclerosis

3 International Advisory Board Chairman: Grundy S.M. (USA)

Abdel-Aziz O. (Egypt) Fuster V. (USA) Notarbartolo A. (Italy) Assmann G. () Galli C. (Italy) O’Leary D.H. (USA) Aviram M. () Gensini G.F. (Italy) Olsson A.G. () Avogaro A. (Italy) Ginsberg H.N. (USA) Ooi T.C. () Badimon L. () Goldberg A.C. (USA) Pagnan A. (Italy) Ballantyne C.M. (USA) Gotlieb A.I. (Canada) Paoletti R. (Italy) Barter P. (Australia) Greten H. (Germany) Patsch J. (Austria) Beisiegel U. (Germany) Gülec H.S. () Pitt B. (USA) Bernini F. (Italy) Guyton J.R. (USA) Poledne R. () Betteridge J. (UK) Hajjar D.P. (USA) Poli A. (Italy) Bonnet J. () Hamsten A. (Sweden) Rader D.J. (USA) Breslow J.L. (USA) Hancu N. () Reiner Z. (Croatia) Brewer H.B., Jr. (USA) Hanefeld M. (Germany) Rubba P. (Italy) Brites F. (Argentina) Hansson G.K. (Sweden) Rubinstein A. (Israel) Brown B.G. (USA) Hatton M.W.C. (Canada) Rye K.-A. (Australia) Calabresi L. (Italy) Havekes L.M. (The ) Sacks F.M. (USA) Calandra S. (Italy) Humphries S.E. (UK) Sadikot S.M. (India) Campbell G.R. (Australia) Juhan-Vague I. (France) Schaefer J. (Germany) Carmena R. (Spain) Kanjuh V. (Serbia and Schneider W.J. (Austria) Carrageta M. () Montenegro) Scott J. (UK) Catapano A.L. (Italy) Kastelein J.J.P. (The Netherlands) Shepherd J. (UK) Ceska R. (Czech Republic) Katan M.B. (The Netherlands) Sniderman A. (Canada) Chait A. (USA) Kipshidze N.N. (Republic of Sposito A. () Chandrakasan G. (India) Georgia) Staels B. (France) Channon K.M. (UK) Kisyanto Y. (Indonesia) Stalenhoef A.F. (The Netherlands) Chapman M.J. (France) Kita T. (Japan) Steiner G. (Canada) Chen J-W. (Taiwan, R.O.C.) Kolovou G. () Sullivan L.G. (Australia) Chen M-F. (Taiwan, R.O.C.) Kovanen P. () Szollar L.G. (Hungary) Corsini A. (Italy) Lauro D. (Italy) Tall A. (USA) Crea F. (Italy) Lauro R. (Italy) Taskinen M.-R. (Finland) Crepaldi G. (Italy) Leiter L.A. (Canada) Tikkanen M.J. (Finland) Cuevas A. (Chile) Leitersdorf E. (Israel) Tokgözoglu L. (Turkey) Curtiss L.K. (USA) Licata G. (Italy) Tremoli E. (Italy) Davignon J. (Canada) Mahley R.W. (USA) Tybjærg-Hansen A. () De Backer G. () Mancini M. (Italy) Uauy R. (UK) De Caterina R. (Italy) Manzato E. (Italy) Utermann G. (Austria) Després J.-P. (Canada) Marais D. () Vainstein N. (Argentina) Ding P.Y.-A. (Taiwan, R.O.C.) Marchioli R. (Italy) Von Eckardstein A. (Switzerland) Djuric D.M. (Serbia and Marcovina S.M. (USA) Watts G. (Australia) Montenegro) Matsuzawa Y. (Japan) Wenger N.K. (USA) Drexler H. (Germany) McPherson R. (Canada) Xavier H. (Brazil) Durrington P.N. (UK) Mezzetti A. (Italy) Yamashita S. (Japan) Espiga De Macedo M. (Portugal) Mordasini R. (Switzerland) Yang Y. (China) Fellin R. (Italy) Moriguchi E. (Brazil) Ylä-Herttuala S. (Finland) Fernández-Britto J.E. (Cuba) Nabel E.G. (USA) Zambon A. (Italy) Ferrannini E. (Italy) Naruszewicz M. () Zhu J. (China) FitzGerald G.A. (USA) Nestel P.J. (Australia) Forte T. (USA) Newby A.C. (UK) Franceschini G. (Italy) Nissen S.E. (USA) Frikke-Schmidt R. (Denmark) Noseda G. (Switzerland)

4 Scientific Committees

Congress Presidents International Atherosclerosis Antonio M. Gotto, Jr. (New York, NY, USA) Society (IAS) Ernst J. Schaefer (Boston, MA, USA) President: ISA 2009 Local Scientific Jean-Charles Fruchart (Loos, France) Program Committee Past President: Alan Daugherty (Lexington, KY, USA) Scott M. Grundy (Dallas, TX, USA) Michael A. Gimbrone, Jr. (Boston, MA, USA) Henry N. Ginsberg (New York, NY, USA) President Elect: Daniel Levy (Framingham, MA, USA) W. Virgil Brown (Atlanta, GA, USA) Peter Libby (Boston, MA, USA) Alice Lichtenstein (Boston, MA, USA) Secretary: Aldons J. Lusis (Los Angeles, CA, USA) Philip J. Barter (Sydney, Australia) Jose M. Ordovas (Boston, MA, USA) Paul M. Ridker (Boston, MA, USA) Treasurer: Vassillis I. Zannis (Boston, MA, USA) Sidney C. Smith, Jr. (Chapel Hill, NC, USA)

ISA Program Committee Members at Large: Scott M. Grundy, Chair (Dallas, TX, USA) America: W. Virgil Brown (Atlanta, GA, USA) Ruth McPherson (Ottawa, ON, Canada) Jean-Charles Fruchart (Loos, France) Chris J. Packard (Glasgow, UK) Ada Cuevas (Santiago, Chile) Eder Quintao (São Paulo, Brazil) Pacific Rim: Jun-ren Zhu (Shangai, China) Shaukat M. Sadikot (Mumbai, India) Contact Information Europe: John J.P. Kastelein (Amsterdam, Scientific-Organizing Secretariats The Netherlands) Ann S. Jackson, MBA Richard Ceska (Prague, Czech Republic) Giovanni Lorenzini Medical Foundation 6535 Fannin, M.S. A-601 President XV ISA Congress: Houston, TX 77030 USA Ernst J. Schaefer (Boston, MA, USA) Phone: (+1) 713-797-0401 Regional Federation Chairs: Fax: (+1) 713-796-8853 Email: [email protected] Europe: S. Lale Tokgözoglu (Ankara, Turkey) Emanuela Folco, PhD America: Fondazione Giovanni Lorenzini Jean Davignon (Montreal, QC, Canada) Via A. Appiani 7 20121 Milan, Italy Asia: Phone: (+39) 02 29006267 Yuji Matsuzawa (Osaka, Japan) Fax: (+39) 02 29007018 Email: [email protected] Senior Advisers to the Board: Heiner Greten (Hamburg, Germany) Rodolfo Paoletti (Milan, Italy) Local Organizing Secretariat Antonio M. Gotto, Jr. (New York, NY, USA) Pam Ballinger, CMP Association Headquarters, Inc. 15000 Commerce Parkway Suite C Mt. Laurel, NJ 08054 USA Phone: (+1) 856-439-0500 ext 4439 Fax: (+1) 856-439-0525 Email: [email protected]

5 Supporters The ISA2009 would like to thank the following companies for their support:

AstraZeneca Pharmaceuticals LP

Abbott

Kowa Company, Ltd. and Kowa Pharmaceuticals America, Inc.

Merck Co., Inc.

Merck/Schering-Plough Pharmaceuticals

Roche

6 Aegerion Pharmaceuticals, Inc.

Arisaph Pharmaceuticals, Inc.

Genzyme

LipoScience

Schering-Plough K.K.

Schering-Plough

Unilever R&D

Vatera Capital LLC

Covidien Ethicon Endo-Surgery, Inc.

Lilly USA, LLC

The ISA2009 would also like to thank the following for their support:

European Atherosclerosis Society

The International Chair of Cardiometabolic Risk

R3i Foundation

7 General Information

Venue Symposium Website The Symposium is held at: Home page for the ISA 2009 Symposium is: John B. Hynes Veterans www.isa2009.org Memorial Convention Center 900 Boylston Street Abstract Publications Boston, MA 02115 USA In an effort to practice social responsibility, the Web site: www.mccahome.com ISA2009 has published the abstracts presented during the meeting on a CD-ROM. A printed copy of an Secretariat and Registration Desk Abstract Book has not been produced this year. The The Registration Desk is located on level 2 of the decision to use this product solution is one small John B. Hynes Veterans Memorial Convention way to help keep our land and the inhabitants of it in Center outside Halls C-D. The pre-registration and prime condition for years to come. You may preview on-site registration desks are open as follows: the abstracts online at the Cyber Café in the Exhibit Hall or on your personal laptop anywhere in the Saturday, June 13 3:00 PM - 6:00 PM Convention Center. Sunday, June 14 10:00 AM - 8:00 PM Monday, June 15 7:00 AM - 6:30 PM Insurance Tuesday, June 16 7:00 AM - 6:30 PM Registration for the Symposium implies that Wednesday, June 17 7:00 AM - 6:30 PM the delegate agrees that the IAS (International Thursday, June 18 7:00 AM - 3:00 PM Atherosclerosis Society), the XV International Symposium on Atherosclerosis Organizing In the Registration/Secretariat Area the following Committee, the Boston Atherosclerosis Society, services are available: and the Giovanni Lorenzini Medical Foundation • Pre-Registration (Milan and Houston) do not assume any liability or • On-Site Registration responsibility whatsoever. Symposium delegates • ISA 2009 Secretariat are requested to make their own arrangements for • ECM/CME Credits medical, travel, and personal insurance. • Message Center • Information • Hotel Booking Press Office • Restaurant Reservations A press office is available in the Symposium Venue. • Boston Tour Information Journalist and interested participants may refer to the Press Office for more information about press Mobile Phones, Beepers, material and press conferences. and Electronic Devices Delegates are kindly requested to turn off their Official Language mobile phones, beepers, and other electronic devices The official language of the Symposium is English. during all scientific sessions. Simultaneous translation is not provided. Both presentations and discussions will be given in English. Slide Library A Slide Library of key selected presentations will be available after the Symposium on www.isa2009.org, Scientific Exhibition www.athero.org, and www.lorenzinifoundation.org. During the Symposium, an exhibit of pharmaceutical and chemical companies, manufactuers of medical equipment, food industries, and publishers will be Cyber Café and Message Center held in the Convention Center. A Cyber Café is offered to participants by the Symposium. The Cyber Café will be equipped with computers, printers, and Internet connections and is Exhibition Hours located in the Exhibition Area. The Message Center Sunday, June 14 7:30 PM - 9:00 PM will be linked through the Cyber Café. You may Monday, June 15 9:30 AM - 4:30 PM leave and pick up messages for fellow attendees Tuesday, June 16 9:30 AM - 4:30 PM here. There is also a “Message Center” desk in the Wednesday, June 17 9:30 AM - 4:30 PM registration area. The Hynes Convention Center is equipped with free wireless Internet.

8 General Information

Practical Information Business Center Local Currency and Banking There is a business center located in the John B. The local currency is the U.S. dollar. All major credit Hynes Convention Center main lobby. The business cards are accepted at all hotels, shops and restaurants. center will be open during the following hours: There are two automatic teller machines (ATM) Sunday, June 14 9:00 AM – 5:00 PM easily accessible to the Hynes, one at the entrance off Monday, June 15 7:30 AM – 5:30 PM Bolyston Street (Lower level) and one directly outside Tuesday, June 16 7:30 AM – 5:30 PM the entrance to the Prudential Center Mall. Wednesday, June 17 7:30 AM – 5:30 PM Thursday, June 18 7:30 AM – 4:30 PM Tips and Gratuities It is the common practice in the U.S. to tip restaurant First Aid servers, bellman and taxi drivers. The standard tip in A First Aid office is located in the John B. Hynes restaurants is 18-20 percent. For bellmen and airport Convention Center off the main lobby on level one. baggage handlers, the standard is $1.00 per bag. For A registered nurse is available during registration taxis, 15 percent is acceptable. and meeting hours.

Post Office For emergencies, contact Convention Center The nearest post office is located in the Prudential Security. Do not dial 911. The Center Security will Center, at 800 Boylston Street. dispatch emergency techs.

Electricity Lost and Found The electrical power voltage is 110 Volts. Foreign Lost items left in meeting rooms will be turned into appliances could require an adapter. Hynes Security. There is a security office located off the lobby on level one. Please note: The ISA is NOT Weather responsible for anything left in meeting rooms. June weather in Boston is generally sunny and warm. The temperature often rises during the day at an Smoking Policy average of 67°F (19°C). Smoking is prohibited in all areas of the John B. Hynes Convention Center. ADA Compliance The John B. Hynes Convention Center and all Eco-Wise ISA2009 participating hotels are fully accessible to the physi- In effort to practice social responsibility, the cally challenged. Anyone needing special assistance conference bag provided is made out of recycled should notify the appropriate hotel and/or center materials. The decision to use this product solution and indicate the type of assistance needed. The ISA is one small way to help keep our land and the 2009 cannot ensure the availability of appropriate inhabitants of it in prime condition for years to come. assistance without prior notice.

9 Registration

Only registered participants may attend the scientific Privacy Law (For Italian Participants Only) sessions and the social events offered by the The personal data will be handled exclusively by the Symposium. ISA 2009 Committee according to the law 675/96 and the law decree 196/2003. REGISTRATION FEES

Participant $880 USD Name Changes Name changes on site are charged a handling Student/Post-Doc/ $270 USD fee of $30. Resident/Intern Nurse/Nutritionist/Dietician $375 USD Badges The official badge must be worn for admission *Student/Post-Doc/Resident/Intern and Nurse/ to all scientific session and other activities of the Nutritionist/Dietician rates will be granted only to Symposium. those who document their position by presenting an official statement from the head of their Department or Institution or a copy of their license. Lost badges are replaced for a handling fee of $30 with proof of the original registration. Participants and Students/Post-Docs/Residents/ Interns and Nurses/Nutritionists/Dieticians are Badge ribbons will show different colors: entitled to: Speakers - Red • Receive Final Program and Abstracts Exhibitors - Yellow on CD-ROM Young Investigators - Blue • Attend all Scientific Sessions Poster Presenters - Orange • Attend the Opening Ceremony of the Symposium and the Welcome Reception Meals • Access to all Exhibits from June 14 to June 18 Breakfast and lunch will be available in the convention center for purchase. Social Programs Certificate of Attendance WELCOME RECEPTION Certificates of Attendance will be available on Sunday, June 14 7:30 PM - 9:00 PM request at the end of the Symposium. Exhibit Hall D - Exhibit Area All attendees are invited to attend the Welcome Reception in the Exhibit Hall immediately after the Opening Ceremony.

EAS YOUNG INVESTIGATORS NETWORKING RECEPTION Tuesday, June 16 5:30 PM - 8:00 PM Exhibit Hall C - Poster Area

Young Investigators under the age of 35 are invited to attend a reception sponsored by the European Atherosclerosis Society. Drink tickets will be available to all Young Investigators. Please go to the Secretariat/Registration Desk to obtain your ticket. You must present your young investigator ribbon to receive your ticket or photo identification will be required for proof of age.

10 Scientific Program Information

The Scientific Program includes: Plenary Lectures, For Speakers: Master Lectures, Clinical Symposia, Workshops, • Please check in your slide presentation at Selected Oral Communications, and Poster Sessions least three hours prior to your presentation. for submitted papers. • The CR-ROM or the Pen Drive must be Audiovisual Equipment delivered to the Speaker Ready Room. If • The Speaker Ready Room is linked with it is possible, please deliver the day before, all the Symposium Rooms. The Speaker otherwise it must be delivered at least four Ready Room is located in Room 207 of the hours before the beginning of the Sessions. Hynes Convention Center. • Please bring two copies (one as back up) of • The Symposium Rooms will be equipped the electronic media containing your slides. for PowerPoint presentations (LCD-panel • Locate your Symposium Room and be projection system for video projection and there at least 10 minutes before the one computer.) beginning of the Session. Guidelines for Speakers and Chairmen • Respect the timing allowed for your For Chairmen: presentation. • Locate your Symposium Room and be there at least 10 minutes before the beginning of the Session. • Respect all timing assigned to the Session and to each presentation. Continuing Medical Information (CME)

Accreditation relationships will be made available at the meeting. This activity has been planned and implemented in Faculty are also expected to openly disclose any accordance with the Essential Areas and policies of discussion of off-label and/or investigational uses of the Accreditation Council for Continuing Medical drugs in their presentations. Education (ACCME) through the joint sponsorship of the National Lipid Association and Giovanni Obtaining CME Credit Certificate Lorenzini Medical Science Foundation. The National You may claim CME credit online for ISA 2009. Lipid Association is accredited by the ACCME to Statements of credit will be awarded based on your provide continuing medical education for physicians. attendance and completion of an online evaluation form. To obtain credit, please go to www.isa2009. The National Lipid Association designates this org and click on CLAIM CME. To log in, enter educational activity for a maximum of 33.5 AMA your unique 10-character CME Claim Code that was PRA Category 1 Credit(s) ™. Physicians should only provided to you in your registration materials. You claim credit commensurate with the extent of their will be able to print your CME statement of credit participation in the activity. immediately using computer kiosks and printers available onsite at the Cyber Café, or you may Full Disclosure Policy complete the forms online at your convenience until The National Lipid Association adheres to the Friday, July 3, 2009. ACCME essential areas and policies regarding industry support of continuing medical education. For questions regarding CME credit after the All faculty participating in the continuing medical meeting commences, please contact the NLA office education programs of the XV International at [email protected]. Symposium on Atherosclerosis are expected to disclose to the program audience any real or Note: CME Credits will only be provided for the apparent conflict(s) of interest related to the content total elapsed time spent in education sessions. Credit of their presentation(s). Full disclosure of faculty can not be doubly awarded for sessions taking place concurrently.

11

Italian CME Credits/Crediti ECM (for Italian Commercial Support Disclosure participants only) The CME Sessions of the ISA 2009 have been CME credits (Crediti ECM) have been applied for supported by educational grants from the following from the Italian Ministry of Health. Interested Italian companies (at time of publication): Abbott, participants must request the ECM envelope at the AstraZeneca, Lilly USA, LLC., Ethicon Endo- ECM/CME Desk in the Registration Area. Surgery, Inc., Kowa Pharmaceuticals America, Inc., Merck & Co., Inc., Merck/Schering-Plough To obtain credits, Italian participants must: Pharmaceuticals, Roche, and R&D. • Return the evaluation form, duly filled in, to the ECM/CME Desk; • Return the multiple choice questionnaires. The anagraphical data must be compulsorily indicated since required by the Ministry of Health; Poster Sessions

Posters have been selected among the abstracts Poster Discussion: One of the authors will be submitted by the participants. All participants are available at the poster site as follows: invited to come and view the posters which are • Monday, June 15 displayed in the Poster Area from Monday, June 15 From 10:00 AM to 10:30 AM to Wednesday, June 17, 2009 from 8:30 AM until From 12:30 PM to 1:30 PM 6:15 PM. From 3:00 PM to 3:30 PM Mounting and Removal of the Posters: The mounting and removal of the posters must be done • Tuesday, June 16 by the authors according to the following schedule: From 10:00 AM to 10:30 AM From 12:30 PM to 1:30 PM • Monday, June 15 From 3:00 PM to 3:30 PM Mounting: 7:00 AM - 8:00 AM Removal: 6:15 PM - 7:15 PM • Wednesday, June 17 From 10:00 AM to 10:30 AM From 12:30 PM to 1:30 PM • Tuesday, June 16 From 3:00 PM to 3:30 PM Mounting: 7:00 AM - 8:00 AM Removal: 6:15 PM - 7:15 PM Please Note: • For each accepted abstract, the registration • Wednesday, June 17 fee of at least one of the Authors is required. Mounting: 7:00 AM - 8:00 AM Removal: 6:15 PM - 7:15 PM • “Poster assistants” will be present for any information or help you may need. The organizers are not responsible for any item, including posters, left in the room. • Facilities for slide projection are not available at the site of the poster presentation. • Photocopies made from the reduced photograph of your poster and any additional material may be distributed by the author(s) at the poster site.

12

YOUNG INVESTIGATOR AWARDS CORPORATE SUPPORTED SATELLITE SYMPOSIA Wednesday, June 17 5:45 PM - 8:30 PM Republic Ballroom - Sheraton Boston Hotel This activity is not part of the official ISA2009sessions. CME Credit is not offered. Thirty (30) awards may be made to recognize Monday, June 15: 12:30 PM - 2:00 PM scientific merit and outstanding research Genzyme achievements in a poster presentation by an MEDPED Educational Symposium: investigator 35 years old or less, who has submitted “What’s New and Exciting in Familial an abstract in the competition. Selection is based on Hypercholesterolemia? Exciting Changes originality, importance of work, work accomplished, and Future Developments” quality of experimental design and methodology, Republic Ballroom - Sheraton Boston Hotel strength and reliability of data and means of Lunch will be served. Seating is on a first-come expression. first-serve basis.

These abstracts will be reviewed each day of the Tuesday, June 16: 6:00 AM - 8:00 AM Symposium by the Awards Committee for the LipoScience selection of up to 30 winners and the names of Are Cholesterol Measures of LDL and the semi-finalists will be posted each day in the HDL Falling Short? Recent Outcomes Registration area. Each winner will receive a Data Provide New Insights certificate and an award. Constitution Ballroom - Sheraton Boston Hotel Breakfast will be served. Seating is on a first-come We would like to thank the following for their first-serve basis. support of the Young Investigator Awards: International Atherosclerosis Society Tuesday, June 16: 6:00 AM - 8:00 AM Kowa Company, Ltd. and Kowa Pharmaceuticals Roche America, Inc. Should HDL Be a Target of Therapy? Schering-Plough K.K. Republic Ballroom - Sheraton Boston Hotel Breakfast will be served. Seating is on a first-come Registration Fees and Hotel/Travel Grants for first-serve basis. Young Investigators Registration Fees and Hotel/Travel Grants have Tuesday, June 16: 12:30 PM - 2:00 PM been made available by the ISA 2009 Symposium to Aegerion Pharmaceuticals, Inc. young investigators 35 years old or less, with limited The Potential Role of MTP-Inhibitors in the financial resources whose abstract has been selected Treatment of Hyperlipidemia for an oral or poster presentation. Republic Ballroom - Sheraton Boston Hotel Lunch will be served. Seating is on a first-come first-serve basis. INTERNATIONAL ATHEROSCLEROSIS SOCIETY (IAS) GENERAL ASSEMBLY Wednesday, June 17: 2:30 PM - 3:30 PM Room 210

13 Exhibits The purpose of the exhibits, an integral part of the meeting’s educational activity, is to complement the scientific and clinical sessions. Attendees can evaluate the latest developments in products and/or services relevant to the study, prevention, and treatment of lipids, cardiovascular, and metabolic diseases and disorders.

Abbott 314 Berkeley HeartLab 118 200 Abbott Park Road 839 Mitten Road Abbott Park, IL 60064 Burlingame, CA 94010 Phone: 847-935-3848 Phone: 650-651-8181 Fax: 847-938-1160 Fax: 650-697-5620 Web Site: www.abbott.com Web Site: www.bhlinc.com

Abbott is a global, broad-based health care company Berkeley HeartLab’s cardiovascular risk reduction devoted to discovering new medicines, new program combines comprehensive risk assessment technologies and new ways to manage health. Our & therapeutic response monitoring with personalized products span the continuum of care, from nutritional lifestyle therapy recommendations & support to help products to medical devices and pharmaceutical patients achieve increased therapeutic compliance & therapies. Our comprehensive product line encircles life better outcomes. itself – addressing important health needs for all ages.

Biosound Esaote, Inc 212 AstraZeneca 225 8000 Castleway Drive 1800 Concord Pike Indianapolis, IN 46250 Wilmington, DE 19803 Phone: 317-813-6000 Phone: 302-885-4379 Fax: 317-813-6600 Fax: 302-885-8881 Web Site: www.biosound.com Web Site: www.astrazeneca.com Biosound Esaote, a market leader in diagnostic AstraZeneca is a major international healthcare portable and console-based ultrasound systems, business engaged in the research, development, offers the MyLab®series, a high-performance manufacturing and marketing of meaningful ultrasound family. Features of the MyLab include prescription medicines and supplier for healthcare a fully integrated and automatic IMT measurement services. AstraZeneca is one of the world’s leading package based on the analysis of the RF signal, pharmaceutical companies and is a leader in which provides more reliable and precise gastrointestinal, cardiovascular, neuroscience, information than previous methods. The MyLab respiratory, oncology and infectious disease line offers outstanding image quality and advanced medicines. For more information visit www. diagnostic capabilities for more confident diagnoses. astrazeneca-us.com

Athera Biotechnologies AB 110 Boston Heart Lab 120 Fogdevreten 2A 2 Central Street Stockholm, 171 77 Framingham, MA 01701 Sweden Phone: 617-680-0806 Phone: +46705525115 Fax: 617-830-0025 Web Site: www.athera.se Web Site: www.bostonheartlab.com

Athera develops novel products for treatment Boston Heart Lab provide the latest in advanced and prevention of cardiovascular disease (CVD). lipid testing to assess, diagnose and manage CVDefine®, a unique new immunological biomarker, cardiovascular risk. With Boston Heart Lab’s adds important and independent information proprietary cutting edge diagnostics, treatment for research in cardiovascular risk assessment. plans can be tailored to meet each patient’s needs to CVDefine®is an easy-to-use ELISA research kit for maximize health benefits. quantitative analysis of anti-PC in human blood.

14 Exhibits

Cambridge Theranostics Ltd. 107 diaDexus’ lead product, the PLAC®Test, measures Babraham Research Lp-PLA 2 (lipoprotein-associated phospholipase A 2) Babraham, Cambridge LB223AT a vascular-specific inflammatory enzyme implicated in the formation of rupture-prone plaque. It is plaque Phone: +44 1223 497131 rupture and thrombosis, not stenosis, that cause the Fax: +44 1223 844427 majority of cardiovascular events. Web Site: www.cambridgetheranostics.co.uk DiagnOptics 215 Cambridge Theranostics, a spin off biotech L.J. Zielstraweg 1, Meditech Center company from Cambridge University, has now 9713GX Groningen launched Ateronon , a new product that inhibits Netherlands the atherogenic process caused by the oxidative Phone: +31-50-5890612 damage of plasma lipoproteins. Ateronon is the only Fax: +31-50-5890613 clinically proven inhibitor of plasma lipoprotein Web Site: www.diagnoptics.com oxidation. The product is being sold worldwide, with initial emphasis in Europe and the US (more Established in 2003, DiagnOptics is the pioneer information available at www.ateronon.com). and inventor of cutting edge diagnostic devices that Cambridge Theranostics has also developed the can non-invasively diagnose and assess the risk of AtheroAbzymeTM ELISA test that supports the diabetes and its complications. administration of Ateronon through identification Its technological advance in detecting fluorescence of patients or asymptomatic individuals with active of the AGEs (Advanced Glycation End products) has atherogenesis and monitoring and optimisation of led to the invention of the AGE Reader™ - a state of their preventive treatment. the art non-invasive device which can determine the tissue accumulation of AGEs within 30 seconds. AGEs are essential biomarkers of metabolic and Denka Seiken Co., LTD 108 glycemic stress and have been implicated as 3-4-2 Nihonbashi Kayabacho, Chuo-Ku causative factors in the progression of a host of age Tokyo, 103-0025 related diseases, such as atherosclerosis, diabetes, Japan renal failure and Alzheimer. The amount of AGE Phone: +81-3-3669-9421 in tissue serves as an important risk predictor of Fax: +81-3-3669-9390 diabetes and its complications. Web Site: www.denka-seiken.co.jp

Denka Seiken manufactures clinical chemistry and Elsevier 313 latex-enhanced serum protein reagents for automated 1795 Nauset Road chemistry analyzers such as CRP, Lp(a), Myoglobin, Eastham, MA 02643 HDL-C, LDL-C, etc. Denka Seiken currently Phone: 774-207-0278 features a reagent that can quantitatively determines Fax: 774-207-0278 small, dense low-density lipoproteins. The s LDL-C Web Site: www.elsevier.com “SEIKEN” is a homogeneous assay consisting of two ready-to-use liquid reagents to be used on As the world’s leading publisher of science and automated chemistry analyzers. The test is fully health information, Elsevier serves more than automated and has within-run precisions of 1 – 2 %. 30 million scientists, students, and health and information professionals worldwide. We are proud to play an essential role in the global diaDexus, Inc. 115 science and health communities and to contribute 343 Oyster Point Boulevard to the advancement of these critical fields. By South San Francisco, CA 94080 delivering world-class information and innovative Phone: 650-246-6428 tools to researchers, students, educators and Fax: 650-246-6474 practitioners worldwide, we help them increase their Web Site: www.diadexus.com productivity and effectiveness. We continuously make substantial investments that serve the needs of diaDexus is a privately held biotechnology company the global science and health communities. that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value.

15 Exhibits

European Atherosclerosis Society 409 Heart EU 411 Kronhusgatan 11 7 North Road 411 05 Gothenburg Marlow, Bucks SL71PL Sweden United Kingdom Phone: +46 31 724 2795 Phone: +44(0)1628637280 Fax: +46 31 724 2796 Fax: +44(0)1628 628 698 Web Site: www.eas-society.org Web Site: www.heartuk.org.uk

The European Atherosclerosis Society (EAS) was Welcome to HEART EU – a Foundation founded in 1964, with the aim of “advancing and commissioned in 2005 by four European Patient exchanging knowledge concerning the causes, Organisations, each specialising in supporting natural history, treatment and prevention of and representing patients and their families in atherosclerotic disease” – work it continues today, in their countries; each dedicated to highlighting and areas including myocardial infarction, cerebro- and increasing awareness of cholesterol, particularly peripheral vascular disease. that of inherited high cholesterol*, each highlighting Atherosclerosis is set to become an increasingly with passion, the risks, diagnosis and treatment, and important concern as European populations grow each fostering partnerships with their Governments, older. For this reason the EAS has joined forces with Industry and NGO’s (non government organisations). other societies working in the field of atherosclerosis These actions are significantly supported and prevention and others searching for cures for the promoted by HEART EU (an acronym for disease. Our common goal is to provide a framework Hyperlipidaemia, Education, Action, Research and for scientific discussion of new developments Treatment). Alone, however, this assistance is not in basic research, diagnosis and therapy of sufficient, so as a European Foundation HEART EU atherosclerosis. has initiated new ways to help clinicians and patients commission new Country Patient Associations – indeed this assistance has been taken up by Genzyme 319 representatives in many European countries, by those Ikaroslaan 53 in the Middle East and in 2008 as far afield as Hong Zaventem, Brussels 1930 Kong, and Australia. Belgium Phone: +32 478 943116 Fax: +32 2714 1707 International Atherosclerosis Society 405 Web Site: www.genzyme.be Via Appiani 7 Milan, 20121 One of the world’s leading biotechnology Italy companies, Genzyme is dedicated to making a major Phone: +390229006267 positive impact on the lives of people with serious Fax: +39029007018 diseases. Since 1981, the company has grown from Web Site: www.athero.org a small start-up to a diversified enterprise with more than 11,000 employees in locations spanning the The International Atherosclerosis Society (IAS), globe and 2008 revenues of $4.6 billion. In 2007, incorporated in 1979, promotes, at an international Genzyme was chosen to receive the National Medal level, the advancement of science, research, and of Technology, the highest honor awarded by the teaching in the field of atherosclerosis. The IAS President of the United States for technological endeavors to achieve these objectives by promoting innovation. With many established products and the exchange of existing knowledge; encouraging services helping patients in nearly 100 countries, new research ventures and interdisciplinary Genzyme is a leader in the effort to develop and approaches; establishing visiting fellowships for apply the most advanced technologies in the life young investigators; fostering the dissemination of sciences. The company’s products and services are knowledge by organizing international symposia, focused on rare inherited disorders, kidney disease, workshops, courses, and meetings; and through the orthopaedics, cancer, transplant and immune disease, association with a scientific journal. Membership and diagnostic testing. Genzyme’s commitment is open to active researchers who join one of the 60 to innovation continues today with a substantial IAS national or regional constituent societies or who development program focused on these fields, as join as individual members from countries without well as cardiovascular disease, neurodegenerative national affiliated society. Current membership is diseases, and other areas of unmet medical need. now in excess of 17,000 scientists worldwide.

16 Exhibits

International Symposium on 415 LipoScience, Inc. 316 Atherosclerosis 2012 2500 Sumner Boulevard GPO Box 128 Raleigh, NC 27616 Sydney NSW2001 Phone: 919-256-1118 Australia Fax: 919-872-4719 Phone: +61 2 9265 0700 Web Site: www.lipoprofile.com Fax: +61 2 9267 5443 LipoScience offers the NMR LipoProfile® test. The Join us ‘Down Under’ for the XVI International NMR LipoProfile test measures LDL particle number Symposium on Atherosclerosis in 2012! Sydney, (LDL-P) and standard lipid parameters to aid in the Australia’s gateway city is built around one of the management of cardiovascular disease using nuclear largest, most beautiful harbours in the world with magnetic resonance (NMR) technology. For more miles of golden beaches stretching north and south of information, please visit www.lipoprofile.com. the city on the shore of the Pacific Ocean. To find out more information or express your interest, email us at [email protected]. Merck/Schering-Plough Pharmaceuticals 119 351 N. Sumneytown Pike North Wales, PA 19454 Japan Atherosclerosis Society 413 Phone: 267-305-5000 2-20-15 Shinbashi Fax: 267-305-1266 Minato-ku, Tokyo 105-0004 Web Site: www.vytorin.com Japan www. zetia.com Phone: +813-3571-4605 Fax: +813-3571-4606 We invite you to visit our exhibit featuring Web Site: http://jas.umin.ac.jp/en/ VYTORIN® (ezetimibe/simvastatin) tablets and ZETIA® (ezetimibe) tablets. Inquiries about our Japan Atherosclerosis Society specializes in the professional, informational and educational services study of etiology, prevention and treatment of are welcomed. www.vytorin.com www.zetia.com. atherosclerosis by the members in the fields of basic and clinical sciences, nutrition, statistics, agricultures etc. Our official journal “Journal of Atherosclerosis National Lipid Association 407 and Thrombosis” is promoting submissions from 6816 Southpoint Parkway, Suite 1000 around the world. Visit our booth and pick up the Jacksonville, FL 32216 free samples of JAT and the English version of our Phone: 904-998-0854 guidelines “Guideline for Diagnosis and Prevention Fax: 904-998-0855 of Atherosclerotic Cardiovascular Diseases, 2007 Web Site: www.lipid.org Edition.” The National Lipid Association (NLA) is a nonprofit, multidisciplinary medical society focused on Kowa enhancing the practice of lipid management in 530 Industrial Park Boulevard 221 clinical medicine. The NLA represents more than Montgomery, AL 36117 3,500 members in the United States and provides Phone: 334-288-1288 continuing medical education for physicians Fax: 334-288-2788 and other healthcare professionals to advance Web Site: www.kowapharma.com professional development and attain certification in clinical lipidology. The NLA’s public health mission Kowa Pharmaceuticals America, Inc. is a specialty is to help reduce deaths related to high cholesterol, pharmaceutical company focused primarily in the and the Association defines “clinical lipidology” as areas of cardiology, pain and migraine. A privately “a multidisciplinary branch of medicine focusing on held pharmaceutical company headquartered in lipid and lipoprotein metabolism and their associated Montgomery, Alabama, we are focusing our efforts disorders.” on the acquisition, development, licensing, and marketing of pharmaceutical products.

17 Exhibits

Numira Biosciences 423 Quatimetrix Corp. 217 2151 Michelson Drive, Suite 250 2005 Manhattan Beach Boulevard Irvine, CA 92612 Redondo Beach, CA 90278 Phone: 949-567-0920 Phone: 310-536-0006 Fax: 949-756-8651 Web Site: www.4qc.com Web Site: www.numirabio.com A manufacturer of clinical diagnostic products for As a specialty contract research organization (CRO), over a quarter of a century, Quantimetrix has become Numira Biosciences has set the bar for high- a cutting-edge, independent company that provides resolution imaging and analysis of small animal products and services for a worldwide market. We’ve specimens. We provide researchers with quantifiable, grown into a company-owned, 86,000 square foot visible evidence of disease progression, drug efficacy facility located in Redondo Beach, California. and drug side effects in their animal models. Quantimetrix Corporation develops and Virtual Histology is an ideal tool to use for manufactures clinical diagnostic products for atherosclerosis research. Virtual Histology enables domestic and international distribution including the 2D and 3D visualization of plaque in the aorta Lipoprint®, the only test for measuring LDL and coronary arteries of diseased animal models. subfraction cholesterol. Our control products Our proprietary contrast agents, combined with include urinalysis, general chemistry and specialty powerful software tools, result in datasets comprised chemistry controls. Our control products are liquid, of slice views, 3-D movies, and data tables that ready to use, with long-term stability. Other quality provide unique insights into plaque thickness, products include electrophoresis systems, diagnostic roughness, volume, area, and a number of additional assays, and OEM products. measurements.

Takeda Pharmaceuticals North America, Inc. 406 Progenika, Inc. 320 145 Commercial Street 500 Technology Square, 1st Floor Boston, MA 02109 Cambridge, MA 02139 Phone: 617-686-0799 Phone: 617-500-5100 Fax: 857-350-3887 Fax: 617-577-0311 Web Site: www.tpna.com Web Site: www.progenika.com/us/ Takeda Pharmaceuticals North America, Inc. is Progenika develops and commercializes DNA dedicated to serving patients by providing innovative based tests to improve diagnosis and treatment. products that improve their lives with better The parent organization, Progenika Biopharma healthcare. It is a wholly owned subsidiary of Takeda SA, of Derio, Spain, is a European leader in Pharmaceutical Company Limited, Japan’s largest multiplex genotyping technologies. It was the pharmaceutical company and one with a more than first company to receive the CE Mark from the 227-year heritage. Takeda’s US clinical development European Commission for a clinical diagnostic activities are conducted via Takeda Global Research microarray, LIPOchip®, which it markets in Europe & Development Center, Inc. to diagnose familial hypercholesterolemia (FH). Takeda focuses on a variety of therapeutic areas Progenika Biopharma also developed and markets including diabetes, cardiovascular disease, central BLOODchip, the most comprehensive blood group nervous system disorders, gastroenterology, genotyping tool available to improve patient safety bone and joint disorders, chronic kidney disease, and blood transfusion compatibility, which also has gynecological disorders, and infectious disease. the CE Mark. Progenika, Inc., the Cambridge MA With a promising pipeline and successful products based US subsidiary, operates a high complexity in multiple therapeutic areas, the company is one of laboratory certified under the Clinical Laboratory the fastest growing pharmaceutical companies in the Improvement Amendments of 1988 (“CLIA”) from United States. which it offers blood group genotyping services and diagnostic testing for FH, while simultaneously supporting the Company’s diagnostic product development programs.

18 Exhibits

Unilever North America 106 UVic Genome BC Proteomics Centre 113 800 Sylvan Avenue (C-230) Vancouver Island Technology Park Englewood Cliffs, NJ 07632 #3101-4464 Markham Street Phone: 201-894-7416 Victoria, BC V8Z 7X8 Fax: 201-871-8018 Canada Web Site: www.promiseinstitute.org Phone: 250-483-3226 Fax: 250-483-3238 At Unilever, we are committed to challenging, Web Site: www.proteincentre.com inspiring and empowering consumers to make heart healthy food choices through our global heart health brands - Promise®/Becel®/Flora®. Visit www. promiseinstitute.org for nutrition information, recipes, and professional and patient resources.

19 Exhibit Floor Plan

20 XV International Symposium on Atherosclerosis Boston, MA, USA • June 14 - 18, 2009 SCHEDULE AT A GLANCE

7:00 7:15 SUNDAY, JUNE 14 MONDAY, JUNE 15 TUESDAY, JUNE 16 WEDNESDAY, JUNE 17 THURSDAY, JUNE 18 7:30 7:45 8:00 8:15 8:30 Plenary Session I: Plenary Session II: Plenary Session III: Plenary Session IV: 8:45 Inhibitors of Cholesterol Synthesis Pathogenesis of Atherosclerosis and Risk Factors Lifestyle and Atherosclerosis Other Lipid Modifying Treatments for Atherosclerosis 9:00 and Atherosclerosis 8:00 - 10:00 am 8:00 - 10:00 am 8:00 - 10:00 am 9:15 8:00 - 10:00 am 9:30 9:45 10:00 Poster Discussion and Break Poster Discussion and Break Poster Discussion and Break Poster Discussion and Break 10:15 10:00 - 10:30 am 10:00 - 10:30 am 10:00 - 10:30 am 10:00 - 10:30 am 10:30 10:45 11:00 Clinical Symposium I Clinical Symposium III Clinical Symposium V Clinical Symposium VII 11:15 10:30 am - 12:00 pm Workshop Session I 10:30 am - 12:00 pm Workshop Session III 10:30 am - 12:00 pm Workshop Session V 10:30 am - 12:00 pm Workshop Session VII 11:30 10:30 am - 12:30 pm 10:30 am - 12:30 pm 10:30 am - 12:30 pm 10:30 am - 12:30 pm 11:45 12:00 Break Break Break Break 12:15 12:30 12:45 Poster Discussion Poster Discussion Poster Discussion Break 1:00 12:30 - 1:30 pm 12:30 - 1:30 pm 12:30 - 1:30 pm 12:30 - 1:30 pm 1:15 Pre-Session I 1:30 1:00 - 2:00 pm Master Master Master 1:45 Clinical Master Clinical Master Session III Clinical Clinical Master Session VII Master Session VIII Session II Master Session IV Session V Session VI 2:00 Session I 1:30 - 2:30 pm 1:30 - 2:30 pm 1:30 - 2:30 pm ICCR Symposium 1:30 - 2:30 pm Symposium 1:30 - 2:45 pm Symposium 1:30 - 2:30 pm 1:30 - 2:30 pm Symposium 2:15 Workshop II 1:30 - 2:45 pm IV VI VIII 1:30 - 3:00 pm 1:30 - 3:00 pm 1:30 - 3:00 pm 1:30 - 3:00 pm 2:30 Pre-Session II Session IAS 2:00 - 3:00 pm 2:45 2:00 - 3:30 pm Assembly Closing Remarks 3:00 Break Break Break 2:30 - 3:30 pm 3:15 3:30 3:45 4:00 Pre-Session III 4:15 3:30 - 5:00 pm Workshop Session II Workshop Session IV Workshop Session VI 4:30 3:30 - 5:30 PM 3:30 - 5:30 pm 3:30 - 5:30 pm 4:45 5:00 5:15 Pre-Session IV 5:30 5:00 - 5:50 pm 5:45 6:00 6:15 EAS Young Investigators Reception 6:30 Opening Ceremony Hynes Convention Center Special Presentation and Young Investigator Awards 6:45 6:00 - 7:30 pm 5:30 - 8:00 pm Republic Ballroom, Sheraton Boston Hotel 7:00 5:45 - 8:30 pm 7:15 7:30 7:45 8:00 Welcome Reception Hynes Convention Center 8:15 7:30 - 9:00 pm 8:30 8:45 SUNDAY, JUNE 14, 2009 June 14 Sunday,

JOINT PRE-SESSIONS WITH THE NATIONAL LIPID ASSOCIATION AUDITORIUM

Pre-Session I: Where Are We with Guidelines for Heart Disease Risk Reduction? Chairs: SC Smith, Jr. (Chapel Hill, NC, USA), NJ Stone (Chicago, IL, USA)

Time Presentation Publication No. 1:00 PM - 1:15 PM OVERVIEW OF THE GUIDELINES PROCESS 1 SC Smith, Jr. (Chapel Hill, NC, USA)

1:15 PM - 1:25 PM HISTORY OF NHLBI’S CHOLESTEROL 2 EDUCATION PROGRAM, ATP I TO III. INSIGHTS GAINED NJ Stone (Chicago, IL, USA)

1:25 PM - 1:35 PM CANADIAN GUIDELINES TREATMENT 3 OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE 2009 J Genest (Montreal, QC, Canada)

1:35 PM - 1:45 PM THE JAPANESE GUIDELINES 4 T Teramoto (Itabashi, Japan)

1:45 PM - 1:55 PM GUIDELINES IN SOUTH AMERICA 5 RD Santos (São Paulo, Brazil)

1:55 PM - 2:05 PM THE EUROPEAN GUIDELINES 6 DA Wood (London, UK)

2:05 PM - 2:15 PM PERSPECTIVES AND CONCLUSIONS - R Hobbs (Birmingham, UK)

Pre-Session II: Women and Heart Disease - Should Treatment Strategies and Guidelines Be Different? Chairs: KE Watson (Los Angeles, CA, USA), SL Tokgözoglu (Ankara, Turkey)

Time Presentation Publication No. 2:15 PM - 2:30 PM DIETARY GUIDELINES: SHOULD THERAPY 7 BE DIFFERENT FOR WOMEN? AH Lichtenstein (Boston, MA, USA)

2:30 PM - 2:45 PM DO AFRICAN-AMERICAN WOMEN 8 REQUIRE DIFFERENT THERAPY? KE Watson (Los Angeles, CA, USA)

2:45 PM - 3:00 PM THE NON-US PERSPECTIVE 9 SL Tokgözoglu (Ankara, Turkey)

3:00 PM - 3:15 PM SECONDARY PREVENTION IN WOMEN 10 JM Foody (Boston, MA, USA)

3:15 PM - 3:45 PM PANEL DISCUSSION: WHY SHOULD - GUIDELINES BE DIFFERENT FOR WOMEN THAN FROM THOSE FOR MEN?

*Abstract not available at the time of publication 21 YIA - Young Investigators Award Nominee SUNDAY, JUNE 14, 2009

JOINT PRE-SESSIONS WITH THE NATIONAL LIPID ASSOCIATION AUDITORIUM

Pre-Session III: What is the Current and Future Status of Research Funding? Chairs: AM Gotto, Jr. (New York, NY, USA), MJ Chapman (Paris, France)

Time Presentation Publication No. 3:45 PM - 3:55 PM FUNDING FROM THE NATIONAL HEART, 11 LUNG, AND BLOOD INSTITUTE S Shurin (Bethesda, MD, USA)

3:55 PM - 4:05 PM FUNDING IN EUROPE *12 MJ Chapman (Paris, France)

4:05 PM - 4:15 PM FUNDING IN JAPAN 13 Y Matsuzawa (Osaka, Japan)

4:15 PM - 4:25 PM SUMMARY OF THE AAMC GUIDELINES 14 M Simmerling (New York, NY, USA)

4:25 PM - 4:35 PM DISCUSSION -

Pre-Session IV: Should There Be an International Effort to Develop Clinical Lipidology as a Subspecialty? Chair: WV Brown (Atlanta, GA, USA), JR Guyton (Durham, NC, USA)

Time Presentation Publication No. 4:35 PM - 4:40 PM CLINICAL LIPIDOLOGY IN THE US - VW Brown (Atlanta, GA, USA)

4:40 PM - 4:45 PM CLINICAL LIPIDOLOGY IN ITALY - R Paoletti (Milan, Italy)

4:45 PM - 4:50 PM CLINICAL LIPIDOLOGY IN TURKEY - SL Tokgözoglu (Ankara, Turkey)

4:50 PM - 4:55 PM CLINICAL LIPIDOLOGY IN JAPAN - Y Matsuzawa (Osaka, Japan)

4:55 PM - 5:00 PM CLINICAL LIPIDOLOGY IN AUSTRALIA - G Watts (Perth, Australia)

5:00 PM - 5:05 PM CLINICAL LIPIDOLOGY IN BRAZIL - RD Santos (São Paulo, Brazil)

5:05 PM - 5:25 PM BOARD CERTIFICATION PROCESS IN - THE UNITED STATES JR Guyton (Durham, NC, USA)

*Abstract not available at the time of publication 22 YIA - Young Investigators Award Nominee SUNDAY, JUNE 14, 2009 June 14 Sunday,

OPENING CEREMONY AUDITORIUM

Time Presentation Publication No. 6:00 PM - 6:05 PM HISTORY OF THE INTERNATIONAL - SYMPOSIA ON ATHEROSCLEROSIS AM Gotto, Jr. (New York, NY, USA)

6:05 PM - 6:10 PM WELCOME TO BOSTON AND ISA XV 2009 - EJ Schaefer (Boston, MA, USA)

6:10 PM - 6:15 PM WELCOME FROM THE INTERNATIONAL - SOCIETY OF ATHEROSCLEROSIS J-C Fruchart (Loos, France)

6:20 PM - 6:25 PM MESSAGE FROM THE EUROPEAN - SOCIETY OF ATHEROSCLEROSIS MJ Chapman (Paris, France)

6:15 PM - 6:20 PM A WELCOME FROM THE ARTERIOSCLEROSIS, - THROMBOSIS, AND VASCULAR BIOLOGY COUNCIL OF THE AMERICAN HEART ASSOCIATION A Daugherty (Lexington, KY, USA)

6:25 PM - 6:30 PM INTRODUCTION OF DR.’S GOLDSTEIN - AND BROWN M Krieger (Cambridge, MA, USA)

6:30 PM - 7:30 PM KEYNOTE ADDRESS: CHOLESTEROL 16 FEEDBACK - A TALE OF TWO MEMBRANE PROTEINS AND TWO STEROL SENSORS MS Brown (Dallas, TX, USA) and JL Goldstein (Dallas, TX, USA)

7:30 PM Welcome Reception

*Abstract not available at the time of publication 23 YIA - Young Investigators Award Nominee MONDAY, JUNE 15, 2009

PLENARY SESSION I AUDITORIUM

Inhibitors of Cholesterol Synthesis and Atherosclerosis Chairs: AM Gotto, Jr. (New York, NY, USA), A Alberts (Wyckoff, NJ, USA), T Miettinen (Helsinki, Finland), CP Cannon (Boston, MA, USA)

Time Presentation Publication No. 8:00 AM - 8:20 AM CHOLESTEROL BIOSYNTHESIS AND 17 THE DISCOVERY OF STATINS A Endo (Tokyo, Japan)

8:20 AM - 8:30 AM COMMENTARY - A Alberts (Wyckoff, NJ, USA)

8:30 AM - 8:50 AM CLINICAL USE OF STATINS 18 H Mabuchi (Kanazawa, Japan)

8:50 AM - 9:00 AM COMMENTARY - T Miettinen (Helsinki, Finland)

9:00 AM - 9:20 AM STATINS IN THE SECONDARY PREVENTION 19 OF HEART DISEASE TR Pedersen (Olso, Norway)

9:20 AM - 9:30 AM COMMENTARY - CP Cannon (Boston, MA, USA)

9:30 AM - 9:50 AM PREVENTING THE FIRST MYOCARDIAL 20 INFARCTION. ROLE OF STATINS J Shepherd (Glasgow, UK)

9:50 AM - 10:00 AM COMMENTARY AND SESSION CONCLUSIONS - AM Gotto, Jr. (New York, NY, USA)

CLINICAL SYMPOSIUM I AUDITORIUM

New Developments in Statin Therapy Chair: AM Gotto, Jr. (New York, NY, USA)

Time Presentation Publication No. 10:30 AM - 10:55 AM STATIN STRUCTURE FUNCTION DIFFERENCES 21 A Corsini (Milan, Italy)

10:55 AM - 11:20 AM EFFICACY OF STATINS 22 JJP Kastelein (Amsterdam, The Netherlands)

11:20 AM - 11:45 AM CLINICAL RESULTS WITH NEW STATINS 23 J Sasaki (Fukuoka, Japan)

11:45 AM - 12:00 PM CONCLUDING REMARKS - AM Gotto, Jr. (New York, NY, USA)

*Abstract not available at the time of publication 24 YIA - Young Investigators Award Nominee MONDAY, JUNE 15, 2009

WORKSHOP I-1 BALLROOM B

Intervention Studies: Statins in Primary and Secondary Prevention Chairs: C Packard (Glasgow, UK), J Davignon (Montreal, QC, Canada) Monday, June 15

Time Presentation Publication No. 10:30 AM - 10:45 AM LDL LOWERING AND BEYOND IN CHD PREVENTION 24 C Packard (Glasgow, UK)

10:45 AM - 11:00 AM UNTANGLING THE LIPID AND NON-LIPID EFFECTS OF 25 STATINS ON CORONARY ARTERY DISEASE RISK J Davignon (Montreal, QC, Canada)

11:00 AM - 11:15 AM HIGH-DOSE ATORVASTATIN PROVIDES SUSTAINED 26 BENEFIT IN REDUCING RISK OF CV DISEASE AMONG STABLE CHD PATIENTS ≥65 YEARS N Wenger, J LaRosa, J Shepherd (Atlanta, GA, USA, New York, NY, USA and Glasgow, UK)

11:15 AM - 11:30 AM IMPACT OF XUEZHIKANG ON CORONARY EVENTS 27 IN HYPERTENSIVE PATIENTS WITH PREVIOUS MYOCARDIAL INFARCTION (CCSPS STUDY) J-J Li, Z-L Lu, W-R Kou, Z Chen, Y-F Wu, X-H Yu, Y-C Zhao, P Nimoityn, D Capuzzi (Beijing, China and Philadelphia, PA, USA)

11:30 AM - 11:45 AM CONSISTENCY BETWEEN LIPID LOWERING AND 28 REDUCTION OF ISCHEMIC CARDIOVASCULAR EVENTS (ICE) IN THE SIMVASTATIN AND EZETIMIBE IN AORTIC STENOSIS (SEAS) TRIAL I Holme, A Rossebø, T Pedersen (Oslo, Norway)

11:45 AM - 12:00 PM THE DIFFERENT LIPID LOWERING TARGET BY 29 STATINS FOR JAPANESE TO PREVENT CARDIOVASCULAR EVENTS AFTER PERCUTANEOUS CORONARY INTERVENTIONS T Sakamoto, H Ogawa (Kumamoto, Japan)

12:00 PM - 12:15 PM THE EFFECT OF PRAVASTATIN IN THE PATIENTS 30 WITH CHRONIC KIDNEY DISEASE COMBINED WITH METABOLIC SYNDROME IN PRIMARY PREVENTION: A POST HOC ANALYSIS OF MEGA STUDY H Nakamura, K Mizuno (Tokyo, Japan)

12:15 PM - 12:30 PM EZETIMIBE/SIMVASTATIN (E/S) VS ATORVASTATIN 31 (A) IN METABOLIC SYNDROME (MS) PATIENTS WITH HYPERCHOLESTEROLEMIA (HC) J Robinson, C Ballantyne, S Grundy, W Hsueh, H-H Parving, J Rosen, A Adewale, A Polis, J Tomassini, A Tershakovec (Iowa City, IA, USA, Houston, TX, USA, Dallas, TX, USA, Copenhagen, Denmark, Coral Gables, FL, USA and N Wales, PA, USA)

*Abstract not available at the time of publication 25 YIA - Young Investigators Award Nominee MONDAY, JUNE 15, 2009

WORKSHOP I-2 BALLROOM A

Pharmacology and Novel Therapies: Statin Pharmacogenetics Chairs: K Kajinami (Uchinada, Japan), R Krauss (Oakland, CA, USA)

Time Presentation Publication No. 10:30 AM - 10:45 AM UNDERSTANDING GENETIC EFFECTS ON 32 LIPID-LOWERING WITH STATIN THERAPY: FROM CANDIDATE GENES FOR LDL-C REDUCTION TO WHOLE GENOME ANALYSIS OF 22 LIPOPROTEIN FRACTIONS AT BASELINE D Chasman (Boston, MA, USA)

10:45 AM - 11:00 AM STATIN PHARMACOGENOMICS: ROLE OF 33 COMBINED ANALYSIS OF FUNCTIONALLY- RELATED LOCI K Kajinami, R Sato, H Akao, E Schaefer (Uchinada, Japan and Boston, MA, USA)

11:00 AM - 11:15 AM ION MOBILITY ANALYSIS OF LIPOPROTEIN 34 SUBFRACTIONS SUGGESTS THREE INDEPENDENT MECHANISMS OF CARDIOVASCULAR RISK K Musunuru, M Orho-Melander, M Caulfield, R Reitz, G Berglund, B Hedblad, G Engstrom, S Kathiresan, O Melander, R Krauss (Boston, MA, USA, Malmö, Sweden, Cambridge, MA, USA and Oakland, CA, USA)

11:15 AM - 11:30 AM GENE VARIANTS AND PRAVASTATIN LDL 35 LOWERING RESPONSE IN PROSPER E Polisecki, M Robertson, J Shepherd, C Packard, JW Jukema, I Peter, T Van Himbergen, E Schaefer (Boston, MA, USA, Glasgow, UK, Cork, , Leiden, The Netherlands and New York, NY, USA)

11:30 AM - 11:45 AM EFFECTS OF GENETIC VARIANTS IN DRUG 36 METABOLIZING ENZYMES AND TRANSPORTERS ON STATIN SAFETY AND EFFICACY B Tomlinson, M Hu, V Mak, T Chu, V Lee (Shatin, Hong Kong)

11:45 AM - 12:00 PM PHYSIOGENOMIC CONTOURS OF STATIN 37 SAFETY AND EFFICACY G Ruaño, P Thompson, J Kane, C Pullinger, A Windemuth, B Gordon, R Seip, M Kocherla, A Wu (Hartford, CT, USA, San Francisco, CA, USA and New York, NY, USA)

12:00 PM - 12:15 PM PITAVASTATIN IMPROVES THE KIDNEY 38 FUNCTION IN ELEVATED LOW-DENSITY LIPOPROTEIN CHOLESTEROL PATIENTS WITH MILD IMPAIRMENT OF KIDNEY FUNCTION J Kanda (Asahi, Japan)

12:15 PM - 12:30 PM ROLE OF RHO-KINASE IN THE PATHOGENESIS OF 39 CORONARY HYPERCONSTRICTING RESPONSES INDUCED BY PACLITAXEL-ELUTING STENT T Shiroto, S Yasuda, R Tsuburaya, Y Ito, J Takahashi, K Ito, H Ishibashi-Ueda, H Shimokawa (Sendai, Japan and Suita, Japan)

*Abstract not available at the time of publication 26 YIA - Young Investigators Award Nominee MONDAY, JUNE 15, 2009

WORKSHOP I-3A BALLROOM C

Epidemiology of Cardiovascular Disease: Heart Disease Worldwide Chairs: S Reddy (New Delhi, India) J Zhu (Shanghai, China) Monday, June 15

Time Presentation Publication No. 10:30 AM - 10:45 AM CARDIOVASCULAR DISEASES IN LOW AND MIDDLE 40 INCOME COUNTRIES: DIMENSIONS, DETERMINANTS AND DYNAMICS OF HEALTH TRANSITION S Reddy (New Delhi, India)

10:45 AM - 11:00 AM GLOBAL BURDEN OF CARDIOVASCULAR 41 DISEASE: AN OVERVIEW J Zhu (Shanghai, China)

11:00 AM - 11:15 AM WORLDWIDE N-3 FATTY ACID INSUFFICIENCY: 42 IS IT RELATED TO CVD? H Campos, W Zatonski (Boston, MA, USA and Warsaw, Poland)

WORKSHOP I-3B BALLROOM C

A Unique and Global Initiative: The Residual Reduction Risk Initiative (R3i)

Time Presentation Publication No. 11:15 AM - 11:45 AM THE RESIDUAL REDUCTION RISK INITIATIVE: 1520 ADDRESSING A MAJOR CHALLENGE FOR HEALTHCARE J-C Fruchart (Lille, France)

11:45 AM - 12:15 PM NON-LDL-RELATED DYSLIPIDEMIA AND 1519 CORONARY RISK G Assmann (Münster, Germany)

*Abstract not available at the time of publication 27 YIA - Young Investigators Award Nominee MONDAY, JUNE 15, 2009

WORKSHOP I-4 ROOM 302

Genetics: Familial Hyperlipidemia Chairs: J de Graaf (Nijimegen, The Netherlands), F Civeira (Zaragoza, Spain)

Time Presentation Publication No. 10:30 AM - 10:45 AM CLINICAL PRACTICE: A DIAGNOSTIC ALGORITHM 43 FOR ATHEROGENIC APOB DYSLIPOPROTEINEMIAS J de Graaf (Nijmegen, The Netherlands)

10:45 AM - 11:00 AM CONTRIBUTION OF LDL RECEPTOR GENE 44 MUTATIONS TO DIFFERENT HYPER CHOLESTEROLEMIA PHENOTYPES F Civeira (Zaragoza, Spain)

11:00 AM - 11:15 AM CARDIOVASCULAR DISEASE RISK ASSOCIATED 45 WITH FAMILIAL LIPID DISORDERS PN Hopkins (Salt Lake City, UT, USA)

11:15 AM - 11:30 AM COMPARISON OF CAROTID INTIMA-MEDIA 46 THICKNESS IN SUBJECTS WITH FAMILIAL YIA HYPERCHOLESTEROLEMIA AND FAMILIAL COMBINED HYPERLIPIDEMIA E Jarauta, R Mateo, A Bea, S Fiddyment, E Burillo, F Civeira (Zaragoza, Spain)

11:30 AM - 11:45 AM EVIDENCE OF INCREASED CHOLESTEROL 47 SYNTHESIS IN FAMILIAL COMBINED HYPERLIPIDEMIA YIA T van Himbergen, E Schaefer, N Matthan, J de Graaf, A Stalenhoef (Boston, MA, USA and Nijmegen, The Netherlands)

11:45 AM - 12:00 PM PHENOTYPE AND GENOTYPE OF FAMILIAL 48 HYPERCHOLESTEROLEMIA IN OVER 2000 CHILDREN YIA A van der Graaf, H Avis, M Vissers, B Hutten, J Defesche, A Wiegman, S Fouchier, J Kastelein (Amsterdam, The Netherlands)

12:00 PM - 12:15 PM CROSS-SPECIES COMPARISONS OF GWAS DATA AS A 49 SCREENING TOOL TO IDENTIFY NOVEL LOCI FOR LDL-C C Pl, B Haas, M Laakso, P Pajukanta (Los Angeles, CA, USA and Kuopio, Finland)

12:15 PM - 12:30 PM THE FIRST REPORT OF THE TREATMENT OF 50 TRANSPLANT CORONARY ARTERY DISEASE WITH YIA DSA LIPID APHERESIS R Sosland, S Gollub, P Moriarty (Kansas City, KS, USA)

*Abstract not available at the time of publication 28 YIA - Young Investigators Award Nominee MONDAY, JUNE 15, 2009

WORKSHOP I-5 ROOM 312

Nutritional Studies: Dietary Fatty Acids Chairs: BV Howard (Hyattsville, MD, USA), LL Rudel (Winston-Salem, NC, USA) Monday, June 15

Time Presentation Publication No. 10:30 AM - 10:45 AM IMPACT OF ANIMAL VERSUS INDUSTRIAL TRANS 51 FATTY ACIDS ON LIPOPROTEINS IN HUMANS MB Katan, A Wanders, I Brouwer, E Siebelink (Amsterdam, The Netherlands) 10:45 AM - 11:00 AM LESSONS FROM THE DIET TRIAL OF THE WOMEN’S 52 HEALTH INITIATIVE BV Howard (Hyattsville, MD, USA and Washington, DC, USA) 11:00 AM - 11:15 AM DIETARY UNSATURATED FATTY ACIDS ARE UNIQUE 53 IN EFFECTIVENESS IN ATHEROPROTECTION C Degirolamo, L Rudel, T Bell III (Winston-Salem, NC, USA)

11:15 AM - 11:30 AM EFFECTS OF A HIGH INTAKE OF CONJUGATED 54 LINOLEIC ACID, A RUMINANT TRANS FATTY ACID, ON LIPOPROTEINS AND INFLAMMATION MARKERS IN HUMANS A Wanders, I Brouwer, E Siebelink, M Katan (Amsterdam, The Netherlands and Wageningen, The Netherlands) 11:30 AM - 11:45 AM VALIDATION OF THE MedDietSCORE THROUGH 55 PLASMA FATTY ACIDS D Panagiotakos, N Kalogeropoulos, C Pitsavos, C Stefanadis (Athens, Greece) 11:45 AM - 12:00 PM COMPOSITION OF PLASMA AND PLAQUE 56 AMONG CORONARY ARTERY DISEASE SUBJECTS YIA CONSUMING COCONUT OIL/SUNFLOWER OIL S Palazhy, M Vasudevan, K Vaidyanathan, P Kamath (Kerala, India) 12:00 PM - 12:15 PM DIETARY POLYUNSATURATED FATTY ACIDS INDUCE 57 LESS ABCA1 AND MACROPHAGE EXPRESSION IN THE AORTA OF LDLR-KO MICE THAN TRANS AND SATURATED FATTY ACIDS R Machado, E Nakandakare, E Quintão, F Ferreira, V Nunes, P Cazita, S Catanozi, AM Lottenberg (São Paulo, Brazil) 12:15 PM - 12:30 PM MODERATE FISH CONSUMPTION IS ASSOCIATED 58 WITH LOWER LIKELIHOOD OF DEVELOPING LEFT VENTRICULAR SYSTOLIC DYSFUNCTION, IN ACUTE CORONARY SYNDROME PATIENTS C-M Kastorini, C Chrysohoou, D Panagiotakos, P Aggelopoulos, C Liontou, I Skoumas, C Pitsavos, C Stefanadis (Athens, Greece)

*Abstract not available at the time of publication 29 YIA - Young Investigators Award Nominee MONDAY, JUNE 15, 2009

WORKSHOP I-6 ROOM 304

Imaging of Atherosclerosis: The Vulnerable Plaque Chairs: J Muller (Burlington, MA, USA), R Virmani (Gaithersburg, MD, USA)

Time Presentation Publication No. 10:30 AM - 10:45 AM CONSEQUENCES OF ENDOTHELIAL PHENOTYPIC 59 DRIFT DURING PLAQUE PROGRESSION AJ Horrevoets (Amsterdam, The Netherlands) 10:45 AM - 11:00 AM PATHOLOGY, DETECTION AND TREATMENT OF 60 VULNERABLE PLAQUE S Madden, J Muller (Burlington, MA, USA) 11:00 AM - 11:15 AM IMAGING ATHEROSCLEROTIC PLAQUE 61 INFLAMMATION JH Rudd (Cambridge, UK) 11:15 AM - 11:30 AM CRITICAL PATHOLOGIC EVALUATION OF WHAT 62 CONSTITUTES A VULNERABLE PLAQUE R Virmani (Gaithersburg, MD, USA) 11:30 AM - 11:45 AM PSGL-1 IS A KEY MOLECULE FOR PLAQUE 63 STABILITY IN ACUTE CORONARY SYNDROME YIA K Gomita, K Sato, M Sawabe, N Hagiwara (Tokyo, Japan) 11:45 AM - 12:00 PM LYSYL-OXIDASE-DEPENDED EXTRACELLULAR 64 MATURATION OF COLLAGEN IS REDUCED IN YIA HYPERINFLAMED ATHEROSCLEROTIC PLAQUES OF ApoE-/- MICE O Ovchinnikova, A-K Robertson, D Wågsäter, E Folco, M Hyry, J Myllyharju, P Eriksson, N Gavrisheva, E Shlyakhto, P Libby, G Hansson (Stockholm, Sweden, St. Petersburg, Russian Federation, Boston, MA, USA and Oulu, Finland) 12:00 PM - 12:15 PM CHOLESTEROL-LOWERING THERAPY WITH THE 65 CHOLESTEROL ABSORPTION INHIBITOR EZETIMIBE YIA INHIBITS PLAQUE DESTABILIZATION AND RUPTURE IN THE BRACHIOCEPHALIC ARTERIES OF ApoE- DEFICIENT MICE K Sato, T Matoba, K Egashira (Fukuoka, Japan) 12:30 PM - 12:45 PM Withdrawn 66

*Abstract not available at the time of publication 30 YIA - Young Investigators Award Nominee MONDAY, JUNE 15, 2009

WORKSHOP I-7 ROOM 310

Lipoprotein Metabolism: Joint IAS-EAS Workshop “Hepatic Apolipoprotein B Metabolism” Chairs: HN Ginsberg (New York, NY, USA), M-R Taskinen (Helsinki, Finland) Monday, June 15

Time Presentation Publication No. 10:30 AM - 10:45 AM CHARACTERISTICS OF CIRCULATING VLDL 67 RESULTING FROM INSULIN RESISTANCE AND FATTY LIVER LL Schreier (Buenos Aires, Argentina) 10:45 AM - 11:00 AM REGULATION OF VLDL ASSEMBLY AND SECRETION 68 BY LIPIDS, INSULIN, AND ER STRESS HN Ginsberg (New York, NY, USA) 11:00 AM - 11:15 AM IS HEPATIC STEATOSIS THE CULPRIT OF 69 DYSLIPIDEMIA IN SUBJECTS WITH ABDOMINAL OBESITY? M-R Taskinen, M Adiels, S Söderlund, N Lundbom, V Di Marzo, J Borén (Helsinki, Finland, Gothenborg, Sweden and Pozzuoli, Italy) 11:15 AM - 11:30 AM CHANGES IN LIPOPROTEIN COPOSITION IN 70 DIABETIC DYSLIPEMIA M Ståhlman, A Hiukka, M-R Taskinen, K Ekroos, J Borén (Gothenburg, Sweden, Helsinki, Finland and Espoo, Finland) 11:30 AM - 11:45 AM ABNORMAL HEPATIC APOLIPROTEIN B 71 METABOLISM IN TYPE 2 DIABETES B Vergès (Dijon, France) 11:45 AM - 12:00 PM EFFECT OF A PEROXISOME PROLIFERATOR 72 ACTIVATED RECEPTOR (PPAR) BETA/DELTA AGONIST ON LIPOPROTEIN KINETICS IN THE METABOLIC SYNDROME E Ooi, G Watts, B Staels, S Caron, D Sprecher, H Barrett (Perth, Australia, Lille, France and King of Prussia, PA, USA) 12:00 PM - 12:15 PM GENE EXPRESSION PROFILING OF NUCLEAR 73 RECEPTORS IN MOUSE LIVER PARENCHYMAL, YIA ENDOTHELIAL, AND KUPFFER CELLS Z Li, M Hoekstra, JK Kruijt, T Van Berkel (Leiden, The Netherlands) 12:15 PM - 12:30 PM ASP-C5L2 KO MICE DO NOT HAVE INCREASED 74 HEPATIC LIPOPROTEIN PRODUCTION A Fisette, S Paglialunga, K Cianflone (Quebec, QC, Canada)

*Abstract not available at the time of publication 31 YIA - Young Investigators Award Nominee MONDAY, JUNE 15, 2009

WORKSHOP I-8 Room 311

Basic Science and Vascular Biology: Oxidative Stress Chairs: JL Witztum (La Jolla, CA, USA), M Kitakaze (Suita, Japan)

Time Presentation Publication No. 10:30 AM - 10:45 AM HDL – ASSOCIATED PARAOXONASE 1 (PON1) 75 ATTENUATES MACROPHAGE FOAM CELL FORMATION M Aviram (Haifa, Israel) 10:45 AM - 11:00 AM THE ONSET OF ACUTE CORONARY SYNDROME IS 76 ATTRIBUTABLE TO ENDOPLASMIC RETICULUM STRESS IN ATHEROSCLEROTIC PLAQUES M Kitakaze, M Myoishi, O Tsukamoto, N Hashimoto, H Tomoike (Suita, Japan) 11:00 AM - 11:15 AM RHO-KINASE IS AN IMPORTANT THERAPEUTIC 77 TARGET IN CARDIOVASCULAR MEDICINE H Shimokawa (Sendai, Japan) 11:15 AM - 11:30 AM THE ROLE OF OXIDIED PHOSPHOLIPIDS IN *78 MEDIATING LIPOPROTEIN(a) ATHEROGENICITY JL Witztum (La Jolla, CA, USA) 11:30 AM - 11:45 AM SUPEROXIDE-DEPENDENT CATHEPSIN ACTIVATION 79 SYSTEM IS ASSOCIATED WITH HYPERTENSIVE RENAL REMODELING AND REPRESENTS A TARGET FOR STATIN TREATMENT XW Cheng, K Okumura, T Sasaki, M Kuzuya, T Murohara (Nagoya, Japan) 11:45 AM - 12:00 PM PROTEOMIC ANALYSIS OF DEFINED HDL 80 SUBPOPULATIONS REVEALS PARTICLE- SPECIFIC PROTEIN CLUSTERS: RELEVANCE TO ANTIOXIDATIVE FUNCTION W Davidson, R Silva, S Chantepie, W Lagor, M Chapman, A Kontush (Cincinnati, OH, USA and Paris, France) 12:00 PM - 12:15 PM PROTECTION AGAINST ATHEROSCLEROSIS BY HEME 81 OXYGENASE-1 C Li, B Wu, R Midwinter, K Beck, E Collinson, G Maghzal, C Cassano, F Santiago, L Khachigian, J Gamble, R Stocker (Sydney, Australia) 12:15 PM - 12:30 PM MECHANISMS IMPLICATED IN THE POTENT 82 PROTECTION OF LDL FROM OXIDATIVE STRESS YIA MEDIATED BY SMALL, DENSE HDL3 A Zerrad-Saadi, P Therond, M Couturier, S Chantepie, K Rye, M Chapman, A Kontush (Paris, France and Sydney, Australia)

12:30 PM - 12:45 PM MiR-217 REGULATES AGING AND ANGIOGENIC 564 FUNCTIONS IN HUMAN ENDOTHELIUM VIA SIRT1 R Menghini, V Casagrande, M Cardellini, F Amati, A Terrinoni, A Marino, E Martelli, A Ippoliti, G Melino, G Novelli, R Lauro, M Federici (Rome, Italy)

*Abstract not available at the time of publication 32 YIA - Young Investigators Award Nominee MONDAY, JUNE 15, 2009

MASTER SESSION I BALLROOM B

Difficulties of Drug Development Chair: R Paoletti (Milan, Italy) Monday, June 15

Time Presentation Publication No. 1:30 PM - 1:45 PM CANNABINOID RECEPTOR BLOCKERS 83 J-P Després (Quebec, QC, Canada) 1:45 PM - 2:00 PM MICROSOMAL TRANSFER PROTEIN INHIBITORS 84 RE Gregg (Ft. Washington, PA, USA) 2:00 PM - 2:15 PM STATINS 85 A Alberts (Wyckoff, NJ, USA) 2:15 PM - 2:30 PM CETP INHIBITORS 86 PJ Barter (Sydney, Australia) 2:30 PM - 2:45 PM CONCLUDING REMARKS - R Paoletti (Milan, Italy)

MASTER SESSION II BALLROOM A

The Discovery of Lipoprotein Receptors and Their Role in Atherosclerosis

Time Presentation Publication No. 1:30 PM - 2:15 PM THE DISCOVERY OF LIPOPROTEIN RECEPTORS AND 87 THEIR ROLE IN ATHEROSCLEROSIS M Krieger (Cambridge, MA, USA) 2:15 PM - 2:30 PM COMMENTARY - U Beisiegel (Hamburg, Germany)

*Abstract not available at the time of publication 33 YIA - Young Investigators Award Nominee MONDAY, JUNE 15, 2009

CLINICAL SYMPOSIUM II AUDITORIUM

Effects of Statin Therapy on the Carotid Artery, Coronary Atheromas, and Coronary Heart Disease Prevention Chair: P Jones (Houston, TX, USA)

Time Presentation Publication No. 1:30 PM - 1:55 PM EFFECTS OF STATIN THERAPY ON THE CAROTID 88 ARTERY JR Crouse (Winston Salem, NC, USA) 1:55 PM - 2:20 PM CORONARY ATHEROMA 89 SJ Nicholls (Cleveland, OH, USA) 2:20 PM - 2:45 PM PRIMARY PREVENTION OF HEART DISEASE 90 PM Ridker (Boston, MA, USA) 2:45 PM - 3:00 PM CONCLUDING REMARKS - P Jones (Houston, TX, USA)

WORKSHOP ROOM 312

Calories From Beverages: An Underestimated Dietary Target for the Prevention/Management of Obesity/Type 2 Diabetes? Chairs: J-P Després (Quebec, QC, Canada), E Horton (Boston, MA, USA) In partnership with the International Chair on Cardiometabolic Risk

Time Presentation Publication No. INTRODUCTION - E Horton (Boston, MA, USA) 2:00 PM – 2:20 PM GLOBAL DIMENSIONS OF SUGARY BEVERAGES 1521 AND PROGRAMMATIC AND POLICY SOLUTIONS B Popkin (Chapel Hill, NC, USA) 2:20 PM – 2:40 PM SOFT DRINKS AND OBESITY: THE EVIDENCE 1522 G Bray (Baton Rouge, LA, USA) 2:40 PM – 3:00 PM SUGAR-SWEETENED DRINKS AND TYPE 2 DIABETES *1523 F Hu (Boston, MA, USA) CONCLUSION - J-P Després (Quebec, QC, Canada)

*Abstract not available at the time of publication 34 YIA - Young Investigators Award Nominee MONDAY, JUNE 15, 2009

WORKSHOP II-1 BALLROOM B

Intervention Studies: Weight Loss Therapy Chairs: F Rubino (New York, NY, USA), C Apovian (Boston, MA, USA) Monday, June 15

Time Presentation Publication No. 3:30 PM - 3:45 PM FROM “BARIATRIC” TO “METABOLIC” 91 SURGERY: MODERN SCIENCE VERSUS THE STIGMA OF OBESITY F Rubino (New York, NY, USA) 3:45 PM - 4:00 PM DIET TYPE, PARTICIPATION, AND LONG-TERM *92 WEIGHT LOSS FM Sacks (Boston, MA, USA) 4:00 PM - 4:15 PM TREATMENT OF OBESITY 93 C Apovian (Boston, MA, USA) 4:15 PM - 4:30 PM EFFECT OF WEIGHT LOSS ON HIGH DENSITY 94 LIPOPROTEIN APOLIPOPROTEIN A-II KINETICS IN THE METABOLIC SYNDROME T Ng, G Watts, H Barrett, D Chan (Perth, Australia) 4:30 PM - 4:45 PM LONG TERM EFFECTS OF WEIGHT LOSS FROM 95 A VERY-LOW-CARBOHYDRATE DIET ON ENDOTHELIAL FUNCTION IN SUBJECTS WITH ABDOMINAL OBESITY T Wycherley, G Brinkworth, M Noakes, J Keogh, J Buckley, P Clifton (Adelaide, Australia) 4:45 PM - 5:00 PM LDL-CHOLESTEROL LOWERING EITHER THROUGH 96 THERAPEUTIC LIFESTYLE CHANGE INTERVENTION OR HMG-COA REDUCTASE INHIBITOR TREATMENT DECREASES MEAN PLATELET VOLUME VALUES IN PEOPLE WITH ELEVATED LDL-CHOLESTEROL G Erdem, I Tasci, G Celebi, G Ozgur, T Dogru, A Sonmez, C Ercin, S Tapan (Ankara, Turkey) 5:00 PM - 5:15 PM CALORIC RESTRICTION STIMULATES ISCHEMIA- 97 INDUCED ANGIOGENESIS VIA ADIPONECTIN- MEDIATED ACTIVATION OF eNOS R Shibata, N Ouchi, K Walsh, T Murohara (Nagoya, Japan and Boston, MA, USA) 5:15 PM - 5:30 PM METABOLIC SURGERY FOR THE METABOLIC 98 SYNDROME H Buchwald (Minneapolis, MN, USA)

*Abstract not available at the time of publication 35 YIA - Young Investigators Award Nominee MONDAY, JUNE 15, 2009

WORKSHOP II-2 BALLROOM A

Pharmacology and Novel Therapies: Novel Therapies and Safety Aspects Chairs: H Mabuchi (Kanazawa, Japan), PD Thompson (Hartford, CT, USA)

Time Presentation Publication No. 3:30 PM - 3:45 PM COENZYME Q10 REDUCTION WITH STATINS: 99 ANOTHER PLEIOTROPIC EFFECT H Mabuchi (Kanazawa, Japan) 3:45 PM - 4:00 PM STATIN MYALGIA 100 PD Thompson (Hartford, CT, USA) 4:00 PM - 4:15 PM PROPOSED EFFICACY CRITERIA AND CHOLESTEROL 101 TARGETS FOR LDL APHERESIS GR Thompson (London, UK) 4:15 PM - 4:30 PM THE EFFECT OF Q10 AND SELENIUM SUPPLEMENT 102 ON ADVERSE EFFECTS IN STATIN TREATMENT YIA M Bogsrud, K Retterstøl, L Ose, U Malt, B Woldseth (Oslo, Norway) 4:30 PM - 4:45 PM EFFECTS OF LOW DOSE MTP INHIBITION ALONE 103 AND IN COMBINATION WITH OTHER LIPID- LOWERING DRUGS ON HEPATIC FAT AND PLASMA LIPIDS E Meagher, M Davidson, M Rosen, J Robinson, H Bays, L Bloedon, W Sasiela, M Parris, D Rader (Philadelphia, PA, USA, Chicago, IL, USA, Iowa City, IA, USA, Louisville, KY, USA and Bridgewater, NJ, USA) 4:45 PM - 5:00 PM EFFECT OF MIPOMERSEN TREATMENT ON HEPATIC 104 TRIGLYCERIDE CONTENT IN SUBJECTS WITH YIA FAMILIAL HYPERCHOLESTEROLEMIA M Visser, F Akdim, D Basart, J Kastelein, A Nederveen, T Kwoh, D Tribble, E Stroes (Amsterdam, The Netherlands, Hoorn, The Netherlands and Carlsbad, CA, USA) 5:00 PM - 5:15 PM INCREASED PLASMA CERAMIDES FOLLOW STATIN- 105 INDUCED MUSCLE TOXICITY R Laaksonen, G Mombelli, K Tarasov, D Kauhanen, K Koistinen, R Hurme, C Sirtori, K Ekroos (Espoo, Finland and Milan, Italy) 5:15 PM - 5:30 PM DEFICIENT ANTIOXIDATIVE ACTIVITY OF SMALL, 106 DENSE HIGH-DENSITY LIPOPROTEINS (HDL3) YIA IN FAMILIAL HYPERCHOLESTEROLEMIA (FH): THERAPEUTIC CORRECTION BY LDL APHERESIS H Hussein, M Atassi-Dumont, S Saheb, S Chantepie, M Chapman, A Kontush (Paris, France) 5:30 PM - 5:45 PM LIPIDS APHERESIS BY IMMUNOSORBENTS IS 362 THE EFFECTIVE METHODS FOR LDL AND LP(a) ELIMINATION I Adamova, J Berestatskaya, G Konovalov, S Baida, S Pokrovsky (Moscow, Russian Federation)

*Abstract not available at the time of publication 36 YIA - Young Investigators Award Nominee MONDAY, JUNE 15, 2009

WORKSHOP II-3 BALLROOM C

Epidemiology of Cardiovascular Disease: Global Risk Assessment Chairs: RB D’Agostino (Boston, MA, USA), G Assmann (Münster, Germany) Monday, June 15

Time Presentation Publication No. 3:30 PM - 3:45 PM EVALUATING THE IMPACT OF NEW MARKERS ON 107 RISK PREDICTION NR Cook (Boston, MA, USA) 3:45 PM - 4:00 PM CVD GLOBAL RISK MODELS: THE FRAMINGHAM 108 EXPERIENCE RB D’Agostino (Boston, MA, USA) 4:00 PM - 4:15 PM GLOBAL RISK ASSESSMENT FOR CARDIOVASCULAR 109 DISEASE IN 2009 PW Wilson (Atlanta, GA, USA) 4:15 PM - 4:30 PM VASCULAR RISK ASSESSMENT AND MANAGEMENT 110 DA Wood (London, UK) 4:30 PM - 4:45 PM THE PATIENT AT RISK FOR MYOCARDIAL 111 INFARCTION AND STROKE: NEW PROCAM DATA G Assmann (Münster, Germany) 4:45 PM - 5:00 PM COMMON CAROTID ARTERY DIAMETER AS A 112 MARKER OF CARDIOVASCULAR RISK: PRELIMINARY RESULTS OF THE IMPROVE STUDY M Amato, D Baldassarre, E Tremoli, IMPROVE Study Group (Milan, Italy) 5:00 PM - 5:15 PM PATIENTS WITH ATHEROSCLEROSIS MISSED BY 113 FRAMINGHAM 10-YEAR RISK SCORING A Doneen, B Bale, D Feng (Spokane, WA, USA and Lubbock, TX, USA) 5:15 PM - 5:30 PM CAROTID PLAQUE AND IMT IN THE POPULATION 114 BASED REFINE REYKJAVIK STUDY IN CONTEXT WITH THE SHAPE GUIDELINES V Gudnason, B Thorsson, S Sigurdsson, T Aspelund (Kopavogur, Iceland)

*Abstract not available at the time of publication 37 YIA - Young Investigators Award Nominee MONDAY, JUNE 15, 2009

WORKSHOP II-4 ROOM 302

Genetics: Genetics of High Density Lipoproteins Chairs: A Tybjaerg-Hansen (Copenhagen, Denmark), ME Brousseau (Cambridge, MA, USA)

Time Presentation Publication No. 3:30 PM - 3:45 PM IDENTIFICATION OF SUSCEPTIBILITY LOCI FOR THE 115 LOW HDL-C/CHD TRAIT M Brousseau, S Demissie, G Peloso, L Cupples, S Gabriel, D Collins, D Mirel, E Schaefer (Boston, MA, USA, Cambridge, MA, USA and New Haven, CT, USA) 3:45 PM - 4:00 PM LECITHIN: CHOLESTEROL ACYLTRANSFERASE 116 DEFICIENCY SYNDROMES L Calabresi, G Franceschini (Milan, Italy) 4:00 PM - 4:15 PM DOES GENETIC VARIATION IN HDL GENES PREDICT 117 RISK OF ISCHEMIC HEART DISEASE? A Tybjærg-Hansen (Copenhagen, Denmark) 4:15 PM - 4:30 PM WHERE ARE WE WITH THE GENETICS OF HDL? 118 JA Kuivenhoven (Amsterdam, The Netherlands) 4:30 PM - 4:45 PM MUTATION IN APOA PREDICTS INCREASED RISK 119 OF ISCHEMIC HEART DISEASE AND EARLY DEATH YIA WITHOUT LOW HDL CHOLESTEROL C Lundegaard, R Frikke-Schmidt, B Nordestgaard, A Kateifides, D Kardassis, V Zannis, P Grande, A Tybjærg- Hansen (Copenhagen, Denmark, Heraklion, Greece and Boston, MA, USA) 4:45 PM - 5:00 PM STRUCTURAL AND FUNCTIONAL FEATURES OF HDL 120 FROM CARRIERS OF THE R37X MUTATION IN CETP YIA GENE L Calabresi, E Favari, F Bernini, P Nilsson, C Sirtori, P Tarugi, G Franceschini, M Gomaraschi (Milan, Italy, Parma, Italy, Modena, Italy and Malmö, Sweden) 5:00 PM - 5:15 PM GENOMIC SELECTION BY HYBRIDIZATION- 121 ENRICHMENT FOR LARGE SCALE SEQUENCING OF YIA GENES IMPLICATED IN HDL METABOLISM GK Hovingh, D Herman, J Seidman (Amsterdam, The Netherlands and Boston, MA, USA) 5:15 PM - 5:30 PM IDENTIFICATION OF NEW CANDIDATE GENES 122 REGULATING LIPID LEVELS IN A QUANTITATIVE TRAIT LOCI ANALYSIS BETWEEN INBRED MOUSE STRAINS MRL/MPJ AND SM/J M Leduc, S-W Tsaih, G Churchill, B Paigen (Bar Harbor, ME, USA)

*Abstract not available at the time of publication 38 YIA - Young Investigators Award Nominee MONDAY, JUNE 15, 2009

WORKSHOP II-5 ROOM 312

The Metabolic Syndrome and its Implications for Global Cardiometabolic Risk Assessment/Management Chairs: P Libby (Boston, MA, USA), J-P Després (Quebec, QC, Canada) Monday, June 15 In partnership with the International Chair on Cardiometabolic Risk

Time Presentation Publication No. 3:30 PM - 3:35 PM OPENING REMARKS - P Libby (Boston, MA, USA) 3:35 PM - 3:55 PM IS THE CONCEPT OF METABOLIC SYNDROME 123 HELPFUL? NJ Stone (Chicago, IL, USA) 3:55PM - 4:15 PM PATHOPHYSIOLOGY OF METABOLIC SYNDROME 124 AND RELATED GLOBAL CARDIOMETABOLIC RISK. WHAT’S NEW? J Plutzky (Boston, MA, USA) 4:15 PM - 4:35 PM ABDOMINAL OBESITY AND METABOLIC SYNDROME 125 IN CARDIOLOGY: CLINICAL IMPLICATIONS RW Nesto (Burlington, MA, USA) 4:35 PM - 4:55 PM ABDOMINAL OBESITY AND METABOLIC *126 SYNDROME: IMPLICATIONS FOR ASSESSMENT AND MANAGEMENT OF GLOBAL CARDIOMETABOLIC RISK HB Brewer, Jr. (Washington, DC, USA) 4:55 PM - 5:00 PM CLOSING REMARKS - J-P Després (Quebec, QC, Canada)

*Abstract not available at the time of publication 39 YIA - Young Investigators Award Nominee MONDAY, JUNE 15, 2009

WORKSHOP II-6 ROOM 304

Ankle Brachial Index, Pulse Wave Velocity and Other Imaging Modalities Chairs: MH Criqui (La Jolla, CA, USA), J Vita (Boston, MA, USA)

Time Presentation Publication No. 3:30 PM - 3:45 PM ASSESSING ATHEROSCLEROSIS WITH THE ANKLE- 127 BRACHIAL INDEX (ABI) MH Criqui (La Jolla, CA, USA) 3:45 PM - 4:00 PM EVALUATION OF ENDOTHELIAL DYSFUNCTION 128 J Vita (Boston, MA, USA) 4:00 PM - 4:15 PM UTILITY OF THE AUTOMATIC MEASUREMENT OF 129 THE ARTERIAL PRESSURE AS SCREENING AND YIA DIAGNOSIS OF PERIPHERAL ARTERIAL DISEASE C Sanclemente, A Pedragosa, X Pinto, E Corbella, O Mascaro (Barcelona, Spain and Vic, Spain) 4:15 PM - 4:30 PM ETHNIC DIFFERENCES IN ANKLE BRACHIAL 130 INDEX ARE PRESENT IN INDIVIDUALS WITHOUT PERIPHERAL ARTERIAL DISEASE S Singh, K Bailey, I Kullo (Rochester, MN, USA) 4:30 PM - 4:45 PM VELOCITY VECTOR ULTRASOUND IMAGING 131 OF COMMON CAROTID ARTERY WALL MOTION YIA PREDICTS ONE YEAR CARDIOVASCULAR OUTCOME IN PATIENTS WITH SUSPECTED CARDIOVASCULAR DISEASE S Svedlund, C Eklund, P Robertsson, R Volkmann, L-M Gan (Gothenburg, Sweden and Molndal, Sweden) 4:45 PM - 5:00 PM ARTERIAL FUNCTION IN PATIENTS WITH INHERITED 132 DYSLIPIDEMIAS C Masoura, C Pitsavos, I Skoumas, K Aznaouridis, C Vlachopoulos, C Stefanadis (Athens, Greece) 5:00 PM - 5:15 PM HEMODYNAMIC AND HEMORHEOLOGICAL 133 FEATURE INVESTIGATION IN RIGHT CORONARY ARTERY STENOSIS WITH 83% SEVERITY HS Ji, M Kang, KC Kim (Busan, Korea and Seoul, Korea) 5:15 PM - 5:30 PM CAROTID INTIMA MEDIA THICKNESS AS A MEASURE 134 OF CARDIOVASCULAR DISEASE BURDEN IN NIGERIAN AFRICANS WITH DIABETES MELLITUS AND HYPERTENSION B Okeahialam, B Alonge, S Pam, F Puepet (Jos, Nigeria)

*Abstract not available at the time of publication 40 YIA - Young Investigators Award Nominee MONDAY, JUNE 15, 2009

WORKSHOP II- 7 ROOM 310

Lipoprotein Metabolism: Integration of Lipoprotein Metabolism Chairs: HH Barrett (Perth, Australia), MW Huff (London, ON, Canada) Monday, June 15

Time Presentation Publication No. 3:30 PM - 3:45 PM VIEWING LIPOPROTEIN METABOLISM FROM 135 DIFFERENT PERSPECTIVES: INTEGRATION, INDIVIDUAL AND POPULATIONS HH Barrett (Perth, Australia) 3:45 PM - 4:00 PM NARINGENIN PREVENTS THE DYSLIPIDEMIA, APOB 136 OVERPRODUCTION AND HYPERINSULINEMIA IN LDL-RECEPTOR NULL MICE WITH DIET-INDUCED INSULIN RESISTANCE E Mulvihill, E Allister, B Sutherland, R Hegele, MW Huff (London, ON, Canada) 4:00 PM - 4:15 PM KINETICS OF APOB-CONTAINING LIPOPROTEINS: AN 137 UPDATE K Ikewaki (Tokorozawa, Japan) 4:15 PM - 4:30 PM LIPOPROTEIN METABOLISM THROUGH THE 138 LOOKING GLASS: INTEGRATING METABOLISM WITH STABLE ISOTOPE TRACERS G Watts (Perth, Australia) 4:30 PM - 4:45 PM LIPOPROTEIN KINETICS IN SUBJECTS WITH 139 LIPOPROTEIN LIPASE (LPL) GENE MUTATIONS E Ooi, D Sprecher, E Schaefer, M Diffenderfer, N Matthan, H Barrett (Perth, Australia, King of Prussia, PA, USA and Boston, MA, USA) 4:45 PM - 5:00 PM REAL-TIME MAGNETIC RESONANCE IMAGING AND 140 QUANTIFICATION OF LIPOPROTEIN METABOLISM IN YIA VIVO USING NANOCRYSTALS O Bruns, H Ittrich, U Tromsdorf, U Beisiegel, J Heeren (Hamburg, Germany) 5:00 PM - 5:15 PM TWO MUTATIONS IN GPIHBP1 CAUSE SEVERE 141 CHYLOMICRONEMIA AND PROVIDE EVIDENCE YIA FOR A CRITICAL ROLE OF GPIHBP1 IN HUMAN TRIGLYCERIDE METABOLISM R Franssen, A Beigneux, J Hertecant, P Gin, M Weinstein, J Kastelein, A Bensadoun, L Fong, S Young, G Dallinga-Thie (Amsterdam, The Netherlands, Los Angeles, CA, USA, Al Ain, United Arab Emirates and Ithaca, NY, USA) 5:15 PM - 5:30 PM HUMAN CETP AGGREVATES ATHEROSCLEROSIS BY 142 INCREASING VLDL-CHOLESTEROL RATHER THAN BY DECREASING HDL-CHOLESTEROL IN APOE*3- LEIDEN MICE J de Vries-van der Weij, K Toet, S Zadelaar, LM Havekes, T Kooistra, PCN Rensen (Leiden, The Netherlands)

*Abstract not available at the time of publication 41 YIA - Young Investigators Award Nominee MONDAY, JUNE 15, 2009

WORKSHOP II-8 ROOM 311

Basic Science and Vascular Biology: Models of Atherosclerosis Chairs: LK Curtiss (La Jolla, CA, USA), B Paigen (Bar Harbor, ME, USA)

Time Presentation Publication No. 3:30 PM - 3:45 PM ENDOTHELIAL CELL TOLL-LIKE RECEPTOR 143 EXPRESSION AND MACROPHAGE ACCUMULATION ARE INCREASED ONLY IN REGIONS OF DISTURBED BLOOD FLOW IN THE MOUSE AORTA L Curtiss, M Richards, P Tobias (La Jolla, CA, USA) 3:45 PM - 4:00 PM DIFFERENCES IN HEALTH STATUS AFFECT 144 ATHEROSCLEROSIS SUSCEPTIBILITY AMONG INBRED STRAINS OF MICE B Paigen (Bar Harbor, ME, USA) 4:00 PM - 4:15 PM THE CENTRAL ROLE OF ACAT2 AND CHOLESTERYL 145 OLEATE IN ATHEROSCLEROSIS L Rudel, J Sawyer, M Wilson, T Bell (Winston-Salem, NC, USA) 4:15 PM - 4:30 PM ANTIBODY BLOCKING OF ASP-C5L2 INTERACTIONS 146 INCREASES ENERGY EXPENDITURE K Cianflone, S Paglialunga, C Roy, W Cui (Quebec, QC, Canada) 4:30 PM - 4:45 PM ChREBP MEDIATES THE DEVELOPMENT OF HEPATIC 147 STEATOSIS IN THE APGAT2 DEFICIENT MICE YIA V Cortés, A Agarwal, A Garg, J Horton (Dallas, TX, USA) 4:45 PM - 5:00 PM OCCLUSIVE CORONARY ARTERIAL 148 ATHEROSCLEROSIS (OCAA) AND MYOCARDIAL INFARCTION (MI) IN PAIGEN-DIET FED PDZK1/APOE DOUBLE KNOCKOUT (DKO) MICE A Yesilaltay, K Daniels, R Pal, M Krieger, O Kocher (Cambridge, MA, USA and Boston, MA, USA) 5:00 PM - 5:15 PM ACCELERATED ATHEROSCLEROSIS WITH 11β-HSD2- 149 DEFICIENCY IS ASSOCIATED WITH INCREASED YIA INFLAMMATION IN EARLY STAGES OF PLAQUE DEVELOPMENT D Armour, G Deuchar, K Chapman, Y Kotelevtsev (Edinburgh, UK) 5:15 PM - 5:30 PM SELECTIVE DEPLETION OF Foxp3+ REGULATORY 150 T CELLS EXACERBATES EXPERIMENTAL YIA ATHEROSCLEROSIS IN MICE N Gerdes, R Klingenberg, D Strodthoff, T Sparwasser, K Lahl, G Hansson (Stockholm, Sweden, Hannover, Germany and München, Germany)

*Abstract not available at the time of publication 42 YIA - Young Investigators Award Nominee MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 1 BASIC SCIENCE

Poster Board No. Publication No. 1 EFFECT OF CHINESE ACUPUNCTURE ON MOBILIZING ENDOTHELIAL P151 PROGENITOR CELLS INTO BLOOD CIRCULATION OF CEREBRAL ISCHEMIA- REPERFUSION RAT S Cai, Y Zhao, W Yu, S Chen (Chongqing, China) 2 THE CHANGES OF CAVEOLIN-1 AND eNOS IN ENDOTHELIAL CELLS P152 UNDERGOING DISTURBED SHEAR STRESS S Cai, X Dai, B Liu, L Zhang (Chongqing, China) 3 DPI INHIBITS APOPTOSIS AND NADPH OXIDASE 4 EXPRESSION IN HUVECs P153 INDUCED BY AngII Z Ren, S Qu, D Feng (Hengyang, China) 4 HMCO5, HERBAL EXTRACT, INHIBITS NEOINTIMA FORMATION IN BALLOON- P154 INJURED RAT CAROTID ARTERY AND POSSIBLE MECHANISM OF INHIBITION YIA JWY Lee, J-Y Lee, JY Choi, JY Kim, B-S Lee, JE Park (Seoul, Korea) 5 RED WINE IMPROVES HIGH GLUCOSE-STIMULATED ENDOTHELIAL P155 PROGENITOR CELLS DYSFUNCTION VIA eNOS EXPRESSION YIA H-Y Tsai, P-H Huang, F-Y Lin, J-W Chen, S-J Lin (Taipei, Taiwan) 6 CHOLESTEROL LOWERING INHIBITS CRYSTAL FORMATION WITH P156 ASSOCIATED PLAQUE DISRUPTION, THROMBOSIS AND INFLAMMATION R Patel, A Vedre, J Rubinstein, F Shamoun, U Tamhane, G Abela (East Lansing, MI, USA) 7 ATHEROTHROMBOTIC EVENTS IN HYPERLIPIDEMIC HAMSTERS P157 M Barthwal, M Dikshit (Lucknow, India) 8 INHIBITION OF GLYCOSPHINGOLIPID SYNTHESIS STRONGLY REDUCES P158 ATHEROSCLEROSIS DEVELOPMENT IN APOE*3 LEIDEN MICE YIA Monday, June 15 F Bietrix, E Lombardo, C Van Roomen, R Ottenhoff, A Groen, J Aerts (Amsterdam, The Poster Sessions Netherlands) 9 THE ANDROGEN RECEPTOR IS INVOLVED IN GONADAL ATHEROPROTECTION P159 IN BOTH MALE AND FEMALE MICE YIA J Bourghardt, A Wilhelmson, K De Gendt, G Verhoeven, A Krettek, C Ohlsson, Å Tivesten (Gothenburg, Sweden and Leuven, Belgium) 10 THE ROLE OF CAVEOLIN IN EXERCISE-INDUCED IMPROVEMENT OF P160 ENDOTHELIAL FUNCTION IN AGED RATS Y-S Cho, E-J Kim, J-W Suh, K-I Kim (Seongnam, Republic of Korea) 11 IMMOBILIZATION STRESS INDUCES ENDOTHELIAL DYSFUNCTION BY P161 OXIDATIVE STRESS VIA THE ACTIVATION OF THE ANGIOTENSIN II/ITS TYPE I RECEPTOR PATHWAY I-M Chung, S-H Suh, C-K Kim, Y-M Kim (Seoul, Republic of Korea and Chuncheon, Republic of Korea)

YIA - Young Investigators Award Nominee 43 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 12 BLOCKADE OF TGF-b BY CATHETER-BASED LOCAL INTRAVASCULAR GENE P162 DELIVERY DOES NOT ALTER THE IN-STENT NEOINTIMAL RESPONSE, BUT ENHANCES INFLAMMATION IN PIG CORONARY ARTERIES I-M Chung, W Thomas, J Kim, H Ueno (Seoul, Republic of Korea, Seattle, WA, USA and Kitakyusyu, Japan) 13 THE INFLUENCE OF ACUTE AND SUBCHRONIC ADMINISTRATION OF P163 L-ARGININE ON SEIZURES INDUCED BY D,L-HOMOCYSTEINE-THIOLACTONE IN ADULT RATS O Stanojlovic, D Hrncic, A Rasic-Markovic, V Susic, D Djuric (Belgrade, Serbia) 14 EFFECT OF DIETARY SUPPLEMENTATION WITH A COMBINATION OF P164 A MARINE OIL AND AN EXTRA VIRGIN OLIVE OIL ON SERUM LIPIDS, INFLAMMATION AND ATHEROGENESIS IN Apo-E-DEFICIENT MICE FED AN ATHEROGENOUS DIET K-E Eilertsen, E Elvevoll, JO Olsen, M Hoylaerts, B Østerud (Tromsø, Norway and Leuven, Belgium) 15 DIET-INDUCED CORONARY ARTERY ATHEROSCLEROSIS IN SR-BI/LDLR P165 DOUBLE KO MICE YIA M Fuller, B Trigatti (Hamilton, ON, Canada) 16 TACROLIMUS-ELUTING STENT INHIBITS NEOINTIMAL HYPERPLASIA VIA P166 CALCINEURIN/NFAT SIGNALING IN PORCINE CORONARY ARTERY MODEL N Hamada, M Miyata, H Eto, T Shirasawa, A Nagaki, C Tei (Kagoshima, Japan) 17 PROGRESSION OF PATHOGEN ACCELERATED OCCLUSIVE PLAQUE IN THE P167 INNOMINATE ARTERY OF APOLIPOPROTEIN E-DEFICIENT MICE AS DETECTED YIA BY MRI C Hayashi, J Viereck, A Madrigal, F Gibson III, J Hamilton, C Genco (Boston, MA, USA) 18 THE ROLE OF ESTROGEN RECEPTORS ALPHA AND BETA IN P168 ATHEROSCLEROTIC LESION CALCIFICATION IN APOLIPOPROTEIN E-NULL MICE L McRobb, E Liong, J Tan, A Heather (Sydney, Australia) 19 NEW EXPERIMENTAL MODEL OF TYPE 2 DIABETES IN RABBITS PROMOTES P169 RETINA MICROANEURISMS, WHICH ARE ATTENUATED BY RENIN- YIA ANGIOTENSIN BLOCKADE T Helfenstein, J Bottos, S Ihara, D Pomaro, W Relvas, M Farah, A Carvalho, F Fonseca, M Izar (São Paulo, Brazil) 20 EFFECT OF LOSARTAN ON VASCULAR FUNCTION IN FRUCTOSE-FED RATS: P170 THE ROLE OF PERIVASCULAR ADIPOSE TISSUE F Huang, MA Rosas Lezama, JA Perez Ontiveros, E Hong (Mexico City, Mexico) 21 STATIN AND FIBRATE SYNERGISTICALLY INCREASE APOLIPOPROTEIN AV P171 AND DECREASE TRIGLYCERIDES THROUGH UPREGULATION OF PPARA IN YIA RATS X-S Huang, S-P Zhao, L Bai, W Zhao (Changsha, China) 22 THE INFLUENCE OF SILDENAFIL ON OXIDATIVE STRESS PARAMETERS P172 DURING CORONARY AUTOREGULATION ON ISOLATED RAT HEART V Jakovljevic, V Zivkovic, M Vuletic, A Azanjac, N Barudzic, D Djuric (Kragujevac, Serbia and Belgrade, Serbia)

YIA - Young Investigators Award Nominee 44 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 23 THALIDOMIDE INHIBITS ATHEROSCLEROGENESIS IN NEW ZEALAND P173 RABBITS WITH HIGH LIPID DIET Y Kang, L Liu, Q Yang, C Wu, Z Jiang (Hunan, China and Hengyang, China) 24 NARC-1/PCSK9 IS EXPRESSED IN ATHEROSCLEROTIC LESION OF NEW P174 ZEALAND RABBIT Z Tang, L Liu, J Peng, Z Jiang (Hengyang, China) 25 HEPATIC GENE EXPRESSION IN PRAGUE HEREDITARY P175 HYPERCHOLESTEROLEMIC (PHHC) AND WISTAR RATS J Kovar, M Zimolova, M Jirsa, R Poledne (Prague, Czech Republic) 26 ATORVASTATIN AMELIORATES ISCHEMIC LIMB REPAIR IN TYPE 2 DIABETES P176 THROUGH THE IMPROVEMENT OF INSULIN RESISTANCE Y Kureishi-Bando, Y Morimoto, R Shibata, S Shintani, T Murohara (Nagoya, Japan) 27 IMPACT OF SEVERE HYPERTRIGLYCERIDEMIA ON ATHEROGENESIS, P177 PANCREATITIS AND BRAIN DYSFUNCTION G Liu (Beijing, China) 28 THE ROLES OF CAVEOLIN-1 IN ARTERIA CAROTIS ATHEROSCLEROSIS P178 PROMOTED BY ABNORMAL SHEAR STRESS IN NEW ZEALAND RABBITS Q Yang, L Liu (Hengyang, China) 29 PITAVASTATIN SUPPRESSES THE PROGRESSION OF KIDNEY DAMAGE IN 5/6 P179 NEPHRECTOMIZED RAT Y Mori, S Lee, T Hirano (Shinagawa-ku, Japan) 30 HEME OXYGENASE-1 PREVENTS VASCULAR SENESCENCE THROUGH P180 MECHANISMS INVOLVING ROS/SIRT1/p53 PATHWAY IN AGED-MOUSE T Morita, E Terada, B Saji, J Yamasaki (Tokyo, Japan) 31 ENDOGLIN EXPRESSION IN ATHEROGENESIS AND AFTER ATORVASTATIN P181 TREATMENT IN ApoE/LDLr-DEFICIENT MICE YIA P Nachtigal, L Vecerova, S Micuda, E Brcakova, D Solichova (Hradec Kralove, Czech Republic) 32 PITAVASTATIN INCORPORATED NANOPARTICLE-ELUTING STENT P182 ATTENUATES IN-STENT STENOSIS, AND PREVENTS ADVERSE EFFECTS OF YIA SILORIMUS-ELUTING CYPHER STENT IN PORCINE CORONARY ARTERY MODEL Monday, June 15 K Nakano, N Tsukie, K Egashira (Fukuoka, Japan) Poster Sessions 33 ARTERIAL CALCIFICATION AND INTIMAL PROLIFERATION: TWO P183 INDEPENDENT PROCESSES IN ENPP1 DEFICIENCY YIA Y Nitschke, U Hansen, W Völker, P Bruckner, F Rutsch (Muenster, Germany) 34 SMALL ARTERIES AND RENAL MEDULLA ARE MAJOR TARGETS OF P184 ANTIOXIDANT ENZYME DYSFUNCTION IN A MODEL OF ATHEROGENESIS YIA S Oliveira, T Sousa, J Afonso, A Albino-Teixeira (Porto, Portugal) 35 LIPOPROTEIN(a) ACCELERATES ATHEROSCLEROSIS IN UREMIC MICE P185 T Pedersen, S McCormick, S Bro, L Nielsen (Copenhagen, Denmark and Otago, New YIA Zealand)

YIA - Young Investigators Award Nominee 45 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 36 OSTEOPONTIN IS PIVOTAL FOR DEVELOPMENT OF UREMIC P186 ATHEROSCLEROSIS YIA T Pedersen, S Bro, A Hultgardh, L Nielsen (Copenhagen, Denmark and Lund, Sweden) 37 ENDOTHELIAL NF-kB INHIBITION PROTECTS MICE FROM ATHEROSCLEROSIS P187 A Polykratis, R Gareus, E Kotsaki, S Xanthoulea, R Kardakaris, M Gijbels, G Kollias, YIA M de Winther, M Pasparakis (Cologne, Germany, Athens, Greece and Maastricht, The Netherlands) 38 LONG-TERM RECONSTITUTION OF LETHALLY IRRADIATED MICE BY P188 LENTIVIRALLY TRANSDUCED BONE MARROW Lin-c-Kit+-, Lin-c-Kit+Sca-1+- YIA AND CD105+Sca-1+-CELLS N Radukhina, V Shishkina, T Arefieva, P Rutkevich, O Ilyinskaya, E Tararak (Moscow, Russian Federation) 39 ESTABLISHMENT OF A HAMSTER MODEL FOR EVALUATION OF P189 CARDIOCYTOTOXIC DRUGS E Ramos Sanchez, H Goto, T Mauad, D Rodriguez Ferreira Rivero, A Moreira Monteiro, M Gidlund (São Paulo, Brazil) 40 HEAT SHOCK PROTEIN 27 ATHEROPROTECTION IS MEDIATED BY ESTROGEN P190 RECEPTOR b YIA K Rayner, J Sun, Y Chen, M McNulty, T Simard, E O’Brien (Ottawa, ON, Canada) 41 BENEFICIAL IMPACT OF HERBAL ANTI-DIABETIC COMPOUND ON MICRO AND P191 MACROANGIOPATHY: AN EXPERIMENTAL STUDY S Sharma, Reenu, U Rani (New Delhi, India) 42 ROLE OF HEAT SHOCK FACTOR-1 (HSF1) P192 IN UPREGULATION OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN DIABETIC, APOLIPOPROTEIN E-KNOCKOUT MICE AND FIBROBLASTS FROM HSF1- DEFICIENT MICE R Zhao, M Moghadasian, T Mizuno, G Shen (Winnipeg, MB, Canada) 43 PITAVASTATIN AMELIORATES ENDOTHELIAL FUNCTION AND EXERTS ANTI- P193 ATHEROSCLEROTIC EFFECTS ON ANIMAL MODELS OF ATHEROSCLEROSIS H Shibata, Y Yoshinaka, T Maejima, H Yamazaki, S Tanabe, K Sawanobori (Tokyo, Japan) 44 CORRELATION OF VISCERAL FAT ACCUMULATION WITH PLASMA CRP AND P194 ATHEROSCLEROSIS IN METABOLIC SYNDROME-PRONE WHHLMI RABBITS T Ito, S Yamada, T Kobayashi, N Hirayama, M Shiomi (Kobe, Japan) 45 MACROPHAGE ACCUMULATION AND EXPRESSION OF MATRIX P195 METALLOPROTEINASES (MMPS) RELATE TO PLAQUE VULNERABILITY AND ARTERIAL OUTWARD REMODELING T Kobayashi, T Ito, N Hirayama, S Yamada, M Shiomi (Kobe, Japan) 46 CHANGES IN THE STRUCTURE OF AORTAS IN RATS WITH METABOLIC P196 SYNDROME DURING AGING E Soria, ME Rubio, V Guarner (Mexico City, Mexico)

YIA - Young Investigators Award Nominee 46 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 47 AUGMENTED ANGIOGENESIS IN ADVENTITIA PROMOTES PLAQUE P197 PROGRESSION IN APOLIPOPROTEIN E-DEFICIENT MICE K Tanaka, D Nagata, Y Hirata, R Nagai, M Sata (Tokyo, Japan and Tokushima, Japan) 48 EFFECT OF EUCOMMIA ULMOIDES LEAF EXTRACT INHIBITS HYPERTENSION P198 IN CONSCIOUS RATS Z Tang, J Peng (Hengyang, China) 49 ASSOCIATION IN EARLY ATHEROSCLEROSIS WITH RENAL FIBROSIS IN P199 APOLIPOPROTEIN E-DEFICIENT MICE YIA G Tonini, V Nunes de Paiva, N Câmara, M Gidlund (São Paulo, Brazil) 50 PDT APPLICATION FOR EXPERIMENTAL ATHEROSCLEROSIS IN RABBITS P200 O Udartseva, E Andreeva, L Buravkova, E Tararak, I Vozovikov (Moscow, Russian YIA Federation) 51 APOE*3LEIDEN.CETP TRANSGENIC MICE AS MODEL FOR THE METABOLIC P201 SYNDROME YIA A van den Hoek, J van der Hoorn, C van den Hoogen, A van Nieuwkoop, E Offerman, E Pieterman, L Havekes, H Princen (Leiden, The Netherlands) 52 APOE*3LEIDEN-hCETP MICE AS MODEL TO UNRAVEL MECHANISMS P202 UNDERLYING LIPID METABOLISM DISTURBANCES INDUCED BY HIV1 YIA PROTEASE INHIBITORS A van den Hoek, J Baumeister, H Princen, G van ‘t Klooster, J Kurth, M Ott, S Hallenberger, J Bollekens, J Aerssens (Leiden, The Netherlands and Mechelen, Belgium) 53 PROTEASOME INHIBITOR BORTEZOMIB PROMOTES AN UNSTABLE PLAQUE P203 PHENOTYPE IN APOE-DEFICIENT MICE YIA J Van Herck, G De Meyer, W Martinet, H Bult, C Vrints, A Herman (Edegem, Belgium and Wilrijk, Belgium) 54 STROMAL CELL-DERIVED FACTOR-1 AND CXCR4 EXPRESSION P204 UPREGULATION IN INTIMAL HYPERPLASIA INDUCED BY SHEAR FLOW D Wei, G Wang, L Liu, Z Wang, H Huang, C Tang, Y Yang (Chongqing, China and Heng Yang, China) 55 THE ANIMAL MODEL RESEARCH OF VASCULAR GRAFT WITH HELICAL SLOT P205 J Qiu, G Wang, C Tang, J Zhu, H Zhang (Chongqing, China) 56 THE EFFECT OF LDL CONCENTRATION POLARIZATION ON P206 Monday, June 15 Poster Session 1 ATHEROSCLEROSIS Poster Sessions H Liu, G Wang, D Lei, L Ye (Chongqing, China) 57 EFFECT OF SHEAR STRESS CHANGES IN ATHEROSCLEROSIS FORMATION P207 D Lei, G Wang, X He, F Yang (Chongqing, China) 58 CONSTRUCTION AND CDI IMAGING OF ENDOTHELIUM INJURED CAROTID P208 ARTERY ATHEROSCLEROSIS IN RABBIT MODEL L Ye, G Wang, H Liu, D Lei (Chongqing, China) 59 MICROTUS FORTIS MODEL OF HIGH FAT/HIGH SUCROSE/HIGH CHOLESTEROL P209 DIET INDUCED THE VASCULAR COMPLICATIONS OF DIABETES YIA H Wei, Z Wang, J Yu, C Liu, Y Chen, G Xiao, W Yin (Hengyang, China) 60 ORAL INFECTION OF PORPHYROMONAS GINGIVALIS INDUCES PRO- P210 ATHEROGENIC CHANGE IN MICE K Yamazaki, T Maekawa, N Takahashi, T Nakajima, K Tabeta (Niigata, Japan)

YIA - Young Investigators Award Nominee 47 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 61 EFFECTS OF NO-1886 ON INFLAMMATION-ASSOCIATED CYTOKINES IN HIGH- P211 FAT/HIGH-SUCROSE/HIGH-CHOLESTEROL DIET-FED MINIATURE PIGS YIA C Zhang, L Huang, S Qu, W Yin, M Cai, Q Li, H Hou (Hengyang, China) 62 THE RELATIONSHIP BETWEEN PLASMA HOMOCYSTEINE AND P212 APOLIPOPROTEINS CONCENTRATION IN PATIENTS OF PRIOR MYOCARDIAL INFARCTION L Agoston-Coldea, T Mocan, M Gatfosse (Cluj-Napoca, Romania and Coulommiers, France) 63 DIFFERENTIAL MONOCYTIC GENE EXPRESSION IN SUBJECTS WITH P213 PREMATURE MYOCARDIAL INFARCTION YIA S Sivapalaratnam, H Basart, N Watkins, A Goodall, U Krishnan, C Langford, J Kastelein, W Ouwehand, M Trip (Amsterdam, The Netherlands, Cambridge, UK, Leicester, UK and Hinxton, UK) 64 THE ROLE OF TENASCIN-C IN ADVANCED CORONARY ATHEROSCLEROSIS P214 H Akao, M Kitayama, Y Kawai, K Kajinami (Uchinada, Japan) 65 EFFECT OF SULODEXIDE ON ENDOTHELIAL GLYCOCALYX AND VASCULAR P215 PERMEABILITY IN PATIENTS WITH TYPE II DIABETES MELLITUS YIA L Broekhuizen, M Meuwese, H Mooij, B Lemkes, M Gouverneur, M Tang, H Verberne, M Nieuwdorp, H Vink, E Stroes (Amsterdam, The Netherlands) 66 LR11, A NOVEL CIRCULATING MARKER OF CAROTID ATHEROSCLEROSIS, IS P216 ESSENTIAL FOR ANGIOTENSIN II-INDUCED INTIMAL SMOOTH MUSCLE CELL MIGRATION H Bujo, M Jiang, K Ohwaki, W Schneider, Y Saito (Chiba, Japan and Vienna, Austria) 67 HEMOGLOBIN ACTS AS CHEMOTACTIC SIGNAL FOR DENDRITIC CELLS: A P217 PUTATIVE MECHANISM IN THE RECRUITMENT OF INFLAMMATORY CELLS TO YIA THE ATHEROSCLEROTIC VESSEL WALL B Buttari, E Profumo, D Pietraforte, R Businaro, M Minetti, R Riganò (Rome, Italy) 68 IMPLICATION OF THE CaR IN TRANS-DIFFERENTIATION OF SMC IN CVC P218 DURING ATHEROSCLEROSIS YIA A Caudrillier, L Petit, C Boudot, Z Massy, M Brazier, R Mentaverri, S Kamel (Amiens, France) 69 DELETION OF THE LAMININ a4 CHAIN LEADS TO REDUCED INTIMAL P219 HYPERPLASIA YIA Y-T Chang, P-K Tran, U Hedin, K Tran-Lundmark (Stockholm, Sweden) 70 GINKGO BILOBA EXTRACT 761 INDUCTION OF HEME OXYGENASE 1 P220 ACTIVATES ENDOTHELIAL PROGENITOR CELLS AND SUPPRESSES SMOOTH YIA MUSCLE PROGENITOR CELLS J-S Chen, T-C Wu, S-J Lin, J-W Chen (Taipei, Taiwan) 71 CHOLESTIN (MONASCUS PURPUREUS RICE) REDUCES SENESCENCE AND P221 INCREASES PROLIFERATION OF ENDOTHELIAL PROGENITOR CELLS Y-H Chen, Y-L Chen, W-C Chen, P-L Liu, Y-C Chang, C-P Lin (Taichung, Taiwan, Taipei, Taiwan and Kaohsiung, Taiwan)

YIA - Young Investigators Award Nominee 48 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 72 PROPOFOL INHIBITS ANGIOTENSIN II-INDUCED RAT AORTIC SMOOTH P222 MUSCLE CELL PROLIFERATION T-H Cheng, J-C Liu, C-H Chen, K-L Wong (Taichung, Taiwan and Taipei, Taiwan) 73 FLUVASTATIN SYNERGISTICALLY IMPROVES THE ANTIPROLIFERATIVE P223 EFFECT OF EVEROLIMUS ON RAT SMOOTH MUSCLE CELLS BY ALTERING p27Kip1/CYCLIN E EXPRESSION N Ferri, A Granata, F Torti, P Pfister, R Dorent,A Corsini (Milan, Italy, Sophia Antiplois, France and Paris, France) 74 SEVERITY OF CORONARY ATHEROSCLEROSIS AND CARDIOPULMONARY P224 BYPASS AFFECT STEM CELL TRAFFICKING FOLLOWING CARDIAC SURGERY O Dotsenko, Q Xiao, Q Xu, M Jahangiri (London, UK) 75 TL1A IS A MEDIATOR OF HIGH GLUCOSE-INDUCED ENDOTHELIAL APOPTOSIS P225 D Feng W Xiong, Z Jiang, D Feng (Hengyang, China) 76 STUDY OF HIGH GLUCOSE-INDUCED APOPTOSIS IN HUMAN UMBILICAL VEIN P226 ENDOTHELIAL CELLS: ROLE OF NADPH OXIDASE 4 GENE YIA D Feng, W Fan, F Guo, C Zhang, S Qu (Hengyang, China and Nanning, China) 77 THE EFFECT OF L-ARGININE ON BALANCING THE ENDOTHELIAL INJURY P227 AND REPAIR IN EARLY ATHEROSCLEROSIS YIA S Haghjooy Javanmard, M Nematbakhsh (Isfahan, Islamic Republic of Iran) 78 HMG-CoA REDUCTASE INHIBITOR FLUVASTATIN ATTENUATES HYPOXIA P228 INDUCED ENDOTHELIN-1GENE EXPRESSIONS IN VASCULAR SMOOTH MUSCLE CELLS T Hisada, M Ayaori, E Yakushiji, Y Terao, K Nakaya, T Adachi, Y Sakurai, F Ohsuzu, K Ikewaki (Tokorozawa, Japan) 79 MECHANISMS OF NADPH OXIDASE 4 MEDIATED APOPTOSIS IN HUMAN P229 UMBILICAL VEIN ENDOTHELIAL CELLS INDUCED BY HIGH GLUCOSE F Guo, S-L Qu, D-M Feng, Z-S Jiang (Hengyang, China) 80 ENDOTHELIUM-DEPENDENT PROTHROMBOTIC AND FIBRINOLYTIC FACTORS P230 IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE E Shlyakhto, K Khmelnitskaya, M Sitnikova (Saint-Petersburg, Russian Federation) 81 APELIN/APJ AND ADIPONECTIN/T-CADHERIN EXPRESSION IN HUMAN P231 CORONARY ARTERIAL WALL AND PERICORONARY FAT IN CORRELATION YIA Monday, June 15 Poster Session 1 WITH ATHEROSCLEROSIS Poster Sessions C Kostopoulos, S Spiroglou, J Varakis, H Papadaki (Patras, Greece) 82 HSP27 MODULATES OXIDIZED LDL INDUCED DESTRUCTION AND SYNTHESIS P232 OF EXTRACELLULAR MATRIX IN VASCULAR SMOOTH MUSCLE CELLS J Lee, J Kim, J Choi, J Lee, B Lee, J Park (Seoul, Korea) 83 DYSFUNCTION AND APOPTOSIS OF ENDOTHELIAL CELLS VIA LYSOSOMAL P233 DEATH PATHWAY S Eftekhari, X-M Yuan, R Andersson, W Li (Linkoping, Sweden) 84 ROLE OF INSULIN SIGNALLING IN THE TRANSDIFFERENTIATION OF P234 ENDOTHELIAL CELLS INTO SMOOTH MUSCLE CELLS INDUCED BY HIGH GLUCOSE Y Liu, H Li, J Zou (Shaoguan, China)

YIA - Young Investigators Award Nominee 49 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 85 CONJUGATED LINOLEIC ACID REDUCES EXPRESSION OF MIGRATORY P235 REGULATOR SORL1 IN THE VASCULATURE YIA C McCarthy, C Cox, O Belton (Dublin, Ireland) 86 THROMBOSPONDIN INHIBITS DIFFERENTIATION OF ADIPOCYTES P236 S Nomura, T Shingu, K Chayama (Hiroshima, Japan) 87 TELMISARTAN PROTECTS FROM ENDOTHELIAL CELL DAMAGE BY P237 IMPROVING MITOCHONDRIAL FUNCTION THROUGH PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-g INDEPENDENT PATHWAYS T Nozaki, S Sugiyama, H Ogawa (Kumamoto, Japan) 88 CORRELATION OF ENDOTHELIAL PROLIFERATION WITH MONOCYTE P238 ADHESION UNDER LAMINAR OR DISTURBED SHEAR STRESS YIA H Obikane, Y Abiko, H Ueno, N Fukuda, T Matsumoto, M Mitsumata (Tokyo, Japan and Kitakyusyu, Japan) 89 ANGIOTENSIN II-INDUCED Ca2+ IMBALANCE INCREASES IN NEUTROPHILS P239 OF CHRONIC HEMODIALYZED PATIENTS DURING OXIDATIVE BURST I Kis, G Foris, G Paragh, Jr., T Kobling, G Konya, I Seres, G Paragh (Debrecen, Hungary and Budapest, Hungary) 90 ANGIOTENSIN II STIMULATION OF APOPTOSIS AND REACTIVE OXYGEN P240 SPECIES PRODUCTION REQUIRES NADPH OXIDASE 4 EXPRESSION IN HUMAN YIA UMBILICAL VEIN ENDOTHELIAL CELLS S Qu, W Fan, F Guo, X Wei, H Zhu, Z Jiang (Hengyang, China, Nanlin, China and Changsha, China) 91 EPIGENETIC REGULATION AND CHROMATIN REMODELING IN BUTYRATE P241 ARRESTED VASCULAR SMOOTH MUSCLE CELL (VSMC) PROLIFERATION K Ranganna, F Yatsu, O Mathew (Houston, TX, USA) 92 PROLACTIN DOES NOT AFFECT HUMAN PLATELET AGGREGATION OR P242 SECRETION YIA A Reuwer, R Nieuwland, I Fernandez, V Goffin, M Schaap, R Berckmans, J Kastelein, M Twickler (Amsterdam, The Netherlands and Paris, France) 93 ROLE OF IMMUNOGLOBULIN-LIKE CELL ADHESION MOLECULE NECL-5 IN P243 VEGF-INDUCED ANGIOGENESIS Y Rikitake, S Kobayashi, Y Takai, K-I Hirata (Kobe, Japan) 94 INVOLVEMENT OF RAGE, NADPH OXIDASE AND H-Ras/Raf-1 IN GLYCATED P244 LDL-INDUCED EXPRESSION OF HEAT SHOCK FACTOR-1 AND PLASMINOGEN YIA ACTIVATOR INHIBITOR-1 IN VASCULAR ENDOTHELIAL CELLS G Sangle, R Zhao, T Mizuno, G Shen (Winnipeg, MB, Canada) 95 CORONARY ATHEROSCLEROSIS AND EXPRESSION OF MONOCLONAL P245 ANTIBODY 2G12 IN ENDOTHELIAL CELLS M Sano, E Hayashi, T Homma, Y Obana, T Yamada, T Ueno, N Nemoto (Tokyo, Japan) 96 CCN3 INHIBITS NEOINTIMAL HYPERPLASIA THROUGH MODULATION OF P246 SMOOTH MUSCLE CELL GROWTH AND MIGRATION YIA T Shimoyama, S Hiraoka, M Takemoto, Y Saito, H Koseki, K Yokote (Chiba, Japan and Yokohama, Japan)

YIA - Young Investigators Award Nominee 50 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 97 CHEMERIN, VASPIN AND ADIPONECTIN EXPRESSION IN HUMAN P247 PERIADVENTITIAL FAT: CORRELATION WITH ATHEROSCLEROSIS YIA S Spiroglou, C Kostopoulos, J Varakis, H Papadaki (Patras, Greece) 98 ROLES OF ENDOTHELIAL RAP1 SMALL G PROTEIN AND AFADIN IN VEGF- P248 AND S1P-INDUCED ANGIOGENESIS H Tawa, Y Rikitake, Y Takai, K-I Hirata (Kobe, Japan) 99 LOSS OF ENDOTHELIAL INTEGRITY AND ENDOTHELIAL ACTIVATION P249 PRECEDE INTIMAL HYPERPLASIA IN SURGICALLY TRANSFERRED VENOUS GRAFTS IN MICE C-N Tseng, E Karlöf, U Hedin, E Eriksson (Stockholm, Sweden) 100 RELATIONSHIP BETWEEN FILAMIN AND PHENOTYPIC CHANGE IN VASCULAR P250 SMOOTH MUSCLE CELLS YIA M Uchida, I Ishii, M Kitada (Chiba, Japan) 101 PHOTODYNAMIC EFFECTS OF THREE DIFFERENT PHOTOSENSITIZERS ON P251 HUMAN ARTERIAL SMOOTH MUSCLE CELLS YIA O Udartseva, E Andreeva, L Buravkova, E Tararak, I Vozovikov (Moscow, Russian Federation) 102 LYSO-PHOSPHATIDYLCHOLINE INDUCES OSTEOGENIC GENE EXPRESSION P252 AND PHENOTYPE IN VASCULAR SMOOTH MUSCLE CELLS YIA K Vickers, F Castro-Chavez, J Morrisett (Bethesda, MD, USA and Houston, TX, USA) 103 EFFECTS OF SOPHORCARPIDINE ON NUMBER AND FUNCTION OF P253 ENDOTHELIAL PROGENITOR CELLS FROM BONE MARROW OF SD RAT G Wang, L Xiao, X Wu, C Tang, D Jia, Y Liu (Chongqing, China and Hong Kong, China) 104 NOVEL HYDROGEL MEMBRANES FOR CORONARY COVERED STENTS P254 G Wang, T Jiang, J Qiu, L Luo, Y Hou (Chongqing, China) 105 BIOLOGICAL EFFECT AND APPLICATION OF A NOVEL FLUORESCENT GOLD P255 NANOCLUSTER IN ENDOTHELIAL CELLS YIA H-H Wang, C-H Lee, Y-C Lin, C-H Chen, C-L Hsieh, C-H Tsai, J-L Shen, W-H Chan, WH Chang, H-I Yeh (Taipei, Taiwan and Chung-Li, Taiwan) 106 INHIBITORY EFFECTS OF CALPHOSTIN C ON E-LDL-INDUCED ADHESION P256 REACTION OF ENDOTHELIAL CELLS WITH MONOCYTES YIA Z-Q Wang, L-H Li, Z-Y Zhang, X-Y Yang (Xinxiang, China) Monday, June 15 Poster Sessions 107 INVOLVEMENT OF MUSCLIN IN HUMAN UMBILICAL VEIN ENDOTHELIAL P257 CELL APOPTOSIS YIA H Wei, Z Wang, J Yu, G Xiao, G Yi, W Yin (Hengyang, China) 108 AGED GARLIC EXTRACT PRESERVES ENDOTHELIAL P258 TETRAHYDROBIOPTERIN LEVELS AND NITRIC OXIDE BIOAVAILABILITY DURING ELEVATED HOMOCYSTEINE LEVELS VIA ITS ANTIOXIDANT AND THIOL-MODIFYING PROPERTIES N Weiss, N Morihara, N Ide, R Hilge, P Koelle (Dresden, Germany and Munich, Germany) 109 THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA AGONIST P259 ROSIGLITAZONE ATTENUATES ADVANCED GLYCATION END PRODUCTS INDUCED ENDOTHELIAL PROGENITOR CELLS DYSFUNCTION VIA Akt/eNOS SIGNAL PATHWAY C Liang, Z Wu (Shanghai, China)

YIA - Young Investigators Award Nominee 51 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 110 ADVENTITIAL FIBROBLASTS OF APOLIPOPROTEIN E KNOCKOUT MICE P260 EXHIBIT HIGHER ACTIVITIES IN VITRO YIA F Xu, Y Liu, J Ji, R Chen, W Hu (Yantai, China, Binzhou, China and Jinan, China) 111 URSODEOXYCHOLIC ACID INHIBITS ENDOTHELIAL CELL PLASMINONEN P261 ACTIVATOR INHIBITOR-1 EXPRESSION INDUCED BY HIGH GLUCOSE T Yokoi, F Sanada, M Yoshika, K Iekushi, M Masuda, Y Komiyama, Y Taniyama, H Masaki, R Morishita, H Takahashi (Moriguchi, Japan and Suita, Japan) 112 OXIDIZED LDL INDUCED THE BONE MARROW-DERIVED SMOOTH MUSCLE- P262 LIKE CELLS TRANSDIFFERENTIATION INTO FOAM-LIKE CELLS IN VITRO YIA J Yu, Y Li, C Li, R Ruan (Wuhan, China) 113 PROTEOMIC ANALYSIS OF HUMAN LOW DENSITY LIPOPROTEIN REVEALS P263 THE PRESENCE OF PRENYLCYSTEINE LYASE, A HYDROGEN PEROXIDE- GENERATING ENZYME C Banfi, M Brioschi, S Barcella, R Wait, S Galli, E Tremoli (Milan, Italy and London, UK) 114 SPECIFIC FEATURES OF DIABETES MELLITUS IN PATIENTS OF BURYAT P264 POPULATION T Bardymova, I Dedov, L Kolesnikova (Irkutsk, Russian Federation and Moscow, Russian Federation) 115 GLUTATHIONE ANTIOXIDANT PROTECTION IN PATIENTS WITH DIABETES P265 MELLITUS T Bardymova, L Kolesnichenko, E Sergeeva, N Verlan, M Sergeeva (Irkutsk, Russian Federation) 116 RHO KINASE ACTIVITY IN PATIENTS WITH CARDIAC SYNDROME X AND P266 CORONARY ARTERY DISEASE, COMPARED WITH NORMAL POPULATION YIA K-H Chiang, P-Y Liu, J-W Chen, S-J Lin, J Liao (Taipei, Taiwan, Tainan, Taiwan and Cambridge, MA, USA) 117 REGULATION OF b2-GLYCOPROTEIN I GENE EXPRESSION BY HYDROGEN P267 PEROXIDE IN HEPATOMA CELLS YIA W-C Chiu, Z-J Chen, C-J Chen, S-Y Lin, A-N Chiang (Taipei, Taiwan and Taichung, Taiwan) 118 GENERATION OF RECOMBINANT ANTIBODIES TO NITROTYROSINE AND P268 CHLOROTYROSINE TO FACILITATE THE IDENTIFICATION OF NOVEL PROTEIN YIA BIOMARKERS OF ATHEROSCLEROSIS D Hof, S Decasper, A von Eckardstein (Zurich, Switzerland) 119 LONG-TERM PEROXYNITRITE PRODUCTION VIA THE ANGIOTENSIN II/NADPH P269 OXIDASE PATHWAY IN THE VASCULAR WALL OF SHR/NDmcr-cp RATS, A MODEL OF METABOLIC SYNDROME S Kagota, Y Tada, M Kunitomo, K Shinozuka (Nishinomiya, Japan) 120 INFLUENCE OF a-LIPOIC ACID ON GLUTATHIONE SYSTEM AND LIPID P270 PEROXIDATION IN MICE LIVER YIA L Kolesnichenko, V Laletin (Irkutsk, Russian Federation) 121 THE Pro198Leu POLYMORPHISM OF GPx-1 GENE ARE ASSOCIATED WITH P271 CORONARY IN-STENT RESTENOSIS AND INDICES OF OXIDATIVE STRESS J Shuvalova, A Meshkov, A Kaminnyi, R Shirokov, V Kukharchuk (Moscow, Russian Federation)

YIA - Young Investigators Award Nominee 52 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 122 EFFECT OF THE OMEGA-3 FATTY ACIDS EPA AND DHA ON PLASMA AND P272 URINARY F2-ISOPROSTANES: RESULTS FROM TWO PLACEBO-CONTROLLED HUMAN INTERVENTIONS T Mori, E Mas, R Woodman, V Burke, I Puddey, L Beilin (Perth, Australia and Adelaide, Australia) 123 TOCOTRIENOL RICH FRACTION UPREGULATES ENDOTHELIAL NITRIC OXIDE P273 SYNTHASE PROTEIN EXPRESSION IN STIMULATED ENDOTHELIAL CELLS YIA S Muid, G Froemming, M Ali, H Nawawi (Shah Alam, Malaysia and Kuala Terengganu, Malaysia) 124 POSITIVE CORRELATION BETWEEN SEVERITY OF ATHEROSCLEROSIS AND P274 LIVER MITOCHONDRIAL OXIDATIVE STRESS G Dorighello, B Paim, N Inada, A Vercesi, H Oliveira (Campinas, Brazil) 125 EFFECTS OF OXIDIZED OR GLYCATED LDL ON MITOCHONDRIAL P275 RESPIRATORY CHAIN ACTIVITY AND ENZYMES IN ARTERIAL ENDOTHELIAL CELLS S Roy Chowdhury, G Sangle, X Xie, G Shen (Winnipeg, MB, Canada) 126 EFFECT OF OXIDATIVE STRESS ON PLATELET-DERIVED MICROPARTICLES, IN P276 VITRO YIA A Dimitriou, V Chantzichristos, J Mitsios, A Tselepis (Ioannina, Greece) 127 ANGIOPOIETIN-1 PROTECTS ISCHEMIC HEART EXACERBATED BY P277 HYPERGLYCEMIA VIA INCREASE OF ANGIOGENESIS YIA Q Tuo, D Liao (Hengyang, China) 128 ACTIVATED MITOCHONDRIAL ATP-SENSITIVE K+ CHANNELS IN P278 HYPERTRIGLYCERIDEMIC MICE PROMOTES CHANGES IN LIVER REDOX STATE AND BODY METABOLIC RATES L Alberici, H Oliveira, B Paim, A Kowaltowski, A Vercesi (Campinas, Brazil and São Paulo, Brazil) 129 CONTRIBUTION OF NITRIC OXIDE TO THE MITOCHONDRIAL OXIDATIVE P279 STRESS IN HYPERCHOLESTEROLEMIC MICE AC Leite, R Garcia, F Utino, R Castilho, A Cassina, R Radi, H Oliveira, A Vercesi (Campinas, Brazil and Montevideo, Uruguay) 130 TREATMENT OF APO E-DEFICIENT MICE WITH STATIN INHIBITS THE P280 OXIDATIVE STRESS-DEPENDENT LYSOSMAL PROTEASE CATHEPSIN Monday, June 15 ACTIVATION SYSTEM: IMPLICATION FOR PLAQUE STABILITY Poster Sessions XW Cheng, M Kuuzya, T Sasaki, K Nakamura, H Song, L Hu, A Inoue, G-P Shi, T Murohara, K Okumura (Nagoya, Japan) 131 IDENTIFICATION OF NOVEL PROTEIN BIOMARKERS OF ATHEROSCLEROTIC P281 CARDIOVASCULAR DISEASE YIA S Decasper, D Hof, A von Eckardstein (Zurich, Switzerland) 132 TARGETED DELIVERY OF STEM CELLS TO ATHEROSCLEROTIC ARTERIES P282 USING IMMUNOLIPOSOMES Y-J Geng, M Klegerman, C Holland, D McPherson (Houston, TX, USA and Cincinnati, OH, USA) 133 FIBRONECTIN AND COLLAGEN IV IN ATHEROSCLEROSIS P283 R Gopalan (Chennai, India)

YIA - Young Investigators Award Nominee 53 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 134 DL-PROPARGYLGLYCINE EXACERBATES ATHEROSCLEROSIS IN P284 APOLIPOPROTEIN E-KNOCKOUT MICE YIA Z Jiang, Y Liu, C Tang, Z Jiang (Hengyang, China and Beijing, China) 135 IDENTIFICATION OF EXTREMELY HIGH-RISK PLAQUES ON THE BASIS P285 OF LOW ENDOTHELIAL SHEAR STRESS: IMPLICATIONS FOR RISK YIA STRATIFICATION K Koskinas, A Coskun, Y Chatzizisis, M Jonas, C Feldman, P Stone (Boston, MA, USA) 136 HIGH-RISK CORONARY PLAQUES DEVELOP IN REGIONS OF PERSISTENTLY P286 LOW ENDOTHELIAL SHEAR STRESS: A LONG-TERM, SERIAL NATURAL YIA HISTORY IVUS STUDY K Koskinas, Y Chatzizisis, A Coskun, M Jonas, P Stone, C Feldman (Boston, MA, USA) 137 THROMBIN RECEPTOR (PAR1), TISSUE FACTOR AND IRON BINDING PROTEINS P287 IN HUMAN CAROTID ATHEROSCLEROSIS W Li, E Osman, C Forssell, X-M Yuan (Linköping, Sweden) 138 DIFFERENTIAL PROTEOMICS REVEAL CONSISTENT DIFFERENCES IN P288 PROTEIN DISTRIBUTION BETWEEN REGIONS WITHIN HUMAN SYMPTOMATIC YIA CAROTID PLAQUES F Olson, C Sihlbom, P Davidsson, J Hulthe, G Bergström, B Fagerberg (Gothenburg, Sweden and Mölndal, Sweden) 139 THE SOLUBLE UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR P289 IS ASSOCIATED WITH CARDIOVASCULAR DISEASE AND RISK FACTORS IN YIA PATIENTS WITH SYMPTOMATIC CAROTID ATHEROSCLEROSIS F Olson, M Ryndel, T Thurison Sørensen, G Høyer-Hansen, B Fagerberg (Gothenburg, Sweden and Copenhagen, Denmark) 140 PREVENTION OF RUPTURE OF ESTABLISHED ATHEROSCLEROTIC PLAQUES P290 BY TREATMENT WITH APOLIPOPROTEIN A-I DUE TO MODULATION OF SMOOTH MUSCLE CELL PHENOTYPE G Reimers, J Rickards, P Chan, K-A Rye, J Cohn, C Jackson, P Barter, K Rodgers (Camperdown, Australia and Bristol, UK) 141 MMP-8 AND MMP-10/TIMP-1 IMBALANCE IS ASSOCIATED WITH LESION P291 PROGRESSION IN EXPERIMENTAL AND CLINICAL ATHEROSCLEROSIS J Rodriguez, J Orbe, A Cenarro, J Barrenetxe, A Purroy, M Belzunce, F Civeira, J Paramo (Pamplona, Spain and Zaragoza, Spain) 142 A SELECTIVE ACAT1 INHIBITOR, K-604, STABILIZES ATHEROSCLEROTIC P292 LESION VERSUS PACTIMIBE IN APOLIPOPROPTEIN E-KNOCKOUT MICE Y Yoshinaka, H Shibata, H Kobayashi, K Shibuya, S Tanabe, A Miyazaki, K Sawanobori (Tokyo, Japan) 143 RANDOMIZED,CONTROLLED INTERVENTION TRIAL OF LIPOSOMAL P293 COENZYME Q10(LI-Q-Sorb) IN EXPERIMENTAL ATHEROSCLEROSIS P Chattopadhyay, R Singh, F Mustafa (Moradabad, India) 144 A SENSITIVE AMPEROMETRIC IMMUNOSENSOR FOR MYELOPEROXIDASE P294 BASED ON LAYER BY LAYER ASSEMBLY OF MULTI-WALLED CARBON YIA NANOTUBES/THIONINE/GOLD NANOPARTICES-CHITOSAN M Zhou, G Xie, G Wang (Chongqing, China)

YIA - Young Investigators Award Nominee 54 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 2 CLINICAL ASPECTS OF CARDIOVASCULAR DISEASE

Poster Board No. Publication No. 145 SURVEY OF EDUCATIONAL LEVELS, MARITAL STATUS, NUTRITION P295 GUIDELINES COMPLYING, AND GENERAL PREVENTION MEASURES ASSOCIATION WITH HYPERTENSION CONTROL C Feldstein, A de los Santos, M Akopian, D Garrido (Buenos Aires, Argentina) 146 CARDIOVASCULAR DISEASES RISK FACTORS AT PATIENTS WITH ARTERIAL P296 HYPERTENSION AND ABDOMINAL OBESITY ACCORDING TO ATP III AND IDF RECOMMENDATIONS G Kaspruk, O Mitchenko, V Romanov, I Chulajevska (Kyiv, Ukraine) 147 ATHEROSCLEROSIS COULD BE A MAJOR CONTRIBUTING FACTOR IN THE P297 PREVALENCE OF HYPERTENSION IN WEST AFRICA YIA Z Nwosu (Abakaliki, Nigeria) 148 LEFT VENTRICULAR GEOMETRY AND FUNCTION IN ISOLATED SYSTOLIC P298 HYPERTENSION: INFLUENCE OF GENDER M Picca, F Agozzino (Milan, Italy) 149 IS OVERWEIGHT AND OBESITY CORRELATED WITH BLOOD PRESSURE? P299 M Polakowska, W Piotrowski (Warsaw, Poland) 150 PREINFARCTION ANGINA AND EFFECTIVENESS OF THROMBOLYSIS IN ST P300 ELEVATION ACUTE MYOCARDIAL INFARCTION YIA O Ampartzidou, M Zairis, S Makrygiannis, H Bilianou, D Cokkinos, S Foussas (Pireaus, Greece and Athens, Greece) 151 ASSOCIATION OF CIGARETTE SMOKING WITH EARLY ONSET OF ACUTE P301 CORONARY SYNDROME AND LIPID DISORDER; SUB-ANALYSIS OF JAPAN- ACS J Ando, Y Hirata, R Nagai, M Matsuzaki (Bunkyo, Japan and Ube, Japan) Monday, June 15 Poster Sessions 152 DOES ISCHEMIA MODIFIED ALBUMIN ADDED PROGNOSTIC VALUE TO THE P302 THROMBOLYSIS IN MYOCARDIAL INFARCTION RISK SCORE IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION TREATED WITH PRIMARY ANGIOPLASTY ? A Dominguez-Rodriguez, S Samimi-Fard, P Abreu-Gonzalez, I Hernandez-Baldomero, A Jimenez-Sosa (Tenerife, Spain) 153 INTRACORONARY COMPARED WITH INTRAVENOUS BOLUS ABCIXIMAB P303 APPLICATION IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTIONS: EFFECT ON SOLUBLE CD40 LIGAND A Dominguez-Rodriguez, P Abreu-Gonzalez, F Bosa-Ojeda, P Avanzas, S Samimi-Fard, F Marrero-Rodriguez (Tenerife, Spain and Oviedo, Spain) 154 ASSESSING CHROMOGRANIN A RELEASE IN ACUTE PHASE OF ST ELEVATED P304 MYOCARDIAL INFARCTION YIA S Ferraro, G Marano, L Rossi, C Vendramin, L Ciardi, G Bellomo, P Boracchi, A Bongo, E Biganzoli (Novara, Italy and Milan, Italy) 155 CHANGES OF PLASMINOGEN SYSTEM ACTIVITY IN PATIENTS WITH ACUTE P305 CORONARY SYNDROME YIA A Gontar (Kiev, Ukraine)

YIA - Young Investigators Award Nominee 55 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 156 ASSOCIATION OF ADIPONECTIN WITH LEFT VENTRICULAR SYSTOLIC P306 FUNCTION AND FUTURE CARDIOVASCULAR EVENTS IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION S Huang, P Huang (Taipei, Taiwan) 157 ENDOGENOUS HYDROGEN SULFIDE MEDIATES THE CARDIOPROTECTION P307 INDUCED BY POSTCONDITIONING Y Huang, Z Jiang, W Xie, Z Zhao (Hengyang, China) 158 ARGINASE INHIBITION MEDIATES CARDIOPROTECTION DURING ISCHEMIA- P308 REPERFUSION YIA C Jung, A Gonon, P-O Sjoquist, J Lundberg, J Pernow (Stockholm, Sweden) 159 ECG CHANGES IN LEADS II, III, AVF AT PATIENTS WITH NON Q WAVE MI P309 ACCORDING TO BASAL ANTERIOR LESION D Karnialiuk, I Serfinovich (Grodno, Belarus) 160 CLINICAL IMPACT OF CONTINOUS QUALITY IMPROVEMENT ON P310 REDUCING DOOR-TO-BALLOON TIME AND MORTALITY IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION UNDERGOING PRIMARY ANGIOPLASTY C Liu, F Kuo, W Huang, G Mar, C Cheng, S Lin, K Chiou, S Wann (Kaohsiung City, Taiwan and Taipei, Taiwan) 161 ADIPONECTIN AND CIGARETTE SMOKING IN ACUTE MYOCARDIAL P311 INFARCTION A Sotoodeh Jahromi, M Shojaie, M Parsa Mahjoob (Jahrom, Islamic Republic of Iran) 162 RAPID TESTING FOR CARDIAC ENZYMES: PHILIPPINE HEART CENTER P312 PROFILE OF ACUTE MYOCARDIAL INFARCTION B Reyna-Asuncion (Quezon City, Philippines) 163 INFARCTION HEART P313 I Serafinovich (Grodno, Belarus) 164 ANNEXIN V AND ANTI-ANNEXIN V ANTIBODY: TWO INTERESTING ASPECTS P314 OF ACUTE MYOCARDIAL INFARCTION M Shojaie, A Sotoodah, S Roozme, E Kholoosi, S Dana (Jahrom, Islamic Republic of Iran) 165 PLATELET BEHAVIOUR IN PATIENTS WITH DRUG-ELUTING STENTS AFTER P315 THIENOPYRIDINE TREATMENT DISCONTINUATION M Camera, D Villa, D Trabattoni, A Bartorelli, P Bogani, M Brambilla, E Tremoli (Milan, Italy) 166 PLATELET TRANSCRIPTOME PROFILING IN STABLE ANGINA AND NON-ST P316 ELEVATION ACUTE CORONARY SYNDROME K Gertow, G Marenzi, G Colombo, M Brambilla, L Ruggiero, M De Metrio, E Tremoli, M Camera (Milan, Italy) 167 HPA-1 VARIANTS REVEAL EQUAL FLUORESCENCE RESONANCE ENERGY P317 (FRET) SIGNALS UPON INSIDE-OUT SIGNALING YIA V Stoldt, A El Kattouti, R Scharf (Duesseldorf, Germany) 168 ENHANCED PLATELET ACTIVATION INDEXES IN ATRIAL FIBRILLATION P318 PATIENTS: ROLE OF COEXISTING ATHEROSCLEROTIC RISK FACTORS D Ferro, L Polimeni, L Perri, S Basili, F Violi (Rome, Italy) 169 LOW TOTAL SERUM CHOLESTEROL - RISK FACTOR FOR EARLY STENT P319 THROMBOSIS? V Kanic, F Naji, M Penko, V Nedog (Maribor, ) 170 EXAMINATION OF 14 VENOUS THROMBOSIS IN RECENT 5 YEARS P320 Y Minagawa, O Shimooki (Kuji, Japan)

YIA - Young Investigators Award Nominee 56 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 171 THROMBOSIS RISK FACTORS IN HIT PATIENTS AFTER CARDIAC SURGERY P321 A Neykova, B Tzvetkov, M Kirsch (Creteil, France) YIA 172 ANTITHROMBOTIC AND ANTIATHEROGENIC EFFECT OF CLOPIDOGREL ON P322 PATIENTS WITH ACUTE CORONARY SYNDROME YIA K Kalantzi, A Dimitriou, H Milionis, I Goudevenos, A Tselepis (Ioannina, Greece) 173 BIOACTIVE MODIFICATION OF L-POLYLACTIC ACID (L-PLA) MATRIX P323 ON SURFACE OF 316L STAINLESS STEEL STENT TO IMPROVE IMPLANT BIOCOMPATIBILITY L Luo, G Wang, T Jiang, T Yin, Y Li, Y Hou, Y Li, J Qiu, Y Liu (Chongqing, China and Hong Kong, China) 174 PULSE WAVE VELOCITY DETERMINATION AS A TOOL FOR PREVENTING P324 CARDIOVASCULAR DISEASE IN A RURAL FILIPINO POPULATION H Marcoyannopoulou Fojas, E Barrios (Taguig City, Philippines and Quezon City, Philippines) Monday, June 15 Poster Sessions

YIA - Young Investigators Award Nominee 57 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 3 EPIDEMIOLOGY OF CARDIOVASCULAR DISEASE

Poster Board No. Publication No. 175 GENDER DIFFERENCES IN APOLIPOPROTEIN B PARTICLES CONCENTRATION P325 AND APOLIPOPROTEIN B/LDL-C RATIO IN A HEALTHY POPULATION FROM ARGENTINA D Siniawski, W Masson, P Sorroche, L Casañas, W Scordo, J Krauss, A Cagide (Buenos Aires, Argentina) 176 THE PREVALENCE OF CAROTID ARTERY STENOSIS IN CORONARY DISEASE P326 POPULATION IN NORTH AFRICA C Abdelkhirane, K Adnan, A Naji (Casablanca, Morocco) 177 INFLAMMATION AND HEMOSTATIC FACTORS AS RISK FACTORS OF P327 PERIPHERAL ATHEROSCLEROSIS IN DIFFERENT PERIODS OF LIFE YIA A Barsukov, V Andreev, M Melnikov, A Svetlikov, V Zelinsky (Saint-Petersburg, Russian Federation) 178 HYPERURICAEMIA AND CARDIOVASCULAR DISEASE RISK IN INDIVIDUALS P328 IN A DEVELOPING COUNTRY YC Chia, S Pengal (Kuala Lumpur, Malaysia and Penang, Malaysia) 179 PREDICTION OF THE POPULATION AT RISK OF ATHEROTHROMBOTIC P329 DISEASE IS INDEPENDENT OF BLOOD SUGAR LEVEL W Feeman, Jr. (Bowling Green, OH, USA) 180 COMPARISON OF ABILITY OF FRAMINGHAM RISK SCORE WITH BOWLING P330 GREEN STUDY GRAPH TO PREDICT THE POPULATION AT RISK OF ATHEROTHROMBOTIC DISEASE W Feeman, Jr. (Bowling Green, OH, USA) 181 ASSESSMENT OF SOME ATHEROSCLEROSIS RISK FACTORS IN APPARENTLY P331 HEALTHY SUBJECTS FROM TWO AZOREAN POPULATIONS R Ferin, M Lima, ML Pavão (Ponta Delgada, Portugal) 182 PROFILE OF ATHEROSCLEROSIS IN US REPRESENTATIVE SAMPLE P332 K Fox J Robinson, M Bullano, S Grandy (Iowa City, IA, USA, Monkton, MD, USA and Wilmington, DE, USA) 183 ESTIMATES OF CARDIOVASCULAR RISK REDUCTION WITH NIACIN P333 EXTENDED-RELEASE AND SIMVASTATIN IN MIXED DYSLIPIDEMIA W Insull, P Jiang, M Tian, R Thakkar, R Padley (Houston, TX, USA and Abbott Park, IL, USA) 184 IS RISK ASSESSMENT TOOL SUITABLE FOR NO CAUCASIAN DIABETIC P334 POPULATION: A NORTH AFRICAN POPULATION? YIA O Laaribi O Laaribi (Tanger, Morocco) 185 DIABETES MELLITUS 2: CARDIOVASCULAR RISK FACTORS AND DRUG P335 TREATMENTS IN PRIMARY CARE IN SPAIN T Mantilla, A Lorenzo, B Garcia (Madrid, Spain) 186 DIGITAL ASSESSMENT OF ENDOTHELIAL FUNCTION AND ISCHEMIC HEART P336 DISEASE IN WOMEN YIA Y Matsuzawa, S Sugiyama, H Ogawa (Kumamoto, Japan)

YIA - Young Investigators Award Nominee 58 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 187 DIETARY HABITS EVALUATION INCREASES ACCURACY AND REDUCES P337 ESTIMATING BIAS IN CARDIOVASCULAR DISEASE RISK PREDICTION MODELS D Panagiotakos, C Chrysohoou, C Pitsavos, Y Skoumas, C Stefanadis (Athens, Greece) 188 NON-INVASIVE VASCULAR FUNCTION TESTING AIDS IN THE EVALUATION OF P338 PATIENTS WITH CHEST PAIN YIA E Patvardhan, K Heffernan, J Ruan, R Karas, J Kuvin (Boston, MA, USA) 189 PERIPHERAL AUGMENTATION INDEX: A NOVEL NON-INVASIVE MARKER OF P339 CORONARY ARTERY DISEASE YIA E Patvardhan, K Heffernan, R Karas, J Kuvin (Boston, MA, USA) 190 DOES THE INDIVIDUAL GLOBAL RISK INFLUENCE THE MEDICAL CARE? THE P340 NATIONAL MULTICENTER HEALTH SURVEY (WOBASZ) A Piwonska, W Piotrowski, J Piwonski (Warsaw, Poland) 191 THE RISK OF CARDIOVASCULAR DEATH AND MYOCARDIAL INFARCTION P341 AFTER AN ACUTE CORONARY EVENT IS INDEPENDENTLY ASSOCIATED WITH YIA HOPELESSNESS AND LOSS OF PLEASURE DEPRESSIVE SYMPTOMS A Placido, D Munhoz, T Morato, A Gurgel, A Macedo, J Quinaglia e Silva, A Sposito (Brasilia, Brazil) 192 EPIDEMIOLOGY OF PRECURSORS OF ATHEROSCLEROSIS IN CHILDREN P342 - YUSAD STUDY S Simeunovic, Z Milincic, I Novakovic, S Nedeljkovic, M Vukotic, D Simeunovic, D Nikolic (Belgrade, Serbia) 193 CORRELATION BETWEEN OBSTRUCTIVE SLEEP APNEA SYNDROME (OSAS) P343 AND CARDIOVASCULAR RISK (CVR) FACTORS. HOW TO OBTAIN A PRECOCIOUS INDIVIDUATION GM Vincentelli, MR Pirro, M Monti, B Moscatelli, F Alegiani (Rome, Italy) 194 RISK FACTOR CONTROL AND TREATMENT IN REPUBLIC OF SRPSKA PATIENTS P344 WITH KNOWN CORONARY HEART DISEASE 2005-2006 D Vulic, S Loncar, M Krneta, R Skrbic, A Lazarevic (Banja Luka, Bosnia and Herzegowina) 195 FEELING DISCONTENT PREDICTS CARDIOVASCULAR EVENTS IN 58-YEAR P345 OLD HEALTHY MEN G Bergstrom, C Schmidt, P Wahrborg, B Fagerberg (Gothenburg, Sweden) Monday, June 15 Poster Sessions 196 SOCIO-DEMOGRAPHIC AND HEALTH-RELATED FACTORS ASSOCIATED P346 WITH LEISURE TIME PHYSICAL ACTIVITY LEVEL: DATA FROM THE YIA MASSALOMBARDA PROJECT A Cicero, G Noera, M Giovannini, E Grandi, A Gaddi (Bologna, Italy) 197 ABC PROJECT - EUROPEAN INITIATIVE TO IMPROVE PATIENT COMPLIANCE P347 P Kardas (Lodz, Poland) 198 IMPAIRED ENDOTHELIAL FUNCTION IN NURSES WORKING NIGHT SHIFTS P348 W Kim, CS Park, H Park, W Kim, K-S Kim (Seoul, Republic of Korea and Gwangju, Republic of Korea) 199 CHARACTERISTIC OF DYSLIPIDEMIA IN SMOKING AND NON-SMOKING P349 PATIENTS WITH CORONARY DISEASE YIA E Lytvyak (Dnipropetrovsk, Ukraine) 200 EFFECT OF OF ISFAHAN HEALTHY HEART PROGRAM INTERVENTIONS ON P350 NUTRITIONAL BEHAVIOUR OF IRANIAN ADULTS N Mohammadifard, R Kelishadi, F Sajjadi, M Maghroon (Isfahan, Islamic Republic of Iran)

YIA - Young Investigators Award Nominee 59 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 201 ASSOCIATIONS OF CHRONIC INTAKE OF POTATO CHIPS AND CORONARY P351 ARTERY DISEASE RISK FACTORS. A POSSIBLE ROLE OF ACRYLAMIDE M Naruszewicz (Warsaw, Poland) 202 THE HIGH GLOBAL RISK OF FATAL CVD EVENT. DOES IT STIMULATE P352 PERSONS TO MORE HEALTHFUL ACTIVITIES? A Piwonska, W Piotrowski, J Piwonski (Warsaw, Poland) 203 DOES LOW SOCIAL SUPPORT LEVEL CAUSE THE LIMITATION OF P353 CARDIOVASCULAR DISEASES PREVENTION? J Piwonski, A Piwonska (Warsaw, Poland) 204 CARDIOVASCULAR RISK FACTORS IN PERSONS WITH AND WITHOUT P354 DEPRESSIVE SYMPTOMS J Piwonski, E Sygnowska, A Piwonska (Warsaw, Poland) 205 ASSOCIATION BETWEEN SUICIDE AND CARDIOVASCULAR DISEASE: TIME P355 SERIES OF 27 YEARS A Placido, A Sposito (Brasilia, Brazil) 206 PREVALENCE OF ELEVATED ARTERIAL BLOOD PRESSURE AND RELATION P356 WITH ANTHROPOMETRIC MEASURES IN VILNIUS POPULATION P Serpytis, S Glaveckaite, T Juodelis (Vilnius, Lithuania) 207 QUANTITATIVE EXPRESSION OF THE LARGEST SUBCLASS OF HDL P357 (H5C),VLDLTG AND SMALL LDL PARTICLES (sLDLP) IN INFANTS AND THEIR PARENTS P Kwiterovich, D Virgil, V Khouzami, J Otvos (Baltimore, MD, USA, Raleigh, MD, USA and Raleigh, NC, USA) 208 APOLIPOPROTEIN A5 AND E GENE VARIANTS DETERMINE THE EFFICACY OF P358 STATIN TREATMENT M Vrablik, J Hubacek, V Adamkova, V Lanska, K Hirschfeldova, L Zlatohlavek, T Stulc, A Horinek, M Prusikova, R Ceska (Prague, Czech Republic)

YIA - Young Investigators Award Nominee 60 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 4 GENETICS

Poster Board No. Publication No. 209 THE IMPACT OF DIABETES ON MAJOR CARDIOVASCULAR EVENTS IN P359 PATIENTS WITH FAMILIAL COMBINED HYPERLIPOPROTEINEMIA C Masoura, I Skoumas, K Aznaouridis, V Metaxa, L Papadimitriou, C Pitsavos, C Stefanadis (Athens, Greece) 210 EFFECT OF IRON DEPOSITS ON LIPID PHENOTYPE IN FAMILIAL COMBINED P360 HYPERLIPIDEMIA YIA R Mateo-Gallego, E Jarauta, P Calmarza, P Martin-Fortea, E Burillo, A Bea, A Cenarro, F Civeira (Zaragoza, Spain) 211 EPIDEMIOLOGY OF FAMILIAL COMBINED HYPERLIPIDEMIA IN A GREEK P361 POPULATION: 10 YEAR FOLLOW UP L Papadimitriou, J Skoumas, C Pitsavos, A Tsokanis, C Chrysohoou, V Nikolaou, K Masoura, C Stefanadis (Athens, Greece) 213 ESTROGEN RECEPTOR ALPHA POLYMORPHISMS: ARE THEY RELATED TO P363 HIGH HDL-C? R Arnhold, E Kuhlisch, H Kostka, S Bergmann (Dresden, Germany) 214 FAT INTAKE INFLUENCES THE EFFECT OF THE LIPC C-514T POLYMORPHISM P364 ON HDL-C LEVELS IN CHILDREN P Riestra, L López-Simón, H Ortega, G Lydia, J Martin-Moreno, S Schoppen, C Garces (Madrid, Spain and Valencia, Spain) 215 LOSS OF DISULFIDE BOND IN LECITHIN:CHOLESTEROL ACYL TRANSFERASE P365 DUE TO A Cys313–>Tyr MUTATION CAUSES FAMILIAL LCAT DEFICIENCY IN A YIA PATIENT OF MOROCCAN DESCENT A Holleboom, E Stroes, J Kastelein, J Defesche, J Kuivenhoven, C Hollak (Amsterdam, Monday, June 15 The Netherlands) Poster Sessions 216 THE EFFECTS OF ABCG5/G8 POLYMORPHISMS ON PLASMA HDL P366 CHOLESTEROL CONCENTRATIONS DEPEND ON SMOKING HABIT IN THE YIA BOSTON PUERTO RICAN HEALTH STUDY M Junyent, K Tucker, C Smith, J Mattei, C-Q Lai, L Parnell, JM Ordovas (Boston, MA, USA) 217 A NOVEL MISSENSE MUTATION OF ABCA1 IN TRANSMEMBRANE ALPHA- P367 HELIX IN A JAPANESE PATIENT WITH TANGIER DISEASE M Maekawa, J Kikuchi, K Kotani, K Nagao, T Odgerel, K Ueda, M Kawano, Y Furukawa, I Sakurabayshi (Saitama, Japan, Tochigi, Japan and Kyoto, Japan) 218 CETP TAQIB POLYMORPHISM AND PLASMA HDL-C LEVELS IN PREPUBERTAL P368 CHILDREN YIA L López-Simón, P Riestra, MA Lasunción, S Schoppen, C Garcés (Madrid, Spain) 219 INFLUENCE OF CETP Taq IB POLYMORPHISM ON LIPID PROFILE AND HDL P369 SUBPOPULATIONS DISTRIBUTION IN WOMEN WITH AND WITHOUT DIABETES YIA G Russo, B Asztalos, K Horvath, A Di Benedetto, A Giandalia, E Schaefer, D Cucinotta (Messina, Italy and Boston, MA, USA)

YIA - Young Investigators Award Nominee 61 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 220 PHYSICAL INACTIVITY INTERACTS WITH AN ENDOTHELIAL LIPASE P370 POLYMORPHISM TO MODULATE HIGH DENSITY LIPOPROTEIN IN THE GOLDN STUDY C Smith, D Arnett, M Tsai, C Lai, L Parnell, J Shen, M Junyent, M Laclaustra, J Ordovas (Boston, MA, USA, Birmingham, AL, USA, Minneapolis, MN, USA and Madrid, Spain) 221 A NOVEL MUTATION IN CETP GENE AS A CAUSE OF CETP DEFICIENCY IN A P371 CAUCASIAN KINDRED P Tarugi, M Gomaraschi, P Nilsson, E Favari, MP Adorni, F Bernini, C Sirtori, G Franceschini, L Calabresi (Modena, Italy, Milan, Italy, Malmö, Sweden and Parma, Italy) 222 AN INTERPLAY BETWEEN A COMMON ABCA1 POLYMORPHISM AND apoE P372 ISOFORMS IN HDL LEVELS DETERMINATION YIA K Hirschfeldova, M Sedova, M Vrablik, H Svobodova, J Zvarova, J Hubacek, R Ceska (Prague, Czech Republic) 223 RISK FACTORS FOR ATHEROGENESIS IN CAD PATIENTS P373 D Labudovic, S Alabakovska, K Tosheska Trajkovska, S Jovanova (Skopje, Republic of Macedonia) 224 APOLIPOPROTEIN(a) POLYMORPHISMS IN TWO ETHNIC POPULATIONS FROM P374 REPUBLIC OF MACEDONIA K Tosheska Trajkovska, D Labudovic, S Alabakovska, B Todorova (Skopje, Republic of Macedonia)

YIA - Young Investigators Award Nominee 62 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 5 IMAGING OF CARDIOVASCULAR DISEASE

Poster Board No. Publication No. 225 CLINICAL SIGNIFICANCE OF BRANCHIAL-ANKLE PULSE WAVE VELOCITY P375 AS A MARKER OF PERIPHERAL ARTERY DISEASE IN PATIENTS WITH TYPE 2 DIABETES M Iiyama, Y Go, H Kitaoka (Sakai, Japan) 226 Withdrawn P376 227 SKIN AUTOFLUORESCENCE IN LOWER ARM, BUT NOT IN CALF, IS RELATED P377 TO CARDIOVASCULAR RISK IN HIGH RISK PATIENTS YIA B Jochemsen, J van Doormaal, U Mulder, R Graaff, A Smit (Groningen, The Netherlands) 228 EFFECTS OF LONG-TERM LDL-c LOWERING ON ATHEROSCLEROSIS IN P378 ADULTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA YIA S Sivapalaratnam, L van Loendersloot, B Hutten, M Trip, J Kastelein, E de Groot (Amsterdam, The Netherlands) Monday, June 15 Poster Sessions

YIA - Young Investigators Award Nominee 63 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 6 INTERVENTION STUDIES

Poster Board No. Publication No. 229 SHORT-TERM THIAZIDE TREATMENT IMPROVES BLOOD PRESSURE, P379 GLUCOSE, LIPID PROFILES, AND BIOMARKERS IN DIASTOLIC HYPERTENSION C-C Huang, H-B Leu, T-C Wu, S-J Lin, J-W Chen (Taipei, Taiwan) 230 DOES PLANT STEROL IN A DIET HAVE AN EFFECT ON BLOOD PRESSURE? P380 M Kozlowska-Wojciechowska, M Naruszewicz (Warsaw, Poland) 231 EFFECTS OF INSULIN SENSITIVITY AND ANTI-INFLAMMATION AFTER P381 SUPPLEMENT WITH N-3 POLYUNSATURATED FATTY ACID IN METABOLIC SYNDROME H Choe, J-Y Kim, J Yoon, M-S Ahn, K-H Lee, S-H Lee (Gyeonggi-do, Republic of Korea and Kangwon-do, Republic of Korea) 232 ACHIEVEMENT OF GLYCEMIC CONTROL BY SITAGLIPTIN, IN PATIENTS WITH P382 NOT WELL REGULATED TYPE 2 DIABETES E Paschalidou, I Efthimiadis, V Milioni, S Pavlidou, M Vlachopoulou, A Efthimiadis (Thessaloniki, Greece) 233 COMBINING SARTANS OF DIFFERENT DEGREE OF PPARg ACTIVATING P383 CAPACITY WITH ROSUVASTATIN IN PATIENTS WITH HYPERTENSION, IMPAIRED FASTING GLUCOSE AND MIXED DYSLIPIDEMIA C Rizos, E Liberopoulos, M Florentin, M Kostapanos, H Milionis, M Elisaf (Ioannina, Greece) 234 THE EFFECTS OF PIOGLITAZONE ON NEOINTIMA VOLUME AND P384 ATHEROSCLEROSIS PROGRESSION AT EIGHT MONTHS AFTER ZOTAROLIMUS- ELUTING STENT IMPLANTATION IN DIABETIC PATIENTS SJ Hong, CW Goh, K-M Lee, CM Ahn, DS Lim (Seoul, Korea) 235 ARGAN OIL MAY REDUCE CARDIOVASCULAR RISK ASSOCIATED WITH P385 OBESITY A Adlouni, M Cherki, A Khalil, M El Messal (Casablanca, Morocco and Sherbrooke, QC, Canada) 236 CONSERVATIVE TREATMENT OF L-ASPARGINASE-ASSOCIATED LIPID P386 ABNORMALITIES IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA H Cohen, B Bielorai, D Harats, A Toren, O Hamiel (Tel-Hashomer, Israel and Tel Aviv, Israel) 237 ATHEROSCLEROSIS PREVENTION WITH THE ANTI-INFLAMMATORY DIETARY P387 SUPPLEMENT INFLAMINAT YIA T Gorchakova, V Myasoedova, I Sobenin, A Orekhov (Moscow, Russian Federation) 238 IDENTIFYING VERY HIGH RISK PATIENTS OF CORONARY ARTERY DISEASE P388 IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA FROM CLINICAL FEATURES M Harada-Shiba, T Sugisawa, Y Yoshimasa, A Yamamoto, S Yokoyama, H Tomoike (Suita, Japan and Nagoya, Japan) 239 IMPACT OF STATINS ON THE CLINICAL FATE OF HETEROZYGOUS FAMILIAL P389 HYPERCHOLESTEROLEMIA M Harada-Shiba, T Sugisawa, Y Yoshimasa, A Yamamoto, S Yokoyama, H Tomoike (Suita, Japan, Minoh, Japan and Nagoya, Japan)

YIA - Young Investigators Award Nominee 64 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 240 EFFECTS OF DIFFERENT STATINS ON APOLIPOPROTEIN B/A1, GLUCOSE P390 METABOLISM AND INFLAMMATION AT DOSES LOWERING LDL- YIA CHOLESTEROL EQUIVALENTLY: COMPARISON OF ATORVASTATIN 20 MG, ROSUVASTATIN 10 MG AND ATORVASTATIN/EZETIMIBE 5/5 MG A-Y Her, S-H Lee, Y-G Ko, S-M Kang, D Choi, J-W Ha, Y Jang, N Chung (Seoul, Korea) 241 EFFECTS OF COMBINATION THERAPY OF FLUVASTATIN/FENOFIBRATE P391 VERSUS SIMVASTATIN/EZETIMIBE ON LDL-SUBFRACTIONS IN PATIENTS WITH THE METABOLIC SYNDROME K Winkler, T Schewe, G Pütz, N Ödünc, E Siegel, C Abletshauser, M Hoffmann (Freiburg, Germany, Limburg/Lahn, Germany and Nürnberg, Germany) 242 DIFFERENCES IN VASCULAR RESPONSE AND RENAL FUNCTION P392 FOLLOWING MODERATE OR AGGRESSIVE LIPID LOWERING THERAPY IN HYPERCHOLESTEROLEMIC PATIENTS WITH CARDIOVASCULAR DISEASES T Kiyanagi, K Miyauchi, K Shimada, M Hiki, A Kume, T Miyazaki, K Sumiyoshi, H Daida (Bunkyo-ku, Japan) 243 PRAVASTATIN REDUCED CARDIOVASCULAR EVENTS AND TOTAL MORTALITY P393 IRRESPECTIVE OF DOSAGES H Nakamura, K Mizuno (Tokyo, Japan) 244 FAVORABLE EFFECTS OF COMPREHENSIVE CARDIAC REHABILITATION P394 FOLLOWING PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH PRESERVED SYSTOLIC FUNCTION K Oikawa, A Nikaidoh, Y Takikawa, M Takikawa, N Okamoto, T Kasai, T Kiyooka, N Morita, Y Kobayashi (Tokyo, Japan) 245 EFFECTS OF ACUPUNCTURE AT ST36 ON BLOOD PRESSURE AND P395 ENDOTHELIAL DEPENDENT VASODILATION IN HYPERTENSIVE PATIENTS S-U Park, W-S Jung, J-M Park, C-N Ko, H-S Bae, I-W Lee (Seoul, Korea) 246 SLOVAK TRIAL ON CV RISK REDUCTION FOLLOWING NATIONAL GUIDELINES P396 WITH CaDUET - STRONG DUET D Pella, J Fedacko, R Rybar (Kosice, Slovak Republic) 247 IMPACT OF ENHANCED EXTERNAL COUNTERPULSATION (EECP) P397 ON ANGINA CLASS AND EXERCISE DURATION: A META-ANALYSIS YIA S Shah, R Shapiro, J Snyder (Stockton, CA, USA and Travis AFB, CA, USA) 248 EFFECT OF SIMVASTATIN DOSE ON INFLAMMATION AND ENDOTHELIAL P398 Monday, June 15 FUNCTION AFTER MYOCARDIAL INFARCTION Poster Sessions A Sposito, S Santos, L Silva, N Camargo, A Alexandre, B Alvarenga, J Quinaglia e Silva (Brasilia, Brazil) 249 b-ADRENOCEPTOR ANTAGONISM ATTENUATES THE ANTI-INFLAMMATORY P399 EFFECT OF SIMVASTATIN IN THE ACUTE PHASE OF MYOCARDIAL INFARCTION A Sposito, D Munhoz, T Morato, A Gurgel, J Quinaglia e Silva (Brasilia, Brazil) 250 REBOUND INFLAMMATORY RESPONSE DURING THE ACUTE PHASE OF P400 MYOCARDIAL INFARCTION AFTER SIMVASTATIN WITHDRAWAL A Sposito, LS Carvalho, R Cintra, AL Araujo, A Ono, J Andrade, J Quinaglia e Silva (Brasilia, Brazil) 251 NON-HDL-C/HDL-C RATIO IS IMPORTANT RISK FACTOR FOR ALL-CAUSE AND P401 CARDIOVASCULAR MORTALITY IN VERY OLD FRAIL PEOPLE O Vasovic (Belgrade, Serbia) 252 INFLUENCE OF MODERATE CIGARETTE SMOKING ON THE SERUM P402 CONCENTRATION OF ADIPOKINES S Bergmann (Dresden, Germany)

YIA - Young Investigators Award Nominee 65 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No.

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 7 LIPOPROTEIN METABOLISM

253 ASSOCIATION BETWEEN PLASMA PROPROTEIN CONVERTASE SUBTILISING/ P403 KEXIN TYPE 9 (PCSK9) AND LDL-APOB KINETICS IN MEN D Chan, G Lambert, E Ooi, PH Barrett, G Watts (Perth, Australia) 254 EXPRESSION OF APOLIPOPROTEIN M IN FETAL LIVER: IMPACT OF MATERNAL P404 DIABETES YIA C Christoffersen, M Lindegaard, O Axler, P Damm, B Dahlbäck, L Nielsen (Copenhagen, Denmark and Malmö, Sweden) 255 ANTI-ATHEROGENIC MECHANISMS OF SPHINGOLIPID SYNTHESIS INHIBITOR P405 MYRIOCIN IN HEPATOCYTES YIA E Glaros, W Kim, B Garner (Sydney, Australia) 256 HIGHER FREQUENCY OF ABNORMAL SERUM ANGIOPOIETIN-LIKE PROTEIN P406 3 THAN ABNORMAL CHOLESTERYL ESTER TRANSFER PROTEIN IN JAPANESE HYPERALPHALIPOPROTEINEMIC SUBJECTS H Moon, K Nakajima, K Kamiyama, I Sakurabayashi, T Nagamine (Maebashi, Japan and Saitama, Japan) 257 THE COMPARISON BETWEEN FASTING AND POSTPRANDIAL TG VERSUS P407 REMNANT LIPOPROTEINS IN PLASMA OF 23 VOLUNTEERS K Nakajima, T Nakano, HD Moon, T Nagamine, K Stanhope, P Havel, GR Warnick (Maebashi, Japan, Davis, CA, USA and Alameda, CA, USA) 258 POKKURI DEATH SYNDROME AND REMNANT LIPOPROTEINS P408 K Nakajima, S Takeichi, Y Nakajima, M Fujita (Shinjuku-ku, Japan and Isehara, Japan) 259 INCRETINS ARE ASSOCIATED WITH POSTPRANDIAL TRIGYCERIDES P409 J Dekker, J Rijkelijkhuizen, M Alssema, J Holst, A Mari, T Rhodes, E Eekhoff, T Teerlink, P Scheffer, G Nijpels, G Nijpels, C Girman (Amsterdam, The Netherlands, Copenhagen, Denmark, Padua, Italy and North Wales, PA, USA) 260 EZETIMIBE IMPROVES POSTPRANDIAL HYPERLIPIDEMIA IN PATIENTS WITH P410 TYPE IIb HYPERLIPIDEMIA YIA M Inagaki, D Masuda, K Nakatani, K Tsubakio-Yamamoto, T Ohama, Y Nakagawa- Toyama, M Nishida, M Ishigami, S Yamashita (Suita, Japan and Toyanaka, Japan) 261 SERUM CONCENTRATIONS OF REMNANT LIPOPROTEIN AND P411 APOLIPOPROTEIN B-48 DURING TEST MEAL LOADING IN NORMOLIPIDEMIC YOUNG SUBJECTS T Nagata, S Tsuji, M Ono, R Mamoto, S Tateishi, N Totani, Y Fujioka, I Sato, M Yamamoto (Kobe, Japan) 262 PLASMA MARKERS OF CHOLESTEROL HOMEOSTASIS IN METABOLIC P412 SYNDROME SUBJECTS WITH OR WITHOUT TYPE 2 DIABETES YIA T Ng, E Ooi, D Chan, G Watts (Perth, Australia) 263 FASTING AND POSTPRANDIAL APOLIPOPROTEIN B-48 LEVELS IN NORMAL, P413 OBESE, AND HYPERLIPIDEMIC SUBJECTS S Otokozawa, M Ai, M Diffenderfer, A Tanaka, S Lamon-Fava, E Schaefer (Boston, MA, USA and Tokyo, Japan)

YIA - Young Investigators Award Nominee 66 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 264 NONFASTING OR FASTING, THIS IS NO QUESTION. MEASUREMENTS OF P414 LIPIDS FOR THE DAILY PRACTICE I Reiber, I Mezo (Székesfehérvár, Hungary) 265 EZETIMIBE ENHANCES THE IMPROVEMENT OF POSTPRANDIAL P415 HYPERLIPOPROTEINEMIA BY FIBRATE IN PATIENTS WITH TYPE V HYPERLIPOPROTEINEMIA K Takata, N Tada (Hiroshima, Japan and Kashiwa, Japan) 266 FENOFIBRATE REDUCES POSTPRANDIAL HYPERTRIGLYCERIDEMIA IN CD36- P416 DEFICIENT MICE YIA J Sandoval, Y Toyama, D Masuda, K Yamamoto, K Nakatani, M Inagaki, T Ohama, M Nishida, M Ishigami, S Yamashita (Suita, Japan and Toyonaka, Japan) 267 ISOLATION AND CHARACTERIZATION OF APOLIPOPROTEIN B48-CONTAINING P417 LIPOPROTEINS WITH A MONOCLONAL ANTIBODY AGAINST APOLIPOPROTEIN YIA B48 N Yoshimura, M Kinoshita, T Maeda, J Kusano, D Yasuda, Y Takeoka, K Murata, M Fujita, T Ishikawa, T Teramoto (Itabashi, Japan) 268 RETINOIC ACID RECEPTORS AGONISTS REGULATE ATP-BINDING CASSETTE P418 TRANSPORTER G1 EXPRESSION IN MACROPHAGES VIA LIVER X RECEPTOR RESPONSIVE ELEMENTS M Ayaori, M Ogura, K Nakaya, H Uto-Kondo, E Yakushiji, S-I Takiguchi, Y Terao, M Sasaki, F Ohsuzu, K Ikewaki (Tokorozawa, Japan) 269 RELATIONSHIP BETWEEN PLASMA APOLIPOPROTEIN-M AND HIGH DENSITY P419 LIPOPROTEIN APOA KINETICS IN MEN E Ooi, G Watts, D Chan, LB Nielsen, P Plomgaard, B Dahlback, H Barrett (Perth, Australia, Copenhagen, Denmark and Malmö, Sweden) 270 LIPOPROTEINS AND CHOLESTERYL ESTER TRANSFER PROTEIN LEVELS P420 AS RISK FACTORS FOR SEVERE SEPSIS AND MORTALITY IN HOSPITALIZED PATIENTS C Grion, L Cardoso, T Perazolo, A Garcia, D Barbosa, H Morimoto, T Matsuo, A Carrilho (Londrina, Brazil) 271 PRODUCTION OF RECOMBINANT APOLIPOPROTEIN A-I ZARAGOZA (L144R) P421 FOR STRUCTURAL AND FUNCTIONAL CHARACTERIZATION YIA S Fiddyment S Fiddyment, M Pocovi, E Burillo, M Solanas, A-L Garcia-Otin (Zaragoza, Monday, June 15

Spain) Poster Sessions 272 IMPACT OF ANDROID OBESITY AND INSULIN RESISTANCE ON BASAL AND P422 POSTPRANDIAL SR-BI AND ABCA1-MEDIATED SERUM CHOLESTEROL EFFLUX CAPACITIES N Attia, N Fournier, B Vedie, M Cambillau, A Grynberg, J-L Paul, B Guerci (Chatenay- Malabry, France, Paris, France and Toul, France) 273 AN INFLAMMATORY STATE AS OBSERVED IN PATIENTS WITH SEPSIS AND P423 CROHN’S DISEASE DOES NOT AFFECT ABCA-1 MEDIATED CHOLESTEROL EFFLUX R Franssen, J Kastelein, E Stroes, G Dallinga-Thie, J Kuivenhoven (Amsterdam, The Netherlands) 274 THE CHANGES OF HDL PARTICLE SIZE PHENOTYPES BASED ON REVERSE P424 CHOLESTEROL TRANSPORT IN THE HIGH FAT DIET WITH LPL INHIBITOR TREATED APO E KO MICE M Lee H Oh, M Park, K Kim, E Shin, S Park, S Kim, B Won, I Kang, S Lee, (Seoul, Korea, Incheon, Korea and Daejeon, Korea) 275 MAST CELL CHYMASE-DEPENDENT PROTEOLYSIS OF HDL PARTICLES P425 DURING ANAPHYLACTIC SHOCK IN THE MOUSE REDUCES THEIR ABILITY TO INDUCE CELLULAR CHOLESTEROL EFFLUX M Lee-Rueckert, I Judström, P Kovanen (Helsinki, Finland)

YIA - Young Investigators Award Nominee 67 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 276 Withdrawn P426 277 EFFECTS OF THE RICH DIET IN CHOLESTEROL AND SATURATED FAT IN P427 METABOLISM OF THE HIGH-DENSITY LIPOPROTEIN (HDL) IN HAMSTERS T Oliveira, F Maniero, A Padoveze, R Maranhão (Sao Paulo, Brazil) 278 METFORMIN RESTORES IMPAIRED HDL-MEDIATED CHOLESTEROL EFFLUX P428 DUE TO GLYCATION K Matsuki, N Tamasawa, M Yamashita, J Tanabe, H Murakami, J Matsui, T Imaizumi, K Satoh, T Suda (Hirosaki, Japan) 279 ANGIOPOIETIN-LIKE PROTEIN3 IS STRONGLY ASSOCIATED WITH HEPATIC P429 TRIGLYCERIDE LIPASE, BUT NOT ASSOCIATED WITH LIPOPROTEIN LIPASE AND REMNANT LIPOPROTEINS IN PLASMA HD Moon, T Nakano, K Nakajima, T Nagamine (Maebashi, Japan) 280 ROLE OF ADIPONECTIN IN THE ATHEROPROTECTIVE SYSTEM VIA HDL- P430 CHOLESTEROL T Ohama, K Yamamoto, K Nakatani, M Inagaki, J Sandoval, D Masuda, Y Toyama, M Nishida, M Ishigami, S Yamashita (Suita, Japan) 281 IN AORTIC ENDOTHELIAL CELLS ABCA1 AND ABCG1 TOGETHER WITH SR-BI P431 MODULATE APOA-I AND HDL TRANSPORT RESPECTIVELY P Ohnsorg, L Rohrer, A von Eckardstein (Zurich, Switzerland) 282 REGULATION OF HIGH-DENSITY LIPOPROTEIN PARTICLE METABOLISM WITH P432 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR (PPAR) BETA/DELTA YIA AGONIST IN THE METABOLIC SYNDROME E Ooi, G Watts, D Chan, D Sprecher, H Barrett (Perth, Australia and King of Prussia, PA, USA) 283 EFFECT OF DIETARY CHANGES ON REVERSE CHOLESTEROL TRANSPORT P433 I Kralova Lesna, P Suchanek, R Poledne (Prague, Czech Republic) 284 HDL SUBCLASSES DISTRIBUTION, COMPOSITION AND CHOLESTEROL P434 EFFLUX IN CORONARY PATIENTS WITH LDL-C AT TARGET AND UNCONTROLLED HDL-C AND TRIGLYCERIDES R Posadas-Sanchez, G Cardoso-Saldaña, JG Juarez-Rojas, E Jorge-Galarza, A Medina- Urrutia, N Caracas-Portilla, E Mendoza-Pérez, C Posadas-Romero (Mexico City, Mexico) 285 REVERSE CHOLESTEROL TRANSPORT COMPONENTS ASSOCIATE WITH P435 OOCYTE GROWTH YIA J Saarela, J Metso, W Schneider, M Jauhiainen (Helsinki, Finland and Vienna, Austria) 286 Withdrawn P436 287 PHOSPHOLIPID COMPLEXATION TO THE 37pA Apo MIMETIC PEPTIDE P437 INCREASES CHOLESTEROL EFFLUX BY ABCA1 AND ABCG1 TRANSPORTERS BUT DOES NOT INCREASE IN VIVO REVERSE CHOLESTEROL TRANSPORT A Sethi, J Stonik, X Rousset, S Demosky, J Voogt, S Turner, A Remaley (Bethesda, MD, USA and Emeryville, CA, USA) 288 IMB6791 STIMULATES CHOLESTEROL EFFLUX BY INCREASING THE BINDING P438 OF APOLIPOPROTEIN A-I TO ATP-BINDING CASSETTE TRANSPORTER A1 Z Zhang, J Liu, Y Xu, W Jiang, B Hong, Z Xie, S Si (Beijing, China and Toledo, OH, USA) 289 CHOLESTEROL EFFLUX CAPACITY AND ENDOTHELIAL FUNCTION IN TYPE 2 P439 DIABETES MELLITUS K Tan, H Zhou, S Shiu, Y Wong (Hong Kong, Hong Kong)

YIA - Young Investigators Award Nominee 68 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 290 GLIMEPIRIDE ENHANCES APOA-I- AND HDL-MEDIATED CHOLESTEROL P440 EFFLUX FROM THP-1 MACROPHAGES BY INCREASING ABCA1, ABCG1, AND YIA SR-BI EXPRESSIONS Y Terao, M Ayaori, M Ogura, E Yakushiji, K Nakaya, T Hisada, H Uto-Kondo, S-I Takiguchi, H Ozasa, F Ohsuzu, K Ikewaki (Tokorozawa, Japan) 291 CHOLESTEROL EFFLUX FROM MACROPHAGES INDUCED BY HIGH DENSITY P441 LIPOPROTEIN SUBCLASSES AND TOTAL SERUM YIA P Kazakou, M Petraki, M Elisaf, A Tselepis (Ioannina, Greece) 292 EFFECT OF C-TERMINAL APOE TRUNCATIONS ON BIOGENESIS OF HDL P442 A Vezeridis, V Zannis (Boston, MA, USA) 293 ADVANCES IN THE MEASUREMENT OF REVERSE CHOLESTEROL TRANSPORT P443 (RCT) FLUX RATES IN HUMANS J Voogt, S Turner, A Glass, N Saad, J Luchoomun, J Stark, D Boban, M Hellerstein (Emeryville, CA, USA and Berkeley, CA, USA) 294 TRANS INTESTINAL CHOLESTEROL EFFLUX PATHWAY IS NOT MEDIATED P444 THROUGH HDL C Vrins, M Van Eck, R Ottenhoff, P Rensen, A Groen (Amsterdam, The Netherlands and Leiden, The Netherlands) 295 CHARACTERIZATION OF THE ISOFLAVONE PRATENSEIN AS A NOVEL P445 TRANSCRIPTIONAL UP-REGULATOR OF SCAVERGER RECEPTOR BI IN HepG2 YIA CELLS Y Yang, S Si, B Hong (Beijing, China) 296 ROLE OF APOLIPOPROTEIN E IN THE REVERSE CHOLESTEROL TRANSPORT IN P446 VIVO YIA I Zanotti, F Potì, M Pedrelli, G Stomeo, F Bernini (Parma, Italy) Monday, June 15 Poster Sessions

YIA - Young Investigators Award Nominee 69 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 8 NUTRITION AND LIFESTYLE

Poster Board No. Publication No. 297 INCORPORATION OF n-3 FATTY ACID IN FOUR DIFFERENT TISSUES IN P447 CORONARY ARTERY BYPASS PATIENTS I Aardestrup, R Bülow, S Lundbye-Christensen, E Schmidt, J Andreasen (Aalborg, Denmark) 298 THE EFFECT OF DIFFERENT DOSES OF MARINE n-3 POLYUNSATURATED P448 FATTY ACIDS ON SERUM CONCENTRATIONS OF MMP-9, TIMP-1 AND a2- MACROGLOBULIN IN HEALTHY SUBJECTS A Andreasen, J Vogt, V Andersen, T Obel, J Christensen, E Schmidt (Aalborg, Denmark) 299 TRANS FATTY ACID CONTENT OF SOME IRANIAN COMMERCIAL FOOD P449 PRODUCTS S Asgary, B Nazari, N Sarrafzadegan, S Saberi, L Azadbakht, A Esmaillzadeh (Isfahan, Islamic Republic of Iran) 300 DIETARY INTAKE AND INCORPORATION OF MARINE N-3 FATTY ACIDS P450 IN THE ARTERIAL WALL DOES NOT CORRELATE TO FLOW MEDIATED VASODILATION R Bülow, I Aardestrup, T Obel, J Andreasen, E Schmidt (Aalborg, Denmark) 301 LONG TERM EFFECT OF DIETARY ALPHA-LINOLENIC ACID OR P451 DOCOSAHEXAENOIC ACID ON HEART FUNCTION IN VIVO AND IN VITRO IN YIA HEALTHY ADULT RATS A Brochot, M Guinot, P Weill, A Grynberg, D Rousseau-Ralliard (Châtenay-Malabry, France and Combourtillé, France) 302 CLINICAL OBSERVATION STUDY ON OMEGA-3 FATTY ACIDS EFFECTS ON P452 ATHEROSCLEROSIS RISK FACTORS IN DYSLIPIDAEMIC AND MODERATE HYPERTENSION PATIENTS N Doncheva, Y Niagolov (Sofia, ) 303 n-3 POLYUNSATURATED FATTY ACID DECREASE HOMOCYSTEINE VIA P453 REGULATING mRNA EXPRESSION OF THE ENZYMES IN METHIONINE YIA METABOLSIM IN HepG2 T Huang, L Shen, D Li (Hangzhou, China) 304 EFFECTS OF DIACYLGLYCEROL INGESTION ON GLUCOSE/INSULIN P454 METABOLISM AND CHOLESTEROL LEVELS IN EACH LIPOPROTEIN FRACTION K Ito, H Yanai, H Yoshida, Y Hirowatari, N Sato, N Tada (Kashiwa, Japan and Ayase, Japan) 305 DIETARY INTAKE OF DOCOSAPENTAENOIC ACID AND THE RISK OF ACUTE P455 CORONARY SYNDROME IN HEALTHY MEN AND WOMAN A Joensen, E Schmidt, C Dethlefsen, A Tjonneland, L Rasmussen, K Overvad (Aalborg, Denmark and Copenhagen, Denmark) 306 CONTRASTING EFFECTS OF n-3 EPA AND SATURATED PALMITIC ACID ON P456 MODULATING MACROPHAGE DERIVED LIPASES AND ANTI-INFLAMMATORY RESPONSES UJ Jung, R Deckelbaum (New York, NY, USA)

YIA - Young Investigators Award Nominee 70 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 307 EFFECTS OF OMEGA-3 FATTY ACIDS ON LIPOPROTEIN PROFILES AND HEART P457 RATE VARIABILITY IN PATIENTS WITH MIXED DYSLIPIDEMIA SH Kim, HY Lee, WY Chung, JH Zo, MA Kim, HS Kim, CH Kim, DW Sohn, BH Oh, YB Park, YS Choi (Seoul, Republic of Korea and Seongnam, Republic of Korea) 308 EFFECT OF DIETARY OILS ON HIGH-FAT DIET INDUCED DYSLIPIDEMIA IN P458 MICE YIA Y Kitamura, M Namura, T Shimizu, K Sekine, M Takase, T Okada (Zama City, Japan and Itabashi-ku, Japan) 309 IMPACT OF ELEVATED FREE FATTY ACIDS ON INSULIN AND MARKERS OF P459 INFLAMMATION AND ENDOTHELIAL FUNCTION K Newens, A Thompson, K Jackson, C Williams (Reading, UK) 310 IMPACT OF POLYUNSATURATED FATTY ACIDS ON OXIDIZED LOW DENSITY P460 LIPOPROTEIN-INDUCED MONOCYTE APOPTOSIS YIA M Nowak, A Lucas, K Sayegrih, S Tardivel, S Vicca, A Grynberg, B Lacour (Chatenay- Malabry, France and Paris, France) 311 PLASMA FATTY ACID COMPOSITION IN METABOLIC SYNDROME (MS) P461 M Ohni, K Nakajima, Y Hata (Mitaka-shi, Japan, Kohu-shi, Japan and Mito, Japan) 312 THE CONTENT OF MARINE n-3 FATTY ACIDS IN SERUM P462 PHOSPHATIDYLCHOLINE IS INVERSELY ASSOCIATED WITH SMALL AND YIA VERY SMALL LDL PARTICLE CONCENTRATION INDEPENDENTLY OF TRIGLYCERIDES IN PATIENTS WITH A MOLECULAR DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLEMIA A Sala-Vila, M Cofán, M Junyent, D Zambón, Á García-Otín, A Cenarro, F Civeira, E Ros (Barcelona, Spain and Zaragoza, Spain) 313 OMEGA-3 STATUS IN HUMAN FINGERTIP WHOLE BLOOD - RELATIONSHIP P463 TO ERYTHROCYTES AND PLASMA AND THE EFFECT OF A DOSE-RESPONSE YIA INTERVENTION C Sparkes, A Sinclair, R Gibson, P Else, B Meyer (Wollongong, Australia and Adelaide, Australia) 314 EFFECTIVE DOSE OF OMEGA-3 PUFA FOR TRIGLYCERIDE-LOWERING IN PRE- P464 MENOPAUSAL WOMEN YIA C Sparkes, A Sinclair, R Gibson, P Else, B Meyer (Wollongong, Australia, Melbourne, Australia and Adelaide, Australia) Monday, June 15 315 THE EFFECT OF MARINE n-3 POLYUNSATURATED FATTY ACIDS ON PLASMA P465 Poster Sessions MYELOPEROXIDASE LEVELS IN HEALTHY ADULTS YIA J Stegger, V Andersen, J Vogt, T Obel, J Christensen, E Schmidt (Aalborg, Denmark) 316 DIETARY ALPHA-LINOLENIC ACID SUPPRESSES AORTIC ANGIOTENSIN P466 CONVERTING ENZYME IN SPONTANEOUSLY HYPERTENSIVE RATS YIA Y Suzuki, A Ogawa, T Aoyama, H Takeuchi (Yokosuka, Japan)

YIA - Young Investigators Award Nominee 71 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 9 PHARMACOLOGY OF CARDIOVASCULAR DISEASE

Poster Board No. Publication No. 317 EFFECT OF EVEROLIMUS ON PRE-EXISTING ATHEROSCLEROSIS IN LDLR-/- MICE P467 D Brendel, F Beutner, M Müller, D Teupser, R Baber, U Ceglarek, J Thiery (Leipzig, YIA Germany) 318 METHOTREXATE ASSOCIATED TO LIPID NANOEMULSION REDUCES P468 ATHEROSCLEROSIS INDUCED IN RABBITS AND HAS MINIMAL SIDE EFFECTS YIA A Bulgarelli, C Almeida, C Valduga, M Higuchi, R Maranhão (São Paulo, Brazil) 319 IMPACT OF HIGH DOSES OF THE MTP-INHIBITOR, AEGR-733, ON THE SINGLE P469 DOSE PHARMACOKINETICS OF ATORVASTATIN AND ROSUVASTAIN R Dunbar, L Bloedon, R Gadi, D Duffy, A Baer, W Sasiela, D Rader, M Cuchel (Philadelphia, PA, USA and Bridgewater, NJ, USA) 320 EFFICACY, SAFETY AND TOLERABILITY OF THE MTP INHIBITOR AEGR-733 P470 COMBINED WITH ATORVASTATIN M Davidson, T Littlejohn, S Rodstein, C Price, M Parris, W Sasiela, D Rader (Chicago, IL, USA, Winston-Salem, NC, USA, Edina, MN, USA, Bridgewater, NJ, USA and Philadelphia, PA, USA) 321 IMPACT OF THE MTP-INHIBITOR AEGR-733 ON THE SINGLE-DOSE P471 PHARMACOKINETICS OF EXTENDED-RELEASE NIACIN R Dunbar, L Bloedon, R Gadi, R Movva, A Baer, M Parris, W Sasiela, D Rader, M Cuchel (Philadelphia, PA, USA and Bridgewater, NJ, USA) 322 DISCOVERY OF ANTAGONISTS FOR HUMAN SCAVENGER RECEPTOR CD36 P472 VIA AN ELISA-LIKE HIGH-THROUGHPUT SCREENING ASSAY L Wang, Y Bao, Y Yang, S Si, B Hong (Beijing, China) 323 SHOCK WAVE THERAPY OF ISCHEMIC HEART DISEASE: ASSESSMENT OF THE P473 FIRST RESULTS S Jargin (Moscow, Russian Federation) 324 INHIBITORY EFFECT OF AMD3100 ON ApoE-/- MICE BONE MARROW P474 ENDOTHELIAL PROGENITOR CELLS COLONY FORMING ABILITY AND CXCR4 EXPRESSION Z Wang, X Zhou, X Zhang, Z Jiang (Hengyang, China and Xingning, China) 325 SAFETY AND EFFICACY OF AMT-010 GENE THERAPY IN LIPOPROTEIN LIPASE P475 DEFICIENCY (LPLD) E Stroes, J Kuivenhoven, S van Deventer, J Kastelein (Amsterdam, The Netherlands) 326 COMBINED CHEMOTHERAPY ASSOCIATED WITH LIPIDIC NANOEMULSIONS P476 ACHIEVES MARKED ATHEROSCLEROSIS REGRESSION IN THE RABBIT YIA T Vitorio, M Higuchi, R Maranhão (São Paulo, Brazil) 327 SILYMARIN (FLAVONOLIGNANS COMPLEX FROM MILK THISTLE) P477 PROTECTS ENDOTHELIAL PROGENITOR CELLS AGAINST SENESCENCE YIA INDUCED BY RAPAMYCIN A Parzonko, M Naruszewicz (Warsaw, Poland)

YIA - Young Investigators Award Nominee 72 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 328 NITRIC OXIDE-RELEASING AGENT, LA419, REDUCES ATHEROGENESIS IN P478 APOLIPOPROTEIN E DEFICIENT MICE R Carnicer, N Guillén, J Arbonés-Mainar, M Mourelle, C Arnal, M Navarro, C Barranquero, S Gascón, J Osada (Zaragoza, Spain and Barcelona, Spain) 329 RESVERATROL PROTECTS AGAINST ATHEROSCLEROSIS DEVELOPMENT IN P479 APOE*3-LEIDEN.CETP MICE J Berbée, M-C Wong, Y Wang, J Van der Hoorn, J Romijn, L Havekes, H Princen, P Rensen (Leiden, The Netherlands) 330 OXIDATIVE STRESS BLOCKADE IMPROVES STEM CELL SURVIVAL P480 M Rodriguez-Porcel K Peterson, A Aly, S Gambhir (Rochester, MN, USA and Stanford, CA, USA) 331 CHOLESTEROL REDUCTION IN ERYTHROCYTE MEMBRANE AFTER THERAPY P481 WITH STATINS D Tziakas, G Chalikias, D Stakos, I Tentes, A Thomaidi, S Manousakis, S Chatzikyriakou, JC Kaski, A Kortsaris, H Boudoulas (Alexandroupolis, Greece, London, UK and Athens, Greece) 332 NOVEL LXR AGONIST AZ876 REDUCES ATHEROSCLEROSIS WITHOUT P482 INCREASING TRIGLYCERIDES IN PLASMA AND LIVER YIA J van der Hoorn, D Lindén, M Bekkers, M Voskuilen, U Lindahl, J Oscarsson, E Lindstedt, H Princen (Leiden, The Netherlands and Mölndal, Sweden) 333 MYCOPHENOLATE MOFETIL ATTENUATES PLAQUE INFLAMMATION IN P483 PATIENTS WITH SYMPTOMATIC CAROTID ARTERY STENOSIS S van Leuven, D van Wijk, O Volger, J de Vries, C van der Loos, D de Kleijn, A Horrevoets, A van der wal, O de Boer, G Pasterkamp, M Hayden (Amsterdam, The Netherlands, Nieuwegein, The Netherlands, Utrecht, The Netherlands and Vancouver, Canada) 334 ANALYSIS OF NEOINTIMAL HYPERPLASIA AFTER IMPLANTATION OF A P484 MONOCLONAL ANTIBODY ELUTING STENT T Yin, G Wang, D Du, D Yue, Z Li, Y Wang, L Luo, C Ruan (Chongqing, China and Suzhou, China) 335 ALKALOIDS EXTRACTED FROM LOBELIA CHINENSIS LOUR INHIBITED THE P485 FORMATION OF ATHEROSCLEROSIS INDEPENDENT OF LIPID REDUCTION YIA AND apoE PRESENCE Monday, June 15

J Wang, W Hu, L Li (Jinan, China) Poster Sessions 336 GENETIC DETERMINANTS OF LIPID RESPONSE TO ROSUVASTATIN IN P486 CHINESE PATIENTS WITH HYPERCHOLESTEROLAEMIA YIA M Hu, V Mak, E Poon, T Chu, T Tsui, B Tomlinson (Shatin, Hong Kong) 337 EFFECTS OF COMMON SINGLE NUCLEOTIDE POLYMORPHISMS AND P487 HAPLOTYPES OF SLCO1B1 IN CHINESE ON THE PLASMA LIPID RESPONSES TO SIMVASTATIN V Mak, M Hu, T Chu, E Poon, T Tsui, B Tomlinson (Shatin, Hong Kong) 338 THE EFFECT OF HERBAL DRUGS ON CARDIAC DISEASE P488 S Najafi Doulatabad, Z Mohebi Nobandegani (Yasouj, Islamic Republic of Iran and Shiraz, Islamic Republic of Iran) 339 COMPARISON OF ROSUVASTATIN PLUS OMEGA-3 FATTY ACIDS P489 COMBINATION THERAPY AND ROSUVASTATIN MONOTHERAPY IN THE TREATMENT OF MIXED HYPERLIPIDEMIA: A 8 WEEKS RANDOMIZED TRIAL SU Lee, DG Kang, SK Cho (Gwangju, Korea)

YIA - Young Investigators Award Nominee 73 MONDAY, JUNE 15, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 340 EFFICACY, SAFETY AND TOLERABILITY OF A FIXED DOSE COMBINATION P490 OF TELMISARTAN + ATORVASTATIN IN ADULT INDIAN PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA A Sharma, S Vithiavathi, M Mylaswamy, T Shrikanth, K Satish Ramana, C Bolmall, V Baliga (Mumbai, India, Puducherry, India, Coimbatore, India, Chennai, India and Bengaluru, India) 341 EFFICACY AND TOLERABILITY OF EZETIMIBE, STATIN AND FENOFIBRATE P491 COMBINATION THERAPY IN SEVERE HYPERLIPIDAEMIA C van Heyningen, D Turnock (Liverpool, UK) 342 NO DIFFERENCES IN THE SYSTEMIC EXPOSURE TO ATORVASTATIN BETWEEN P492 ASIAN AND CAUCASIAN SUBJECTS K Gandelman, M Messig, R Laskey (New York, NY, USA) 343 DRUG-DRUG INTERACTION STUDY TO ASSESS THE EFFECTS OF MULTIPLE P493 DOSE OF PITAVASTATIN (LIVALO®) ON STEADY-STATE WARFARIN IN HEALTHY ADULT VOLUNTEERS Y Inagaki, T Hunt, B Arana, M Gosho, R Morgan (Morrisville, NC, USA, Austin, TX, USA and Tokyo, Japan) 344 EICOSAPENTAENOIC ACID ATTENUATES STATIN-INDUCED ER STRESS AND P494 TOXICITY IN CULTURED MYOBLAST CELLS M Ohta, H Kawano, T Notsu, H Naba, K Mizuguchi (Gotemba, Japan) 345 LIPID LOWERING EFFECTS OF MYRISTICA FRAGRANS SEEDS (CRUDE AND P495 ISOLATED FRACTION) IN EXPERIMENTAL HYPERLIPIDEMIC RABBITS A Sharma, M Sharma, S Joshi (Alwar, India and Jaipur, India) 346 LONG-TERM FENOFIBRATE USE IS ASSOCIATED WITH REDUCED P496 PREVALENCE OF LIVER ENZYME ELEVATION IN THE FIELD STUDY D Sullivan, M Donoghoe, J Simes, J George, T Keech (Sydney, Australia) 347 COENZYME Q10 LEVELS AND VASCULAR FUNCTION IN PATIENTS ON LONG- P497 TERM STATIN THERAPY FOR FAMILIAL HYPERCHOLESTEROLEMIA YIA J Young, S Molyneux, C Florkowski, A Reinheimer, R Scott, P George (Christchurch, New Zealand) 348 TREATMENT OF ACUTE STEMI WITH THROMBOLYSIS: TENECTEPLASE VS. P498 STREPTOKINASE P Serpytis, V Bilkis, R Palsauskaite, R Katliorius, R Kugiene, D Jarasuniene (Vilnius, Lithuania and Klaipeda, Lithuania)

YIA - Young Investigators Award Nominee 74 TUESDAY, JUNE 16, 2009

PLENARY SESSION II AUDITORIUM

Pathogenesis of Atherosclerosis and Risk Factors Chairs: G Assmann (Münster, Germany), GK Hansson (Stockholm, Sweden), K Stefansson (Reykjavik, Iceland), Y Matsuzawa (Osaka, Japan)

Time Presentation Publication No. 8:00 AM - 8:20 AM THE BIOLOGY OF ATHEROSCLEROSIS 499 MA Gimbrone, Jr. (Boston, MA, USA) 8:20 AM - 8:30 AM COMMENTARY - GK Hansson (Stockholm, Sweden) Tuesday, June 16 8:30 AM - 8:50 AM THE GENETICS OF ATHEROSCLEROSIS 500 R McPherson, O Jarinova, L Chen, A Stewart (Ottawa, ON, Canada) 8:50 AM - 9:00 AM COMMENTARY - K Stefansson (Reykjavik, Iceland) 9:00 AM - 9:20 AM CORONARY HEART DISEASE RISK AND 501 INFLAMMATORY MARKERS W Koenig (Ulm, Germany) 9:20 AM - 9:30 AM COMMENTARY - Y Matsuzawa (Osaka, Japan) 9:30 AM - 9:50 AM CORONARY HEART DISEASE RISK PREDICTION 502 CM Ballantyne (Houston, TX, USA) 9:50 AM - 10:00 AM COMMENTARY AND SESSION CONCLUSIONS - G Assmann (Münster, Germany)

*Abstract not available at the time of publication 75 YIA - Young Investigators Award Nominee TUESDAY, JUNE 16, 2009

CLINICAL SYMPOSIUM III AUDITORIUM

Use of Omega 3 Fatty Acids for Prevention of Heart Disease and Lipid Lowering Chairs: W Harris (Sioux Falls, SD, USA)

Time Presentation Publication No. 10:30 AM - 10:40 AM INTRODUCTORY REMARKS - W Harris (Sioux Falls, SD, USA) 10:40 AM - 11:00 AM OMEGA 3 FATTY ACIDS AND HEART DISEASE RISK 503 REDUCTION R Marchioli (Santa Maria Imbaro, Italy) 11:00 AM - 11:20 AM EICOSAPENTAENOIC ACID AND HEART DISEASE 504 RISK REDUCTION: SECONDARY PREVENTIN STRATA FROM JELIS M Matsuzaki, M Yokoyama, Y Saito (Ube, Japan, Sumoto, Japan and Chiba, Japan) 11:20 AM - 11:40 AM COMBINATION THERAPY WITH STATINS AND 505 OMEGA 3 FATTY ACIDS MH Davidson (Chicago, IL, USA) 11:40 AM - 12:00 PM CONCLUDING REMARKS - W Harris (Sioux Falls, SD, USA)

*Abstract not available at the time of publication 76 YIA - Young Investigators Award Nominee TUESDAY, JUNE 16, 2009

WORKSHOP III-1 BALLROOM B

Intervention Studies: Lifestyle Modifications, Exercise, and Smoking Cessation Chairs: K Stefansson (Reykjavik, Iceland), JW Coe (Groton, CT, USA)

This session is not certified for CME credit.

Time Presentation Publication No. 10:30 AM - 10:45 AM GENETICS OF NICOTINE DEPENDENCE *506 K Stefansson (Reykjavik, Iceland) 10:45 AM - 11:00 AM DISCOVERY, MOA AND CLINICAL RESULTS OF 507 Tuesday, CHANTIX, AN AID TO SMOKING CESSATION: AN June 16 INVENTOR’S AND FORMER-SMOKER’S PERSPECTIVE JW Coe (Groton, CT, USA) 11:00 AM - 11:15 AM COMPREHENSIVE CARDIAC REHABILITATION 508 PROGRAM STRONGLY PREVENTS NEW ONSET OF MYOCARDIAL ISCHEMIA IN PATIENTS RECEIVED PERCUTANEOUS CORONARY INTERVENTION H Adachi, J Murakami, S Tomono, S Oshima (Maebashi, Japan) 11:15 AM - 11:30 AM AEROBIC EXERCISE TRAINING IMPROVES THE 509 IN VIVO MACROPHAGE REVERSE CHOLESTEROL YIA TRANSPORT IN WILD TYPE AND IN huCETPtg MICE D Rocco, S Catanozi, L Okuda, R Pinto, E Nakandakare, E Quintao, M Passarelli (São Paulo, Brazil) 11:30 AM - 11:45 AM IMPACT OF SMOKING AND HIGH-DENSITY 510 LIPOPROTEINS ON CORONARY PLAQUE REGRESSION DURING STATIN THERAPY IN ACUTE CORONARY SYNDROME; SUB-ANALYSIS OF JAPAN-ACS J Ando, Y Hirata, R Nagai, M Matsuzaki (Bunkyo, Japan and Ube, Japan)

*Abstract not available at the time of publication 77 YIA - Young Investigators Award Nominee TUESDAY, JUNE 16, 2009

WORKSHOP III-2 BALLROOM A

Pharmacology and Novel Therapies: PPAR Alpha and Gamma Agonists Chairs: B Staels (Lille, France), SJ Robins (Framingham, MA, USA)

Time Presentation Publication No. 10:30 AM - 10:45 AM THE RXR-PPAR COMPLEX IN THE REGULATION OF 511 ENERGY BALANCE J Plutzky (Boston, MA, USA) 10:45 AM - 11:00 AM CLINICAL CARDIOVASCULAR OUTCOMES USING 512 PPARα AGONISTS SJ Robins (Framingham, MA, USA) 11:00 AM - 11:15 AM MODULATION OF THE IMMUNE-INFLAMMATORY 513 RESPONSE BY PPARS IN THE METABOLIC SYNDROME AND ATHEROSCLEROSIS B Staels (Lille, France) 11:15 AM - 11:30 AM NEW INROADS DEFINING THE CARDIOMETABOLIC 514 BENEFITS OF PPAR AGONISTS IN DIABETES AND INSULIN RESISTANCE G Watts (Perth, Australia) 11:30 AM - 11:45 AM MBX8025, A NOVEL PPARδ AGONIST: LIPID 515 & METABOLIC EFFECTS IN DYSLIPIDEMIC OVERWEIGHT PATIENTS H Bays, S Schwartz, T Littlejohn III, B Kerzner, R Krauss, X Wang, Y Choi, D Karpf, B Roberts (Louisville, KY, USA, San Antonio, TX, USA, Winston-Salem, NC, USA, Baltimore, MD, USA, Oakland, CA, USA and Hayward, CA, USA) 11:45 AM - 12:00 PM LONG-TERM PROBUCOL TREATMENT PREVENTS 516 CARDIOVASCULAR EVENTS IN CORONARY ARTERY DISEASE PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA H Arai, S Yamashita, H Bujo, M Harada-Shiba, S Matsui, M Fukushima, Y Saito, T Kita, Y Matsuzawa (Kyoto, Japan, Suita, Japan, Chiba, Japan and Osaka, Japan) 12:00 PM - 12:15 PM EFFICACY AND SAFETY OF FENOFIBRIC 517 ACID IN COMBINATION WITH ATORVASTATIN AND EZETIMIBE IN PATIENTS WITH MIXED DYSLIPIDEMIA: A PHASE 3 STUDY P Jones, A Goldberg, H Knapp, M Kelly, C Setze, J Stolzenbach, D Sleep (Houston, TX, USA, St. Louis, MO, USA, Billings, MT, USA and Abbott Park, IL, USA) 12:15 PM - 12:30 PM ACTIVATION OF THE NUCLEAR RECEPTOR PXR 518 DECREASES PLASMA LDL-CHOLESTEROL LEVELS YIA AND INDUCES HEPATIC STEATOSIS IN LDL RECEPTOR KNOCKOUT MICE M Hoekstra, B Lammers, R Out, Z Li, M Van Eck, T Van Berkel (Leiden, The Netherlands)

*Abstract not available at the time of publication 78 YIA - Young Investigators Award Nominee TUESDAY, JUNE 16, 2009

WORKSHOP III-3 BALLROOM C

Epidemiology of Cardiovascular Disease: Biomarkers of CHD Risk Chairs: PW Wilson (Atlanta, GA, USA), A Levy (Haifa, Israel)

Time Presentation Publication No. 10:30 AM - 10:45 AM BIOMARKERS IN THE ASSESSMENT OF 519 CARDIOVASCULAR OUTCOMES PW Wilson (Atlanta, GA, USA) 10:45 AM - 11:00 AM PHARMACOGENOMIC APPLICATION OF THE 520 HAPTOGLOBIN GENOTYPE IN THE PREVENTION OF Tuesday, DIABETIC CARDIOVASCULAR DISEASE June 16 A Levy (Haifa, Israel) 11:00 AM - 11:15 AM SOLUBLE LECTIN-LIKE OXIDIZED LDL RECEPTOR-1 521 (SLOX-1) AS A PROGNOSTIC BIOMARKER FOR ACUTE CORONARY SYNDROME N Kume, H Mitsuoka, K Hayashida, M Tanaka, T Kita (Kyoto, Japan and Osaka, Japan) 11:15 AM - 11:30 AM FVII, FVIIA AND DOWNSTREAM MARKERS OF 522 EXTRINSIC PATHWAY ACTIVATION DIFFER BY EPCR SER219GLY VARIANT IN HEALTHY MEN H Ireland, J Cooper, F Drenos, J Morrissey, M Esnouf, K Bauer, S Humphries (London, UK, Illinois, IL, USA, Oxford, UK and Boston, MA, USA) 11:30 AM - 11:45 AM SYSTOLIC BLOOD PRESSURE IS THE MOST 523 IMPORTANT FACTOR FOR THE PREDICTION OF ARTERIOSCLEROSIS IN WOMEN TS Kim, DY Kim, HH Shin (Seoul, Korea) 11:45 AM - 12:00 PM LOW SERUM LEVELS OF DHEA PREDICT DEATH 524 FROM CARDIOVASCULAR DISEASE IN OLDER MEN C Ohlsson, F Labrie, E Barrett-Connor, L Vandenput, M Karlsson, Ö Ljunggren, Å Tivesten (Gothenburg, Sweden, Quebec, QC, Canada, San Diego, USA, Malmö, Sweden and Uppsala, Sweden) 12:00 PM - 12:15 PM PLASMA MYELOPEROXIDASE CONCENTRATION IS 525 INVERSELY ASSOCIATED WITH BRACHIAL FLOW- MEDIATED VASODILATION IN SUBJECTS WITH ABNORMAL GLUCOSE METABOLISM L van der Zwan, T Teerlink, J Dekker, R Henry, C Stehouwer, C Jakobs, R Heine, P Scheffer (Amsterdam, The Netherlands and Maastricht, The Netherlands)

*Abstract not available at the time of publication 79 YIA - Young Investigators Award Nominee TUESDAY, JUNE 16, 2009

WORKSHOP III-4 ROOM 302

Genetics: Genetics of LDL Chairs: S Humphries (London, UK), JC Defesche (Amsterdam, The Netherlands)

Time Presentation Publication No. 10:30 AM - 10:45 AM GENETICS OF LDL: STATE-OF-THE-ART 526 JC Defesche (Amsterdam, The Netherlands) 10:45 AM - 11:00 AM GENETIC DETERMINANTS OF LDL-C LEVELS: USING 527 THE 50K CARDIO-METABOLIC CHIP TO EXPLORE THE GENETIC ARCHITECTURE OF LIPID TRAITS IN WHITEHALL II S Humphries, P Talmud, F Drenos, S Shah, J Palmen, T Shah, M Kumari, J Pallas, J Casas, J Whittaker, A Hingorani (London, UK) 11:00 AM - 11:15 AM FAMILIAL HYPOBETALIPOPROTEINEMIA DUE TO 528 MISSENSE MUTATIONS IN APOB WHICH AFFECT HEPATIC SECRETION OF APOB-CONTAINING LIPOPROTEINS S Zhong, L Magnolo, Z Yao, P Tarugi (Ottawa, ON, Canada and Modena, Italy) 11:15 AM - 11:30 AM KNOCK-OUT MODELS IN MICE AND MEN SUGGEST A 529 PROATHEROGENIC ROLE FOR USF1 YIA P-P Laurila, K Merikanto, V Olkkonen, M Jauhiainen, L Peltonen (Helsinki, Finland, Cambridge, UK and Boston, MA, USA) 11:30 AM - 11:45 AM GENETIC DIAGNOSIS OF FAMILIAL 530 HYPERCHOLESTEROLEMIA (FH) AND LDL- CHOLESTEROL GOAL ACHIEVEMENT R Alonso, J Villar, F Fuentes, D Zambon, P Mata (Madrid, Spain, Sevilla, Spain, Cordoba, Spain and Barcelona, Spain) 11:45 AM - 12:00 PM A UNIQUE TOOL TO DETECT LDLR, APOB AND PCSK9 531 POINT MUTATIONS AS WELL AS COPY NUMBER YIA CHANGE IN THE LDLR GENE M Stef, L Palacios, M Viegas, D Tejedor, A Martinez, M Pocovi, J Defesche (Derio, Spain, Zaragoza, Spain and Amsterdam, The Netherlands) 12:00 PM - 12:15 PM MOLECULAR GENETIC EPIDEMIOLOGY OF FAMILIAL 532 HYPERCHOLESTEROLEMIA IN HOKURIKU DISTRICT OF JAPAN H Mabuchi, A Nohara, T Noguchi, J Kobayashi, M-A Kawashiri, M Takada, M Tuchida, H Tada, C Nakanishi, M Mori, M Yamagishi, J Koizumi, A Inazu (Kanazawa, Japan) 12:15 PM - 12:30 PM BEXAROTENE INDUCES DYSLIPIDEMIA BY 533 INCREASED VLDL PRODUCTION AND CETP- YIA MEDIATED REDUCTION OF HDL J de Vries-van der Weij, W de Haan, L Hu, J van der Hoorn, L Havekes, H Princen, J Romijn, J Smit, P Rensen (Leiden, The Netherlands)

*Abstract not available at the time of publication 80 YIA - Young Investigators Award Nominee TUESDAY, JUNE 16, 2009

WORKSHOP III-5 ROOM 312

Nutritional Studies: Dietary Cholesterol Absorption and Heart Disease Chairs: T Miettinen (Helsinki, Finland) G Assmann (Münster, Germany)

Time Presentation Publication No. 10:30 AM - 10:45 AM SURROGATE MARKERS OF CHOLESTEROL 534 ABSORPTION AND SYNTHESIS OF YOUNG AND ELDERLY SUBJECTS WITHOUT AND WITH CORONARY RISK T Miettinen, H Gylling (Helsinki, Finland) Tuesday, 10:45 AM - 11:00 AM CHOLESTEROL ABSORPTION AND SYNTHESIS IN 535 June 16 INDIVIDUALS WITH AND WITHOUT A CHD EVENT DURING PRAVASTATIN THERAPY: INSIGHTS FOR THE PROSPER TRIAL N Matthan, N Restighini, M Robertson, I Ford, J Shepherd, A Lichtenstein, E Schaefer (Boston, MA, USA and Glasgow, UK) 11:00 AM - 11:15 AM BASELINE CHOLESTEROL ABSORPTION MARKERS 536 DO NOT PREDICT LDL-CHOLESTEROL REDUCTION BY EZETIMIBE/SIMVASTATIN IN SUBJECTS WITH FAMILIAL HYPERCHOLESTEROLEMIA; A POST-HOC ANALYSIS OF THE ENHANCE TRIAL L Jakulj, M Vissers, B Hutten, A Groen, D Lutjohann, E Veltri, J Kastelein (Amsterdam, The Netherlands, Bonn, Germany and Kenilworth, NJ, USA) 11:15 AM - 11:30 AM CHOLESTEROL METABOLISM IN RELATION TO 537 GLUCOSE TOLERANCE IN A LARGE FINNISH MALE POPULATION H Gylling, J Pihlajamäki, M Hallikainen, P Simonen, J Kuusisto, M Laakso, T Miettinen (Kuopio, Finland and Helsinki, Finland) 11:30 AM - 11:45 AM CLINICAL INVESTIGATIONS INTO THE ROLE OF MTP 538 IN CHYLOMICRON FORMATION USING SLx-4090, AN ENTEROCYTE-SPECIFIC INHIBITOR W Tong, E Paradise, O Schueller, J Ferkany, P Sweetnam (Brighton, MA, USA) 11:45 AM - 12:00 PM ARE OXIDIZED PLANT STEROLS UNDERLYING CHD 539 RISK IN SITOSTEROLEMIA? J Plat, E Theuwissen, D Lutjohann, R Mensink (Maastricht, The Netherlands and Bonn, Germany) 12:00 PM - 12:15 PM TYPE 2 DIABETES STRONGLY INDUCES HEPATIC 540 OVEREXPRESSION OF SULF2, A NOVEL FACTOR THAT SUPPRESSES UPTAKE OF REMNANT LIPOPROTEINS K Chen, M-L Liu, L Schaffer, M Li, KJ Williams (Philadelphia, PA, USA and La Jolla, CA, USA)

*Abstract not available at the time of publication 81 YIA - Young Investigators Award Nominee TUESDAY, JUNE 16, 2009

WORKSHOP III-6 ROOM 304

Imaging of Atherosclerosis: External Ultrasound Imaging Chairs: E de Groot (Amsterdam, The Netherlands), DH O’Leary (Dorchester, MA, USA)

Time Presentation Publication No. 10:30 AM - 10:45 AM IMAGING CAROTID ATHEROSCLEROSIS 541 E de Groot, R Duivenvoorden, E Stroes, J Kastelein (Amsterdam, The Netherlands) 10:45 AM - 11:00 AM EXAMING CAROTID ULTRASOUND IMAGING TRIALS 542 DH O’Leary (Dorchester, MA, USA) 11:00 AM - 11:15 AM ASSOCIATIONS BETWEEN CAROTID ARTERY INTIMA 543 MEDIA THICKNESS, LEUKOCYTES AND HIGH SENSITIVE C REACTIVE PROTEIN IN A HIGH RISK EUROPEAN POPULATION E Tremoli, D Baldassarre (Milan, Italy) 11:15 AM - 11:30 AM CROSS-SECTIONAL EVALUATION OF CAROTID 544 INTIMA-MEDIA THICKNESS (IMT) IN RELATION TO PRIOR CHOLESTEROL-LOWERING DRUG TREATMENT IN A CLINICAL SETTING E Ros, D Zambon, M Junyent, R Gilabert, I Nuñez, A Sala- Vila, M Domenech, M Cofan (Barcelona, Spain) 11:30 AM - 11:45 AM ULTRASOUND CHARACTERISTICS OF CAROTID 545 WALLS ARE AFFECTED BY STEROID TREATMENT IN TAKAYASU’S ARTERITIS S Kwon, S-M Park, J-S Oh, C-K Lee, E-H Lee, J-M Park, B Yoo (Seoul, Korea) 11:45 AM - 12:00 PM HERITABILITY OF ULTRASONIC MEASUREMENTS OF 546 SUBCLINICAL ATHEROSCLEROSIS A Panayiotou, M Griffin, T Tyllis, N Georgiou, D Bond, A Pfeufer, T Meitinger, A Nicolaides (Nicosia, Cyprus and Munich, Germany) 12:00 PM - 12:15 PM HYPERALPHALIPOPROTEINEMIC INDIVIDUALS 547 HAVE PROTECTIVE MODULATION OF CAROTID INTIMA-MEDIA THICKNESS F Santiago, R Nakamura, L Castilho, E de Faria (Campinas, Brazil) 12:15 PM - 12:30 PM CAROTID IMAGING AND RISK FOR 548 CAD IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (FH) AND NON-FH P Hopkins (Salt Lake City, UT, USA)

*Abstract not available at the time of publication 82 YIA - Young Investigators Award Nominee TUESDAY, JUNE 16, 2009

WORKSHOP III-7 ROOM 310

Lipoprotein Metabolism: Metabolism of Triglyceride-Rich Lipoproteins Chairs: U Beisiegel (Hamburg, Germany), JS Cohn (Sydney, Australia)

Time Presentation Publication No. 10:30 AM - 10:45 AM NEW ASPECTS OF POSTPRANDIAL LIPID 549 METABOLISM U Beisiegel (Hamburg, Germany) 10:45 AM - 11:00 AM PLASMA TRIGLYCERIDE METABOLISM IN THE FED 550 STATE - CLINICAL AND PATHOPHYSIOLOGICAL Tuesday, SIGNIFICANCE June 16 JS Cohn (Sydney, Australia) 11:00 AM - 11:15 AM THE DIFFERENCE BETWEEN THE MEASUREMENT 551 OF PLASMA TG AND REMNANT LIPOPROTEINS FOR DIAGNOSTIC USE K Nakajima, T Nakano (Tokushima, Japan) 11:15 AM - 11:30 AM HUMAN TRIGLYCERIDE METABOLISM: NEW 552 PROTEINS, NEW INSIGHTS G Dallinga-Thie, J Kastelein (Amsterdam, The Netherlands) 11:30 AM - 11:45 AM LIPID TRANSFER PROTEINS, INFLAMMATION AND *553 ATHEROSCLEROSIS E Quintao (São Paulo, Brazil) 11:45 AM - 12:00 PM AN OPEN-LABEL, DOSE ESCALATION STUDY 554 TO ASSESS THE SAFETY AND EFFICACY OF AAV1-LPLS447X GENE THERAPY WITH ALIPOGENE TIPARVOVEC (AMT-011) FOR PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA DUE TO LIPOPROTEIN LIPASE DEFICIENCY (LPLD) D Gaudet, D Brisson, J Methot, S van Deventer (Chicoutimi, QC, Canada and Amsterdam, The Netherlands) 12:00 PM - 12:15 PM THE EFFECT OF THE n-3/n-6 PUFA RATIO ON THE 555 POSTPRANDIAL LDL PHENOTYPE AND ISCHEMIA MODIFIED ALBUMIN (IMA). THE LIPGENE STUDY J Hartwich, M Malczewska-Malec, B Kiec-Wilk, I Leszczynska-Golabek, A Dembinska-Kiec, P Perez-Martinez, J Lopez-Miranda, H Roche, AC Tierney (Kraków, Poland, Cordoba, Spain and Dublin, Ireland) 12:15 PM - 12:30 PM TRIACYLGLYCEROL-RICH LIPOPROTEINS 556 INFLUENCE THE INACTIVATION OF LIPOPROTEIN YIA LIPASE BY ANGPTL 3 AND ANGPTL 4 S Nilsson, M Larsson, A Lookene, J Heeren, G Olivecrona (Umeå, Sweden and Hamburg, Germany)

*Abstract not available at the time of publication 83 YIA - Young Investigators Award Nominee TUESDAY, JUNE 16, 2009

WORKSHOP III-8 ROOM 311

Basic Science and Vascular Biology: Joint IAS-EAS Workshop: Inflammation and Atherosclerosis Chairs: C Weber (Aachen, Germany), GK Hansson (Stockholm, Sweden)

Time Presentation Publication No. 10:30 AM - 10:45 AM APOPTOTIC CELL CLEARANCE AND IMMUNE 557 REGULATION IN ATHEROSCLEROSIS Z Mallat (Paris, France) 10:45 AM - 11:00 AM HEMODYNAMIC CONTROL OF ENDOTHELIAL 558 ATHEROPROTECTION G Garcia-Cardena (Boston, MA, USA) 11:00 AM - 11:15 AM CHEMOKINES AS THERAPEUTIC TARGETS IN 559 ATHEROSCLEROSIS C Weber (Aachen, Germany) 11:15 AM - 11:30 AM MECHANISMS OF ATHEROPROTECTIVE IMMUNITY 560 GK Hansson (Stockholm, Sweden) 11:30 AM - 11:45 AM ARTERIAL AND AORTIC VALVE CALCIFICATION 561 ABOLISHED BY ELASTOLYTIC CATHEPSIN S DEFICIENCY IN CHRONIC RENAL DISEASE E Aikawa, M Aikawa, P Libby, G-P Shi, R Weissleder (Boston, MA, USA) 11:45 AM - 12:00 PM DIFFERENTIAL EFFECTS OF ANGIOTENSIN II ON 562 INFLAMMATION IN THE PERIVASCULAR AND YIA VISCERAL ADIPOSE TISSUE T Guzik, K Mihulka, K Budzyn, R Korbut (Cracow, Poland and Atlanta, GA, USA) 12:00 PM - 12:15 PM ROLE OF nNOS IN ATHEROSCLEROSIS 563 P Padmapriya, A Schröttle, S Grüner, A Schäfer, P Huang, J Bauersachs, B Nieswandt, G Ertl, P Kuhlencordt (Wuerzburg, Germany, Boston, MA, USA and Munich, Germany)

*Abstract not available at the time of publication 84 YIA - Young Investigators Award Nominee TUESDAY, JUNE 16, 2009

MASTER SESSION III BALLROOM B

Genetic Testing and Heart Disease Risk Assessment

Time Presentation Publication No. 1:30 PM - 2:15 PM GENETIC TESTING AND HEART DISEASE RISK *565 ASSESSMENT JP Kane (San Francisco, CA, USA) 2:15 PM - 2:30 PM COMMENTARY - S Humphries (London, UK) Tuesday, June 16

MASTER SESSION IV BALLROOM A

The Role of Apolipoprotein E in Heart Disease and Dementia

Time Presentation Publication No. 1:30 PM - 2:30 PM APOLIPOPROTEIN E: STRUCTURE DETERMINES 566 FUNCTION - FROM ATHEROSCLEROSIS TO ALZHEIMER’S DISEASE TO AIDS R Mahley, K Weisgraber, Y Huang (San Francisco, CA, USA) 2:30 PM - 2:45 PM COMMENTARY - VI Zannis (Boston, MA, USA)

CLINICAL SYMPOSIUM IV AUDITORIUM

Use of Niacin and the Statin-Niacin Combination for Heart Disease Prevention Chair: A Taylor (Washington, DC, USA)

Time Presentation Publication No. 1:30 PM - 1:55 PM EFFECTS OF NIACIN ON PLASMA LIPOPROTEINS 567 ML Kashyap (Long Beach, CA, USA and Irvine, CA, USA) 1:55 PM - 2:20 PM EFFECTS OF THE STATIN/NIACIN COMBINATION FOR 568 HEART DISEASE PREVENTION BG Brown (Seatlle, WA, USA) 2:20 PM - 2:45 PM PREVENTION OF RECURRENT CORONARY HEART 569 DISEASE WITH NIACIN ME McGovern (Miami Beach, FL, USA) 2:45 PM - 3:00 PM CONCLUDING REMARKS - A Taylor (Washington, DC, USA)

*Abstract not available at the time of publication 85 YIA - Young Investigators Award Nominee TUESDAY, JUNE 16, 2009

WORKSHOP IV-1 BALLROOM B

Intervention Studies: Translating Intervention into Guidelines Chairs: NJ Stone (Chicago, IL, USA), R Hobbs (Birmingham, UK)

Time Presentation Publication No. 3:30 PM - 3:45 PM TRANSLATING GUIDELINES INTO INTERVENTION 570 R Hobbs (Birmingham, UK) 3:45 PM - 4:00 PM USEFULLNESS OF INTERVENTION STUDIES IN PRIOR 571 GUIDELINES NJ Stone (Chicago, IL, USA) 4:00 PM - 4:15 PM THE NEED TO SIMPLIFY CLINICAL GUIDELINES 572 N Wald (London, UK) 4:15 PM - 4:30 PM CORRELATION OF NON-HDL-C AND LDL-C WITH 573 APOB DURING LIPID-LOWERING THERAPY IN PATIENTS WITH COMBINED HYPERLIPIDEMIA (HL) S Grundy, G Vega, J Tomassini, A Tershakovec (Dallas, TX, USA and N Wales, PA, USA) 4:30 PM - 4:45 PM A COMPARISON OF NON-HDL AND LDL- 574 CHOLESTEROL GOAL ATTAINMENT IN A LARGE, MULTINATIONAL PATIENT POPULATION: THE LIPID TREATMENT ASSESSMENT PROJECT 2 RD Santos, D Waters, M Messig, L Tarasenko, J Jukema, C-W Chiang, J Ferrières, J Verdejo (São Paulo, Brazil, San Francisco, CA, USA, New York, NY, USA, Leiden, The Netherlands, Taipei, Taiwan, Toulouse, France and Tlalpan, Mexico) 4:45 PM - 5:00 PM PREDICTORS OF LDL-CHOLESTEROL (LDL-C) 575 OBJECTIVES ACHIEVEMENT IN FAMILIAL HYPERLIPIDEMIA R Alonso, JL Díaz, P Saenz, A Ruiz, P Mata (Madrid, Spain, A Coruña, Spain and Mérida, Spain) 5:00 PM - 5:15 PM LIPID-LOWERING MEDICATION TWO YEARS 576 AFTER MOLECULAR DIAGNOSIS OF FAMILIAL YIA HYPERCHOLESTEROLEMIA R Huijgen, I Kindt, S Verhoeven, M Vissers, J Kastelein, B Hutten (Amsterdam, The Netherlands) 5:15 PM - 5:30 PM COLESEVELAM ADDED TO STABLE COMBINATION 577 OF STATIN AND EZETIMIBE IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA; THE TRIPLE TRIAL M Trip, R Huijgen, E Bruckert, E Abbink, A Stalenhoef, B Imholz, P Durrington, M Eriksson, F Visseren, J Schaefer, JJP Kastelein (Amsterdam, The Netherlands, Paris, France, Nijmegen, The Netherlands, Waalwijk, The Netherlands, Manchester, UK, Huddinge, Sweden, Utrecht, The Netherlands and Marburg, Germany)

*Abstract not available at the time of publication 86 YIA - Young Investigators Award Nominee TUESDAY, JUNE 16, 2009

WORKSHOP IV-2 BALLROOM A

Pharmacology and Novel Therapies: Inhibition of Cholesterol Synthesis and/or Cholesterol Absorption Chairs: HR Davis (Kenilworth, NJ, USA), A Tavridou (Alexandroupolis, Greece)

This session is not certified for CME credit.

Time Presentation Publication No. 3:30 PM - 3:45 PM INHIBITION OF NIEMANN-PICK C1 (NPC1L1) WITH 578 EZETIMIBE TO REDUCE CHOLESTEROL ABSORPTION, Tuesday, TREAT HYPERCHOLESTEROLEMIA AND PREVENT June 16 ATHEROSCLEROSIS HR Davis (Kenilworth, NJ, USA) 3:45 PM - 4:00 PM PRECLINICAL CHARACTERIZATION OF SQUALENE 579 SYNTHASE INHIBITORS EP2306 AND EP2302 A Tavridou, L Kaklamanis, A Kourounakis, P Kourounakis, A Charalambous, V Manolopoulos (Alexandroupolis, Greece, Athens, Greece, Thessaloniki, Greece and Pikermi, Greece) 4:00 PM - 4:15 PM BASELINE CHOLESTEROL SYNTHESIS MARKERS 580 DO NOT PREDICT SIMVASTATIN-INDUCED LDL- YIA CHOLESTEROL REDUCTION OR CHANGE IN CAROTID INTIMA MEDIA THICKNESS IN SUBJECTS WITH FAMILIAL HYPERCHOLESTEROLEMIA; A POST- HOC ANALYSIS OF THE ENHANCE TRIAL L Jakulj, M Vissers, B Hutten, A Groen, D Lutjohann, E Veltri, J Kastelein (Amsterdam, The Netherlands, Bonn, Germany and Kenilworth, NJ, USA) 4:15 PM - 4:30 PM CHOLESTEROL BALANCE IN THE PRESENCE OF 581 INHIBITION OF INTESTINAL ABSORPTION AND ENDOGENOUS PRODUCTION BY EZETIMIBE AND/OR SIMVASTATIN IN MEN W Taggart, T Musliner, K von Bergmann, D Luetjohann (Rahway, NJ, USA and Bonn, Germany) 4:30 PM - 4:45 PM ATTAINMENT OF SINGLE/DUAL TREATMENT LEVELS 582 FOR LDL-C AND NON-HDL-C, APOB, OR HS-CRP IN PATIENTS WITH METABOLIC SYNDROME (MS): EZETIMIBE(E)/SIMVASTATIN(S) VS ATORVASTATIN(A) CM Ballantyne, S Grundy, W Hsueh, H Parving, J Robinson, J Rosen, J Lin, R Lowe, A Shah, J Tomassini, A Tershakovec (Houston, TX, USA, Dallas, TX, USA, Copenhagen, Denmark, Iowa City, IA, USA, Coral Gables, FL, USA and N. Wales, PA, USA) 4:45 PM - 5:00 PM VERY HIGH PLANT STANOL ESTER INTAKE AND 583 SERUM LIPIDS, STEROLS, LIVER FUNCTION TESTS, CAROTENOIDS, AND FAT SOLUBLE VITAMINS H Gylling, M Hallikainen, M Nissinen, P Simonen, T Miettinen (Kuopio, Finland and Helsinki, Finland)

*Abstract not available at the time of publication 87 YIA - Young Investigators Award Nominee TUESDAY, JUNE 16, 2009

5:00 PM - 5:15 PM EFFECT OF INHIBITION OF CHOLESTEROL 584 ABSORPTION ON LIVER STEATOSIS AND INSULIN YIA RESISTANCE IN ZUCKER OBESE FATTY RATS M Nomura, M Yoshida (Tokyo, Japan) 5:15 PM - 5:30 PM LIPIDOMICS CAN BE USED IN PERSONALIZING 585 CHOLESTEROL SYNTHESIS AND ABSORPTION INHIBITOR TREATMENTS R Laaksonen, I Gouni-Berthold, H Gylling, H Berthold, A Verma, K Tarasov, R Hurme, K Ekroos (Espoo, Finland, Cologne, Germany, Kuopio, Finland and Bonn, Germany)

*Abstract not available at the time of publication 88 YIA - Young Investigators Award Nominee TUESDAY, JUNE 16, 2009

WORKSHOP IV-3 BALLROOM C

Epidemiology of Cardiovascular Disease: Lifestyle and Worldwide Cardiovascular Disease Chairs: H Campos (Boston, MA, USA)

Time Presentation Publication No. 3:30 PM - 3:45 PM MODIFIABLE CVD RISK FACTORS IN COSTA RICA: 586 COMPLEXITIES OF AFFLUENCE AND POVERTY IN MIDDLE INCOME COUNTRIES H Campos (Boston, MA, USA) 3:45 PM - 4:00 PM ATHEROSCLEROSIS AND CHRONIC INFECTION AS 587 Tuesday, CARDIOVASCULAR RISK FACTORS IN THE GENERAL June 16 POPULATION OF JAPAN FROM KYUSHU AND OKINAWA POPULATION STUDY (KOPS) J Hayashi, NBF Furusyo, Y Sawayama (Fukuoka, Japan) 4:00 PM - 4:15 PM B-TYPE NATRIURETIC PEPTIDE LEVELS INCREASE 588 WITH A REDUCTION IN BODY MASS INDEX FOLLOWING COMPREHENSIVE LIFESTYLE CHANGES N Chainani-Wu, G Weidner, D Purnell, S Frenda, C Kemp, D Ornish (Sausalito, CA, USA and San Francisco, CA, USA) 4:15 PM - 4:30 PM FACTORS ASSOCIATED WITH ELEVATED C-REACTIVE 589 PROTEIN IN DYSLIPIDEMIC PATIENTS: ANALYSIS OF THE LIPID TREATMENT ASSESSMENT PROJECT 2 C-W Chiang, R Santos, D Waters, J Verdejo, M Messig, L Tarasenko (Tapiei, Taiwan, São Paulo, Brazil, San Francisco, CA, USA, Tlalpan, Mexico and New York, NY, USA) 4:30 PM - 4:45 PM CHANGES OF RELATIVE IMPORTANCE OF DIFFERENT 590 RISK FACTORS FOR MYOCARDIAL INFARCTION OVER TIME IN THE CZECH POPULATION R Poledne, J Pitha, V Stanek, R Cifkova, P Stavek (Prague, Czech Republic) 4:45 PM - 5:00 PM HOW TO IMPROVE THE MANAGEMENT OF PRE- 591 HOSPITAL AMI PATIENTS IN NORTH AFRICA C Abdelkhirane, A Naji, K Adnan (Casablanca, Morocco) 5:00 PM - 5:15 PM BLOOD LIPIDS IN 75048 TYPE 2 DIABETIC PATIENTS: 592 A POPULATION-BASED SURVEY SHOWING CLEAR GENDER DIFFERENCES AND A NEW PICTURE OF DIABETIC DYSLIPIDEMIA M Eriksson, B Eliasson, J Cederholm, S Gudbjörnsdottir, P Nilsson (Stockholm, Sweden) 5:15 PM - 5:30 PM SERIAL CRP MEASUREMENTS AND PROGNOSIS IN 593 PATIENTS WITH ACUTE MYOCARDIAL INFARCTION YIA S Makrygiannis, M Zairis, O Ampartzidou, D Cokkinos, S Foussas (Pireaus, Greece and Athens, Greece)

*Abstract not available at the time of publication 89 YIA - Young Investigators Award Nominee TUESDAY, JUNE 16, 2009

WORKSHOP IV-4 ROOM 302

Gastrointestinal Surgery for the Treatment of Type 2 Diabetes: A New Perspective for an Old Disease Chairs: J Roth (Whitestone, NY, USA), FX Pi-Sunyer (New York, NY, USA)

Time Presentation Publication No. 3:30 PM - 3:50 PM BARIATRIC SURGERY: DIABETES OUTCOMES 594 H Buchwald (Minneapolis, MN, USA) 3:50 PM - 4:10 PM CARDIOVASCULAR RISKS AND DIABETES-SPECIFIC 595 MORTALITY AFTER GASTRIC BYPASS SURGERY T Adams (Salt Lake City, UT, USA) 4:10 PM - 4:30 PM DIABETES SURGERY: CLINICAL RATIONALE AND *596 MECHANISMS OF ACTION F Rubino (New York, NY, USA) 4:30 PM - 5:15 PM PANEL DISCUSSION: Preventing CVD in Diabetic Patients - – Coronary or Gastric Bypass?

Surgery Perspective H Buchwald (Minneapolis, MN, USA) F Rubino (New York, NY, USA)

Cardiology Perspective AM Gotto, Jr. (New York, NY, USA) T Adams (Salt Lake City, UT, USA)

Endocrinology Perspective A Goldfine(Boston, MA, USA) FX Pi-Sunyer (New York, NY, USA) J Roth (Whitestone, NY, USA)

*Abstract not available at the time of publication 90 YIA - Young Investigators Award Nominee TUESDAY, JUNE 16, 2009

WORKSHOP IV-5 ROOM 312

Nutritional Studies: Dietary Constituents Part I Chairs: AH Lichtenstein (Boston, MA, USA), E Brinton (Salt Lake City, UT, USA)

Time Presentation Publication No. 3:30 PM - 3:45 PM EFFECTS OF ETHANOL INTAKE ON HDL 597 METABOLISM IN HUMANS E Brinton, N Nanjee (Salt Lake City, UT, USA) 3:45 PM - 4:00 PM DIETARY RECOMMENDATIONS TO REDUCE 598 CARDIOVASCULAR DISEASE RISK – HISTORICAL Tuesday, PERSPECTIVE June 16 AH Lichtenstein (Boston, MA, USA) 4:00 PM - 4:15 PM INTAKE OF ALCOHOLIC BEVERAGES AND HEART *599 DISEASE RISK: EVIDENCE FROM POPULATION AND METABOLIC STUDIES E Rimm (Boston, MA, USA) 4:15 PM - 4:30 PM BIOLOGICAL ACTIVITY OF A TRUNCATED FORM OF 600 THE SOYBEAN 7S GLOBULIN α SUBUNIT ON CELL CHOLESTEROL HOMEOSTASIS M Lovati, C Manzoni, S Castiglioni, M Duranti, P Morazzoni (Milan, Italy) 4:30 PM - 4:45 PM DIETARY MILK PHOSPHOLIPID AS A *601 CARDIOVASCULAR NUTRACEUTICAL J Cohn, S Tandy, E Wat, A Kamili, R Chung, M Rowney, A Brown (Sydney, Australia and Melbourne, Australia) 4:45 PM - 5:00 PM THE EFFECT OF INCREASED FRUIT & VEGETABLE 602 (F&V) INTAKE ON MARKERS OF OXIDATIVE STRESS YIA IN AN ELDERLY POPULATION: THE ADIT STUDY N Nadeem, J Woodside, C Neville, S Gilchrist, I Young, J McEneny (Belfast, UK) 5:00 PM - 5:15 PM EFFECTS OF LYCHEE POLYPHENOL ON 603 POSTPRANDIAL SERUM LIPID RESPONSES IN HEALTHY HUMAN SUBJECTS Y Kishimoto, Y Hirata, K Suzuki, K Takenaka, M Iizuka, E Saita, M Toyozaki, M Nagai, K Murakami, N Sugihara, C Taguchi, T Kido, K Kitadate, K Wakame, M Tani, K Kondo (Tokyo, Japan and Sapporo, Japan) 5:15 PM - 5:30 PM COENZYME Q10 AND SELENIUM SUPPLEMENTATION 604 IN PATIENTS WITH STATIN-ASSOCIATED MYOPATHY YIA J Fedacko, D Pella, R Rybar, P Fedackova, V Mechirova (Kosice, . Slovak Republic)

*Abstract not available at the time of publication 91 YIA - Young Investigators Award Nominee TUESDAY, JUNE 16, 2009

WORKSHOP IV-6 ROOM 304

Imaging of Atherosclerosis: Magnetic Resonance Imaging Chairs: J Badimon (New York, NY, USA), E Ros (Barcelona, Spain)

Time Presentation Publication No. 3:30 PM - 3:45 PM IMAGING AS SURROGATE FOR CARDIOVASCULAR 605 DISEASE J Badimon (New York, NY, USA) 3:45 PM - 4:00 PM MAGNETIC RESONANCE IMAGING OF ATHEROMA 606 PLAQUES: FROM BENCH TO BEDSIDE E Ros (Barcelona, Spain) 4:00 PM - 4:15 PM EFFECTS OF DIET-INDUCED WEIGHT LOSS IN OBESE 607 MALES ON CARDIAC AND VASCULAR FUNCTION YIA C Piantadosi, M Worthley, A Nelson, G Wittert, S Worthley (Adelaide, Australia) 4:15 PM - 4:30 PM WALL SHEAR STRESS CORRELATES WITH THE 608 ELASTICITY AND THICKNESS OF THE CAROTID YIA ARTERY WALL: A 3.0 TESLA MRI STUDY R Duivenvoorden, E de Groot, E VanBavel, E Stroes, J Lameris, J Kastelein, A Nederveen (Amsterdam, The Netherlands) 4:30 PM - 4:45 PM TIMING FOR ADEQUATE IMAGING THE 609 VULNERABLE AORTIC LESIONS WITH BIOFUNCTIONALIZED MAGNETIC NANOPARTICLES C-C Wu, M-F Chen, H-E Horng, S-Y Yang, H-C Yang (Taipei, Taiwan) 4:45 PM - 5:00 PM SEGMENT-SPECIFIC RESPONSE TO 610 ATHEROSCLEROSIS WITHIN THE CAROTID ARTERIES DETECTED USING MAGNETIC RESONANCE IMAGING (MRI) J Terry, H Chen, H Underhill, E Kouba, J Carr, R Kraft, C Yuan, T Hatsukami, J Crouse (Winston-Salem, NC, USA and Seattle, WA, USA) 5:00 PM - 5:15 PM MACROPHAGE IMAGING IN GRAFT REJECTION 611 T Christen, M Nahrendorf, M Wildgruber, F Swirski, E Aikawa, P Waterman, K Shimizu, R Weissleder, P Libby (Boston, MA, USA)

*Abstract not available at the time of publication 92 YIA - Young Investigators Award Nominee TUESDAY, JUNE 16, 2009

WORKSHOP IV-7 ROOM 310

Lipoprotein Metabolism: Lipolytic Enzymes and Apolipoproteins Chairs: D Rader (Philadelphia, PA, USA), T Teramoto (Itabashi-ku, Japan)

Time Presentation Publication No. 3:30 PM - 3:45 PM ROLE OF ENDOTHELIAL LIPASE IN HUMAN *612 PHYSIOLOGY D Rader (Philadelphia, PA, USA) 3:45 PM - 4:00 PM APOLIPOPROTEIN B48 IS A MARKER OF 613 POSTPRANDIAL HYPERLIPIDEMIA AND METABOLIC Tuesday, SYNDROME June 16 T Teramoto (Itabashi-ku, Japan) 4:00 PM - 4:15 PM ANTICOAGULANT PROPERTIES OF APOLIPOPROTEIN 614 A-I AND PHOSPHOLIPID TRANSFER PROTEIN C Oslakovic, M Krisinger, M Jauhiainen, C Ehnholm, B Dahlbäck (Malmö, Sweden and Helsinki, Finland) 4:15 PM - 4:30 PM PARAOXONASE 1 (PON1) -107 C/T POLYMORPHISM 615 AFFECTS LIPOPROTEIN SUBCLASS DISTRIBUTION AND LIPID OXIDATION IN PATIENTS WITH ALZHEIMER’S DISEASE A Zambon, D Vianello, G Zarantonello, A Leon, A Cagnin (Padua, Italy) 4:30 PM - 4:45 PM THE ROLE OF PERILIPIN AS A LIKELY CULPRIT IN 616 THE CAUSATION OF DIFFUSE ATHEROSCLEROSIS AND ULTRASTRUCTURAL FACETS OF THE ATHEROMATOUS PROCESS IN ENDARTERECTOMY SPECIMENS S Kuruvilla, A Srinivasan, S Praveen Kumar, K Balakrishnan (Chennai, India) 4:45 PM - 5:00 PM PLA2-MODIFIED POPC MEMBRANES ARE AT LOW pH 617 MORE ORDERED AND DENSE - IMPLICATIONS ON YIA LDL MODIFICATION IN ATHEROGENESIS K Lähdesmäki, S Ollila, A Koivuniemi, P Kovanen, M Hyvönen (Helsinki, Finland, Tampere, Finland, Espoo, Finland and Oulu, Finland)

*Abstract not available at the time of publication 93 YIA - Young Investigators Award Nominee TUESDAY, JUNE 16, 2009

WORKSHOP IV-8 ROOM 311

Basic Science and Vascular Biology: Lipoproteins, Macrophages and Atherosclerosis Chairs: R Nagai (Tokyo, Japan), TJ Van Berkel (Leiden, The Netherlands)

Time Presentation Publication No. 3:30 PM - 3:45 PM CARDIOVASCULAR REMODELING AND ENERGY 618 METABOLISM THROUGH KRÜPPEL-LIKE TRANSCRIPTION FACTOR 5 R Nagai (Tokyo, Japan) 3:45 PM - 4:00 PM MECHANISMS AND CONSEQUENCES OF 619 MACROPHAGE DEATH IN ATHEROSCLEROSIS I Tabas (New York, NY, USA) 4:00 PM - 4:15 PM MACROPHAGE CHOLESTEROL HOMEOSTASIS AND 620 ATHEROGENESIS T Van Berkel, Y Zhao, R Hildebrand, R Out, M Hoekstra, I Meurs, M Van Eck (Leiden, The Netherlands) 4:15 PM - 4:30 PM STUDIES IN apoE-/- AND LDLR-/- MICE 621

REVEAL MULTIPLE ROLES FOR GV sPLA2 IN ATHEROSCLEROSIS B Boyanovsky, M Zack, K Forrest, N Webb (Lexington, KY, USA) 4:30 PM - 4:45 PM INDEPENDENT PROTECTIVE ROLES FOR 622 MACROPHAGE ABCG1 AND APOE IN YIA ATHEROSCLEROTIC LESION DEVELOPMENT B Lammers, R Out, R Hildebrand, C Quinn, D Williamson, M Hoekstra, I Meurs, T Van Berkel, W Jessup, M Van Eck (Leiden, The Netherlands and Sydney, Australia) 4:45 PM - 5:00 PM CYCLOSPORIN A DECREASES APOLIPOPROTEIN 623 E SECRETION FROM HUMAN MACROPHAGES VIA A PP2B-DEPENDENT AND ABCA1-INDEPENDENT PATHWAY M Kockx, L Guo, K Gaus, C Rentero, J Burnett, W Jessup, L Kritharides (Sydney, Australia and Perth, Australia) 5:00 PM - 5:15 PM Withdrawn 624 YIA 5:15 PM - 5:30 PM LIPID ACCUMULATION IN THE ISCHEMIC HEART IS 625 DEPENDENT ON ADRP AND THE VLDL RECEPTOR YIA J Perman, P Boström, S-O Olofsson, J Borén (Gothenburg, Sweden)

*Abstract not available at the time of publication 94 YIA - Young Investigators Award Nominee TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 10 BASIC SCIENCE

Poster Board No. Publication No. 1 LACTOBACILLUS PLANTARUM LIPOTEICHOIC ACID DOWN-REGULATES LPS- P626 INDUCED INFLAMMATORY RESPONSES AND SUPPRESSES ATHEROSCLEROTIC YIA PLAQUE INFLAMMATION JY Kim, J Choi, J-Y Lee, B-S Lee, DK Chung, JE Park (Seoul, Republic of Korea and Suwon, Republic of Korea) 2 ADDITIVE PLEIOTROPIC AFFECT OF ATORVASTATIN ON ADIPONECTIN AND P627 INSULIN SENSITIVITY IN PATIENTS WITH METABOLIC SYNDROME O Mitchenko, V Romanov, L Yakuschko, K Yanovskaya (Kiev, Ukraine) 3 PRO-INFLAMMATORY EFFECTS OF APOLIPOPROTEIN CIII ON MONOCYTIC P628 CELLS D Tsinajinnie, C Reardon, D Franco, J Bagdade (Phoenix, AZ, USA) 4 NON-INVASIVE REAL-TIME IMAGING OF INTIMA THICKNESS, VESSEL P629 DIAMETER AND BLOOD FLOW ASSESSMENT AFTER ARTERIO-VENOUS YIA FISTULA CREATION ON AN INJURED RAT CAROTID ARTERY USING ULTRASOUND BIOMICROSCOPY A Razuvaev, J Ekstrand, E Karlöf, K Lund, K Caidahl, U Hedin, J Roy (Stockholm, Sweden) 5 BIOACTIVITY OF FATTY ACIDS ON ADHESION MOLECULES AND CD40-CD40L P630 SYSTEM L Faine, M Rudnicki, S Ferderbar, S Farsky, H Souza, L Boscá, D Abdalla (São Paulo, Brazil and Madrid, Spain) 6 EXPRESSION OF FATTY ACID BINDING PROTEIN 4/aP2 CORRELATES WITH P631 PLAQUE INSTABILITY YIA H Agardh, A Gabrielsen, J Swedenborg, U Hedin, G Paulsson-Berne (Stockholm, Sweden) 7 THE INFLUENCE OF ONE-YEAR TREATMENT WITH ATORVASTATIN AND P632 ROSUVASTATIN ON INTIMA MEDIA THICKNESS AND SOME BIOCHEMICAL MARKERS M Akhvlediani, E Vorobiova, M Balavadze, T Vakhtangadze, D Gachechiladze (Tbilisi, Georgia) 8 REGRESSION OF HYPERCHOLESTEROLEMIC ATHEROSCLEROSIS IN RABBITS P633 BY HYDROALCOHOLIC EXTRACTS OF HYPERICUM PERFORATUM Tuesday, June 16 S Asgary, N Kabiri, H Madani, P Mahzoni, P Rahim (Isfahan, Islamic Republic of Iran) Poster Sessions 9 SEROPREVALENCE OF CHLAMYDIA PNEUMONIAE ANTIBODIES IN VARIOUS P634 SUBGROUPS OF FIRST ISCHEMIC STROKE YIA VCSS Bandaru, S Kaul, L Vemu, S Alladi (Hyderabad, India) 10 ACTION OF NICOTINIC ACID IN ADIPONECTIN PRODUCTION IN 3T3-L1 P635 ADIPOCYTES UNDER OXYGEN DEPRIVATION YIA R Nakamichi, B Quinto, M Melo, S Lobo, M Batista (São Paulo, Brazil) 11 ApoB-100 PEPTIDE IMMUNIZATION REDUCE MACROPHAGE P636 PLAQUE INFILTRATION IN ApoBec1-/- LDLr-/- MICE WITH ADVANCED ATHEROSCLEROTIC LESIONS D Bengtsson, M Wigren, J Nilsson, G Nordin Fredrikson (Malmö, Sweden)

YIA - Young Investigators Award Nominee 95 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 12 ROLE OF HIGH DENSITY LIPOPROTEINS (HDL) IN HOST DEFENSE AGAINST P637 BACTERIAL PATHOGENS YIA M Biedzka-Sarek, J Metso, S Jokiranta, M Skurnik, M Jauhiainen (Helsinki, Finland) 13 DIET-INDUCED HYPERLIPIDEMIA ACTIVATES MyD88-DEPENDENT INNATE P638 IMMUNE SIGNALING RESULTING IN INCREASED LEUKOCYTE ROLLING IN VIVO A Pistea, K Olofsson, M Lindholm, A Zetterqvist, J Öhman, M Gomez, J Nilsson, H Thorlacius, H Björkbacka (Malmö, Sweden) 14 ADVANCED GLYCOSYLATION END-PRODUCTS OF b2-GLYCOPROTEIN I P639 MODULATE THE MATURATION AND FUNCTION OF DENDRITIC CELLS YIA B Buttari, E Profumo, F Facchiano, A Capozzi, M Sorice, R Riganò (Rome, Italy) 15 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-g ACTIVATION P640 REDUCES INFLAMMATION IN ATHEROSCLEROSIS AS ASSESSED BY SERIAL IN VIVO FLUORESCENCE MOLECULAR IMAGING K Chang, S Francis, E Aikawa, J Figueiredo, P Patel, R Weissleder, J Plutzky, F Jaffer (Boston, MA, USA) 16 CHLOROGENIC ACID REDUCE OXIDATIVE STRESS AND INFLAMMATORY- P641 RELATED GENE EXPRESSION IN HYPERLIPIDEMIC RABBITS W-C Chang, Y-M Yu (Tainan, Taiwan) 17 INHIBITION OF GLUTAMINYL CYCLASE ENHANCES INACTIVATION OF CCL2: P642 A POTENTIAL THERAPY FOR CARDIOVASCULAR DISEASE YIA H Cynis, T Hoffmann, S Schilling, H-U Demuth (Halle, Germany) 18 INTERLEUKIN 15 DEFICIENCY DECREASES ATHEROSCLEROSIS IN P643 APOLIPOPROTEIN E KNOCKOUT MICE YIA O Dadoo, C Richards, A Ashkar, B Trigatti (Hamilton, ON, Canada) 19 INTERLEUKIN-17A AND IL-17F ARE EXPRESSED BY MAST CELLS AND P644 POLYMORPHONUCLEAR GRANULOCYTES BUT NOT BY T (TH17) CELLS IN HUMAN ATHEROSCLEROTIC PLAQUES O de Boer, P Teeling, C van der Loos, A van der Wal (Amsterdam, The Netherlands) 20 HIGH EXPRESSION OF INTERLEUKIN-17E IN NORMAL ARTERIES AND P645 ATHEROSCLEROTIC PLAQUES: AN ANTI-INFLAMMATORY ROLE FOR IL-17E IN VESSEL WALL INFLAMMATION ? O de Boer, P Teeling, C van der Loos, A van der Wal (Amsterdam, The Netherlands) 21 TOWARDS AN UNDERSTANDING OF DIABETIC VASCULOPATHY: MECHANISMS P646 OF HYPEROSMOLARITY-RELATED HYPERGLYCAEMIC DAMAGE R Madonna, E Montebello, G Lazzerini, R De Caterina (Chieti, Italy) 22 INTRAVITAL MICROSCOPY ESTABLISHES VENULES IN ATHEROSCLEROSIS AS P647 MAJOR ENTRY PATHWAYS FOR LEUKOCYTES TO LESIONS E Eriksson (Stockholm, Sweden) 23 ANNEXIN A5 INHIBITS PROINFLAMMATORY EFFECTS OF OXIDIZED LDL AND P648 LYSOPHOSPHATIDYLCHOLINE: IMPLICATIONS FOR PLAQUE RUPTURE AND CARDIOVASCULAR DISEASE H Domeij, X Hua, J Su, A Frostegård, J Haeggström, T Modéer, J Frostegård (Stockholm, Sweden) 24 OXIDIZED CARDIOLIPIN HAS PRO-INFLAMMATORY EFFECTS WHICH ARE P649 INHIBITED BY ANNEXIN A5: IMPLICATIONS FOR CARDIOVASCULAR DISEASE AND CHRONIC INFLAMMATION X Hua, M Wan, J Su, A Frostegård, J Haeggström, J Frostegård (Stockholm, Sweden) 25 KLF5 CONTROLS FIBROGENIC NICHE IN CARDIOVASCULAR AND KIDNEY P650 DISEASE VIA S100 PROTEINS YIA K Fujiu, I Manabe, R Nagai (Tokyo, Japan)

YIA - Young Investigators Award Nominee 96 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 26 EXPRESSION OF ENDOTHELIN AND ITS RECEPTORS IN HUMAN CAROTID P651 ATHEROSCLEROTIC PLAQUES YIA A Rafnsson, H Agardh, L Folkersen, A Gabrielsen, J Pernow (Stockholm, Sweden) 27 POLLUTION EFFECTS ON ATHEROGENESIS AND CARDIOVASCULAR SYSTEM P652 IN DISLIPIDEMIC MICE M Garcia, N Takahashi, P Oyama, S Soares, R Carvalho-Oliveira, H Bueno, L Silva, T Mauad, P Saldiva (São Paulo, Brazil) 28 POLLUTANTS EXACERBATE STEATOHEPATITIS AND GLOMERULITIS IN P653 HYPERLIPEMIC MICE M Garcia, N Takahashi, P Oyama, S Soares, R Carvalho-Oliveira, H Bueno, E Mello, L Silva, T Mauad, C Oliveira, D Malheiros, P Saldiva (São Paulo, Brazil) 29 OXIDATIVE STRESS IN CIRCULATING LEUKOCYTES, BUT NOT IN THE P654 VASCULATURES, PLAYS A DOMINANT ROLE IN THEIR ADHESION DURING ACUTE PHASE VASCULAR INJURY S Hagita, M Osaka, K Shimokado, M Yoshida (Tokyo, Japan) 30 LOW DHCR24 LEVELS ARE ASSOCIATED WITH CHRONIC INFLAMMATION P655 AND APOPTOSIS IN HUMAN ENDOTHELIAL CELLS YIA J Tan, X-H Li, M Bartusch, V DY, E Liong, K McGrath, P Barter, A Heather (Sydney, Australia and Senftenberg, Germany) 31 POSTPRANDIAL LIPOPROTEINS STIMULATE THE RELEASE OF P656 PROINFLAMMATORY CYTOKINES IN HUMAN ADIPOCYTES J Heeren, D Lasrich, J Prawitt, U Beisiegel (Hamburg, Germany and Lille, France) 32 Withdrawn P657 33 NEUTROPHILS INFILTRATION AND GENERATION OF REACTIVE OXYGEN P658 SPECIES IN A HUMAN ATHEROSCLEROTIC PLAQUE T Hosokawa, Y Kumon, T Kobayashi, H Enzan, K Takahashi, K Yuri, H Wakiguchi, T Sugiura (Nankoku, Japan and Kochi, Japan) 34 PROATHEROGENIC PATHOGENS REDUCE THE PUFA/SFA RATIO IN ADIPOSE P659 TISSUES IN APOE-DEFICIENT MICE YIA K Hyvärinen, A Tuomainen, S Laitinen, R Käkelä, I Salminen, G Alfthan, M Jauhiainen, P Kovanen, M Leinonen, P Saikku, P Pussinen (Helsinki, Finland and Oulu, Finland) 35 SOY PHOSPHATIDYLCHOLINE INHIBITED TLR4-MEDIATED MCP-1 P660 EXPRESSION IN CULTURED VASCULAR CELLS A Ishikado, Y Nishio, K Yamane, A Mukose, K Morino, Y Murakami, O Sekine, T Makino, H Maegawa, A Kashiwagi (Otsu, Japan and Takatsuki, Japan) 36 AMD3100 AGGRAVATES ApoE-/- MICE ATHEROSCLEROGENESIS P661 Z Wang, X Zhou, X Zhang, Z Jiang (Hengyang, China and Xingning, China) 37 UP-REGULATING TNF-a, NF-kB EXPRESSION IN ApoE-/- MICE P662 ATHEROSCLEROSIS PLAQUE BY AMD3100 Tuesday, June 16 Z Wang, X Zhou, X Zhang, Z Jiang (Hengyang, China and Xingning, China) Poster Sessions 38 DENDRITIC CELLS PULSED WITH MALONDIALDEHYDE-LDL AGGRAVATE P663 ATHEROSCLEROSIS YIA D Johansson, C Hjerpe, A Hermansson, G Hansson, X Zhou (Stockholm, Sweden) 39 ATHEROPROTECTION BY IMMUNIZATION IS DEPENDENT ON ADAPTIVE P664 IMMUNITY AND INVOLVES EXPANSION OF T REGULATORY CELLS YIA D Johansson, C Hjerpe, A-K Robertson, G Hansson, X Zhou (Stockholm, Sweden) 40 DETECTION OF C. PNEUMONIAE, H. PYLORI, CYTOMEGALOVIRUS AND P665 HERPES SIMPLEX VIRUS IN CORONARY ATHEROMA PLAQUE M Karaduman, C Eyigun, A Kubar, A Bilici, F Cingoz (Ankara, Turkey)

YIA - Young Investigators Award Nominee 97 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 41 APOLIPOPROTEIN CIII MODULATES ADIPOCYTOKINE PRODUCTION IN 3T3-L1 P666 PREADIPOCYTES A Kawakami, Y Abe, K Shimokado, M Yoshida (Tokyo, Japan) 42 INVESTIGATING ANTI-INFLAMMATORY EFFECTS OF TESTOSTERONE IN P667 ATHEROSCLEROSIS YIA D Kelly, D Sellers, M Woodroofe, K Channer (Sheffield, UK) 43 DNAZYME TARGETING TRANSCRIPTION FACTOR c-JUN INHIBITS P668 MYOCARDIAL INFLAMMATION, ROS GENERATION AND INFARCT SIZE AFTER ISCHEMIA-REPERFUSION INJURY L Khachigian (Sydney, Australia) 44 A NEW INSIGHT INTO THE ACUTE CORONARY SYNDROME P669 T Kvantaliani, N Pargalava, P Tsiklauri (Tbilisi, Georgia) 45 THE HEME-HEME OXYGENASE PATHWAY MODULATES INFLAMMATORY P670 EICOSANOID SYNTHESIS IN VASCULAR CELLS YIA B Lamon, R Deeb, A Gotto, Jr., D Hajjar (New York, NY, USA) 46 ROLE OF NADPH OXIDASE IN IL-4-INDUCED PRO-INFLAMMATORY P671 RESPONSES IN VASCULAR ENDOTHELIUM Y Lee, W Lee, P Kim (Blacksburg, VA, USA) 47 THE 7b-HYDROXYCHOLESTEROL INDUCES HUMAN NATURAL KILLER CELL P672 DEATH VIA OXIDATIVE STRESS RELATED LYSOSOMAL DESTABILIZATION W Li, X-M Yuan, L Jonasson (Linköping, Sweden) 48 EFFECT OF IL-17 ON INVASION OF HUMAN COLON CANCER CELLS IN VITRO P673 Q Liao, J He, Y Zhou (Henyang, China) YIA 49 LIPID PROFILE AND SERUM LEVELS OF MARKERS OF INFLAMMATION IN P674 PATIENTS WITH ACUTE BRUCELLOSIS F Apostolou, I Gazi, A Tselepis, M Elisaf, E Liberopoulos (Ioannina, Greece) 50 COMPARISON OF STATIN, FIBRATE AND NICOTINIC ACID EFFECTS ON 3T3-L1 P675 DIFFERENTIATED ADIPOCYTES UNDER INFLAMMATORY STATE YIA S Lobo, B Quinto, A Ribeiro, M Zanella, M Batista (São Paulo, Brazil) 51 SIMVASTATIN EFFECTS ON LEPTIN, APIPONECTIN, PAI-1 AND MCP-1 P676 PRODUCTION IN 3T3-L1 DIFFERENTIATED ADIPOCYTES UNDER YIA INFLAMMATORY STATE S Lobo, B Quinto, A Ribeiro, M Zanella, M Batista (São Paulo, Brazil) 52 INHIBITION OF HMGB1 PROMOTES EXPERIMENTAL ATHEROSCLEROSIS P677 A Lundberg, N Gerdes, H Yang, K Tracey, G Hansson (Stockholm, Sweden and Manhasset, YIA NY, USA) 53 HEAT SHOCK PROTEIN 90 (HSP90) INHIBITORS ATTENUATE INFLAMMATORY P678 RESPONSES IN VITRO AND IN VIVO YIA J Madrigal-Matute, Ó López-Franco, L Blanco-Colio, B Muñoz-Garcia, P Ramos-Mozo, J Egido, JL Martín-Ventura (Madrid, Spain) 54 INHIBITION OF TRANSCRIPTION FACTOR TRANSLOCATION WITH SYNTHETIC P679 PEPTIDES REDUCES ATHEROSCLEROTIC LESIONS IN MICE YIA B Mallavia, G Ortíz-Muñóz, V López-Parra, O López-Franco, P Fernández-Vizarra, J Egido, C Gómez-Guerrero (Madrid, Spain) 55 SYSTEMIC LEVELS OF CCL 3, CCL 4 AND CCL 5 IN ACUTE ISCHEMIC STROKE P680 I Markaki, N Kostulas (Stockholm, Sweden) YIA 56 3D CELL-MATRIX CONTACT PREVENTS IFNg INDUCED UPREGULATION OF P681 ENDOTHELIAL MHC II EXPRESSION IN HIGH GLUCOSE H Methe, E Edelman (Cambridge, MA, USA)

YIA - Young Investigators Award Nominee 98 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 57 GENETIC DELETION OF OX40 LIGAND SUPPRESSES THE DEVELOPMENT OF P682 ATHEROSCLEROSIS IN APOLIPOPROTEIN E-DEFICIENT MICE YIA M Nakano, Y Fukumoto, K Satoh, N Ishii, K Sugamura, H Shimokawa (Sendai, Japan) 58 ACTIVATION OF THE TNFA INFLAMMATORY SYSTEM IN CHILDREN WITH P683 FAMILIAL HYPERCHOLESTEROLEMIA YIA I Narverud, T Ueland, M Nenseter, V Telle-Hansen, K Retterstøl, B Halvorsen, K Otterdal, P Thorsby, L Ose, P Aukrust, K Holven (Oslo, Norway and Kjeller, Norway) 59 SHORT-TERM SPACEFLIGHT ENHANCES PROTEIN AND GENE EXPRESSION P684 OF INTERLEUKIN 6 AND INTERCELLULAR CELL ADHESION MOLECULE-1 IN ENDOTHELIAL CELLS S Muid, G Froemming, K Yusoff, M Ali, H Nawawi (Shah Alam, Malaysia and Kuala Terengganu, Malaysia) 60 4-1BB FACILITATES ATHEROSCLEROSIS VIA BIDIRECTIONAL ACTIVATION OF P685 T CELL AND MONOCYTE/MACROPHAGE IN ATHEROGENIC MICE IH Jung, HJ Jeon, J-H Choi, JG Park, MR Lee, MN Lee, J-Y Yoo, SJ Jeong, BS Kwon, D-Y Kim, GT Oh (Seoul, Korea and Ulsan, Korea) 61 DISTURBANCES IN CHOLESTEROL EFFLUX FROM MACROPHAGE FOAM P686 CELLS INDUCED BY ADVANCED GLYCATED ALBUMIN ARE NOT RELATED TO YIA THE INFLAMMATORY CYTOKINE PRODUCTION L Okuda, D Rocco, E Nakandakare, S Catanozi, M Passarelli (São Paulo, Brazil) 62 INHERITED HUMAN GP 91PHOX DEFICIENCY IS ASSOCIATED WITH IMPAIRED P687 ISOPROSTANE FORMATION AND REDUCED PLATELET RECRUITMENT P Pignatelli, R Carnevale, S Di Santo, V Sanguigni, F Violi, F Violi (Rome, Italy) 63 RESIDENT PERITONEAL INFLAMMATORY CELLS ARE PIVOTAL IN THE P688 DEVELOPMENT OF EXPERIMENTAL ATHEROSCLEROSIS YIA W Relvas, M Izar, T Helfenstein, J Lopes, M Mariano, H Segretto, S Ihara, D Pomaro, F Fonseca (São Paulo, Brazil) 64 ISOLATION OF AN ISOENZYME OF HUMAN GLUTAMINYL CYCLASE P689 S Schilling, H Cynis, H-U Demuth (Halle, Germany) 65 PRO-ATHEROGENIC EFFECTS OF NATURAL KILLER CELLS ARE DEPENDENT P690 ON ACTIVATION BY NATURAL KILLER T CELLS YIA A Selathurai, A Agrotis, B-H Toh, A Bobik (Melbourne, Australia and Clayton, Australia) 66 INFLAMMATION-SENSITIVE BIOMARKERS TO REVEAL POTENTIAL P691 GENDER DIFFERENCES IN RELATION TO LOW GRADE INFLAMMATION IN INDIVIDUALS WITH THE METABOLIC SYNDROME I Shapira, O Rogowski, S Berliner (Tel Aviv, Israel) 67 INCREASED LEVEL OF CXCL13 IN CORONARY ARTERY DISEASE P692 L Smedbakken, W Sandberg, A Yndestad, J Damås, L Gullestad, P Aukrust, B Halvorsen YIA (Oslo, Norway) Tuesday, June 16 68 URBAN AIR POLLUTION ACCELERATES ATHEROSCLEROSIS AND INDUCES P693 Poster Sessions VASCULAR REMODELLING IN HYPERLIPEMIC MICE S Soares, T Mauad, M Gidlund, H Goto, M Bueno Garcia (São Paulo, Brazil) 69 A NOVEL ANTIINFLAMMATORY NATURAL PRODUCT AND ITS ACTIVE P694 INGREDIENT, 7-HYDROXY FRULLANOLIDE, INHIBIT EXPRESSION OF VCAM1 AND ICAM1, AND SLOWS THE PROGRESSION OF ATHEROSCLEROSIS IN HIGH FAT-FED LDLr-/- MICE AND HAMSTERS RA Srivastava, S Parikh, S Sharma (Mumbai, India) 70 LEMON FLAVONOIDS REDUCE HOMOCYSTEINE-INDUCED MONOCYTE P695 INFLAMMATION M Tani, Y Kishimoto, M Iizuka, E Saita, K Suzuki, M Toyozaki, M Nagai, K Murakami, N Sugihara, K Takenaka, C Taguchi, T Kido, M Yoshida, K Kondo (Tokyo, Japan)

YIA - Young Investigators Award Nominee 99 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 71 GroEL, A HEAT SHOCK PROTEIN OF CHLAMYDIA PNEUMONIA, IMPAIRS P696 HUMAN EARLY AND LATE ENDOTHELIAL PROGENITOR CELLS FUNCTION YIA H-Y Tsai, S-J Lin, C-Y Huang, T-L Yang, F-Y Lin (Taipei, Taiwan) 72 TNF-a MAY PLAY AN IMPORTANT ROLE IN INHIBITORY EFFECTS OF RADIX P697 SOPHORAE FLAVESCENTIS EXTRACT ON VASCULAR RESTENOSIS IN A RAT CAROTID MODEL OF BALLOON DILATATION INJURY G Wang, G Long, B Lin, Y Liu (Chongqing, China, Hengyang, China and Kowloon, China) 73 HEAT SHOCK INCREASE MCP-1 AND IL-8 EXPRESSION IN THP-1 P698 MACROPHAGE CELLS S Wang, F Li, Y-Z Yang (Hengyang, China) 74 EVIDENCE OF A ROLE OF T REGULATORY CELLS MEDIATING P699 ATHEROPROTECTION BY APO B 100 PEPTIDE IMMUNIZATION YIA M Wigren, D Bengtsson, P Dunér, H Björkbacka, G Fredrikson, J Nilsson (Malmö, Sweden) 75 CHRONIC HEPATIC INFLAMMATION SEVERELY AGGRAVATES P700 ATHEROSCLEROSIS DEVELOPMENT YIA M Wong, L Hu, J van Diepen, J Romijn, P Voshol, L Havekes, S Shoelson, J Tamsma, P Rensen, P Hiemstra, J Berbée (Leiden, The Netherlands and Boston, MA, USA) 76 REDUCTION OF THE INTRA-SUBUNIT DISULFIDE BOND ACTIVATES P701 MONOMERIC C-REACTIVE PROTEIN TO STIMULATE ENDOTHELIAL CELLS YIA VIA INTERACTION WITH LIPID RAFT MICRO-DOMAINS S-R Ji, L Potempa, J Filep, Y Wu (Lanzhou, P.R. China, Deerfield, IL, USA and Montreal, QC, Canada) 77 THE GLUTAREDOXIN/GLUTATHIONE SYSTEM MODULATES NF-kB ACTIVITY P702 BY GLUTATHIONYLATION OF P65 IN CINNAMALDEHYDE-TREATED ENDOTHELIAL CELLS B-S Wung (Chiayi, Taiwan) 78 EFFECT OF THE SHORT HAIRPIN (shRNA)-SR-PSOX ON SMOOTH MUSCLE P703 CELLS MIGRATION H Yang, W Chen, Y Xu (Hengyang, China) 79 REAL-TIME OBSERVATION OF LEUKOCYTE RECRUITMENT TO MOUSE P704 FEMORAL ARTERY AFTER INJURY M Yoshida, M Osaka, S Hagiata (Tokyo, Japan) 80 APOPTOSIS INDUCED BY 7b-HYDROXYCHOLESTEROL IS ASSOCIATED WITH P705 REGULATION OF p53, b-CATENIN, AND Egr-1 W Li, S Miah, S Jönsson, R Andersson, X-M Yuan (Linköping, Sweden) 81 FcgammaRIIb INHIBITS THE DEVELOPMENT OF ATHEROSCLEROSIS IN MICE P706 M Zhao, H Björkbacka, J Nilsson, G Fredrikson (Malmö, Sweden) 82 PPAR ACTIVATION BY NITROLINOLEATE IS MEDIATED BY MAPK P707 S Ferderbar, L Faine, M Rudnicki, B Heras, L Bosca, D Abdalla (São Paulo, Brazil and Madrid, Spain) 83 MECHANISMS OF ELECTRONEGATIVE LDL-INDUCED APOPTOSIS ON RAW P708 MACROPHAGES: INVOLVEMENT OF FAS-PATHWAY AND IMPLICATIONS FOR Nrf2 A Pedrosa, L Faine, B Heras, L Boscá, D Abdalla (São Paulo, Brazil and Madrid, Spain) 84 TEMPORAL CHARACTERISTICS OF SPECIFIC ANTIGEN EXPRESSION IN P709 HUMAN MONOCYTE-DERIVED MACROPHAGES IN VITRO E Andreeva, S Kashirina, N Samovilova, E Gracheva, E Tararak (Moscow, Russian Federation) 85 METABOLIC STRESS, THIOL OXIDATION AND MACROPHAGE RECRUITMENT P710 R Asmis (San Antonio, TX, USA)

YIA - Young Investigators Award Nominee 100 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 86 MICROARRAY ANALYSIS OF RAW 264.7 MACROPHAGES SILENCED FOR ORP8 P711 O Beaslas, T Vihervaara, V Olkkonen (Helsinki, Finland) YIA 87 SMOOTH MUSCLE CELLS TRANSDIFFERENTIATION TO MACROPHAGE-LIKE P712 CELLS S Bellosta, M Canavesi, A De Francesco, C Anelli, A Corsini (Milan, Italy) 88 IN VITRO MACROPHAGE GLYCOXIDATION INDUCES CHOLESTEROL P713 ACCUMULATION DUE TO RETICULUM ENDOPLASMIC STRESS YIA G Castilho, C Xavier, E Nakandakare, F Laurindo, M Passarelli (São Paulo, Brazil) 89 LOW-DOSE RITONAVIR INDUCED DRASTIC CHANGES IN CD36 AND P714 ADIPOPHILIN EXPRESSIONS IN PERIPHERAL BLOOD MONOCYTIC CELLS YIA FROM HEALTHY VOLUNTEERS S Collot-Teixeira, M Boffito, F de Lorenzo, S Yilmaz, L Waters, C Fletcher, D Back, S Mandalia, A Pozniak, B Gazzard, J McGregor (London, UK, Liverpool, UK and Paris, France) 90 EVEROLIMUS INHIBITS MONOCYTE MIGRATION AND THEIR ACCUMULATION P715 IN CAROTID LESIONS OF CHOLESTEROL-FED RABBITS R Baetta, A Granata, N Ferri, L Arnaboldi, M Canavesi, S Bellosta, P Pfister, A Corsini (Milan, Italy and Basel, Switzerland) 91 ABCA1 MODULATE CELLULAR MIGRATION AND MEMBRANE RUFFLING P716 INDUCED BY FREE CHOLESTEROL IN MACROPHAGES FOAM CELLS E Favari, MP Adorni, S Costa, A Granata, A Corsini, N Ronda, R Gatti, F Bernini (Parma, Italy and Milan, Italy) 92 THE EFFECT OF BALSAMIC VINEGAR ON LDL OXIDATION AND FOAM CELL P717 FORMATION M Iizuka, Y Kishimoto, E Saita, K Suzuki, M Toyozaki, M Nagai, K Murakami, N Sugihara, K Takenaka, M Tani, K Kondo (Tokyo, Japan) 93 CLINICAL DOSE OF PITAVASTATIN PREVENTS FOAM CELL FORMATION IN P718 RAW264.7 MACROPHAGES BY OXIDIZED LOW DENSITY LIPOPROTEIN I Ishii, M Kitahara, T Tamaki, Y Saito, M Kitada (Chiba, Japan, Minamisaitama, Japan and Higashimurayama, Japan) 94 Withdrawn P719 YIA 95 DOWNREGULATION OF PCSK9 EXPRESSION SUPPRESSES THP-1 DERIVED P720 MACROPHAGES APOPTOSIS INDUCED BY OX-LDL L Liu, M Xie, Z Tang, Z Jiang (Hengyang, China) 96 L-TYPE CALCIUM CHANNEL BLOCKER, AZELNIDIPINE SUPPRESSES Ox-LDL- P721 INDUCED MACROPHAGE PROLIFERATION YIA H Kinoshita, T Matsumura, N Ishii, K Taketa, T Nishikawa, E Araki (Kumamoto, Japan) 97 ASTAXANTHIN SUPPRESSES MATRIX METALLOPROTEINASES (MMPs) P722 ACTIVITY AND SCAVENGER RECEPTORS EXPRESSION IN MACROPHAGES Tuesday, June 16 Y Kishimoto, M Tani, M Iizuka, E Saita, K Suzuki, M Toyozaki, M Nagai, K Murakami, N Poster Sessions Sugihara, K Takenaka, C Taguchi, T Kido, H Sone, H Kurata, K Kondo (Tokyo, Japan) 98 ALTERED microRNA EXPRESSION PROFILE IN RAT FOAM CELLS P723 D Liao, H Ling, C Xia, B Zhu, S Tang, C Tang, W Yin, L Zhang (Hengyang, China and Portorange City, FL, USA) 99 MACROPHAGES OF ADIPOSE TISSUE: POTENTIAL NEW TARGETS FOR P724 NUCLEAR RECEPTOR LXR AGONISTS? YIA T Mayi, F Pattou, B Staels, G Chinetti (Lille, France) 100 PC-CHOLESTEROL COMPLEX AS A NOVEL MARKER FOR FOAM CELL DEATH P725 CAN BE SUPPRESSED BY VASCULAR STATIN M Mori, N Yamaguchi, A Takano, Y Kamisaka, H Kobayashi, C Sasaki, H Itabe, T Takano, M Fujimoto (Cyoshi, Japan, Hatanodai, Japan and Sagamiko, Japan)

YIA - Young Investigators Award Nominee 101 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 101 INSULIN RESISTANCE INCREASES THE ATHEROSCLEROTIC PROPERTIES OF P726 MONOCYTES M Sarigianni, K Paletas, A Tsapas, M KaloYIAnni, D Konstantinidis, G Koliakos (Thessaloniki, Greece) 102 VIMENTIN IN MACROPHAGE LIPID ACCUMULATION AND ATHEROSCLEROSIS P727 DEVELOPMENT YIA J Perman, S-O Olofsson, J Borén (Gothenburg, Sweden) 103 OxLDL AND EXPRESSION OF MACROPHAGE-SPECIFIC FUNCTIONS: P728 LYSOSOMAL DEGRADATION DEPENDENT/INDEPENDENT PATHWAYS A Radhika, P Sudhakaran (Trivandrum, India) 104 CANNABINOID 1 RECEPTOR BLOCKADE WITH RIMONABANT REDUCES P729 ATHEROSCLEROSIS THOROUGH ELEVATION OF ADIPONECTIN AND YIA ACTIVATION OF REVERSE CHOLESTEROL TRANSPORT SYSTEM K Sugamura, S Sugiyama, H Ogawa (Kumamoto, Japan) 105 MODULATION OF NOTCH PROCESSING BY g-SECRETASE REDUCED DIET- P730 INDUCED ATHEROSCLEROSIS IN APOLIPOPROTEIN E-DEFICIENT MICE K Takeshita, T Aoyama, R Kikuchi, XW Cheng, J Liao, T Murohara (Nagoya, Japan and Boston, MA, USA) 106 DIFFERENTIAL ACCUMULATION OF OXIDIZED LDL IN M1 AND M2 P731 MACROPHAGES L van Tits, R Stienstra, M Netea, L Joosten, A Stalenhoef (Nijmegen, The Netherlands) 107 HYPERLIPIDEMIC SERUM ALTERS MACROPHAGE LIPID CONTENT, FATTY P732 ACID COMPOSITION AND GENE EXPRESSION YIA B Wong, R Kyle, K Croft, C Quinn, W Jessup, B Yeap (Perth, Australia and Sydney, Australia) 108 A ROLE OF UBIQUITIN-POSITIVE (UB+) FOAM CELLS IN THE AORTIC AND P733 MITRAL VALVULAR DISEASES WITH ATHEROSCLEROSIS T Yamada, S Sueyoshi, H Kiba, K Itoh, M Mitsumata, T Ueno, T Matsumoto, K Uehara, T Mizutani (Tokyo, Japan) 109 CHRONIC HYPOXIA ACTIVATES THE Akt AND b - CATENIN PATHWAYS IN P734 HUMAN MACROPHAGES H Yamazaki, J-O Deguchi, E Aikawa, M Aikawa (Boston, MA, USA and Charlestown, MA, USA) 110 SODIUM-LITHIUM COUNTERTRANSPORT ACTIVITY CORRELATES TO P735 INFLAMMATION AND BODY LENGTH CJ Behre, F Olson, V Wallenius, H Herlitz, B Fagerberg (Gothenburg, Sweden) 111 EFFECT OF DIABETES CONTROL ON SERUM HSP60 AND INFLAMMATION P736 C Blasi, E Kim, A Knowlton (Rome, Italy and Davis, CA, USA) 112 DO NOVEL BIOMARKERS CORRELATE WITH PRECLINICAL P737 ATHEROSCLEROSIS? YIA A Boguszewski, S Szpunar, R Aboufakher, R Bess, D Doan, J Frank, G Cohen (Detroit, MI, USA) 113 HYPERALPHALIPOPROTEINEMIA IS NOT ASSOCIATED WITH MODIFICATIONS P738 OF PLASMA PRO-INFLAMMATORY FACTORS C Nunes, S Mazon, R Nakamura, M Gidlund, E de Faria (Campinas, Brazil and São Paulo, Brazil) 114 ASSOCIATION OF Lp-PLA2 WITH CORONARY ARTERY DISEASE IN AFRICAN P739 AMERICANS AND CAUCASIANS A Erdembileg, S Landis, T Pearson, L Berglund (Davis, CA, USA, South San Francisco, CA, USA and Rochester, NY, USA)

YIA - Young Investigators Award Nominee 102 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 115 OPTIMAL GENE EXPRESSION ANALYSIS IN PLAQUE TISSUE P740 L Folkersen, H Agardh, U Hedin, G Berne, A Gabrielsen (Stockholm, Sweden) YIA 116 LOX-1 BINDS TO C-REACTIVE PROTEIN AND MEDIATES ITS EFFECTS ON P741 CARDIOVASCULAR SYSTEM YIA Y Fujita, A Kakino, K Otsui, S Yamaguchi, N Nishimichi, H Matsuda, T Sawamura (Suita, Japan and Higashi-Hiroshima, Japan) 117 RISK FACTORS FOR ATHEROSCLEROSIS ARE ASSOCIATED WITH PHENOTYPIC P742 CHANGES OF PERIPHERAL BLOOD MONOCYTES YIA T Guzik, M Bzowska, B Jasiewicz-Honkisz, M Czesnikiewicz-Guzik, R Korbut, J Pryjma (Cracow, Poland) 118 EFFECTS ON INFLAMMATORY MEDIATORS IN CRITICALLY ILL PATIENTS P743 WITH ACUTE KIDNEY INJURY (AKI) UNDER CONTINUOUS VENO-VENOUS YIA HEMODIAFILTRATION I Iizuka, B Quinto, M Góes, J Monte, M Durão, O Santos, B Santos, V Pereira, M Dalboni, M Cendoroglo, M Batista (São Paulo, Brazil) 119 NEUTROPHILS - A POTENTIAL SOURCE FOR INCREASED SERUM MMP-9 IN P744 CORONARY ARTERY DISEASE YIA S Jönsson, I Bergström, W Li, L Nilsson, L Jonasson (Linköping, Sweden) 120 EVALUATION OF PLASMA CIRCULATORY MARKERS, CHLAMYDIA P745 PNEUMONIAE AND HIGH SENSITIVE C-REACTIVE PROTEIN IN CORONARY YIA ARTERY DISEASE PATIENT H Jha, P Srivastava, J Prasad, A Mittal (New Delhi, India) 121 PREPROCEDURAL C-REACTIVE PROTEIN PREDICTIVE VALUE IN P746 ANGIOGRAPHIC IN-STENT RESTENOSIS AFTER CORONARY STENT PLACEMENT IN PATIENTS WITH STABLE ANGINA A Khosravi, G Kiani Mehr, M Poormoghadas, A Tavasoli (Isfahan, Islamic Republic of Iran) 122 PM2.5 AND PM10 INDUCE OXIDATIVE STRESS AND APOPTOTIC DEATH P747 IN HUMAN ENDOTHELIAL CELLS: THEIR POSSIBLE RELATION WITH CARDIOVASCULAR DISEASES A Montiel-Davalos, M Ibarra-Sanchez, E Alfaro-Moreno, R Lopez-Marure (Mexico City, Mexico) 123 AP-1 IS CRITICAL FOR ENDOTHELIAL MATRIX METALLOPROTEINASE-10 P748 (MMP-10) EXPRESSION INDUCED BY THROMBIN YIA S Martínez de Lizarrondo, J Orbe, J Rodríguez, O Calvayrac, C Rodríguez, J Martínez González, J Páramo (Pamplona, Spain and Barcelona, Spain) 124 SERUM CONCENTRATIONS OF LINOLEIC ACIDS AND THEIR DERIVATIVES BY P749 LIPID PEROXIDATION ARE INCREASED IN PATIENTS WITH CD36 DEFICIENCY YIA D Masuda, M Inagaki, K Nakatani, K Tsubakio-Yamamoto, T Ohama, Y Nakagawa- Toyama, M Nishida, M Ishigami, S Yamashita (Suita, Japan and Toyonaka, Japan) Tuesday, June 16 Poster Sessions 125 EFFECTS OF LIFE STYLE INTERVENTION & COMBINATION LIPID MODIFYING P750 THERAPY ON LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 K Reddy, M Singh, R Batsell, J Bangit, M Zaheer (Sugar Land, TX, USA and Houston, TX, USA) 126 CIRCULATING AUTOANTIBODIES AGAINST HUMAN OXIDIZED LDL ARE P751 RELATED TO VASCULAR HEALTH YIA A Santos, F Fonseca, S Fischer, C Monteiro, S Brandao, A Carvalho, M Gidlund, A Figueiredo-Neto, M Izar (São Paulo, Brazil) 127 DETECTION OF PENTRAXIN 3 (PTX3) EXPRESSION IN HUMAN P752 ATHEROSCLEROTIC LESIONS YIA A Savchenko, R Ohashi, S Jiang, G Hasegawa, T Kodama, M Naito (Niigata, Japan and Tokyo, Japan)

YIA - Young Investigators Award Nominee 103 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 128 NOVEL INFLAMMATORY RISK MARKERS INCLUDING LPPLA2 AND RISK OF P753 CHD IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH) M Seed, J Betteridge, M Caslake, J Cooper, S Humphries, A Neil (London, UK, Glasgow, UK and Oxford, UK) 129 RESTING HEART RATE IS ASSOCIATED WITH THE METABOLIC SYNDROME P754 - AN ADDITIONAL CONNECTION BETWEEN RESTING HEART RATE AND CARDIOVASCULAR DISEASE I Shapira, O Rogowski, S Berliner (Tel Aviv, Israel) 130 DETECTION OF OMEGA-3 OXYLIPINS IN HUMAN PLASMA AND RESPONSE TO P755 TREATMENT WITH OMEGA-3 ACID ETHYL ESTERS G Shearer, W Harris, T Pederson, J Newman (Sioux Falls, SD, USA and Davis, CA, USA) 131 LOW PREVALENCE OF ELEVATED LEVELS OF LIPOPROTEIN ASSOCIATED P756 PHOSPHOLIPASE A2 MASS OBSERVED AMONG PERSONS WITH INCREASED YIA LEVELS OF HIGH DENSITY LIPOPROTEIN CHOLESTEROL K Reddy, M Singh, J Bangit, R Batsell, M Zaheer, M Wegner (Sugar Land, TX, USA, Houston, TX, USA and San Fransisco, CA, USA) 132 T CELL ACTIVATION AND APOPTOSIS IN CORONARY ARTERY DISEASE P757 A Szymanowski, K Backteman, J Ernerudh, L Jonasson (Linköping, Sweden) YIA 133 COMBINED ENDURANCE AND RESISTANCE TRAINING IN FEMALE AND MALE P758 PATIENTS WITH CHRONIC HEART FAILURE E Miche, M Schneider, B Zoller, E Roelleke, A Radzewitz (Gernsbach, Germany)

YIA - Young Investigators Award Nominee 104 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 11 CLINICAL STUDIES

Poster Board No. Publication No. 134 MODELING ATTAINMENT OF NORMAL LIPID LEVELS IN SWISS PATIENTS P759 RECEIVING ER NIACIN/LAROPIPRANT ADDED TO STATIN THERAPY G Davies, H Phatak, A Roediger, B Ambegaonkar, V Sazonov, T Szucs (Whitehouse Station, NJ, USA, Glattbrugg, Switzerland and Zurich, Switzerland) 135 TREATMENT BELIEFS AND ADHERENCE TO FOLLOW-UP IN A LIPIDS CLINIC P760 A Elis, M Lishner, S Melamed (Kfar-Saba, Israel) 136 SHOULD DIRECT LDL-CHOLESTEROL ASSAYS REPLACE THE FRIEDEWALD P761 CALCULATED LDL-CHOLESTEROL? F Faas, H Spencer (Little Rock, AR, USA) 137 USE OF REAL WORLD DATA TO MEASURE THE UNINTENDED CONSEQUENCES P762 OF SWITCHING LIPID-LOWERING MEDICATIONS D Gianarkis, D Flores (New York, NY, USA) 138 CARDIOVASCULAR LDL GOAL ATTAINMENT IN A LARGE RURAL SETTING P763 N Goswami, P Bailey, M Reedy, M Lloyd (Springfield, IL, USA and Maryville, IL, USA) 139 THE EFFECTS OF EXTENDED RELEASE NIACIN IN COMBINATION WITH P764 OMEGA 3 FATTY ACID SUPPLEMENTS IN THE TREATMENT OF ELEVATED YIA LIPOPROTEIN(a) A Helmbold, J Blevins, L Castillo-Rojas, E Shry, B Rubal, A Slim (San Antonio, TX, USA) 140 SIMULTANEOUS TREATMENT EFFECTIVNESS OF DYSLIPIDEMIA, DIABETES P765 MELLITUS TYPE 2 AND ARTERIAL HYPERTENSION YIA K Kapanadze, N Kipshidze (Tbilisi, Georgia) 141 HOW TO IMPROVE PATIENT COMPLIANCE WITH LIPID LOWERING P766 MEDICATION? P Kardas (Lodz, Poland) 142 LDL CHOLESTEROL LEVELS AFTER DISCHARGE FROM AN ACUTE CORONARY P767 SYNDROME. A STUDY FROM NORTHERN JUTLAND, DENMARK L Kobbelgaard, M Petersen, M Jakobsen, E Schmidt (Aalborg, Denmark) 143 DIFFERENCES IN INSULIN RESISTANCE RELATED FACTORS OF CHRONIC P768 HEPATITIS B AND C PATIENTS YIA H Mukae, N Furusyo, T Koga, H Ohnishih, S Maeda, Y Sawayama, J Hayashi (Fukuoka, Tuesday, June 16 Japan) Poster Sessions 144 THE LIPID PROFILE AND TROPONIN I LEVELS ON PROGRESS IN PATIENTS P769 WITH LATTER THROMBOTIC STROKE S Pagoni, S Paximadas, D Syrigos, D Koutete, S Vrionis, J Pilios, E Koukou, A Kordalis (Athens, Greece) 145 ROBUST EFFICACY OF PITAVASTATIN AND COMPARABLE SAFETY TO P770 PRAVASTATIN S Stender, N Hounslow (Copenhagen, Denmark and Wokingham, UK) 146 A RANDOMIZED CONTROLLED STUDY TO COMPARE THE EFFECT OF P771 ROSUVASTATIN 5MG WITH ATORVASTATIN 10MG ON PLASMA LIPIDS IN JAPANESE PATIENTS WITH HYPERCHOLESTEROLEMIA. (ASTRO-2 STUDY) T Yamazaki, M Kurabayashi (Tokyo, Japan and Maebashi, Japan)

YIA - Young Investigators Award Nominee 105 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 147 A RANDOMIZED CONTROLLED STUDY TO COMPARE THE EFFECT OF P772 ROSUVASTATIN 2.5MG WITH PRAVASTATIN 10MG ON PLASMA LIPIDS IN JAPANESE PATIENTS WITH HYPERCHOLESTEROLEMIA (ASTRO-1 STUDY) T Yamazaki, M Kurabayashi (Tokyo, Japan and Maebashi, Japan) 148 EFFICACY OF EZETIMIBE ADDED TO ATORVASTATIN VS UP-TITRATION OF P773 ATORVASTATIN IN THE ELDERLY F Zieve, O Ben-Yehuda, C Constance, N Wenger, S Bird, R Lee, M Hanson, C Jones-Burton, A Tershakovec (Richmond, VA, USA, San Diego, CA, USA, Montreal, QC, Canada, Atlanta, GA, USA and North Wales, PA, USA)

YIA - Young Investigators Award Nominee 106 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 12 EPIDEMIOLOGY OF CARDIOVASCULAR DISEASE

Poster Board No. Publication No. 149 MICRORNA’S: PROMISING BIOMARKERS IN CARDIOVASCULAR DISEASE P774 A Bakker, S-J Pinto-Sietsma (Amsterdam, The Netherlands) YIA 150 DETERMINANTS OF CAROTID INTIMA MEDIA THICKNESS (IMT) IN A HIGH P775 RISK EUROPEAN POPULATION: BASELINE RESULTS OF THE IMPROVE STUDY D Baldassarre, E Tremoli, IMPROVE Study Group (Milan, Italy) 151 SONOGRAPHIC IMAGING OF CAROTID ATHEROSCLEROSIS IS A BETTER P776 PREDICTOR OF CORONARY ARTERY DISEASE THAN C-REACTIVE PROTEIN YIA (CRP) F Beutner, D Teupser, M Scholz, S Gielen, G Schuler, J Thiery (Leipzig, Germany) 152 ASSOCIATIONS BETWEEN HUMAN LEUKOCYTE ANTIGEN (HLA) GENOTYPE P777 AND ACUTE MYOCARDIAL INFARCTION H Björkbacka, E Lavant, G Fredrikson, O Melander, G Berglund, J Carlson, J Nilsson (Malmö, Sweden) 153 CHRONIC EXPOSURE TO SEVERAL DIFFERENT INFECTIOUS AGENTS MIGHT P778 CONTRIBUTE THE CORONARY ATHEROTHROMBOSIS DEVELOPMENT YIA I Burazor, A Vojdani, M Burazor, N Burazor (Nis, Serbia and Beverly Hills, CA, USA) 154 LOW TITERS OF NATURAL ANTI-PHOSPHORYLCHOLINE IgM ANTIBODIES P779 PREDICT INCREASED MORTALITY AND MORBIDITY IN ACUTE CORONARY SYNDROMES K Caidahl, M Hartford, T Karlsson, K Pettersson, U deFaire, J Frostegård (Stockholm, Sweden and Göteborg, Sweden) 155 IS LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN HIGH DENSITY P780 LIPOPROTEIN A RISK FACTOR FOR CORONARY VASCULAR DISEASE IN THE ELDERLY? M Caslake, J Cooney, E Murray, D Bedford, M Roberston, C Packard (Glasgow, UK) 156 CHANGES IN EMERGING CARDIAC BIOMARKERS FOLLOWING AN INTENSIVE P781 LIFESTYLE INTERVENTION N Chainani-Wu, G Weidner, D Purnell, S Frenda, C Kemp, D Ornish (Sausalito, CA, USA and San Francisco, CA, USA) 157 EFFECTS OF ATORVASTATIN-FENOFIBRATE COMBINATION COMPARED P782

TO ATORVASTATIN MONOTHERAPY ON LIPID PROFILE IN PATIENTS WITH Tuesday, June 16 Poster Sessions COMBINED DYSLIPIDEMIA G Derosa, S Salvadeo, I Ferrari, A Cicero (Pavia, Italy and Bologna, Italy) 158 EFFECT OF MANIDIPINE-ROSUVASTATIN COMBINATION ON FIBRINOLYSIS, P783 INFLAMMATION MARKERS AND INSULIN SENSITIVITY IN HYPERTENSIVE HYPERCHOLESTEROLEMIC PATIENTS R Fogari, S Salvadeo, I Ferrari, P Maffioli, A Mugellini, P Preti, G Derosa (Pavia, Italy) 159 ANTIRETROVIRAL THERAPY AND LIPODYSTROPHY AS PREDICTORS OF SUB- P784 CLINICAL ATHEROSCLEROSIS G Guaraldi, N Alexopoulos, C Stentarelli, S Zona, G Orlando, F Carli, G Ligabue, A Lattanzi, R Rossi, MC Modena, F Palella, P Raggi (Modena, Italy, Atlanta, GA, USA and Chicago, IL, USA)

YIA - Young Investigators Award Nominee 107 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 160 HYPERRESISTINEMIA IS AN INDEPENDENT RISK FACTOR FOR ENDOTHELIAL P785 DYSFUNCTION AND ANGIOGRAPHIC EXTENT IN PATIENTS WITH CORONARY HEART DISEASE X-S Huang, X-Q Pu (Changsha, China) 161 FACTOR ANALYSIS OF CARDIOVASCULAR DISEASE RISK VARIABLES P786 ASSOCIATED WITH LOW LEVELS OF CIRCULATING SOLUBLE TWEAK Z Jelic-Ivanovic, S Spasic, J Kotur-Stevuljevic (Belgrade, Serbia) 162 RESTING HEART RATE REMAINS AN INDEPENDENT RISK FACTOR FOR P787 MORTALITY IN HEALTHY SUBJECTS AFTER ADJUSTING FOR INFLAMMATORY MARKERS, THE COPENHAGEN CITY HEART STUDY (CCHS) G Jensen, J Marott, M Jensen (Copenhagen, Denmark) 163 LOW SERUM BILIRUBIN LEVELS AND INCREASED CAROTID INTIMA-MEDIA P788 THICKNESS HC Kim (Seoul, Republic of Korea) 164 NON-HDL-CHOLESTEROL AND PREDICTION OF MYOCARDIAL INFARCTION P789 IN THE GENERAL JAPANESE POPULATION: JICHI MEDICAL SCHOOL COHORT STUDY K Kotani, S Ishikawa, T Gotoh, K Kayaba, Y Nakamura, E Kajii (Tochigi, Japan and Saitama, Japan) 165 A NEW APPROACH TO CLASSIFYING CHD IN NORMOLIPODEMIC P790 INDIVIDUALS USING HIGH PERFORMANCE LIPOPROTEIN DENSITY YIA PROFILING C Larner, R Henriquez, R Macfarlane, C McNeal, S Sheather (College Station, TX, USA) 166 LEUKOCYTE RHO KINASE (ROCK) ACTIVITY AND PRIOR STATIN USE P791 PREDICT CLINICAL OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION P-Y Liu, J-H Chen, J Liao (Tainan, Taiwan and Boston, MA, USA) 168 IMPLEMENTATION OF ACTIONS AND INITIAL RESULTS IN PUBLIC STATE P793 SERVANTS: CARDIOVASCULAR PREVENTING PROGRAM L Martinez, P Queiroz, M Morales, C Cruz, M Shirassu (São Paulo, Brazil) 169 TELOMERES ARE SHORTER IN MI AND CABG PATIENTS COMPARED TO P794 HEALTHY SUBJECTS; CORRELATION WITH ENVIRONMENTAL AND GENETIC YIA RISK FACTORS C Maubaret, K Salpea, J Cooper, HIFMECH Consortium, J Sanders, H Montgomery, S Humphries (London, UK) 170 SIMULTANEOUS QUANTIFICATION OF OXIDATIVE STRESS AND PLATELETS P795 ACTIVATION IN ATHEROSLEROTIC PATIENTS YIA F Minardi, V Cavalca, F Veglia, I Squellerio, L Dainese, A Guarino, E Tremoli, D Caruso (Milan, Italy) 171 PREVALENCE OF OBESITY IN PATIENTS SUFFERING FROM P796 HYPERCHOLESTEROLEMIA Z Mohebbi, S Najafi, M Zoladl (Shiraz, Islamic Republic of Iran and Yasouj, Islamic Republic of Iran) 172 HIGH PLASMA LEVELS OF MMP-8 IN UNSTABLE ANGINA P797 Y Momiyama, R Ohmori, R Kato, H Taniguchi, F Ohsuzu (Tokyo, Japan, Utsunomiya, Japan and Saitama, Japan) 173 THE ANALYSIS OF HIGH DENSITY LIPOPROTEIN COMPONENTS IN SERUM TO P798 IDENTIFY BIOMARKERS FOR CARDIOVASCULAR DISEASE YIA D Moore, R Macfarlane, S Chatterjee, C McNeal (College Station, TX, USA, Baltimore, MD, USA and Temple, TX, USA) 174 THE BIOIMAGE STUDY: NOVEL APPROACHES TO RISK ASSESSMENT IN THE P799 PRIMARY PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE P Muntendam, P Gardiner (Waltham, MA, USA) YIA - Young Investigators Award Nominee 108 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 175 CORRELATION BETWEEN LAG TIME OF LDL TO IN VITRO OXIDATION AND IN P800 VIVO Ox-LDL IN THE PATIENTS WITH CAD YIA H Nayeri, G Naderi, S Asgry, M Sadeghi (Isfahan, Islamic Republic of Iran) 176 EPIGENETIC PHEROMONES CAUSE DISEASE: THE ELECTRODEPOSITION P801 MECHANISM OF ATHEROSCLEROSIS B Nicholson (Tampa, FL, USA) 177 EFFECTS OF LOW DOSE PRAVASTATIN THERAPY ON SERUM SUPEROXIDE P802 DISMUTASE ACTIVITIES IN JAPANESE HYPERCHOLESTEROLEMIC SUBJECTS H Ozasa, M Ogura, E Yakushiji, S Takiguchi, Y Terao, K Nakaya, H Kondo, M Ayaori, K Ikewaki (Tokorozawa, Japan) 178 GREATER ADHERENCE TO THE MEDITERRANEAN DIET INCREASES P803 ADIPONECTIN LEVELS AMONG CARDIOVASCULAR DISEASE FREE ADULTS: THE ATTICA STUDY E Fragopoulou, D Panagiotakos, C Pitsavos, C Chrysohoou, C Stefanadis (Athens, Greece) 179 CONNECTION BETWEEN SERUM LEPTIN, ADIPONECTIN, ASYMMETRIC P804 DIMETHYLARGININE LEVELS AND PARAOXONASE ACTIVITY IN RENAL TRANSPLANT PATIENTS L Locsey, I Seres, F Sztanek, L Asztalos, L Szabo, G Paragh (Debrecen, Hungary) 180 SERUM HEAT SHOCK PROTEIN 27 (Hsp27) ANTIGEN AND IMMUNOGLOBULIN P805 M (IgM) ANTIBODY LEVELS APPEAR TO BE RELATED TO THE PRESENCE OF INSULIN RESISTANCE AND CARDIOVASCULAR DISEASE (CVD) DF Pengiran Burut, A Borai, C Livingstone, G Ferns (Guildford, UK) 181 EVALUATION OF PROTEIN C HIGHLY SENSITIVE CHILDREN AND P806 ADOLESCENTS IN MUNICIPALITY OF ITAPETININGA-BRAZIL A Pereira, T Martinez, A Sposito, H Nascimento (São Paulo, Brazil and Brasilia, Brazil) 182 ASSOCIATION OF LIPOPROTEIN (A) WITH CLINICAL EVENTS AFTER P807 PERCUTANEOUS CORONARY INTERVENTION M Ezhov, Y Matchin, O Afanasieva, Y Docenko, M Afanasieva, A Lyakishev, S Pokrovsky (Moscow, Russian Federation) 183 CORONARY AGEING IN HIV-INFECTED PATIENTS P808 N Alexopoulos, G Guaraldi, S Zona, G Orlando, F Carli, G Ligabue, F Fiocchi, R Rossi, MC Modena, F Palella, P Raggi (Atlanta, GA, USA, Modena, Italy and Chicago, IL, USA) 184 THE PREVALENCE OF ELEVATED LEVELS OF INFLAMMATORY BIOMARKERS P809 Lp-PLA2 AND hs-CRP AMONG APPARENTLY HEALTHY YOUNG ADULTS K Reddy, M Singh, R Batsell, J Bangit, M Zaheer, M Wegner (Sugar Land, TX, USA, Houston, TX, USA and South San Francisco, CA, USA) 185 PROLACTIN LEVELS AND THE RISK OF FUTURE CORONARY ARTERY P810 DISEASE IN APPARENTLY HEALTHY MEN AND WOMEN. A PROSPECTIVE YIA

CASE-CONTROL STUDY NESTED IN THE EPIC-NORFOLK COHORT Tuesday, June 16 Poster Sessions A Reuwer, M Twickler, B Hutten, F Molema, N Wareham, G Dallinga-Thie, R Bogorad, V Goffin, J Kastelein, K-T Khaw, M Boekholdt (Amsterdam, The Netherlands, Nijmegen, The Netherlands, Cambridge, UK and Paris, France) 186 CORRELATION BETWEEN INFLAMMATION MARKERS AND ADIPOKINES IN P811 HEALTHY MEN - FOCUS ON BIOMARKERS: HIGH SENSITIVE C-REACTIVE PROTEIN, TUMOR NECROSIS FACTOR-a, SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR 2, ADIPONECTIN AND LEPTIN C Sartika, W Lukito, A Wijaya, I Patellongi (Makassar, Indonesia and Jakarta, Indonesia) 187 INFLAMMATORY MARKERS AND INTIMA MEDIA THICKNESS (CIMT) P812 C Schubert, K Cruickshanks, C Acher, B Klein, R Klein, M Tsai, F Nieto (Madison, WI, USA and Minneapolis, MN, USA)

YIA - Young Investigators Award Nominee 109 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 188 THE CONSIDERATION OF ETHNICITY IN CORONARY RISK PREDICTION P813 USING CRP YIA T Shah, J Addo, P Newcombe, J Casas, L Smeeth, A Hingorani (London, UK) 189 ADIPONECTIN AND VASCULAR PROPERTIES IN OBESE PATIENTS. IS IT A P814 NOVEL BIOMARKER OF EARLY ATHEROSCLEROSIS? M Shargorodsky (Holon, Israel) 190 STUDY ON THE PLASMA BIOMARKER PROTEIN IN PROFILES IN P815 HYPERLIPIDEMIA AND ATHEROSCLEROSIS J-N Song, J-L Liu, B-S Chen, X-Z Fang, X-D Li (Beijing, China) 191 INDIAN DIABETES RISK SCORE (IDRS) AND IT’S ASSOCIATION WITH P816 AUGMENTATION INDEX (AI); A MARKER OF PRECLINICAL FUNCTIONAL ATHEROSCLEROTIC CHANGES: THE CHENNAI URBAN RURAL EPIDEMIOLOGY STUDY (CURES) B Srivastava, V Mohan (Chennai, India) 192 MYELOPEROXIDASE AND C-REACTIVE PROTEIN ARE BOTH NEGATIVELY P817 ASSOCIATED WITH THE ARGININE/ADMA RATIO, LINKING INFLAMMATION TO REDUCED NITRIC OXIDE PRODUCTION L van der Zwan, P Scheffer, J Dekker, C Stehouwer, R Heine, T Teerlink (Amsterdam, The Netherlands and Maastricht, The Netherlands) 193 THE RELATIONSHIP BETWEEN SERUM URIC ACID LEVELS AND THE P818 PRESENCE AND SEVERITY OF CORONARY ARTERY DISEASE YIA O Deveci, G Kabakci, S Okutucu, E Tulumen, H Aksoy, B Kaya, B Evranos, K Aytemir, L Tokgözoglu, A Oto, H Ozkutlu (Ankara, Turkey) 194 THE RELATIONSHIP BETWEEN MICROALBUMINURIA AND EXTENT OF P819 CORONARY ATHEROSCLEROSIS YIA O Deveci, G Kabakci, E Tulumen, S Okutucu, H Aksoy, B Kaya, U Canpolat, K Aytemir, L Tokgözoglu, A Oto, H Ozkutlu (Ankara, Turkey) 195 APOLIPOPROTEIN B VERSUS LDL-CHOLESTEROL: ASSOCIATION WITH P820 OTHER RISK FACTORS FOR ATHEROSCLEROSIS H Vaverkova, D Karasek, D Novotny, D Jackuliakova, J Lukes, J Frohlich (Olomouc, Czech Republic and Vancouver, BC, Canada) 196 AUTOANTIBODIES TO OXIDIZED LOW DENSITY LIPOPROTEIN IN RELATION P821 WITH CORONARY ARTERY DISEASE Y Soto, H Conde, R Aroche, V Brito, P Luaces, A Nasiff, A Obregón, A Vazquez (Havana, Cuba) 197 PULSE WAVE VELOCITY, CAROTID INTIMA-MEDIA THICKNESS AND P822 CARDIOVASCULAR DISEASE IN THE BEAVER DAM OFFSPRING STUDY (BOSS) W Zhong, K Cruickshanks, C Schubert, FJ Nieto, J Pankow, C Acher, G-H Huang, B Klein, B Klein, R Klein, T Tweed (Madison, WI, USA, Minneapolis, MN, USA and Hsinchu, Taiwan) 198 EZETIMIBE (E) ADDED TO ATORVASTATIN (A): EFFECT ON LIPOPROTEIN P823 SUBCLASS CHOLESTEROL CONTENT IN PATIENTS WITH HIGHER VERSUS LOWER TRIGLYCERIDE LEVELS (TG) H Bays, S Conard, L Leiter, E Jensen, A Shah, M Hanson, A Tershakovec (Louisville, KY, USA, Dallas, TX, USA, Toronto, Canada and North Wales, PA, USA) 199 CAN LIPID/APOLIPOPROTEIN FACTORS ACCOUNT FOR RESIDUAL RISK IN P824 PATIENTS ATTAINING CURRENT LDL-C TARGETS? A Olsson, C Lindahl, R Fayyad, S Bhatia, I Holme (Linköping, Sweden, Stockholm, Sweden, New York, NY, USA and Oslo, Norway) 199A N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE AND ECHOCARDIOGRAPHY P1524 FOR THE PREDICTION OF CARDIOVASCULAR EVENTS M Iannaccone, A Magliaro (Avellino, Italy)

YIA - Young Investigators Award Nominee 110 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 13 GENETICS

Poster Board No. Publication No. 200 INTERACTION OF PROSTACYCLIN SYNTHASE AND PEROXISOME P825 PROLIFERATOR-ACTIVATED RECEPTOR DELTA GENE POLYMORPHISMS INFLUENCES BLOOD GLUCOSE LEVEL MY Lui, M Waye, M Ng, J Chan, Y-Y Ho (Shatin, Hong Kong and New York, NY, USA) 201 CARDIOVASCULAR RISK IN CHILDREN P826 F Abello, O Guardamagna, V Baracco (Turin, Italy) YIA 202 PHARMACOGENETIC STUDY OF CHOLESTERYL ESTER TRANSFER PROTEIN P827 GENE AND ATORVASTATIN TREATMENT IN HYPERCHOLESTEROLAEMIC YIA SUBJECTS K Anagnostopoulou, G Kolovou, P Kostakou, V Kolovou, M Stamatelatou, C Mihas, I Vasiliadis, O Diakoumakou, D Mikhailidis, D Cokkinos (Athens, Greece, Kimi, Greece and London, UK) 203 CORRELATION BETWEEN INTIMA MEDIA THICKNESS MEASUREMENTS P828 AND BIOCHEMICAL MARKERS OF PRECLINICAL ATHEROSCLEROSIS IN YIA CHILDHOOD V Baracco, F Abello, O Guardamagna (Turin, Italy) 204 FAMILIAL HYPERCHOLESTEROLAEMIA: A PERSPECTIVE OF 10 YEARS OF P829 STUDY IN PORTUGAL YIA A Alves, A Medeiros, V Francisco, M Bourbon, Investigators of the PSFH (Lisbon, Portugal) 205 MOLECULAR STUDY OF FAMILIAL LIPOPROTEIN DISORDERS P830 T Santos, Q Rato, M Bourbon (Lisbon, Portugal) YIA 206 INTERACTION OF C-REACTIVE PROTEIN GENE SNP +2147 A/G AND P831 ADIPONECTIN +276G/T ON LIPID PROFILES AMONG SCHOOL CHILDREN IN TAIWAN N-F Chu, F-H Lin, S-C Wang, D-M Wu (Taipei, Taiwan) 207 LDL RECEPTOR MUTATION IN A DRUZE KINDRED - CLINICAL, BIOCHEMICAL P832 AND GENETIC CHARACTERISTICS H Cohen, D Harats, N Wael, Y Anikster, K Mazor-Aronovitch, O Pinhas-Hamiel (Tel- Hashomer, Israel, Nahariya, Israel and Tel Aviv, Israel)

208 APPLICABILITY OF THE CARDIOVASCULAR RISK PREDICTOR “SCORE” TO P833 Tuesday, June 16 Poster Sessions PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA O Descamps, S Humphries (Haine Saint-Paul, Belgium and London, UK) 209 MUTATIONAL ANALYSIS IN NORTHWESTERN GREECE PATIENTS WITH P834 CLINICAL DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLEMIA YIA M Diakou, G Miltiadous, S Xenophontos, M Cariolou, M Elisaf (Ioannina, Greece and Nicosia, Cyprus) 210 CHARACTERIZATION OF THE LOW DENSITY LIPOPROTEIN RECEPTOR (LDLR) P835 GENE MUTATION IN ALBANIA YIA M Diakou, G Miltiadous, S Xenophontos, M Cariolou, M Elisaf (Ioannina, Greece and Nicosia, Cyprus)

YIA - Young Investigators Award Nominee 111 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 211 GENETIC AND MOLECULAR MODELLING APPROACH IN THE STUDY OF FH IN P836 MOROCCO M El Messal, A Kettani, A Adlouni (Casablanca, Morocco) 212 FAMILIAL HYPERCHOLESTEROLEMIA FAMILY SCREENING IN THE CZECH P837 REPUBLIC T Freiberger, M Plotena, P Zapletalova, R Goldmann, L Tichy, L Fajkusova (Brno, Czech Republic) 213 SCREENING FOR PCSK9 MUTATIONS IN SPANISH PATIENTS WITH P838 AUTOSOMAL DOMINANT HYPERCHOLESTEROLEMIA UNRELATED TO LDLR OR APOB Á-L García-Otín, M Strunk, M Pueyo, M Solanas, S Fiddyment, M Aceves, D Tejedor, M Pocoví, F Civeira (Zaragoza, Spain and Derio, Spain) 214 THE RS17321515 (TRIB1) POLYMORPHISM MODULATES PLASMA LIPID P839 LEVELS IN RESPONSE TO THE SMOKING STATUS AND THE PRESENCE YIA OF ARCUS CORNEALIS: INSIGHT FROM THE SPANISH FAMILIAL HYPERCHOLESTEROLEMIA COHORT STUDY A Garcia Rios, P Perez Martinez, J Lopez Miranda, R Alonso Karlezi, F Fuentes Jimenez, P Mata Lopez, J Ordovas Muñoz, F Perez Jimenez (Cordoba, Spain, Madrid, Spain and Boston, MA, USA) 215 FAMILIAL HYPERCHOLESTEROLEMIA IN NORWAY - SUBSTANTIAL P840 VARIATION IN FREQUENCY OF GENETIC TESTING AND DEGREE OF FOLLOW UP IN DIFFERENT GEOGRAPHICAL REGIONS A Graesdal, L Ostli, K-E Arnesen (Oslo, Norway) 216 NON-FUNCTIONALITY OF THREE LDL-R AND ApoB GENE MUTATIONS THAT P841 WERE ASSUMED TO CAUSE FAMILIAL HYPERCHOLESTEROLEMIA YIA R Huijgen, I Kindt, S Fouchier, J Defesche, B Hutten, J Kastelein, M Vissers (Amsterdam, The Netherlands) 217 IMPACT OF LDL RECEPTOR MUTATIONAL CLASS ON CAROTID P842 ATHEROSCLEROSIS IN FAMILIAL HYPERCHOLESTEROLEMIA (FH) YIA M Junyent, R Mateo, R Gilabert, M Cofan, I Nunez, M Pocovi, M Mallen, D Zambon, D Tejedor, J Vega, F Almagro, F Civeira, E Ros (Boston, MA, USA, Zaragoza, Spain, Barcelona, Spain, Derio, Spain and San Sebastian, Spain) 218 ASSOCIATIONS BETWEEN APOLIPOPROTEIN E GENE POLYMORPHISM AND P843 ATHEROGENIC LIPOPROTEIN PROFILE IN A LONG TERM HEMODIALYSIS YIA PATIENTS H Lahrach, M Timinouni, L Er-Rachdi, A Kettani, B Ramdani, N Ghalim, R Saïle (Casablanca, Morocco) 219 RELATIONSHIP BETWEEN PLASMA PCSK9 AND LDL LEVELS IN FAMILIAL P844 HYPERCHOLESTEROLEMIA (FH) AND HYPOBETALIPOPROTEINEMIA (FHBL) G Lambert (Camperdown, Australia and Nantes, France) 220 NOVEL ICT SOLUTION FOR THE DUTCH NATIONAL SCREENING PROGRAM P845 FOR FAMILIAL HYPERCHOLESTEROLEMIA P Lansberg, I Kindt, J van Vliet (Amsterdam, The Netherlands and Amersfoort, The Netherlands) 221 DETECTION OF FAMILIAL HYPERCHOLESTEROLAEMIA IN A COHORT OF P846 CORONARY HEART DISEASE PATIENTS IN WESTERN AUSTRALIA YIA K Liyanage, J Burnett, F van Bockxmeer (Crawley, Australia and Perth, Australia) 222 THE PREVALENCE OF APOLIPOPROTEIN B-100 GENE MUTATIONS IN RUSSIAN P847 FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS A Meshkov, D Stambolsky, P Malyshev, T Kotkina, S Boitsov, V Kukharchuk (Moscow, Russian Federation)

YIA - Young Investigators Award Nominee 112 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 223 THE COMBINATION OF THE “HYPERTRIGLYCERIDEMIC WAIST” PHENOTYPE P848 AND MENOPAUSE INCREASES CORONARY ARTERY DISEASE RISK AT YIA A HIGHER LEVEL THAN DOES FAMILIAL HYPERCHOLESTEROLEMIA IN WOMEN J Methot, T Bouhali, D Brisson, L Bouchard, G Tremblay, D Gaudet (Chicoutimi, QC, Canada) 224 HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN CZ (A 15-YEAR P849 EXPERIENCE WITH EXTRACORPOREAL LDL-ELIMINATION) M Blaha, E Mistrik, V Blaha, C Andrys, D Solichova (Hradec Kralove, Czech Republic) 225 CLINICAL AND PARA CLINICAL CHARACTERISTIC OF PATIENTS WITH M I P850 Z Mohebbi, S Nagafi (Shiraz, Islamic Republic of Iran and Yasouj, Islamic Republic of Iran) 226 PROFILES OF GAIN-OF-FUNCTION PCSK9 E32K MUTATION: INCLUDING P851 PURE HOMOZYGOTE AND COMPOUND HETEROZYGOTE WITH LDLR GENE MUTATION T Noguchi, S Katsuda, M-A Kawashiri, A Nohara, J Kobayashi, A Inazu, M Takata, M Tsuchida, H Tada, C Nakanishi, M Yamagishi, H Mabuchi (Kanazawa, Japan) 227 SYNERGISTIC IMPACT OF FARNESOID X RECEPTOR AND UPSTREAM P852 TRANSCRIPTION FACTOR 1 GENE VARIANTS ON LIPOPROTEIN METABOLISM A Nohara, T Noguchi, H Tada, C Nakanishi, M Tsuchida, M Takata, M-A Kawashiri, A Inazu, J Kobayashi, M Yamagishi, H Mabuchi (Kanazawa, Japan and Ishikawa, Japan) 228 THE USE OF DVD IN INFORMATION OF FH TO YOUNG PATIENTS P853 L Ose (Oslo, Norway) 229 THE ROLE OF TNF-a GENE POLYMORPHISM IN ATHEROSCLEROSIS RISK P854 ASSESSMENT G Roytberg, O Serebryakova, O Sharkhun, T Ushakova (Moscow, Russian Federation) 230 HIGH TRIGLYCERIDES, LOW HDL CHOLESTEROL, AND SMALL LDL P855 PARTICLES PREDICT INCIDENT TYPE 2 DIABETES IN NON-DIABETIC YIA CORONARY PATIENTS C Saely, A Vonbank, P Rein, S Beer, S Aczel, T Marte, H Drexel (Feldkirch, Austria and Triesen, Liechtenstein) 231 IDENTIFICATION OF SIX PCSK9 SNPS IN THE GREEK GENERAL POPULATION P856 AND GREEK FH PATIENTS YIA E Koniari, E Laios, A Skouma, E Drogari (Athens, Greece) 232 APOLIPOPROTEIN C3 POLYMORPHISM INTERACTS WITH DIETARY FAT TO P857 MODULATE TRIGLYCERIDES IN THE GOLDN STUDY C Smith, D Arnett, C Lai, M Tsai, L Parnell, M Junyent, J Ordovas (Boston, MA, USA, Birmingham, AL, USA and Minneapolis, MN, USA) 233 THE LIPOCHIP EXPERIENCE IN SPAIN P858

M Stef, L Palacios, D Tejedor, A Martinez (Derio, Spain) YIA Tuesday, June 16 Poster Sessions 234 IMPACT OF ACCELERATION OF POST-PRANDIAL REMNANT LIPOPROTEIN P859 CLEARANCE IN AUTOSOMAL RECESSIVE HYPERCHOLESTEROLEMIA (ARH) YIA H Tada, M-A Kawashiri, T Nakano, K Nakajima, M Takata, A Nohara, A Inazu, J Kobayashi, H Mabuchi, M Yamagishi (Kanazawa, Japan and Tokushima, Japan) 235 IMPACT OF RAPID DEVELOPMENT OF CAROTID ATHEROSCLEROSIS IN P860 YOUNG FAMILIAL HYPERCHOLESTEROLEMIA (FH): COMPARISON WITH NON-FH LITTERMATES M Takata, M-A Kawashiri, A Nohara, T Noguchi, H Tada, C Nakanishi, M Tsuchida, A Inazu, J Kobayashi, H Mabuchi, M Yamagishi (Kanazawa, Japan)

YIA - Young Investigators Award Nominee 113 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 236 EVALUATION OF LIPOPROTEIN-RELATED INDICES FOR CHD IN THE PATIENTS P861 WITH TYPE 2 DIABETES J Tanabe, K Matsuki, H Murakami, M Yamashita, J Matsuki, N Tamasawa, T Suda (Hirosaki, Japan) 237 SERUM OXYSTEROL LEVELS ARE ELEVATED IN A PATIENT WITH GIANT P862 NECROTIC TENDON XANTHOMATOSIS AND CAROTID AND CORONARY YIA ATHEROSCLEROSIS K Tsubakio-Yamamoto, T Ohama, M Inagaki, K Nakatani, J Sandoval, D Masuda, Y Nakagawa-Toyama, M Nishida, M Ishigami, S Yamashita (Suita, Japan) 238 FUNCTIONAL DEFECTS IN LDL-RECEPTOR DO NOT LIMIT ACUTE CORTISOL P863 RESPONSE S van Wissen, M Vergeer, L Schwocho, J Kastelein, M Twickler (Amsterdam, The Netherlands and Edison, NJ, USA) 239 GENETIC ANALYSIS OF VARIANTS ON GENES INFLUENCING INFLAMMATION P864 AND INSULIN RESISTANCE: EFFECT ON CORONARY ARTERY DISEASE YIA M AshokKumar, R SaiBabu, K Thangaraj, KM Cherian, C Emmanuel (Chennai, India and Hyderabad, India) 240 A NEW BIOINDEX FOR EVALUATION OF MULTIPLE RISK FACTORS FOR P865 ATHEROSCLEROSIS IN YOUNG ADOLESCENT CHILDREN OF EARLY CORONARY ARTERY DISEASE PATIENTS IN EASTERN INDIA D Basu, D Basu (Kolkata, India) 241 USE OF GENOME-WIDE ASSOCIATION STUDIES IN SELECTION OF P866 CANDIDATE SNPs J Bolton, J Price (Edinburgh, UK) 242 Withdrawn P867 243 A PROSTACYCLIN SYNTHASE (PTGIS) GENE POLYMORPHISM INCREASES P868 RISK OF CORONARY ARTERY DISEASE (CAD) YIA E Theodoraki, P Fili, T Nikopensius, G Kolovou, V Peppes, N Zakopoulos, A Metspalu, G Dedoussis (Athens, Greece and Tartu, Esthonia) 244 HEPATIC LIPASE C-480T POLYMORPHISM IS ASSOCIATED WITH SERUM P869 LIPIDS LEVELS BUT NOT WITH EARLY MARKERS OF SUBCLINICAL ATHEROSCLEROSIS AMONG YOUNG ADULTS Y-M Fan, O Raitakari, M Kahonen, N Hutri-Kahonen, M Juonala, J Marniemi, J Viikari, T Lehtimaki (Tampere, Finland and Turku, Finland) 245 IDENTIFICATION OF APOB AND PCSK9 MUTATIONS CAUSING A NON-ADH P870 PHENOTYPE IN MOLECULAR DIAGNOSED ADH PATIENTS YIA S Fouchier, R Huijgen, K Vis, J Defesche, J Kastelein (Amsterdam, The Netherlands) 246 PARAOXONASE POLYMORPHISM IS AN INDEPENDENT PREDICTOR OF 5- P871 YEAR MORTALITY IN STABLE CORONARY DISEASE YIA L Funari Ferri, A Pereira, W Hueb, J Krieger, N Lopes (São Paulo, Brazil and Toronto, ON, Canada) 247 A GENETIC VARIANT, rs599389, MODULATES THE RISK OF MYOCARDIAL P872 INFARCTION IN THE STOCKHOLM HEART EPIDEMIOLOGY PROGRAM (SHEEP) THROUGH THE INTERACTION WITH SERUM LIPID LEVELS B Gigante, M Vikström, K Leander, S Ye, U de Faire (Stockholm, Sweden and London, UK) 248 THROMBIN RECEPTOR (F2R) AND INTERLEUKIN 6 (IL6) HAPLOTYPES P873 INTERACTION MODULATES THE RISK OF MYOCARDIAL INFARCTION (MI) B Gigante, M Vikström, A Bennet, U de Faire (Stockholm, Sweden)

YIA - Young Investigators Award Nominee 114 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 249 TELOMERE LENGTH IS ASSOCIATED WITH OXIDATIVE STRESS AND UCP2 P874 GENE VARIATION IN TYPE 2 DIABETES PATIENTS K Salpea, P Talmud, J Cooper, K Abelak, J Stephens, S Humphries (London, UK and Swansea, UK) 250 OSTEOPROTEGERIN GENE POLYMORPHISM IS NOT ASSOCIATED WITH P875 ANGIOGRAPHIC CORONARY ARTERY STENOSIS AND CALCIFICATION IN KOREAN S-H Jo, Y-J Choi, H-S Kim, G-Y Cho, S-G Kim, HJ Kim (Anyang-si, Gyeonggi-do, Republic of Korea) 251 SEROTONIN TRANSPORTER GENE AND ISCHEMIC STROKE IN TAIWANESE P876 SUBJECTS S-H Jou, T-T Lin, S-C Yu, C-S Liu (Changhua, Taiwan and Tachia Township, Taiwan) 252 A COMPOSITE SCORING OF GENOTYPES DISCRIMINATES CORONARY HEART P877 DISEASE RISK BEYOND CONVENTIONAL RISK FACTORS IN THE BOSTON YIA PUERTO RICAN HEALTH STUDY M Junyent, K Tucker, J Shen, Y-C Lee, C Smith, J Mattei, C-Q Lai, L Parnell, JM Ordovas (Boston, MA, USA) 253 ASSOCIATION BETWEEN C609T VARIANT IN NQO1 AND CAROTID ARTERY P878 PLAQUES IN PATIENTS WITH TYPE 2 DIABETES ES Kang, SJ Han, HJ Kim, SH Kim, CW Ahn, BS Cha, M Nam, HC Lee (Seoul, Korea, Suwon, Korea, Goyang, Korea and Incheon, Korea) 254 DIFFERENTIAL EXPRESSION OF INTERLEUKIN-5 RECEPTOR ISOFORMS IN P879 PATIENTS WITH OBSTRUCTIVE CORONARY ARTERY DISEASE M Greene, M Merhige, D Leonard (Lewiston, NY, USA and Niagara Falls, NY, USA) 255 IS THE F352V VARIANT OF KLOTHO A RISK PREDICTOR FOR STROKE IN THE P880 YOUNG? YIA V Majumdar, D Nagaraja, R Christopher (Bangalore, India) 256 CANDIDATE GENES, WHICH PRODUCTS ARE INVOLVED IN REGULATION P881 OF LIPID TRANSPORT AND SYNTHESIS, AND GENETIC PREDISPOSITION TO YIA CORONARY ARTERY DISEASE A Nikitin, D Zateyshchikov, A Brovkin, L Minushkina, V Nosikov (Moscow, Russian Federation) 257 CONNEXIN37 C1019T POLYMORPHISM IN WOMEN IS WEAKLY ASSOCIATED P882 WITH INSULIN RESISTANCE, BUT NOT WITH DIABETES MELLITUS TYPE 1 OR 2 J Pitha, P Pithova, J Hubacek, S Eisenreichova, T Neskudla, T Pelikanova, V Lanska (Prague, Czech Republic) 258 DETECTION OF ATHEROGENIC AND THROMBOGENIC POLYMORPHISMS AND P883 MUTATIONS IN PATIENTS WITH DYSLIPIDEMIA R Prusa, K Kotaska, T Franek, J Cepova (Prague, Czech Republic) Tuesday, June 16 Poster Sessions 259 LACK OF ASSOCIATION OF ANGIOTENSIN CONVERTING ENZYME GENE P884 INSERTION/DELETION POLYMORPHISM AND MYOCARDIAL INFARCTION AT VERY YOUNG AGES L Rallidis, C Varounis, A Gialeraki, V Sourides, J Lekakis, D Kremastinos (Athens, Greece) 260 GENETIC POLYMORPHISMS OF APOA5 ARE ASSOCIATED WITH P885 HYPERTRIGLYCERIDEMIA AND HYPERGLYCEMIA IN CHILEAN SUBJECTS YIA WITH CAD N Saavedra, P Jaramillo, J Caamaño, C Lanas, F Lanas, L Salazar (Temuco, Chile)

YIA - Young Investigators Award Nominee 115 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 261 ASSOCIATION BETWEEN GENETIC VARIANTS ON THE CHROMOSOMAL P886 LOCI 9P21.3, 6Q25.1, AND 2Q36.3 AND ANGIOGRAPHICALLY DETERMINED CORONARY ARTERY DISEASE S Geller-Rhomberg, A Mündlein, C Saely, G Sonderegger, P Rein, S Beer, A Vonbank, H Drexel (Feldkirch, Austria and Triesen, Liechtenstein) 262 SIGNIFICANT IMPACT OF GENETIC VARIANTS ON CHROMOSOMAL LOCUS P887 1P13.3 ON SERUM LDL-CHOLESTEROL AND ON ANGIOGRAPHICALLY CHARACTERIZED CORONARY ARTERY DISEASE A Mündlein, S Geller-Rhomberg, C Saely, G Sonderegger, P Rein, S Beer, A Vonbank, H Drexel (Feldkirch, Austria and Triesen, Liechtenstein) 263 GENE POLYMORPHISMS AND SUSCEPTIBILITY TO CORONARY ARTERY P888 DISEASE IN CHILEAN SUBJECTS L Salazar, P Jaramillo, N Saavedra, J Caamaño, F Lanas (Temuco, Chile) 264 SYNERGISTIC EFFECT BETWEEN CONTEMPORANEOUS CARRIER-STATE OF P889 “PROATHEROSCLEROTIC” ALLELES OF MTHFR AND E-SELECTIN GENES AND YIA HYPERCHOLESTEROLEMIA INCREASES THE RISK OF CORONARY ARTERY DISEASE B Sarecka-Hujar, I Zak, J Krauze (Katowice, Poland) 265 THE CORRELATION OF ATHEROSCLEROTIC LESIONS IN THE INTERNAL P890 CAROTID ARTERY AND PARAOXONASE GENE POLYMORPHISM AND ITS ASSOCIATION WITH CEREBROVASCULAR RISK FACTORS B-S Shin (Jeonju, Korea) 266 MITOCHONDRIAL DNA 16189T TO C VARIANT IN PATIENTS WITH TYPE 2 P891 DIABETES COMBINED PERIPHERAL ARTERIAL DISEASE S-L Su, C-S Liu, C-L Kuo, B Lin (Changhua, Taiwan) 267 FAS -670G/A POLYMORPHISM IS ASSOCIATED WITH AN INCREASED RISK FOR P892 MYOCARDIAL INFARCTION Y Takemura, H Hanasaki, K Fukuo, O Yasuda, M Ohishi, H Rakugi (Suita, Japan and Nishinomiya, Japan) 268 CARDIOVASCULAR COMPLICATIONS OF ESSENTIAL HYPERTENSION MIGHT P893 BE ASSOCIATED WITH CYTOKINE GENE POLYMORPHISMS YIA Y Timasheva, T Nasibullin, O Mustafina (Ufa, Russian Federation) 269 COPY NUMBER VARIATION IN GLUTATHIONE S-TRANSFERASES M1 AND T1 P894 AND RISK OF ISCHEMIC CARDIOVASCULAR DISEASE YIA M Nørskov, R Frikke-Schmidt, S Loft, B Nordestgaard, A Tybjærg-Hansen (Copenhagen, Denmark) 270 GENETIC VARIANTS IN PHOSPHOLIPID TRANSFER PROTEIN (PLTP) AFFECT P895 PLTP ACIVITY, HIGH-DENSITY LIPOPROTEIN SIZE AND RISK OF CORONARY YIA ARTERY DISEASE M Vergeer, S Boekholdt, N Wareham, M Sandhu, J Kastelein, S Debenham, K-T Khaw, R Dullaart, A van Tol, M Trip, G Dallinga-Thie (Amsterdam, The Netherlands, Cambridge, UK and Groningen, The Netherlands) 271 ASSOCIATION OF CHOLESTERYL ESTER TRANSFER PROTEIN Taq1B P896 POLYMORPHISM AND CORONARY ARTERY DISEASE IN THAIS D Warodomwichit, J Ordovas, S Jongjirasiri, J Laothamatas, T Sura, S Yamwong, M Busabaratana, S Pingsuthiwong, T Yingchoncharoen, S Komindr, P Sritara (Bangkok, Thailand and Boston, MA, USA) 272 G(-455) A POLYMORPHISM OF FGB GENE IS ASSOCIATED WITH CAROTID P897 INTMA MEDIA THICKNESS IN PATIENTS WITH ACUTE CORONARY SYNDROME D Zateyshchikov, O Aseycheva, A Nikitin, M Evdokimova, B Sidorenko, V Nosikov (Moscow, Russian Federation)

YIA - Young Investigators Award Nominee 116 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 14 IMAGING OF CARDIOVASCULAR DISEASE

Poster Board No. Publication No. 273 COMPUTERIZED NAIL FOLF VIDEO CAPILLAROSCOPY AND SYSTEMIC’S P898 DISEASES DIAGNOSIS YIA S Bouzifi, D Hakem, D Mesloub, S Benmeziane, A Berrah (Algiers City, Algeria) 274 CAROTID IMT MEASUREMENTS: A COMPARISON BETWEEN s-VHS OR CD-rom P899 RECORDED ULTRASONIC SCANS YIA S Castelnuovo, E Tremoli, D Baldassarre, “IMPROVE Study Group” (Milan, Italy) 275 PREDICTIVE VALUE OF VELOCITY VECTOR IMAGING-ASSISTED WALL P900 MOTION ANALYSIS DURING ADENOSINE STRESS ECHO IN PATIENTS WITH YIA SUSPECTED CORONARY ARTERY DISEASE C Eklund, S Gao, M Lomsky, L-M Gan (Gothenburg, Sweden) 276 LIGHT OR REGULAR CIGARETTES CONSUMPTION: EFFECT ON ENDOTHELIAL P901 FUNCTION YIA B Frigerio, S Castelnuovo, M Amato, A Ravani, E Tremoli, C Sirtori, D Baldassarre (Milan, Italy) 277 NEW ROBUST AUTOMATED BORDER DETECTION (ABDP) METHOD FOR P902 CAPTURING C-IMT: SCREENING FOR ATHEROSCLEROSIS YIA T Fukumoto, S Lynum, T Suzuki, M Kato, I Okabayashi, R Bedi, K Ishikawa (Yokohama, Japan and Issaquah, WA, USA) 278 CAROTID LUMEN AND VESSEL DIAMETERS AND THEIR RELATIONSHIPS P903 WITH CAROTID INTIMA-MEDIA THICKNESS (IMT) IN FOUR ETHNIC GROUPS: THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS A Godreau, A Dyer, D Lloyd-Jones, G Burke, J Polak, B Wasserman, K Liu (Madison, WI, USA, Chicago, IL, USA, Winston-Salem, NC, USA, Boston, MA, USA and Baltimore, MD, USA) 279 ULTRASOUND MONITORING OF CAROTID ATHEROSCLEROSIS IN PERI- P904 AND POSTMENOPAUSAL WOMEN TREATED WITH PHYTOESTROGEN-RICH YIA DIETARY SUPPLEMENT KARINAT V Myasoedova, T Gorchakova, I Sobenin, A Orekhov (Moscow, Russian Federation) 280 SEMI-AUTOMATED METHOD TO EVALUATE ECHOLUCENCY (SAME) IN P905 PLAQUES U Prahl, P Holdfeldt, G Bergström, T Gustavsson, C Schmidt, B Fagerberg, J Hulthe Tuesday, June 16 (Gothenburg, Sweden) Poster Sessions 281 PLAQUES IN THE COMMON CAROTID ARTERY ARE INDEPENDENT P906 PREDICTORS OF ANGIOGRAPHICALLY DETERMINED CORONARY ARTERY YIA DISEASE P Rein, T Kathrein, S Beer, A Vonbank, C Saely, H Drexel (Feldkirch, Austria and Triesen, Liechtenstein) 282 THE AVL-NEB LEAD AND ECHOCARDIOGRAPHY TOPICAL DISPARITIES FOR P907 POSTERIOR MYOCARDIAL INFARCTION I Serafinovich (Grodno, Belarus) 283 CORRELATION BETWEEN CAROTID INTIMA-MEDIA THICKNESS (CIMT) AND P908 GLOBAL LEFT VENTRICULAR FUNCTION U Stanko, U Goran (Zagreb, Croatia)

YIA - Young Investigators Award Nominee 117 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 284 VALVULAR DYSFUNCTIONS WITH REGURGITATION OR CALCIFICATION P909 OF CARDIAC VALVES DUE TO ARTERIOSCLEROSIS. COMPARISON WITH CORONARY CALCIFICATION AND CAROTID ATHEROSCLEROTIC CHANGES M Tsushima, T Yamada (Tokyo, Japan and Osaka, Japan) 285 VASCULAR ENDOTHELIAL FUNCTION IS CLOSELY RELATED TO GLUCOSE P910 METABOLISM IN HEALTHY JAPANESE SUBJECTS K Watanabe, M Ouchi, K Suzuki, S Futami-Suda, T Suzuki, H Nakano, K Oba (Tokyo, Japan) 286 ACUTE EFFECT OF SUBLINGUAL NITROGLYCERIN ON CORONARY FLOW P911 RESERVE IN HEALTHY YOUNG VOLUNTEERS A Wittfeldt, C Eklund, L-M Gan, M Afzelius (Gothenburg, Sweden) 287 INFLUENCE OF THE ARTERIAL PULSE ON BLOOD FLOW P912 M Beraia (Tbilisi, Georgia) 288 MR IMAGING OF ATHEROSCLEROTIC PLAQUES IN BRACHIOCEPHALIC P913 ARTERIES OF APOEKO MICE C Parolini, E Rigamonti, C Cabella, L Miragoli, L Poggi, G Valbusa, C Sirtori, G Chiesa (Milan, Italy)

YIA - Young Investigators Award Nominee 118 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 15 INTERVENTION STUDIES

Poster Board No. Publication No. 289 TOBACCO CONTINUES DESPITE MANIFEST CARDIOVASCULAR DISORDERS: P914 TOBACCO CESSATION CLINICS CRYING NEED OF THE HOUR YIA S Dwivedi, R Aggarwal, A Aggarwal (Delhi, India) 290 SMOKING AND LIPIDS P915 A Akhavan Tabib, Z Siadat, A Akhavan tabib, N Sarrafzadegan, R Klishade, S Zarfeshani, YIA A Khosravi (Isfahan, Islamic Republic of Iran) 291 EXTENDED RELEASE NIACIN IMPROVES HDL-CHOLESTEROL BUT NOT P916 ENDOTHELIAL FUNCTION IN SMOKERS YIA K Heffernan, R Karas, P Mooney, J Kuvin (Boston, MA, USA) 292 SMOKING AND OXIDATIVE STRESS EXPRESSION IN HEMODIALYSIS PATIENTS P917 S Radenkovic, N Lecic, N Radenkovic (Nis, Serbia) 293 EFFECTS OF SMOKING ON LIPIDS AND APOLIPOPROTEINS IN HEALTHY P918 PEOPLE W Masson, J Krauss, D Siniawski, P Sorroche, W Scordo, L Casañas, A Cagide (Buenos Aires, Argentina) Tuesday, June 16 Poster Sessions

YIA - Young Investigators Award Nominee 119 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 16 LIPOPROTEIN METABOLISM

Poster Board No. Publication No. 294 FORMATION OF PREb1-HDL DURING LIPOLYSIS OF TRIGLYCERIDE-RICH P919 LIPOPROTEIN J Kobayashi, O Miyazaki, I Fukamachi, A Mori, H Hashimoto, M-A Kawashiri, A Nohara, A Inazu, H Mabuchi (Kanazawa, Japan and Tsukuba, Japan) 295 EFFECTS OF EICOSAPENTAENOIC ACID AND ITS OXIDATION PRODUCTS ON P920 CELLULAR LIPASE EXPRESSION R Mamoto, S Tsuji, M Ono, T Nagata, S Tateishi, N Totani, Y Fujioka (Kobe, Japan) 296 APOLIPOPROTEIN A-V IS A POTENT MODULATOR OF HDL AND VLDL P921 COMPONENT IN PREADOLESCENT CHILDREN YIA Y Abe, T Okada, Y Kuromori, M Hara, E Saito, F Iwata, M Ayusawa, H Mugishima (Tokyo, Japan) 297 BASELINE apoB-100 AND TRIGLYCERIDE KINETICS PREDICTS POSTPRANDIAL P922 TRIGLYCERIDE AND apoB-48 ACCUMULATION IN CHYLOMICRON, VLDL1 AND YIA VLDL2 FRACTIONS M Adiels, N Matikainen, J Westerbacka, S Söderlund, J Borén, M-R Taskinen (Göteborg, Sweden and Helsinki, Finland) 298 OXIDATIVE STRESS AFTER FAT OVERLOAD IN PERSONS WITH BASELINE P923 HYPERTRIGLYCERIDEMIA WITH OR WITHOUT THE METABOLIC SYNDROME F Cardona, MI Queipo-Ortuño, M Murri, F Tinahones (Malaga, Spain) 299 NMR LIPOPROTEIN SUBCLASSES AND THE APOE GENOTYPE INFLUENCE P924 CAROTID ATHEROSCLEROSIS IN PATIENTS WITH SYSTEMIC LUPUS YIA ERYTHEMATOSUS M Gonzàlez, J Ribalta, G Vives, S Iftimie, R Ferré, N Plana, M Guardiola, G Dallinga- Thie, L Masana, A Castro (Reus, Spain and Amsterdam, The Netherlands) 300 INCREASED BINDING TO TRIGLYCERIDE-RICH LIPOPROTEINS AND P925 DESTABILIZED STRUCTURE OF APOLIPOPROTEIN E4 AND A-I FORMS THAT INDUCE HYPERTRIGLYCERIDEMIA I Gorshkova, V Zannis, D Atkinson (Boston, MA, USA) 301 CLINICAL SIGNIFICANCE OF REMNANT LIPOPROTEIN CHOLESTEROL P926 DETERMINATION IN METABOLIC SYNDROME-STUDIES WITH A NEWLY DEVELOPED HOMOGENOUS ASSAY M Ishigami, M Taguchi, M Nishida, T Moriyama, S Yamashita, T Yamamura (Suita, Japan) 302 FABP4 PLASMA LEVELS ARE ASSOCIATED WITH THE LIPID PROFILE OF P927 FAMILIAL COMBINED HYPERLIPIDEMIA IN THE PRESENCE OF OBESITY A Cabre, I Lazaro, M Cofan, E Jarauta, N Plana, A Garcia-Otin, J Ascaso, R Ferre, F Civeira, E Ros, L Masana (Barcelona, Spain and Zaragoza, Spain) 303 APOPROTEIN A5 PROTECTS FROM ATHEROSCLEROSIS IN APOE AND IN LDL P928 RECEPTOR DEFICIENT MICE M Merkel, A Naumann, O Bruns, A Laatsch, D Teupser, P Gords, J Heeren (Hamburg, Germany, Leipzig, Germany and Leuven, Belgium)

YIA - Young Investigators Award Nominee 120 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 304 CHARACTERISTICS OF REMNANT LIPOPROTEINS SEPARATING FROM P929 POSTPRANDIAL NORMOLIPIDEMIC SUBJECTS BY HPLC T Nakano, H Moon, T Nagamine, S Akamatsu, K Nakajima (Tokushima, Japan and Maebashi, Japan) 305 DIETARY FAT QUALITY AND QUANTITY OF FAT DIFFERENTIALLY P930 INFLUENCES LIPOPROTEIN METABOLISM IN PATIENTS WITH METABOLIC SYNDROME P Perez-Martinez, Y Jimenez-Gomez, C Marin, J Hartwich, M Malczewska-Malec, I Golabek, B Kiec-Wilk, C Cruz-Teno, MJ Gomez-Luna, C Defoort, F Perez-Jimenez, H Roche, J Lopez-Miranda (Cordoba, Spain, Cracow, Poland, Marseille, France and Dublin, Ireland) 306 CONSUMPTION OF DIETS WITH DIFFERENT TYPE OF FAT INFLUENCES P931 TRIACYLGLYCEROLS-RICH LIPOPROTEINS PARTICLE NUMBER AND SIZE DURING THE POSTPRANDIAL STATE P Perez-Martinez, A Garcia-Rios, J Delgado-Lista, C Cruz-Teno, A Camargo, E Yubero- Serrano, J Ordovas, F Perez-Jimenez, J Lopez-Miranda (Cordoba, Spain and Boston, MA, USA) 307 SERUM apoB48 LEVELS ARE ELEVATED IN METABOLIC SYNDROME AND P932 DIABETES MELLITUS K Tanimura, M Nagao, S Mariko, T Harada, Y Nakajima, F Okajima, A Asai, H Kotake, O Shinichi (Tokyo, Japan and Sendai, Japan) 308 APOLIPOPROTEINS C-II AND C-III AND SMALL DENSE LDL CHOLESTEROL P933 LEVELS IN NON-DIABETIC OBESE SUBJECTS WITH METABOLIC SYNDROME T Filippatos, V Tsimihodimos, M Kostapanos, C Kostara, C Tzallas, E Bairaktari, A Tselepis, M Elisaf (Ioannina, Greece) 309 DEVELOPING A MATHEMATICAL MODEL TO DETERMINE THE RATES OF P934 LIPOPROTEIN METABOLIC PROCESSES FROM A SINGLE PLASMA SAMPLE YIA D van Schalkwijk, A Freidig, K van Bochove, L Havekes, B van Ommen, J van der Greef, A de Graaf (Zeist, The Netherlands, Leiden, The Netherlands and Amsterdam, The Netherlands) 310 DISRUPT: POSTPRANDIAL METABOLISM INSIGHTS FROM A COMPREHENSIVE P935 DATABASE C Walden, K Jackson, C Pichardo-Almarza, P Murray, D Clarke, B O’Malley, A Smith, C Williams, A Minihane (Bedfordshire, UK and Reading, UK) 311 ATYPICAL VLDL EXERTS ENDOTHELIAL DYSFUNCTION AND HDL COULD P936 NEUTRALIZE THIS ACTION V Zago, S Gorzalczany, D Lucero, C Taira, R Wikinski, L Schreier (Buenos Aires, Argentina) 312 SHIFT FROM apoE TO apoCIII IN TRIGLYCERIDE-RICH LIPOPROTEIN P937 METABOLISM ESTABLISHES HYPERTRIGLYCERIDEMIA YIA

C Zheng, C Khoo, J Furtado, F Sacks (Boston, MA, USA) Tuesday, June 16 Poster Sessions

YIA - Young Investigators Award Nominee 121 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 17 NUTRITION AND LIFESTYLE

Poster Board No. Publication No. 313 PREVALENCE AND INCIDENCE RATE OF CARDIOVASCULAR DISEASES, IN P938 RELATIONS TO THE CHANGING LIFESTYLE IN AFRICAN SOCIETY R Abidoye, K Odeyemi, J Renner (Mushin, Nigeria) 314 SUDDEN CARDIAC DEATH (SCD) RISK FACTORS UNDER NUTRITIONAL LOAD P939 IN CHD PATIENTS N Nikolaishvili, N Kakauridze, T Kurtanidze (Tbilisi, Georgia) 315 AEROBIC EXERCISE AFFECTS THE CORRELATION BETWEEN THE WAIST P940 CIRCUMFERENCE AND THE TRIGLYCERIDES/HDL-CHOLESTEROL RATIO IN ASSOCIATION WITH MODIFICATIONS IN THE LDL PROFILE IN PATIENTS WITH METABOLIC SYNDROME A Casella-Filho, I Trombetta, F Cesena, P DaLuz, A Chagas (São Paulo, Brazil) 316 MODIFICATION OF FUNCTIONAL CHARACTERISTICS OF LIPOPROTEINS AND P941 CHANGES IN THEIR COMPOSITION BY SHORT-TERM EXERCISE IN PATIENTS WITH METABOLIC SYNDROME A Casella-Filho, I Trombetta, F Cesena, P DaLuz, A Chagas (São Paulo, Brazil) 317 REGULAR AEROBIC MODERATE EXERCISE IN YOUNG MALES LEADS TO A P942 DECREASE IN CETP ACTIVITY AND PROMOTES VLDL AND LDL FAVORABLE COMPOSITION CHANGES P Baglioni, W Neto, L Kato, L Castilho (Campinas, Brazil) 318 ENDOTHELIAL-DEPENDENT VASODILATION IS ASSOCIATED WITH EXERCISE P943 CAPACITY IN SMOKERS YIA K Heffernan, E Patvardhan, R Karas, J Kuvin (Boston, MA, USA) 319 TELEMEDICINE PROGRAM WITH COMBINED SELF-MEASUREMENT HEALTH P944 SENSOR MONITORING FOR LIFE STYLE MODIFICATION S Homma, H Suzuki, S Hyodo, T Hasegawa (Tokyo, Japan) 320 ECCENTRIC ENDURANCE EXERCISE SIGNIFICANTLY IMPROVES FASTING P945 GLUCOSE AND GLUCOSE TOLERANCE IN NON-DIABETIC SUBJECTS YIA A Vonbank, C Saely, P Rein, T Bochdansky, V Kiene, S Beer, J Blocher, S Aczel, H Drexel (Feldkirch, Austria and Triesen, Liechtenstein) 321 THE EFFECTS OF RESISTANCE TRAINING ON LOW-DENSITY LIPOPROTEIN P946 METABOLISM YIA J Silva, A Morikawa, MJ Alves, C Vinagre, R Maranhão (São Paulo, Brazil)

YIA - Young Investigators Award Nominee 122 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 18 PHARMACOLOGY OF CARDIOVASCULAR DISEASE

Poster Board No. Publication No. 322 EZETIMIBE/SIMVASTATIN (E/S) AND ATORVASTATIN (A) TREATMENT MODIFY P947 APOB, LDL-C, AND NON-HDL-C CORRELATIONS IN METABOLIC SYNDROME (MS) PATIENTS AT MODERATELY HIGH RISK(MHR)/HIGH RISK(HR) FOR CHD CM Ballantyne, S Grundy, W Hsueh, H Parving, J Robinson, J Rosen, J Lin, R Lowe, A Shah, A Tershakovec (Houston, TX, USA, Dallas, TX, USA, Copenhagen, Denmark, Iowa City, IA, USA, Coral Gables, FL, USA and N. Wales, PA, USA) 323 EZETIMIBE(E)+ATORVASTATIN(A) VS. A UP-TITRATION IN MODERATELY HIGH P948 CHD RISK (MHR) OR HIGH CHD RISK (HR) PATIENTS: EFFECTS OF BASELINE BODY MASS INDEX (BMI), FASTING BLOOD SUGAR (FBS) AND HS-CRP H Bays, S Conard, L Leiter, S Bird, J Lin, R Lowe, A Shah, A Tershakovec (Louisville, KY, USA, Dallas, TX, USA, Toronto, Canada and North Wales, PA, USA) 324 INFLUENCE OF AGE, GENDER, AND RACE ON THE EFFICACY OF EZETIMIBE P949 PLUS ATORVASTATIN VS. ATORVASTATIN UP-TITRATION IN MODERATELY HIGH/HIGH CHD RISK PATIENTS H Bays, S Conard, L Leiter, S Bird, R Lowe, A Tershakovec (Louisville, KY, USA, Dallas, TX, USA, Toronto, ON, Canada and North Wales, PA, USA) 325 LONG-TERM EFFICACY OF PRESCRIPTION OMEGA-3 FATTY ACIDS P950 COADMINISTERED WITH SIMVASTATIN IN HYPERTRIGLYCERIDEMIC PATIENTS H Bays, K Maki, J McKenney, R Doyle, E Stein (Louisville, KY, USA, Bloomington, IN, USA, Richmond, VA, USA, Libery Corner, NJ, USA and Cincinnati, OH, USA) 326 THE IMPACT OF HEMODIALYSIS UPON ATORVASTATIN LEVELS IN PATIENTS P951 WITH END STAGE RENAL DISEASE V Blaha, L Novakova, P Solich, R Safranek, E Mistrik, M Bláha, D Solichova, S Dusilova- Sulkova (Hradec Kralove, Czech Republic) 327 C-REACTIVE PROTEIN LOWERING WITH ROSUVASTATIN IN THE METEOR P952 STUDY M Bots, M Palmer, D Grobbee, J Crouse, D O’Leary, G Evans, J Raichlen (Utrecht, The Netherlands, Staffordshire, UK, Winston-Salem, NC, USA, Boston, MA, USA and Wilmington, DE, USA) 328 ASSESSMENT OF CAROTID PLAQUE PROGRESSION WITH ULTRASOUND IN A P953 LOW-RISK POPULATION Tuesday, June 16 S Dogan, R Meijer, D Grobee, J Crouse, D O’Leary, G Evans, J Raichlen, M Palmer, Poster Sessions M Bots (Utrecht, The Netherlands, Leiden, The Netherlands, Winston-Salem, NC, USA, Dorchester, MA, USA, Wilmington, DE, USA and Keele, UK) 329 EZETIMIBE DECREASES HEPATIC STEATOSIS AND INFLAMMATION IN P954 SUBJECT WITH METABOLIC SYNDROME ON WEIGHT LOSS DIET D Chan, S Gan, PH Barrett, G Watts (Perth, Australia) 330 COMPARISON OF THE COMBINED EFFECT OF ATORVASTATIN/DIOSGENIN VS P955 ATORVASTATIN/EZETIMIBE ON HYPERCHOLESTEROLEMIC RATS J Díaz, I Juarez, J Blé, A Rodríguez, G Ruíz, A Marín (Mexico City, Mexico and Tabasco, Mexico)

YIA - Young Investigators Award Nominee 123 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 331 THE EFFECTS OF EZETIMIBE AND ORLISTAT, ALONE OR IN COMBINATION, P956 ON HIGH DENSITY LIPOPROTEIN (HDL) SUBCLASSES AND HDL-ASSOCIATED ENZYME ACTIVITIES IN OVERWEIGHT AND OBESE PATIENTS WITH HYPERLIPIDAEMIA E Nakou, T Filippatos, D Kiortsis, C Derdemezis, M Georgoula, M Petraki, A Tselepis, M Elisaf (Ioannina, Greece) 332 ROSUVASTATIN PREVENTS VENTRICULAR REMODELING INDEPENDENT OF P957 BLOOD PRESSURE LOWERING IN HYPERTENSIVE RABBITS YIA G Giunta, E Guevara, L Marziali, G Yannarelli, L Gomez Rosso, T Meroño, R Favaloro, F Brites, L Cuniberti (Buenos Aires, Argentina) 333 TESTING OF ANTI- AND PRO-ATHEROGENIC SUBSTANCES ON CELL P958 MONOCULTURES S Jargin (Moscow, Russian Federation) 334 EFFECTS OF MOMORDICIN ON ATHEROGENESIS OF ApoE-/- MICE AND P959 EXPRESSION OF INTESTINAL CHOLESTEROL TRANSPORT RELATED GENES Z Wang, Y Song, X Zhang, Z Jiang (Hengyang, China) 335 DISCOVERY OF A NOVEL AND POTENT CHOLESTEROL ABSORPTION P960 INHIBITOR (CAI) AS PROMISING ORALLY ACTIVE LIPID LOWERING DRUG YIA M Kanou, Y Nisiwaki, A Nakano, Y Sugimoto, Y Yamanaka, S Kondo (Tokyo, Japan) 336 EFFECT OF THREE MONTH ADMINISTRATION OF ROSUVASTATIN ON RISK P961 FACTORS OF ATHEROSCLEROSIS YIA M Korotvicka, A Steinerova, J Racek, F Stozicky, L Spisak, M Spisakova (Pilsen, Czech Republic) 337 PITAVASTATIN IMPROVES LIPID PROFILES AND REDUCES INFLAMMATION P962 - KISHIMEN MULTI-CENTER PROSPECTIVE STUDY N Kume, Y Fujioka, A Taniguchi, K Tanaka, S Kagimoto, K Hirata, Y Nakamura, T Yamamoto, S Fujimoto, Y Hamamoto, K Tsuda, N Inagaki, Y Seino, H Koshiyama (Kyoto, Japan, Kobe, Japan, Osaka, Japan and Amagasaki, Japan) 338 CONTRIBUTION OF MULTIPLE COMPONENTS TO THE LIPID-MODIFYING P963 EFFECTS OF XUEZHIKANG Z Duan, S Guo, D Capuzzi, S Li (Beijing, China, Philadelphia, PA, USA and West Windsor, NJ, USA) 339 IMPACT OF STATIN DOSE ON LIPID LEVELS IN PATIENTS WITH P964 ATHEROSCLEROTIC DISEASE: RESULTS FROM THE VOYAGER INDIVIDUAL PATIENT DATA META-ANALYSIS S Nicholls, G Brandrup-Wognsen, M Palmer, P Barter (Cleveland, OH, USA, Mondal, Sweden, Keele, UK and Sydney, Australia) 340 STATIN DOSE EFFECTS ON LIPID LEVELS IN PATIENTS WITH DIABETES P965 MELLITUS: OBSERVATIONS FROM THE VOYAGER INDIVIDUAL PATIENT DATA (IPD) META-ANALYSIS S Nicholls, G Brandrup-Wognsen, M Palmer, P Barter (Cleveland, OH, USA, Mondal, Sweden, Keele, UK and Sydney, Australia) 341 EFFECT OF AGE/GENDER/RACE ON EZETIMIBE/SIMVASTATIN VS. P966 ATORVASTATIN EFFICACY IN METABOLIC SYNDROME PATIENTS WITH MODERATELY HIGH/HIGH CHD RISK J Robinson, C Ballantyne, S Grundy, W Hsueh, H Parving, J Rosen, J Lin, R Lowe, A Shah, A Tershakovec (Iowa City, IA, USA, Houston, TX, USA, Dallas, TX, USA, Copenhagen, Denmark, Coral Gables, FL, USA and N. Wales, PA, USA)

YIA - Young Investigators Award Nominee 124 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 342 INFLUENCE OF METABOLIC SYNDROME (MS) FACTORS AND INSULIN P967 RESISTANCE (IR) ON EZETIMIBE (E)/SIMVASTATIN (S) AND ATORVASTATIN (A) EFFICACY IN PATIENTS WITH MS AND MODERATELY HIGH (MH) OR HIGH (H) CHD RISK J Rosen, C Ballantyne, S Grundy, W Hsueh, H Parving, J Robinson, J Lin, R Lowe, A Shah, A Tershakovec (Coral Gables, FL, USA, Houston, TX, USA, Dallas, TX, USA, Copenhagen, Denmark, Iowa City, IA, USA and N. Wales, PA, USA) 343 QUARTER AND HALF DOSE OF ROSUVASTATIN PLUS EZETIMIBE P968 AMERIOLATED LDL-CHOLESTEROL, OTHER LIPID PARAMETERS AND HIGH SENSITIVE CRP COMPARED WITH REGUAR DOSE ROSUVASTATIN ALONE I Sakuma, N Kishimoto (Sapporo, Japan and Kuriyama, Japan) 344 EFFECTS OF PITAVASTATIN ON VARIOUS SERUM LIPIDS; A RANDOMIZED P969 CONTROLLED TRIAL N Sakuma, T Doumori, T Saeki, T Itou, S Suzuki, M Kunimatu (Mizuhocho, Mizuhoku, Nagoya, Japan) 345 THE INFLUENCE OF HIGH AND LOW ROSUVASTATIN DOSES ON ANGIOGENIC P970 FACTORS SERUM LEVELS IN CORONARY ARTERY DISEASE PATIENTS YIA A Semenova, I Sergienko, V Masenko, V Kukharchuk (Moscow, Russian Federation) 346 ROSUVASTATIN, LIPIDS AND INSULIN RESISTANCE IN TYPE 2 DIABETES P971 G Silvani, L Buci, S Acquati, R Manini, L Gagliardi, A Tartaglia (Forlì, Italy) 347 CHANGES IN THE INTESTINAL ABSORPTION OF PHYTOSTEROLS AND P972 CHOLESTEROL BY EZETIMIBE AND/OR SIMVASTATIN IN MEN W Taggart, T Musliner, M Reber, T Sudhop, A Sapre, K von Bergmann, D Luetjohann (Rahway, NJ, USA, Wuppertal, Germany and Bonn, Germany) 348 HYPOLIPIDEMIC TREATMENT IN ISOLATED HYPERLIPIDEMIA: EFFECTS ON P973 CIRCULATING MMP-2, MMP-3 AND TIMP-2 I Tasci, S Tapan, G Erdem, G Celebi, G Ozgur, C Ercin, A Sonmez, T Dogru (Ankara, Turkey) 349 EFFECTS OF COADMINISTRATION OF ATORVASTAIN WITH EZETIMIBE ON P974 NEW ZEALAND WHITE RABBITS’ ATHEROSCLEROSIS L-H Li, X-Y Yang, Z-Q Wang, Z-Y Zhang (Xinxiang, China) 350 MECHANISMS OF EZETIMIBE AFFECTING THE PROGRESSION OF P975 ATHEROSCLEROTIC PLAQUE IN NEW ZEALAND WHITE RABBITS Z-Q Wang, L-H Li, X-Y Yang, Z-Y Zhang, Z-H Yuan, Y-Z Yang (Xinxiang, China and Hengyang, China) 351 STUDY IN THE EFFECTS OF ATORVASTATIN ON C57BL/6J MICE’ P976 ATHEROSCLEROSIS X-Y Yang, L-H Li, Z-Q Wang, Z-Y Zhang (Xinxiang, China) 352 2-METHOXYIATRADIOL REVERSES ATORVASTATIN-INDUCED CELL P977

ROUNDING IN HUMAN VASCULAR SMOOTH MUSCLE CELLS YIA Tuesday, June 16 Poster Sessions H Yin, Y Gui, X-L Zheng (Calgary, AB, Canada) 353 XUEZHIKANG, AN EXTRACT OF CHOLESTIN, DECREASES TRIGLYCERIDES P978 THROUGH INCREASING APOLIPOPROTEIN AV VIA A PPARA-UPREGULATED YIA PATHWAY X-S Huang, S-P Zhao, L Bai, W Zhao (Changsha, China) 354 ENHANCED EFFECT OF BEZAFIBRATE ON HDL SUBFRACTIONS IN PATIENTS P979 WITH DYSBETALIPOPROTEINEMIA: RESULTS FROM A CROSSOVER STUDY WITH ATORVASTATIN M-A Kawashiri, J Kobayashi, A Nohara, A Inazu, H Mabuchi, M Yamagishi (Kanazawa, Japan)

YIA - Young Investigators Award Nominee 125 TUESDAY, JUNE 16, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 355 PERFLUOROHEXANESULFONATE AND PERFLUOROOCTANESULFONATE P980 DECREASE PLASMA CHOLESTEROL AND TRIGLYCERIDES IN APOE*3LEIDEN. CETP MICE BY REDUCING VLDL PRODUCTION AND INCREASING VLDL AND HDL CLEARANCE E Pieterman, P Rensen, A Maas, J van der Hoorn, L Havekes, D Ehresman, S Chang, J Butenhoff, H Princen (Leiden, The Netherlands and St. Paul, MN, USA) 356 Withdrawn P981 357 PREGNANE X RECEPTOR AGONISM DECREASES PLASMA HDL LEVELS IN P982 APOE*3-LEIDEN.CETP MICE W De Haan, M Hoekstra, J Romijn, J Jukema, L Havekes, H Princen, P Rensen (Leiden, The Netherlands) 358 EFFECTS OF T0901317 ON LIPID ACCUMULATION AND THE EXPRESSION OF P983 STEROL REGULATORY ELEMENT BINDING PROTEIN 1c IN THE LIVER OF apoE- /- MICE C-K Tang, Y-W Hu, X-X Li, J Xiao, X-H Liu, Z-C Mo (Hengyang, China) 359 PPAR d AGONIST GW501516 STRONGLY PREVENTS DEVELOPMENT OF P984 ATHEROSCLEROSIS IN APOE*3LEIDEN MICE YIA J van der Hoorn, C van den Hoogen, E Pieterman, H Princen (Leiden, The Netherlands) 360 PIOGLITAZONE ATTENUATES MYOCARDIAL ISCHEMIA-REPERFUSION INJURY P985 VIA UPREGULATION OF TGFb1, ERK1/2 AND COX-2 H Wang H Wang, P Ye, Z Li, Y Li (Beijing, China) 361 PLASMA PROPROTEIN CONVERTASE SUBTILISING/KEXIN TYPE 9 (PCSK9) P986 CONCENTRATIONS ARE DECREASED BY FENOFIBRATE IN STATIN-TREATED TYPE 2 DIABETIC PATIENTS G Watts, G Lambert, S Hamilton, G Chew, A Jenkins, D Chan (Perth, Australia, Sydney, Australia and Melbourne, Australia)

YIA - Young Investigators Award Nominee 126 WEDNESDAY, JUNE 17, 2009

PLENARY SESSION III AUDITORIUM

Lifestyle and Atherosclerosis Chairs: EJ Schaefer (Boston, MA, USA), W Harris (Sioux Falls, SD, USA), MB Katan (Amsterdam, The Netherlands), DJA Jenkins (Toronto, ON, Canada)

Time Presentation Publication No. 8:00 AM - 8:20 AM NITRIC OXIDE DERIVATIVES, PROSTANOIDS, 987 AND VASCULAR BIOLOGY DP Hajjar (New York, NY, USA) 8:20 AM - 8:30 AM COMMENTARY - W Harris (Sioux Falls, SD, USA) 8:30 AM - 8:50 AM EFFECTS OF DIETARY FATTY ACIDS AND 988 CHOLESTEROL ON CARDIOVASCULAR RISK & OUTCOMES; THE OLD AND THE NEW P Nestel (Melbourne, Australia) 8:50 AM - 9:00 AM COMMENTARY -

MB Katan (Amsterdam, The Netherlands) Wednesday, June 17 9:00 AM - 9:20 AM OBESITY AND DIABETES PREVENTION 989 DM Nathan (Boston, MA, USA) 9:20 AM - 9:30 AM COMMENTARY - DJA Jenkins (Toronto, ON, Canada) 9:30 AM - 9:50 AM LIFESTYLE AND HEART DISEASE RISK WORLDWIDE 990 S Anand (Hamilton, ON, Canada) 9:50 AM - 10:00 AM COMMENTARY SESSION AND CONCLUSIONS - EJ Schaefer (Boston, MA, USA)

*Abstract not available at the time of publication 127 YIA - Young Investigators Award Nominee WEDNESDAY, JUNE 17, 2009

CLINICAL SYMPOSIUM V AUDITORIUM

Glucose Lowering Therapy for Atherosclerosis in Diabetes Chair: J Betteridge (London, UK), JD Brunzell (Seattle, WA, USA)

Time Presentation Publication No. 10:30 AM - 10:55 AM MEASURING CAROTID-INTIMAL MEDIAL 991 THICKNESS TO EVALUATE CVD RISK IN DIABETES T Mazzone (Chicago, IL, USA) 10:55 AM - 11:20 AM CORONARY ATHEROMAS 992 SJ Nicholls (Cleveland, OH, USA) 11:20 AM - 11:45 AM HEART DISEASE RISK REDUCTION 993 J Betteridge (London, UK) 11:45 AM - 12:00 PM CONCLUDING REMARKS - JD Brunzell (Seattle, WA, USA)

*Abstract not available at the time of publication 128 YIA - Young Investigators Award Nominee WEDNESDAY, JUNE 17, 2009

WORKSHOP V-1 BALLROOM B

Clinical Aspects of Cardiovascular Disease Chairs: D Levy (Framingham, MA, USA), P Munroe (London, UK)

Time Presentation Publication No. 10:30 AM - 10:45 AM BLOOD PRESSURE INDEPENDENT EFFECTS OF 994 ANGIOTENSIN II ON ATHEROSCLEROSIS A Daugherty, H Lu, L Cassis (Lexington, KY, USA) 10:45 AM - 11:00 AM HYPERTENSION 2009: LESSONS FROM 995 OBSERVATIONAL STUDIES AND CLINICAL TRIALS TO GUIDE PATIENT CARE D Levy (Framingham, MA, USA) 11:00 AM - 11:15 AM PROGRESS IN DETERMINING GENES CAUSING 996 HYPERTENSION P Munroe (London, UK) 11:15 AM - 11:30 AM ROMEO (RETHINK ORGANIZATION TO IMPROVE 997

EDUCATION AND OUTCOMES). A 4-YEAR Wednesday,

MULTICENTRE RANDOMISED CONTROLLED TRIAL June 17 OF GROUP CARE FOR THE MANAGEMENT OF TYPE 2 DIABETES M Trento, M Porta (Turin, Italy) 11:30 AM - 11:45 AM THE EFFECTS OF GLICLAZIDE AND GLIBENCLAMIDE 998 ON THE DEVELOPMENT OF ATHEROSCLEROSIS IN A DIABETIC MOUSE MODEL R O’Brien, P Koh, M Olukman, M Cooper, T Allen (Heidelberg, Australia and Prahran, Australia) 11:45 AM - 12:00 PM CLUSTERIN-TRANSDUCED CARDIAC STEM CELLS 999 ENHANCES POST-INFARCT CARDIOVASCULAR TISSUE REPAIR Y-J Geng, J Willerson (Houston, TX, USA) 12:00 PM - 12:15 PM ANTIHYPERTENSIVE TREATMENT: RELATIONSHIP 1000 WITH COGNITIVE FUNCTION A Vicario, N Vainstein, M Del Sueldo, J Zilberman, G Cerezo (Caba, Argentina and Buenos Aires, Argentina) 12:15 PM - 12:30 PM PLASMA PHOSPHOLIPID EPA BUT NOT DHA IS 1001 PREDICTIVE OF ALL-CAUSE MORTALITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: DATA FROM INFARCTION PROGNOSIS (IPS) REGISTRY S-H Lee, M-J Shin, J-W Ha (Seoul, Republic of Korea and Gyeongsan, Republic of Korea)

*Abstract not available at the time of publication 129 YIA - Young Investigators Award Nominee WEDNESDAY, JUNE 17, 2009

WORKSHOP V-2 BALLROOM A

Pharmacology and Novel Therapies: Therapy with Niacin Chairs: ML Kashyap (Long Beach, CA, USA), RJ Clarke (Oxford, UK)

Time Presentation Publication No. 10:30 AM - 10:45 AM EFFECT OF NIACIN ON HDL-CHOLESTEROL AND 1002 HDL-APO AI M Kashyap, L Zhang, V Kamanna (Long Beach, CA, USA and Irvine, CA, USA) 10:45 AM - 11:00 AM NIACIN AFFECTS LIPOPROTEIN METABOLISM IN 1003 DYSLIPIDEMIC SUBJECTS S Lamon-Fava, M Diffenderfer, PH Barrett, B Asztalos, E Schaefer (Boston, MA, USA and Perth, Australia) 11:00 AM - 11:15 AM ARE NIACIN’S SIDE EFFECTS A BARRIER TO ITS USE? 1004 ME McGovern (Miami Beach, FL, USA) 11:15 AM - 11:30 AM FOLIC ACID, HOMOCYSTEINE AND RISK OF 1005 CORONARY HEART DISEASE STROKE AND CANCER: META-ANALYSIS OF 8 TRIALS INVOLVING 37,500 PARTICIPANTS RJ Clarke (Oxford, UK) 11:30 AM - 11:45 AM EZETIMIBE/SIMVATASTATIN (E/S) PLUS EXTENDED 1006 RELEASE NIACIN (N) IN HYPERLIPIDEMIA (HL) PATIENTS WITH DIABETES (DM) OR METABOLIC SYNDROME (MS) S Fazio, J Guyton, J Lin, J Tomassini, A Shah, A Tershakovec (Nashville, TN, USA, Durham, NC, USA and N Wales, PA, USA) 11:45 AM - 12:00 PM NEW ONSET DIABETES MELLITUS (DM) IN PATIENTS 1007 WITH HYPERLIPIDEMIA (HL) TAKING EZETIMIBE/ SIMVASTATIN (E/S) +/- NIACIN (N) J Guyton, S Fazio, A Adewale, E Jensen, J Tomassini, A Tershakovec (Durham, NC, USA, Nashville, TN, USA and N Wales, PA, USA) 12:00 PM - 12:15 PM NIACIN INHIBITS ACUTE VASCULAR INFLAMMATION 1008 IN RABBITS B Wu, L Yan, F Charlton, K-A Rye (Sydney, Australia) 12:15 PM - 12:30 PM ADDITION OF NIACIN EXTENDED-RELEASE TO 1009 BASELINE STATIN TREATMENT REDUCES hsCRP IN PATIENTS WITH MIXED DYSLIPIDEMIA AND ELEVATED hsCRP R Karas, M Davidson, M Kashyap, R Thakkar, P Jiang, R Padley (Boston, MA, USA, Chicago, IL, USA, Long Beach, CA, USA and Abbott Park, IL, USA)

*Abstract not available at the time of publication 130 YIA - Young Investigators Award Nominee WEDNESDAY, JUNE 17, 2009

WORKSHOP V-3 BALLROOM C

Epidemiology of Cardiovascular Disease: Obesity, Insulin Resistance, and Diabetic Dyslipidemia: From Basic Science to Populations Chairs: PN Durrington (Manchester, UK), R Carmena (Valencia, Spain)

Time Presentation Publication No. 10:30 AM - 10:45 AM TARGETING INFLAMMATION IN T2D AND CVD: *1010 UNDERLYING MECHANISMS AND RESPONSE TO SALICYLATES S Shoelson (Boston, MA, USA) 10:45 AM - 11:00 AM LDL GLYCATION, A POTENTIALLY ATHEROGENIC 1011 MODIFICATION IN NON-DIABETIC AND DIABETIC PEOPLE PN Durrington (Manchester, UK) 11:00 AM - 11:15 AM NEW PERSPECTIVES IN TREATING DIABETIC 1012 DYSLIPIDEMIA R Carmena (Valencia, Spain) Wednesday,

11:15 AM - 11:30 AM LIPOPROTEINS MODULATE FUNCTION APOPTOSIS 1013 June 17 OR PROLIFERATION OF PRIMARY HUMAN AND MURINE PANCREATIC BETA-CELLS S Ruetti, L Rohrer, M Donath, A von Eckardstein (Zurich, Switzerland) 11:30 AM - 11:45 AM LONG-TERM EFFECT OF ADDING FENOFIBRIC 1014 ACID TO MODERATE-DOSE STATIN ON C-REACTIVE PROTEIN LEVELS IN PATIENTS WITH MIXED DYSLIPIDEMIA M Davidson, R Guthrie, M Kelly, C Setze, D Sleep (Chicago, IL, USA, Columbus, OH, USA and Abbott Park, IL, USA) 11:45 AM - 12:00 PM PLASMA KINETICS OF THE ESTERIFIED 1015 CHOLESTEROL OF AN LDL-LIKE NANOEMULSION IN YIA PATIENTS WITH TYPE 2 DIABETES MELLITUS C Oliveira, M Bertato, B Wajchenberg, A Lerario, R Maranhão (Sao Paulo, Brazil) 12:00 PM - 12:15 PM IMPAIRED REGULATION OF TACE/TIMP3 1016 PROTEOLYTIC SYSTEM IN SKELETAL MUSCLE OF OBESE TYPE 2 DIABETIC SUBJECTS. A NEW MECHANISM OF INSULIN RESISTANCE IN HUMANS A Monroy, M Federici, A Chavez, S Kamath, S Reyna, M Palomo, N Musi, D Tripathy, R DeFronzo, F Folli (San Antonio, TX, USA and Rome, Italy) 12:15 PM - 12:30 PM RELATION OF THE “HYPERTRIGLYCERIDEMIC 1017 WAIST” PHENOTYPE TO GLUCOSE INTOLERANCE AND TYPE 2 DIABETES IN POSTMENOPAUSAL WOMEN J Methot, D Brisson, P Perron, D Gaudet (Chicoutimi, QC, Canada)

*Abstract not available at the time of publication 131 YIA - Young Investigators Award Nominee WEDNESDAY, JUNE 17, 2009

WORKSHOP V-4 ROOM 302

Genetics: Genetics, Lipoproteins, and Metabolic Syndrome Chairs: AJ Lusis (Los Angeles, CA, USA), RA Hegele (London, ON, Canada)

Time Presentation Publication No. 10:30 AM - 10:45 AM SYSTEMS GENETICS APPROACH TO METABOLIC 1018 SYNDROME AJ Lusis (Los Angeles, CA, USA) 10:45 AM - 11:00 AM FEATURES OF THE METABOLIC SYNDROME IN 1019 YOUTH WITH AND WITHOUT TYPE 2 DIABETES S Marcovina, D Dabelea, N West (Seattle, WA, USA and Denver, CO, USA ) 11:00 AM - 11:15 AM GENETICS OF CHD AND LIPOPROTEINS *1020 JP Kane (San Francisco, CA, USA) 11:15 AM - 11:30 AM HYPERTRIGLYCERIDEMIA: A MOSAIC OF GENETIC 1021 EFFECTS RA Hegele (London, ON, Canada) 11:30 AM - 11:45 AM APOA5 AND APOC3 GENOTYPES IN PATIENTS WITH 1022 DYSLIPIDEMIA AND INSULIN RESISTANCE YIA L Niculescu, M Vladica, A Sima (Bucharest, Romania) 11:45 AM - 12:00 PM DECREASED INSULIN SENSITIVITY OF OBESE 1023 DYSLIPIDEMIC SUBJECTS WITH METABOLIC SYNDROME IS REVEALED IN THE POSTPRANDIAL STATE D Khoury, N Hwalla, V Frochot, J-M Lacorte, M Chabert, A Kalopissis (Beirut, Lebanon and Paris, France) 12:00 PM - 12:15 PM THE DYSLIPIDEMIA OF MOTHERS WITH FAMILIAL 1024 HYPERCHOLESTEROLEMIA DETERIORATES LIPID LEVELS IN THEIR ADULT OFFSPRING A van der Graaf, M Vissers, D Gaudet, D Brisson, S Sivapalaratnam, T Roseboom, A Janssen, J Kastelein, B Hutten (Amsterdam, The Netherlands and Chicoutimi, QC, Canada)

*Abstract not available at the time of publication 132 YIA - Young Investigators Award Nominee WEDNESDAY, JUNE 17, 2009

WORKSHOP V-5 ROOM 312

Nutritional Studies: Dietary Carbohydrates and Omega 3 Fatty Acids Chairs: DJA Jenkins (Toronto, ON, Canada), K Stanhope (Davis, CA, USA)

Time Presentation Publication No. 10:30 AM - 10:45 AM DIETARY SUGARS: DIFFERENTIAL EFFECTS ON LIPID 1025 METABOLISM, INSULIN SENSITIVITY AND ADIPOSE DISTRIBUTION K Stanhope, P Havel (Davis, CA, USA) 10:45 AM - 11:00 AM THE DIETARY GLYCEMIC INDEX AND 1026 CARDIOVASCULAR DISEASE DJA Jenkins, C Kendall, J Wong, J Sievenpiper (Toronto, ON, Canada) 11:00 AM - 11:15 AM A LOW GLYCEMIC LOAD DIET FOR OBESITY AND 1027 HEART DISEASE DS Ludwig (Boston, MA, USA)

11:15 AM - 11:30 AM n-3 VS SATURATED FATTY ACIDS DO NOT AFFECT 1028 Wednesday,

ARTERIAL INFLAMMATORY MARKERS PRIOR TO June 17 ATHEROSCLEROSIS IN MICE C Torrejon, U Jung, R Deckelbaum (New York, NY, USA) 11:30 AM - 11:45 AM ROLE OF SOLUBLE EPOXIDE HYDROLASE IN THE 1029 ANTI-PLATELET EFFECTS OF EICOSAPENTAENOIC ACID AND DOCOSAHEXAENOIC ACID IN HEALTHY VOLUNTEERS Y Mavrommatis, S Wood, M-J Gordon, B de Roos (Aberdeen, UK) 11:45 AM - 12:00 PM SERUM LEVELS OF INTERLEUKIN-18 ARE REDUCED 1030 BY DIET AND n-3 FATTY ACID INTERVENTION IN ELDERLY HIGH-RISK MEN M Trøseid, I Seljeflot,H Arnesen (Oslo, Norway) 12:00 PM - 12:15 PM DIETARY KRILL OIL SUPPLEMENTATION 1031 SIGNIFICANTLY REDUCES HEPATOMEGALY, HEPATIC STEATOSIS AND HYPERCHOLESTEROLEMIA IN HIGH- FAT FED MICE S Tandy, R Chung, E Wat, A Kamili, K Berge, M Griinari, J Cohn (Sydney, Australia, Oslo, Norway and Helsinki, Finland) 12:15 PM - 12:30 PM PRODUCTS WITH A DECREASED GLYCEMIC INDEX 1032 HAVE NO EFFECT ON METABOLIC RISK MARKERS YIA R Vrolix, R Mensink (Maastricht, The Netherlands and Wageningen, The Netherlands)

*Abstract not available at the time of publication 133 YIA - Young Investigators Award Nominee WEDNESDAY, JUNE 17, 2009

WORKSHOP V-6 ROOM 304

Imaging of Atherosclerosis: Cardiac Calcium and Computer Tomographic Angiography Chairs: ME Clouse (Boston, MA, USA), RD Santos (São Paulo, Brazil)

Time Presentation Publication No. 10:30 AM - 10:45 AM CARDIAC MDCTA 2009: A MOVING TARGET 1033 ME Clouse (Boston, MA, USA) 10:45 AM - 11:00 AM USE AND LIMITATIONS OF CORONARY ARTERY 1034 CALCIFICATION TO STUDY ATHEROSCLEROSIS RD Santos (São Paulo, Brazil) 11:00 AM - 11:15 AM TECHNICAL CHALLENGES IN CCTA TRIALS 1035 P Cella, L Hilaire (Princeton, NJ, USA) 11:15 AM - 11:30 AM EFFECT OF CONVENTIONAL RISK FACTORS ON THE 1036 PRESENCE OF CORONARY ARTERY DISEASE AS YIA ASSESSED BY 64-MDCT IN PATIENTS WITH LOW- STAGE CHRONIC KIDNEY DISEASE R Mitsutake, S-I Miura, Y Shiga, K Saku (Fukuoka, Japan) 11:30 AM - 11:45 AM QUANTITATIVE ASSESSMENT OF TOTAL CORONARY 1037 ARTERY PLAQUES VOLUME USING MULTI-SLICE YIA COMPUTED TOMOGRAPHY IS ASSOCIATED WITH METABOLIC SYNDROME M Konishi, S Sugiyama, H Ogawa (Kumamoto, Japan) 11:45 AM - 12:00 PM VASCULAR CALCIFICATION, BONE DENSITY, AND 1038 CORONARY ARTERY DISEASE: SIMULTANEOUS ASSESSMENT BY CARDIAC CT ANGIOGRAPHY EJ Kim, HS Yong, HS Seo, JO Na, CU Choi, JW Kim, HE Lim, S-W Rha, JH Park, CG Park, DJ Oh (Seoul, Korea) 12:00 PM - 12:15 PM VULNERABILITY OF ATHEROPLAQUES WITHIN 1039 THE PROXIMAL THIRD CORONARY ARTERIES IN CT ANGIOGRAPHY FOR SUBCLINICAL POPULATION T-Y Chiu, J-W Chen, C-P Lin, C-L Chern (Taoyuan City, Taiwan and Taipei, Taiwan)

*Abstract not available at the time of publication 134 YIA - Young Investigators Award Nominee WEDNESDAY, JUNE 17, 2009

WORKSHOP V-8 ROOM 311

Basic Science and Vascular Biology: Cellular Lipid Metabolism Chairs: EA Fisher (New York, NY, USA), MC Phillips (Philadelphia, PA, USA)

Time Presentation Publication No. 10:30 AM - 10:45 AM THE CELLULAR REGULATION OF VLDL 1040 METABOLISM AND ITS RELEVANCE TO DIETARY FAT AND INSULIN RESISTANCE EA Fisher (New York, NY, USA) 10:45 AM - 11:00 AM CELLULAR LIPID EFFLUX AND HDL BIOGENESIS 1041 MC Philipps (Philadelphia, PA, USA) 11:00 AM - 11:15 AM ABCA12 – A NEW REGULATOR OF CELLULAR LIPID 1042 METABOLISM D Sviridov, W D’Souza, A Murphy, N Mukhamedova, J Chin- Dusting, D Hacking, D Hilton, B Kile, I Smyth (Melbourne, Australia)

11:15 AM - 11:30 AM HIGH DENSITY LIPOPROTEINS (HDL) INCREASE 1043 Wednesday,

PANCREATIC β-CELL INSULIN SECRETION YIA June 17 M Fryirs, P Barter, F Tabet, A Heather, K Rye (Sydney, Australia) 11:30 AM - 11:45 AM APOLIPOPROTEIN E IS REQUIRED FOR ADIPOCYTE 1044 DIFFERENTIATION AND ENHANCES THE YIA PATHOPHYSIOLOGY ASSOCIATED WITH DIET- INDUCED OBESITY A Bartelt, J Heeren (Hamburg, Germany) 11:45 AM - 12:00 PM COORDINATED FUNCTION OF C/EBP-β AND PPAR-β 1045 IN THE REGULATION OF CARDIAC FATTY ACID- RESPONSIVE GENES J Suzuki, M Fujii, M Ueno, T Kimura, M Imagawa, Y Zenimaru, S Takahashi, H Kimura, F Kraemer, I Miyamori (Fukui, Japan and Stanford, CA, USA) 12:00 PM - 12:15 PM RAD51 PLAYS A VITALLY IMPORTANT ROLE IN 1046 ADIPOSE TISSUE PROLIFERATION AND SYSTEMIC YIA INSULIN RESISTANCE S Matsumoto, I Manabe, R Nagai (Bunkyo-ku, Japan)

*Abstract not available at the time of publication 135 YIA - Young Investigators Award Nominee WEDNESDAY, JUNE 17, 2009

MASTER SESSION V BALLROOM A

The Unstable Plaque

Time Presentation Publication No. 1:30 PM - 2:15 PM THE “UNSTABLE” ATHEROSCLEROTIC PLAQUE 1048 P Libby (Boston, MA, USA) 2:15 PM - 2:30 PM COMMENTARY - F Crea (Rome, Italy)

MASTER SESSION VI BALLROOM B

The Discovery of Genes Linked to Lipid Metabolism and Atherosclerosis

Time Presentation Publication No. 1:30 PM - 2:15 PM THE DISCOVERY OF GENES LINKED TO LIPID 1047 METABOLISM AND ATHEROSCLEROSIS RM Lawn (Palo Alto, CA, USA) 2:15 PM - 2:30 PM COMMENTARY - RA Hegele (London, ON, Canada)

CLINICAL SYMPOSIUM VI AUDITORIUM

Combined Inhibition of Cholesterol Synthesis and Absorption Chair: EJ Schaefer (Boston, MA, USA)

Time Presentation Publication No. 1:30 PM - 1:55 PM COMBINED STATIN-EZETIMIBE THERAPY 1049 CM Ballantyne (Houston, TX, USA) 1:55 PM - 2:20 PM THE SANDS TRIAL: THE EFFECT OF STATINS 1050 WITH VERSUS WITHOUT EZETIMIBE ON CAROTID ATHEROSCLEROSIS IN TYPE 2 DIABETES J Fleg, M Meta, B Howard, M Roman, W Howard (Bethesda, MD, USA, Hyatsville, MD, USA, New York City, NY, USA and Washington, DC, USA) 2:20 PM - 2:45 PM ONGOING CLINICAL TRIALS OF THE STATIN/ 1051 EZETIMIBE COMBINATION E Braunwald (Boston, MA, USA) 2:45 PM - 3:00 PM CONCLUDING REMARKS - EJ Schaefer (Boston, MA, USA)

*Abstract not available at the time of publication 136 YIA - Young Investigators Award Nominee WEDNESDAY, JUNE 17, 2009

WORKSHOP VI-1 BALLROOM B

Intervention Studies: Estrogens, Gender Differences and Heart Disease Risk Chairs: R Karas (Boston, MA, USA), JE Manson (Boston, MA, USA)

Time Presentation Publication No. 3:30 PM - 3:45 PM HRT AND CVD: EVOLVING DATA AND EVOLVING *1052 CONCEPTS HN Hodis (Los Angeles, CA, USA) 3:45 PM - 4:00 PM HORMONE THERAPY AND CARDIOVASCULAR 1053 DISEASE: WHERE ARE WE NOW? JE Manson (Boston, MA, USA) 4:00 PM - 4:15 PM ESTROGEN AND CARDIOVASCULAR DISEASE: *1054 LESSONS LEARNED FROM BASIC SCIENCES R Karas (Boston, MA, USA) 4:15 PM - 4:30 PM SELECTIVE ESTROGEN RECEPTOR-α AGONIST 1055 TREATMENT RESTORES ENDOTHELIAL FUNCTION

WHEN INITIATED EARLY AFTER SURGICAL Wednesday,

MENOPAUSE IN RATS June 17 A Cignarella, C Pinna, RM Gaion, C Bolego (Padova, Italy and Milan, Italy) 4:30 PM - 4:45 PM CONCERTED SCAVENGER RECEPTOR-BI AND 1056 ESTROGEN RECEPTOR-DEPENDENT 17-BETA YIA ESTRADIOL UPTAKE AND CHOLESTEROL EFFLUX MEDIATED BY ESTRADIOL FATTY ACYL ESTER- ENRICHED HIGH-DENSITY LIPOPROTEIN PARTICLES IN HUMAN THP-1 MACROPHAGES R Badeau, J Metso, K Wähälä, M Tikkanen, M Jauhiainen (Helsinki, Finland) 4:45 PM - 5:00 PM RALOXIFENE AND STROKE RISK BASED ON THE 1057 FRAMINGHAM STROKE RISK SCORE E Barrett-Connor, D Cox, J Song, B Mitlak, L Mosca, D Grady (La Jolla, CA, USA, Indianapolis, IN, USA, New York, NY, USA and San Francisco, CA, USA) 5:00 PM - 5:15 PM IMPROVED CATALASE ACTIVITY AND CAROTID 1058 INTIMA-MEDIA THICKNESS MODULATION WITH POSTMENOPAUSAL THERAPY V Castanho, Í Espirito Santo, R Nakamura, E de Faria (Campinas, Brazil) 5:15 PM - 5:30 PM DECREASED PLASMA APOLIPOPROTEIN AV AND 1059 INCREASED TRIGLYCERIDE ARE ASSOCIATED YIA WITH OBESITY AND INSULIN RESISTANCE IN POSTMENOPAUSAL WOMEN M Hu, S-P Zhao, X-S Huang, L Bai (Changsha, China)

*Abstract not available at the time of publication 137 YIA - Young Investigators Award Nominee WEDNESDAY, JUNE 17, 2009

WORKSHOP VI-2 BALLROOM A

Pharmacology and Novel Therapies: Transfer Protein Inhibition Chairs: D Rader (Philadelphia, PA, USA), D Sviridov (Melbourne, Australia)

Time Presentation Publication No. 3:30 PM - 3:45 PM UPDATE ON CETP INHIBITION *1060 D Rader (Philadelphia, PA, USA) 3:45 PM - 4:00 PM CHOLESTERYL ESTER TRANSFER PROTEIN 1061 INHIBITION AND REVERSE CHOLESTEROL TRANSPORT D Sviridov, U Tchoua, N Mukhamedova, E Niesor, J Mizrahi, C Maugeais (Melbourne, Australia and Basel, Switzerland) 4:00 PM - 4:15 PM PLTP, MACROPHAGES AND ATHEROSCLEROSIS 1062 A van Tol (Rotterdam, The Netherlands) 4:15 PM - 4:30 PM DALCETRAPIB HAS NO CLINICALLY RELEVANT 1063 DRUG-DRUG INTERACTIONS WITH PRAVASTATIN OR ROSUVASTATIN M Derks, M Abt, M Phelan, L Turnbull, G Meneses-Lorente, N Bech (Basel, Switzerland) 4:30 PM - 4:45 PM SEPARTATING MECHANISM-BASED & OFF-TARGET 1064 ACTIONS OF CETP-INHIBITORS USING CETP GENE POLYMORPHISMS: MENDELIAN RANDOMISATION FOR DRUG TARGET VALIDATION R Sofat, Torcetrapib/CETP Genetics Collaboration (London, UK) 4:45 PM - 5:00 PM TRANSFER OF CHOLESTERYL ESTER FROM HDL TO 1065 LDL BY A CETP-INDEPENDENT PATHWAY IN MICE M Amar, J Stonick, A Remaley (Bethesda, MD, USA) 5:00 PM - 5:15 PM HIGH DENSITY LIPOPROTEINS (HDLs) INDUCE A 1066 MILD OXIDATIVE STRESS RESPONSE IN HUMAN ENDOTHELIAL CELLS THAT INCREASES CELLULAR ANTIOXIDANT PROTEIN EXPRESSION AND PROTECTS AGAINST INFLAMMATORY INSULT A Heather, X-H Li, K McGrath, K Rye, P Barter (Sydney, Australia and Melbourne, Australia)

*Abstract not available at the time of publication 138 YIA - Young Investigators Award Nominee WEDNESDAY, JUNE 17, 2009

WORKSHOP VI-3 BALLROOM C

Epidemiology of Cardiovascular Disease: Cardiometabolic Risk Chair: JD Brunzell (Seattle, WA, USA)

Time Presentation Publication No. 3:30 PM - 3:45 PM COMPARISON OF 2-YEAR EVENT RATES BETWEEN 1067 WESTERN AND EASTERN EUROPEAN DIABETICS WITH ESTABLISHED ATHEROTHROMBOSIS (RESULTS FROM THE REACH-REGISTRY) K Parhofer, J Röther, C Binz, M Schwertfeger, T Limbourg, D Bhatt, G Steg, M Krempf, U Zeymer (Munich, Germany, Minden, Germany, Berlin, Germany, Ludwigshafen, Germany, Boston, MA, USA, Paris, France and Nantes, France) 3:45 PM - 4:00 PM LOW ADIPONECTIN CONCENTRATION IS A RISK 1068 FACTOR FOR MYOCARDIAL INFARCTION AND LEVELS ARE INFLUENCED BY GENETIC VARIANTS J Persson, P Eriksson, T Gustafsson, G Paulsson Berne, P Lundman (Stockholm, Sweden) Wednesday, 4:00 PM - 4:15 PM ELEVATED LEVELS OF OXIDIZED LIPOPROTEIN(A) 1069 June 17 ARE ASSOCIATED WITH THE PRESENCE AND SEVERITY OF ACUTE CORONARY SYNDROMES J Wang, C Zhang, Y Meng, A Han, J Gong, K Li (Nanjing, China) 4:15 PM - 4:30 PM NON-HDL CHOLESTEROL PREDICTS THE PRESENCE 1070 OF METABOLIC SYNDROME IN ADOLESCENTS C Li, E Ford, P McBride, P Kwiterovich, B McCrindle, S Gidding (Atlanta, GA, USA, Madison, WI, USA, Baltimore, MD, USA, Toronto, ON, Canada and Wilmington, DE, USA) 4:30 PM - 4:45 PM PLASMA PENTRAXIN 3 LEVELS REFLECT 1071 METABOLIC SYNDROME IN PATIENTS WITH CORONARY ARTERY DISEASE T Miyazaki, S Chiuve, F Sacks, P Ridker, P Libby, M Sagara, M Aikawa (Boston, MA, USA and Tokyo, Japan) 4:45 PM - 5:00 PM CHILDREN WITH HYPERTENSION ARE PRONE 1072 TO DEVELOP METABOLISM SYNDROME AND ATHEROSCLEROSIS F Sung, T Su, C Liao, K Chien, Y Lee (Taichung, Taiwan and Taipei, Taiwan) 5:00 PM - 5:15 PM STABLE J-SHAPED PROSPECTIVE RELATIONSHIP 1073 BETWEEN BMI AND HIGH MEDICAL EXPENDITURE FROM TAIWAN CARDIOVASCULAR POOLING PROJECT: IMPLICATIONS FOR DEFINING AND PREVENTING OBESITY W-H Pan, H-J Chen, W-T Yeh, H-Y Chang (Taipei, Taiwan and Maoli, Taiwan) 5:15 PM - 5:30 PM OBESITY, OVERWEIGHT AND CAROTID 1074 ATHEROSCLEROSIS IN MENOPAUSAL WOMEN P Rubba, M Gentile, A Mattiello, F Rubba, A Baiano, M Nunziata, P Chiodini, S Panico (Napoli, Italy)

*Abstract not available at the time of publication 139 YIA - Young Investigators Award Nominee WEDNESDAY, JUNE 17, 2009

WORKSHOP VI-4 ROOM 302

Genetics: Genetics of Cardiovascular Disease Chairs: K Stefansson (Reykjavik, Iceland), S Kathiresan (Boston, MA, USA)

Time Presentation Publication No. 3:30 PM - 3:45 PM GENETIC MARKERS FOR CHD RISK ASSESSMENT *1075 ABOVE AND BEYOND STANDARD S Kathiresan (Boston, MA, USA) 3:45 PM - 4:00 PM INSIGHT FROM THE GENETICS OF CARDIOVASCULAR - DISEASES K Stefansson (Reykjavik, Iceland) 4:00 PM - 4:15 PM QUANTITATIVE ANALYSIS OF CAROTID PLAQUE 1077 DENSITY IN RELATION TO GENE EXPRESSION YIA PROFILES K Lund, A Razuvaev, J Roy, G Paulsson-Berne, U Hedin, K Caidahl (Stockholm, Sweden) 4:15 PM - 4:30 PM INTEGRATED ASSOCIATIONS OF GENOTYPES 1078 WITH MULTIPLE BLOOD BIOMARKERS LINKED TO CORONARY HEART DISEASE RISK S Humphries, F Drenos, J Casas, J Palmen, L Smeeth, A Hingorani, P Talmud (London, UK) 4:30 PM - 4:45 PM PAN3 GENE IDENTIFIED AS CANDIDATE 1079 ATHEROSCLEROSIS MODIFIER GENE IN MICE AND HUMANS S Berisha, J Hsu, J Smith (Cleveland, OH, USA) 4:45 PM - 5:00 PM THE CHROMOSOME 9p21 LOCUS OF CORONARY 1080 ARTERY DISEASE AFFECTS EXPRESSION OF YIA ADJACENT ATHEROSCLEROSIS CANDIDATE GENES L Holdt, F Beutner, M Scholz, S Gielen, G Schuler, J Thiery, D Teupser (Leipzig, Germany) 5:00 PM - 5:15 PM FUNCTIONAL MUTATION IN ABCG1 PREDICTS RISK 1081 OF ISCHEMIC HEART DISEASE IN THE GENERAL YIA POPULATION J Schou, R Frikke-Schmidt, B Nordestgaard, D Kardassis, E Thymiakou, P Grande, A Tybjærg-Hansen (Copenhagen, Denmark and Heraklion, Greece)

*Abstract not available at the time of publication 140 YIA - Young Investigators Award Nominee WEDNESDAY, JUNE 17, 2009

WORKSHOP VI-5 ROOM 312

Nutritional Studies: Plant Sterols, Stanols, Fiber, and Nutritional Supplements Chairs: H Gylling (Kuopio, Finland), P Jones (Winnipeg, MB, Canada)

Time Presentation Publication No. 3:30 PM - 3:45 PM THE ROLE OF PLANT STANOLS IN ATHEROSCLEROSIS 1082 H Gylling, T Miettinen (Kuopio, Finland) 3:45 PM - 4:00 PM NEW INSIGHTS INTO PLANT STEROL METABOLISM: 1083 CHOLESTEROL LOWERING AND BEYOND P Jones (Winnipeg, MB, Canada) 4:00 PM - 4:15 PM NUTRITIONAL STUDIES - PLANT STEROLS, STANOLS, 1084 FIBER AND NUTRITIONAL SUPPLEMENT PM Kris-Etherton (University Park, PA, USA) 4:15 PM - 4:30 PM EFFECTS OF LONG TERM PLANT STEROL AND 1085 STANOL CONSUMPTION ON THE RETINAL

VASCULATURE: A RANDOMIZED CONTROLLED Wednesday, TRIAL IN STATIN USERS June 17 E Kelly, J Plat, R Mensink, F Hendrikse, T Berendschot (Maastricht, The Netherlands) 4:30 PM - 4:45 PM CARDIOPROTECTIVE EFFECTS OF n-3PUFA AND 1086 PHYTOSTEROLS IN HYPERLIPIDEMIA YIA M Micallef, M Garg (Callaghan, Australia and New Lambton, Australia) 4:45 PM - 5:00 PM DIETARY PLANT STANOLS DOSE-DEPENDENTLY 1087 DECREASE LDL-CHOLESTEROL – BUT NOT CHOLESTEROL-STANDARDIZED β-CAROTENE – AT INTAKES UP TO 9 G A DAY R Mensink, A de Jong, J Plat (Maastricht, The Netherlands) 5:00 PM - 5:15 PM STANOL ESTERS ATTENUATE THE AGGRAVATING 1088 EFFECT OF DIETARY CHOLESTEROL ON ATHEROSCLEROSIS IN HOMOZYGOUS WATANABE RABBITS M Schrøder, C Husche, K Pilegaard, D Lütjohann, A Mortensen (Søborg, Denmark and Bonn, Germany) 5:15 PM - 5:30 PM PLANT STEROL-ENRICHED FERMENTED MILK 1089 REDUCES PLASMA CHOLESTEROL: A META- ANALYSIS C Nicolle, E Bruckert, A Notarbartolo, L Masana, E Mannarino, S Salah, C Cortese (Palaiseau, France, Paris, France, Palermo, Italy, Tarragona, Spain, Perugia, Italy and Rome, Italy)

*Abstract not available at the time of publication 141 YIA - Young Investigators Award Nominee WEDNESDAY, JUNE 17, 2009

WORKSHOP VI-6 ROOM 304

Basic Science and Vascular Biology: Specialty Topics in Vascular Biology Chair: MA Gimbrone, Jr. (Boston, MA, USA)

Time Presentation Publication No. 3:30 PM - 3:45 PM POTENTIAL ROLE FOR INSULIN IN SPROUTING 1090 OF NEOVESSELS WITHIN ATHEROSCLEROTIC YIA PLAQUES; NEW PATHWAYS OF MICROVASCULAR COMPLICATIONS IN MACROVASCULAR DISEASE OF DIABETES K Rensing, F Houttuijn Bloemendaal, E Weijers, P Koolwijk, V van Hinsbergh, C van der Loos, J Kastelein, J von der Thüsen, T Twickler (Amsterdam, The Netherlands) 3:45 PM - 4:00 PM THERAPEUTIC EFFECTS OF ANNEXIN A5 ON 1091 ACCELERATED ATHEROSCLEROSIS IN VEIN GRAFTS IN HYPERCHOLESTEROLEMIC MICE M Ewing, M de Vries, M Nordzell, K Pettersson, J Jukema, P Quax (Leiden, The Netherlands and Stockholm, Sweden) 4:00 PM - 4:15 PM IMPAIRED ELASTIN FUNCTION INCREASES 1092 FEATURES OF PLAQUE INSTABILITY IN APOE- YIA DEFICIENT MICE J Van Herck, G De Meyer, W Martinet, H Bult, C Vrints, A Herman (Edegem, Belgium and Wilrijk, Belgium) 4:15 PM - 4:30 PM ALTERNATIVE NFKB SIGNALLING IN 1093 ATHEROGENESIS YIA S Dühring, L Holdt, J Ernst, F Weih, J Thiery, D Teupser (Leipzig, Germany) 4:30 PM - 4:45 PM INCREASED MMP-9/TIMP-1-RATIO IN PERIPHERAL 1094 CIRCULATING CD14+ MONOCYTES IS ASSOCIATED WITH PROGRESSION OF CORONARY ARTERY DISEASE S Brunner, H Methe (Munich, Germany) 4:45 PM - 5:00 PM HIGH DENSITY LIPOPROTEINS (HDL) REDUCE THE 1095 EXPRESSION OF CHEMOKINE RECEPTORS CCR2 AND CX3CR1 IN MONOCYTES C Bursill, L Castro, P Barter, K Rye (Sydney, Australia) 5:00 PM - 5:15 PM ATHEROSCLEROSIS AND INFLAMMATION IN 1096 HEMODIALYSIS (HD) PATIENTS: THE IMPACT OF INTERVENTION E Mistrik, S Dusilova-Sulkova, V Blaha, M Kalousova, C Andrys (Hradec Kralove, Czech Republic and Prague, Czech Republic) 5:15 PM - 5:30 PM Withdrawn 1097

*Abstract not available at the time of publication 142 YIA - Young Investigators Award Nominee WEDNESDAY, JUNE 17, 2009

WORKSHOP VI-7 ROOM 310

Lipoprotein Metabolism: Lipoprotein Receptors Chairs: T Kodama (Komaba, Japan), A Rodriguez (Baltimore, MD, USA)

Time Presentation Publication No. 3:30 PM - 3:45 PM LIPID AND LIPOPROTEIN RECEPTORS IN 1098 MACROPHAGE T Kodama, T Tanaka (Komaba, Japan) 3:45 PM - 4:00 PM AN UPDATE ON THE ROLE OF SCAVENGER 1099 RECEPTOR CLASS B TYPE I IN HUMANS A Rodriguez (Baltimore, MD, USA) 4:00 PM - 4:15 PM SCAVENGER RECEPTOR B1 HOSTS A SELF- 1100 REGULATING INTRONIC microRNA AT A YIA POLYMORPHIC LOCUS K Vickers, A Remaley (Bethesda, MD, USA) 4:15 PM - 4:30 PM THE HDL RECEPTOR SR-BI MODULATES PLATELET 1101

FUNCTION AND SUSCEPTIBILITY TO THROMBOSIS Wednesday,

IN VIVO June 17 S Korporaal, I Meurs, M Vergeer, T Van Berkel, J Kuiper, J Kuivenhoven, M Van Eck (Leiden, The Netherlands and Amsterdam, The Netherlands) 4:30 PM - 4:45 PM ApoE IS AN IMPORTANT MEDIATOR OF LRP1 1102 FUNCTIONS IN THE LIPID METABOLISM, YIA ADIPOGENESIS AND GLUCOSE HOMEASTASIS P Gordts, A Bartelt, J Heeren, A Roebroek (Leuven, Belgium and Hamburg, Germany) 4:45 PM - 5:00 PM AGE-LDL INDUCES A PRO-OXIDANT AND PRO- 1103 INFLAMMATORY STATE AND THE EXPRESSION OF SPECIFIC RECEPTORS IN HUMAN VASCULAR SMOOTH MUSCLE CELLS A Sima, G Botez, C Stancu, A Manea, M Raicu, M Simionescu (Bucharest, Romania) 5:00 PM - 5:15 PM FUNCTION OF MUSCULAR VERY LOW- 1104 DENSITY LIPOPROTEIN RECEPTOR IN UPTAKE YIA OF TRIGLYCERIDE-RICH LIPOPROTEIN AND CONTROLLING PLASMA TRIGLYCERIDE CONCENTRATION Y Zenimaru, S Takahashi, T Kimura, M Imagawa, J Suzuki, I Miyamori (Fukui, Japan) 5:15 PM - 5:30 PM LRP1b, A LDL RECEPTOR FAMILY MEMBER 1105 WITH LIMITED TISSUE DISTRIBUTION, BINDS TO FIBRINOGEN AND INDIRECTLY VIA HDL TO CLUSTERIN J Haas, P Widschwendter, J Oberdanner, K Salzmann, B Sarg, H Lindner, J Patsch, P Marschang (Innsbruck, Austria)

*Abstract not available at the time of publication 143 YIA - Young Investigators Award Nominee WEDNESDAY, JUNE 17, 2009

WORKSHOP VI-8 ROOM 311

Basic Science and Vascular Biology: HDL Proteins and Inflammation Chairs: MJ Chapman (Paris, France), F DeBeer (Lexhington, KY, USA)

Time Presentation Publication No. 3:30 PM - 3:45 PM HDL AND INFLAMMATION: IN VITRO AND IN VIVO 1106 STUDIES AL Catapano (Milan, Italy) 3:45 PM - 4:00 PM INSIGHTS INTO HDL FUNCTION FROM LIPIDOMIC *1107 AND PROTEOMIC ANALYSES MJ Chapman (Paris, France) 4:00 PM - 4:15 PM IMPACT OF SERUM AMYLOID A ON HDL 1108 COMPOSITION, LEVELS AND FUNCTION F De Beer, M De Beer, N Webb, J Wroblewski, D Rateri, A Ji, D Van Der Westhuvzen (Lexhington, KY, USA) 4:15 PM - 4:30 PM THE HDL PROTEOME: MARKER-AND PERHAPS 1109 MEDIATOR-OF CVD JW Heinecke (Seattle, WA, USA) 4:30 PM - 4:45 PM EFFECTS OF NON-ENZYMATIC GLYCATION ON 1110 THE ANTI-INFLAMMATORY PROPERTIES OF APOLIPOPROTEIN A-I K-A Rye (Sydney, Australia) 4:45 PM - 5:00 PM ANTI-INFLAMMATORY PROPERTIES OF 1111 RECONSITUTED HDL IN A CHRONIC MODEL OF YIA INFLAMMATION B Di Bartolo, C Bursill, K-A Rye, S Nicholls, A Heather, P Barter (Sydney, Australia and Cleveland, OH, USA) 5:00 PM - 5:15 PM EVIDENCE THAT apoA-II IS ANTI-INFLAMMATORY IN 1112 VITRO AND IN VIVO YIA L Li, C Bursill, P Barter, K Rye (Sydney, Australia) 5:15 PM - 5:30 PM HIGH DENSITY LIPOPROTEIN PROTEIN PROFILING IN 1113 HUMAN EXPERIMENTAL ENDOTOXEMIA J Levels, R Maree, P Geurts, J-A Kuivenhoven, J Meijers (Amsterdam, The Netherlands and Liege, Belgium)

Young Investigator Awards Presentations Republic Ballroom - Sheraton Boston Hotel The Cholesterol Wars

Time Presentation Publication No.

6:00 PM - 6:30 PM THE CHOLESTEROL WARS 1114 D Steinberg (La Jolla, CA, USA)

6:30 PM - 7:30 PM AWARDS

7:30 PM - 8:30 PM RECEPTION

*Abstract not available at the time of publication 144 YIA - Young Investigators Award Nominee WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 19 BASIC SCIENCE

Poster Board No. Publication No. 1 DIFFERENTIAL ATHEROSCLEROTIC VASCULAR RESPONSE TO P1115 LOCAL ENDOTHELIAL SHEAR STRESS BASED ON THE SEVERITY OF YIA HYPERLIPIDEMIA Y Chatzizisis, K Koskinas, M Jonas, A Coskun, E Edelman, P Stone, C Feldman (Boston, MA, USA) 2 EFFECT OF A PROTEIN SUPPLEMENTATION ON THE WEIGHT-CONTROL AND P1116 ANTI-ATHEROGENIC PROPERTIES OF FENUGREEK GALACTOMANNAN YIA W Dakam, R Matsinkou, J Ngondi, J Oben (Yaounde, Cameroon) 3 THROMBOTIC POTENTIAL IN HIGH FAT HIGH FRUCTOSE DIET FED P1117 HYPERLIPIDEMIC HAMSTER M Dikshit, M Barthwal (Lucknow, India) 4 EFFECT OF CITRUS LIMON BURM F. ON LIPIDS AND LIPOPROTEINS IN P1118 RABBITS WITH ATHEROGENIC DIET M Rafiei, M Boshtam, J Moshtaghian, G Naderi (Isfahan, Islamic Republic of Iran) 5 LIPID-LOWERING EFFECTS OF METHANOLIC EXTRACT OF VERNONIA P1119 AMYGDALINA LEAVES IN RATS FED ON HIGH CHOLESTEROL DIET YIA O Adaramoye, O Akintayo, J Achem, M Fafunso (Ibadan, Nigeria) 6 REDUCED RATE OF MYOCARDIAL AND BRAIN ISCHEMIA IN THE P1120 METABOLIC SYNDROME-HISPANIC POPULATION P Altieri, Y Figueroa, N Escobales, M Crespo, H Banchs (San Juan, Puerto Rico) 7 CARDIAC LIPOPROTEIN SECRETION AFFECTS TRIGLYCERIDE P1121 HOMEOSTASIS, CARDIAC STRESS, AND HEMODYNAMIC FUNCTION IN YIA LIPOTOXIC HEART DISEASE E Bartels, J Nielsen, L Hellgren, T Ploug, L Nielsen (Copenhagen, Denmark, Arhus, Denmark and Søborg, Denmark) 8 EFFECTS OF MACROPHAGE ABCA7 DEFICIENCY ON LIPID METABOLISM P1122 AND THE DEVELOPMENT OF ATHEROSCLEROSIS IN LDL RECEPTOR YIA KNOCKOUT MICE L Calpe-Berdiel, I Meurs, K Habets, E Josselin, D Ye, R Out, R Hildebrand, T Van Berkel, G Chimini, M Van Eck (Leiden, The Netherlands and Marseille, France) 9 MicroRNAs 122 AND 370 CONTROL GENES INVOLVED IN LIPID METABOLISM P1123 AND HEPATIC TRIGLYCERIDE ACCUMULATION YIA D Iliopoulos, K Drosatos, V Zannis (Boston, MA, USA and Heraklion, Greece) 10 HIGH DENSITY LIPOPROTEIN (HDL) CAN INFLUENCE THE FORMATION OF FOAM P1124 CELLS BY A RAPID REGULATION OF RECEPTORS (FcgRI AND CD36) INVOLVED IN THE UPTAKE OF MODIFIED LOW DENSITY LIPOPROTEIN (mLDL) M Carvalho, C Vendarame, H Goto, E Yamashiro-Kanashiro, D Ketelhuth, M Gidlund

(São Paulo, Brazil and Stockholm, Sweden) Wednesday, June 17 Poster Sessions 11 NO-1886 UP-REGULATES NIEMANN-PICK C1 PROTEIN (NPC1) EXPRESSION P1125 THROUGH LIVER X RECEPTOR a SIGNALING PATHWAY IN THP-1 MACROPHAGE-DERIVED FOAM CELLS Y-W Hu, Z-C Mo, X-X Li, J Xiao, X-H Liu, C-K Tang (Hengyang, China)

YIA - Young Investigators Award Nominee 145 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 12 TGF-ß1 UPREGULATES EXPRESSION OF ABCA1, ABCG 1 AND SR- P1126 BI THROUGH LIVER X RECEPTOR a SIGNALING PATHWAY IN THP-1 MACROPHAGE-DERIVED FOAM CELLS Y-W Hu, Z-C Mo, X-X Li, J Xiao, X-H Liu, C-K Tang (Hengyang, China) 13 GENDER DIFFERENCES OF LDL RECEPTOR PRODUCTION IN RESPONSE TO P1127 STATIN TREATMENT J Hwang-Levine, E Cadenas, H Hodis (Los Angeles, CA, USA) 14 HYDROGEN SULFIDE PREVENTS FOAM CELL FORMATION: POSSIBLE P1128 INVOLVEMENT IN DOWNREGULATION OF CD36 EXPRESSION IN THP-1- YIA DERIVED MACROPHAGES Z Zhao, Z Jiang, C Tang (Hengyang, China and Beijing, China) 15 EPITOPE ANALYSIS OF A NOVEL HOMO SYNAPSE ASSOCIATED P1129 PROTEIN AND PREPARATION OF ANTIBODY AND EXPRESSION RESEARCH R Wang, Z Jiang, Z Wang (Hengyang City, China) 16 THE ROLE OF -203A/C POLYMORPHISM IN THE REGULATION OF P1130 CHOLESTEROL 7A-HYDROXYLASE EXPRESSION YIA M Zimolova, J Kovar, M Jirsa, R Poledne (Praha, Czech Republic) 17 TRANSLOCATION OF ACAT1 FROM ER TO LATE ENDOSOME ASSOCIATED P1131 MEMBRANES IN CHOLESTEROL-RICH HUMAN MACROPHAGES YIA X Lei, N Sakashita, Y Fujiwara, C Chang, T-Y Chang, M Takeya (Kumamoto, Japan and Hanover, NH, USA) 18 EFFECT OF APOLIPOPROTEIN A-I MIMETIC PEPTIDE D4-F ON EXPRESSION OF P1132 ATP-BINDING CASSETTE TRANSPORTER A1 THROUGH PKA SIGNALING AND CHOLESTEROL EFFLUX IN THP-1 MACROPHAGE-DERIVED FOAM CELLS X-H Liu, Y-W Hu, X-X Li, J Xiao, Z-C Mo, C-K Tang (Hengyang, China) 19 IN VIVO GLYCATED ALBUMIN IMPAIRS THE REMOVAL OF CHOLESTEROL P1133 INDUCING LIPID ACCUMULATION IN MACROPHAGES YIA A Machado-Lima, R Pinto, C Holanda, R Iborra, E Nakandakare, ML Corrêa- Giannella, M Passarelli (São Paulo, Brazil) 20 LYSOSOMAL DYSFUNCTION IN ATHEROSCLEROTIC HEART DISEASE P1134 M Greeve, G MacIntosh, P Meikle (Melbourne, Australia) 21 EFFECTS OF ADVANCED OXIDATION PROTEIN PRODUCTS ON ABCA1 P1135 EXPRESSION AND CHOLESTEROL EFFLUX IN THP-1 MACROPHAGE- DERIVED FOAM CELLS Z-C Mo, Y-W Hu, X-X Li, J Xiao, X-H Liu, C-K Tang (Hengyang, China) 22 SEX HORMONES DECREASE INTRACELLULAR CHOLESTEROL P1136 ACCUMULATION CAUSED BY MODIFIED LIPOPROTEIN A Orekhov, I Sobenin, A Smirnov (Moscow, Russian Federation) 23 ANGIOTENSIN II-STIMULATED HUMAN MONOCYTES ARE INVOLVED IN P1137 HYPERCHOLESTEROLEMIA G Konya, G Foris, T Kobling, I Seres, G Paragh (Debrecen, Hungary) 24 OSBPL10, A NOVEL CANDIDATE GENE FOR LOW HDL AND HIGH TG TRAITS, P1138 REGULATES CELLULAR LIPID METABOLISM J Perttila, K Merikanto, J Naukkarinen, M-R Taskinen, I Virtanen, V Olkkonen, L Peltonen (Helsinki, Finland and Cambridge, UK) 25 REDUCED ABCA-1 EXPRESSION IN MACROPHAGES SUBMITTED TO P1139 GLYCOXIDATION RELATES TO AN INCREASED MITOCHONDRIAL AND YIA NADPH OXIDASE-MEDIATED OXIDATIVE STRESS AND TO A DIMINISHED MITOCHONDRIAL RESPIRATORY CHAIN ACTIVITY R Pinto, B Paim, A Machado-Lima, N Inada, E Nakandakare, A Vercesi, M Passarelli (São Paulo, Brazil and Campinas, Brazil)

YIA - Young Investigators Award Nominee 146 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 26 THE OMEGA-3 FATTY ACID DOCOSAHEXAENOATE ATTENUATES INSULIN- P1140 INDUCED CD36 EXPRESSION IN HUMAN MISCOVASCULAR ENDOTHELIAL CELLS D Schiavone, R Madonna, R De Caterina (Chieti, Italy) 27 AGE-LDL IS A RISK FACTOR FOR ACCELERATED ATHEROSCLEROSIS IN P1141 DIABETES L Toma, C Stancu, G Botez, A Sima, M Simionescu (Bucharest, Romania) 28 LIPOPOLYSACCHARIDE DOWN-REGULATES EXPRESSION OF ABCA1 BY P1142 TLR4-NF-kB PATHWAY IN THP-1 MACROPHAGE DERIVED FOAM CELLS C-K Tang, Z-C Mo, Y-W Hu, X-X Li, X-H Liu, J Xiao (Hengyang, China) 29 INTERLEUKIN-6 DOWN-REGULATES LXR-DEPENDENT EXPRESSION OF P1143 ATP-BINDING CASSETTE TRANSPORTER A1/G1 VIA A JAK/STAT SIGNALING PATHWAY-DEPENDENT WAY J Xiao, Y-W Hu, X-X Li, X-H Liu, Z-C Mo, C-K Tang (Hengyang, China) 30 INSULIN DECREASES CHOLESTEROL EFFLUX FROM MACROPHAGES BY P1144 INHIBITING CHOLESTERYL ESTER HYDROLASE YIA M Yamashita, N Tamasawa, K Matsuki, J Tanabe, H Murakami, J Matsui, T Suda (Hirosaki, Japan) 31 EFFECTS OF SEROTONIN AND A HYDROLYZED PRODUCT OF P1145 DIACYLGLYCEROL ON EXPRESSIONS OF GENES ASSOCIATED WITH ENERGY EXPENDITURE H Yanai, H Yoshida, K Ito, Y Hirowatari, N Sato, N Tada (Kashiwa, Japan and Ayase, Japan) 32 ADIPOPHILIN FACILITATE ACAT1 EXPRESSION IN RAW264.7 CELLS P1146 Z Yuan, A Huang, X Liu (Hengyang, China) 33 LIPID METABOLISM AND ALTERNATIVE THERAPY METHODS IN PATIENTS P1147 WITH SILENT MYOCARDIAL ISCHEMIA ON THE BACKGROUND OF DIABETES MELLITUS, TYPE II R Zaslavkaya, E Tulemisov, B Aitmagambetova (Moscow, Russian Federation) 34 EFFECTS OF IBROLIPIM ON ATP BINDING CASSETTE TRANSPORTER P1148 A1 EXPRESSION AND CHOLESTEROL EFFLUX IN THP-1 MACROPHAGE- YIA DERIVED FOAM CELLS C Zhang, L Huang, S Qu, W Yin, C Tang, X Wei (Hengyang, China) 35 RECOMBINANT APOLIPOPROTEIN M SECRETION STIMULATED BY HDL P1149 J Ahnström, O Axler, B Dahlbäck (Malmö, Sweden) YIA 36 SYNTHETIC LXR AGONIST, T0901317, INCREASES PLASMA PARAOXONASE P1150 1 ACTIVITY IN RATS WITH EXPERIMENTAL HYPERLEPTINEMIA THROUGH THE ANTIINFLAMMATORY MECHANISM J Beltowski (Lublin, Poland) 37 HIGH DENSITY LIPOPROTEINS (HDL) REDUCE CHEMOKINE EXPRESSION IN P1151 MONOCYTES AND ENDOTHELIAL CELLS YIA C Bursill, L Castro, P Barter, K Rye (Sydney, Australia) 38 RECONSTITUTED HIGH DENSITY LIPOPROTEIN ATTENUATES P1152 ATHEROGENESIS BY UP-REGULATING HSP27 EXPRESSION AND DOWN- YIA REGULATING THE MMP9 IN apoE-/- MICE J Choi, B Lee, K Kim, J Kim, J Lee, JE Park (Seoul, Korea) Wednesday, June 17

39 THE INTRINSICALLY DISORDERED STRUCTURE OF APOE4 MAY UNDERLIE P1153 Poster Sessions CONFORMATION-PRONE DISEASES A Dergunov, G Siest, S Visvikis-Siest (Moscow, Russian Federation and Nancy, France)

YIA - Young Investigators Award Nominee 147 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 40 IN VITRO PROPERTIES OF AN APOLIPOPROTEIN A-I MIMETIC PEPTIDE P1154 B Di Bartolo, C Bursill, K-A Rye, S Nicholls, A Heather, P Barter (Sydney, Australia YIA and Cleveland, OH, USA) 41 PARAOXONASE 1 ACTIVITY, HOMOCYSTEINE AND CRP IN PATIENTS WITH P1155 ACUTE CORONARY SYNDROMES T Domagala, R Januszek, M Rzeszutko, K Kotula-Horowitz, S Polanski, A Szczeklik (Krakow, Poland) 42 NIACIN INHIBITS MYELOPEROXIDASE ACTIVITY AND OXIDATIVE P1156 DEGRADATION OF HDL AND APO AI IN HUMAN LEUKOCYTIC MYELOID CELL LINE HL-60: IMPACT ON ANTI-INFLAMMATORY PROPERTIES OF HDL S Ganji, X Xiong, V Kamanna, M Kashyap (Long Beach, CA, USA and Irvine, CA, USA) 43 CETP LIBERATES LIPID-POOR ApoA-I FROM ACUTE PHASE HDL AND P1157 REDUCES HDL LEVELS DURING INFLAMMATION IN VIVO YIA A Jahangiri, M de Beer, J Wroblewski, V Noffsinger, A Ji, F de Beer (Lexington, KY, USA) 44 OXIDIZED HIGH DENSITY LIPOPROTEIN AND ITS SUBFRACTIONS INHIBIT P1158 THE EXPRESSION OF TISSUE FACTOR PATHWAY INHIBITORS IN HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS X Peng, Z Jiang, Z Zhao, Z Tang, L Liu (Hengyang, China) 45 HDL INHIBITS TOBACCO SMOKE-INDUCED GENERATION OF P1159 PROCOAGULANT MICROPARTICLES FROM HUMAN MONOCYTES: A NOVEL YIA CARDIOPROTECTIVE EFFECT M Li, D Yu, K Williams, M-L Liu (Philadelphia, PA, USA and Tianjin, China) 46 ANTI-INFLAMMATORY EFFECT OF PARAOXONASE1 P1160 S Loued, M Isabelle, H Berrougui, A Khalil (Sherbrooke, QC, Canada) YIA 47 DIFFERENTIAL EFFECT OF NATIVE AND OXIDISED HIGH DENSITY P1161 LIPOPROTEIN (HDL) SUBFRACTIONS ON HUMAN CORONARY ARTERY YIA ENDOTHELIAL CELLS (HCAEC) P McPherson, L Wade, I Young, A McGinty, J McEneny (Belfast, UK) 48 APOLIPOPROTEIN E4 AND ITS REDUCTION FOLLOWING LDL-APHERESIS P1162 P Moriarty, C Gibson, J Backes, J Luyendyk (Kansas City, KS, USA) 49 MECHANISMS INVOLVED IN THE ANTIATHEROGENIC ACTION OF CURCUMIN P1163 P Sudhakaran, K Saja, P Boban (Trivandrum, India) 50 EZETIMIBE RESULTS IN INCREASED HDL LIPID CONTENT AND P1164 PARTICLE SIZE K Ekroos, M Ståhlman, A Verma, T Sylvänne, R Hurme, H Berthold, I Gouni-Berthold, J Borén, R Laaksonen (Espoo, Finland, Gothenburg, Sweden, Bonn, Germany and Cologne, Germany) 51 AGED GARLIC EXTRACT INHIBITS CD36 EXPRESSION AND FOAM CELL P1165 FORMATION IN HUMAN MACROPHAGES N Morihara, N Ide, N Weiss (Munich, Germany and Dresden, Germany) 52 RED WINE INCREASES THE NUMBER AND FUNCTIONS OF CIRCULATING P1166 ENDOTHELIAL PROGENITOR CELLS P-H Huang, J-W Chen, S-J Lin (Taipei, Taiwan)

YIA - Young Investigators Award Nominee 148 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 20 CLINICAL ASPECTS OF CARDIOVASCULAR DISEASE

Poster Board No. Publication No. 53 C-REACTIVE PROTEIN PREDICTS FUNCTIONAL STATUS AND CORRELATES P1167 WITH LEFT VENTRICLE EJECTION FRACTION IN PATIENTS WITH CHRONIC YIA STABLE ANGINA P Avanzas, R Arroyo-Espliguero, J Quiles, JC Kaski (London, UK) 54 EXCLUSIVE OLIVE OIL CONSUMPTION IS ASSOCIATED WITH LOWER P1168 LIKELIHOOD OF DEVELOPING LEFT VENTRICULAR SYSTOLIC DYSFUNCTION YIA IN ACUTE CORONARY SYNDROME PATIENTS C-M Kastorini, C Chrysohoou, D Panagiotakos, P Aggelopoulos, C Liontou, I Skoumas, C Pitsavos, C Stefanadis (Athens, Greece) 55 HOMOCYSTEINE, MTHFR POLYMORFISMS AND ARTERIAL OCCLUSIVE P1169 DISEASE M Krstevska, S Dzhekova-Stojkova, G Bosilkova, A Petlichovski, M Spiroski (Skopje, Republic of Macedonia) 56 THE POSSIBLE RELATIONSHIP BETWEEN DEFICIENCY OF FOLIC ACID IN THE P1170 DIET WITH PROINFLAMMATORY STATUS IN HEART FAILURE M Makarewicz-Wujec, M Kozlowska-Wojciechowska, M Naruszewicz (Warsaw, Poland) 57 LOW BONE MINERAL DENSITY - A RISK OF CORONARY AND CAROTID P1171 ATHEROSCLEROSIS IN POSTMENOPAUSAL WOMEN R Sato, K Kajinami, H Akao, A Motoyama (Uchinada, Japan) 58 ASSOCIATION OF HYPERTENSION AND DYSLIPIDEMIA IN KOREAN P1172 POSTMENOPAUSAL WOMEN HH Shin (Seoul, Korea) 59 AGE-DEPENDENT CHANGES IN LIPID METABOLISM ARE ASSOCIATED WITH P1173 CEREBROVASCULAR DISEASE AND STROKE IN POSTMENOPAUSAL WOMEN E Tereshina, N Vodolagina, O Pleteneva (Moscow, Russian Federation) 60 ARTERIAL VASOREACTIVITY IN PREPUBERTAL AND ADOLESCENT CHILDREN P1174 WITH TYPE I DIABETES USING INSULIN PUMP N Batellino, M Šebeštjen, T Batellino, I Keber (Ljubljana, Slovenia) 61 RELATIONSHIP BETWEEN WEIGHT AND CARDIOVASCULAR RISK FACTORS P1175 A Akhavan Tabib, Z Siadat, A Akhavan tabib, A Bahonar, S Zarfeshani, H Alikhassi, J YIA Najafian (Isfahan, Islamic Republic of Iran) 62 CARDIOVASCULAR (CV) RISK MARKERS IN A GROUP OF OBESE AND LEAN P1176 SUBJECTS WITH POLYCYSTIC OVARIAN SYNDROME (PCOS) YIA S Blair, T Kyaw Tun, J Gibney, N Phelan, J McEneny, I Young (Belfast, UK and Dublin, Ireland) 63 INCREASED ATHEROGENIC RISK IN MEN AT HIGHER WAIST CIRCUMFERENCE P1177 QUARTILES Wednesday, June 17

F Brites, L Gomez Rosso, T Meroño, G Giunta, L Marzialli, L Boero, L Schreier, L Poster Sessions Cuniberti (Buenos Aires, Argentina)

YIA - Young Investigators Award Nominee 149 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 64 RELATIONSHIP BETWEEN BODY MASS INDEX AND CARDIOVASCULAR RISK P1178 FACTORS IN A WOMEN SURVEY M Del Sueldo, N Vainstein, G Cerezo, A Vicario, J Zilberman (Villa Maria, Argentina and Caba, Argentina) 65 EMERGING CARDIOVASCULAR RISK FACTORS, INFLAMMATORY MARKERS P1179 AND INSULIN RESISTANCE IN AN OBESE CHILDREN POPULATION F Fabiani, C Gonzalez, E Melguizo, A Barco, T Arrobas (Seville, Spain) 66 IS THERE ANY RELATION BETWEEN METABOLIC SYNDROME AND P1180 HYPOTHYROIDISM? YIA E Faludi, A Tome, A Faludi, D Araujo, H Zatz, R Souza, M Bertolami, Y Nakamura (São Paulo, Brazil) 67 INSULIN RESISTANCE AND ATHEROSCLEROSIS ARE CHARACTERIZED BY P1181 INCREASED ACTIVITY OF THE ECTODOMAIN SHEDDING PROCESS YIA M Cardellini, R Menghini, E Martelli, S Rizza, O Porzio, A Mauriello, L Spagnoli, F Romeo, A Solini, A Ippoliti, R Lauro, F Folli, M Federici (Rome, Italy, Pisa, Italy and San Antonio, TX, USA) 68 OCCULT IMPAIRED GLUCOSE METABOLISM IN PATIENTS WITH P1182 ATHEROSCLEROSIS IS RELATED TO THE NUMBER OF AFFECTED VASCULAR DISTRICTS AND INFLAMMATION S Rizza, M Cardellini, E Martelli, O Porzio, F Romeo, A Ippoliti, R Lauro, M Federici (Rome, Italy) 69 MIGLITOL IMPROVES POSTPRANDIAL HYPERGLYCEMIA, P1183 HYPERINSULINEMIA AND ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH CORONARY ARTERY DISEASE M Hiki, K Shimada, T Kiyanagi, T Kurata, A Kume, K Sumiyoshi, N Inoue, K Fukao, T Miyazaki, K Hirose, H Daida (Tokyo, Japan) 70 DIFFERENT SUBPOPULATIONS AND INCREASED APOPTOSIS OF P1184 ENDOTHELIAL PROGENITOR CELLS IN PATIENTS WITH VASCULAR DISEASE YIA AND DIABETES C Jung, A Rafnsson, A Shemyakin, F Böhm, J Pernow (Stockholm, Sweden) 71 SODIUM, POTASSIUM, CREATININE AND ITS RATIOS IN TYPE 2 DIABETES P1185 MELLITUS WOMEN: A PROSPECTIVE STUDY V Juturu (DobbsFerry, NY, USA) 72 PROSPECTIVE RANDOMIZED MULTICENTER COMPARISON OF P1186 ROSUVASTATIN AND ATORVASTATIN IN ASIAN PATIENTS WITH METABOLIC SYNDROME AND INCREASED LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL S-H Kim, J-H Shin, K Han, S Baek, J Sung, M Hyon, D Lim, Y Ahn, Y Kim, D Kim, Y Choi, C Park, H-S Kim (Seoul, Korea, Suwon, Korea and Seoul, Republic of Korea) 73 SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS (sRAGE) P1187 IN TYPE 2 DIABETIC PATIENTS: RELATION TO INSULIN RESISTANCE AND ATHEROGENESIS N Kravchun, M Gorshunska, N Krasova, I Karachentsev, E Jansen, V Poltorak (Kharkiv, Ukraine and Bilthoven, The Netherlands) 74 TUMOUR NECROSIS FACTOR-a (TNF-a) IN INSULIN RESISTANT TYPE P1188 2 DIABETIC PATIENTS WITH ESSENTIAL HYPERTENSION (EH) OR ITS ASSOCIATION WITH CARDIOVASCULAR DISEASE (CVD) N Kravchun, M Gorshunska, N Krasova, I Karachentsev, E Jansen, V Poltorak (Kharkiv, Ukraine and Bilthoven, The Netherlands) 75 ASSOCIATION BETWEEN FIBRINOGEN LEVEL, INSULIN RESISTANCE AND P1189 DYSLIPIDEMIA. (PYRGOS STUDY) I Lentzas, V Garmiri, E Chatzopoulou, A Katsanaki, A Papathanasiou, G Matzouranis (Gastouni, Greece and Evinochori, Greece)

YIA - Young Investigators Award Nominee 150 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 76 INFLUENCE OF VISCERAL AND SUBCUTANEOUS FAT ON CAROTID INTIMA- P1190 MEDIA THICKNESS IN DYSLIPIDEMIC PATIENTS YIA M Mannarino, M Pirro, R Helou, G Schillaci, D Covelli, E Mannarino (Perugia, Italy) 77 Withdrawn P1191 78 SERUM LEVELS OF ENDOTHELIAL MONOCYTE-ACTIVATING POLYPEPTIDE-II P1192 AND E-SELECTIN IN OBESE AND NON-OBESE DIABETIC PATIENTS YIA L Mogylnytska (Khmelnytsky, Ukraine) 79 INFLUENCE OF BODY WEIGHT ON ADIPOKINES, SERUM PARAOXONASE P1193 ACTIVITY AND ASYMMETRIC DIMETHYLARGININE LEVELS IN HEMODIALYZED PATIENTS F Sztanek, I Seres, L Locsey, B Szlanka, B Borbas, G Paragh (Debrecen, Hungary) 80 INCREASED PHOSPHOLIPID TRANSFER PROTEIN ACTIVITY ASSOCIATED P1194 WITH THE DYSFUNCTIONAL HIGH DENSITY LIPOPROTEIN IN TYPE 2 DIABETIC SUBJECTS WITH OR WITHOUT HIGH LEVEL OF TRIGLYCERIDE RICH LIPOPROTEINS S Qin, H Sang (Taian, China) 81 OVERWEIGHT OR OBESITY FOR PRIMARY PREVENTION OF P1195 CARDIOVASCULAR DISEASE IN THE PRIMARY CARE SETTING AND CARDIOVASCULAR RISK J Rodriguez, C Villaverde, J Perez, J Panisello, D Bleda, P Trave (Barcelona, Spain, Igualada, Spain, Viladecans, Spain and Hospitalet de Llobregat, Spain) 82 DISTINCT PLASMA FATTY ACID PATTERNS ASSOCIATE WITH INSULIN P1196 RESISTANCE AND COMPONENTS OF THE METABOLIC SYNDROME IN HEALTHY OFFSPRING OF TYPE 2 DIABETES PATIENTS L Scheja, M Vossen, K Toedter, U Beisiegel (Hamburg, Germany) 83 METABOLIC CONTROL AND ARTERIAL VASOREACTIVITY IN CHILDREN WITH P1197 TYPE I DIABETES USING INSULIN PUMP M Sebestjen, N Battelino, T Battelino, I Keber (Ljubljana, Slovenia) 84 ALTERATION OF PARAOXONASE-1 ACTIVITY IN CHILDHOOD OBESITY AND P1198 ITS RELATION TO ADIPOKINE LEVELS I Seres, P Koncsos, F Sztanek, E Varga, G Paragh (Debrecen, Hungary) 85 ENDOTHELIN-1 INHIBITS INSULIN-STIMULATED GLUCOSE UPTAKE IN P1199 SKELETAL MUSCLE IN VIVO AND IN VITRO YIA A Shemyakin, F Salehzadeh, F Böhm, A Gonon, H Wagner, S Efendic, A Krook, J Pernow (Stockholm, Sweden) 86 Withdrawn P1200 87 IS INSULIN THE CAUSE OF ATHEROSCLEROSIS IN TYPE-1 DIABETES P1201 MELLITUS? A PILOT STUDY YIA S Suneja, N Chandra (New Delhi, India) 88 THE ANTI-INFLAMMATORY AND ANTIOXIDANT PROPERTIES OF P1202 APOLIPOPROTEIN (APO) A-I FROM DIABETIC PATIENTS ARE IMPAIRED YIA F Tabet, G Lambert, A Jenkins, P Barter, K-A Rye (Sydney, Australia and Melbourne, Australia) 89 ATORVASTATIN INDUCES THE EXPRESSION OF SOLUBLE RECEPTOR FOR P1203 ADVANCED GLYCATION END PRODUCTS

X Tam, S Shiu, WS Chow, Y Wong, J Betteridge, K Tan (Hong Kong, Hong Kong and Wednesday, June 17 London, UK) Poster Sessions 90 FROM NORMAL STATUS TO METABOLIC SYNDROME P1204 A Udristioiu (Targu Jiu, Romania)

YIA - Young Investigators Award Nominee 151 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 91 ARE OXIDIZED LDL LEVELS ASSOCIATED WITH INSULIN RESISTANCE? P1205 RETROSPECTIVE ANALYSIS IN TYPE 2 DIABETES PATIENTS D Vaz, G Rocha, I Palma, F Borges, J Oliveira (Oporto, Portugal) 92 INSULIN RESISTANCE INDUCED BY FRUCTOSE-FED RESULTED IN CHANGE P1206 OF VASCULAR STRUCTURE OF AORTA AND MESENTERIC ARTERY IN THE 2- KIDNEY, 1 CLIP HYPERTENSIVE RAT G Long, B Hu, G Wang (Chongqing, China and Hengyang, China) 93 EFECTS OF ROSA LAEVIGATA MICKX ON RENAL ADVANCED GLYCATION P1207 END PRODUCTS AND THEIR RECEPTOR EXPRESSION IN EARLY DIABETIC YIA NEPHROPATHY RATS Y Zhou, Q Liao, Q Zhang (Hengyang, China) 94 RELATIONSHIP BETWEEN GLYCATED HEMOGLOBIN, BLOOD PRESSURE AND P1208 CAROTID ARTERY ATHEROSCLEROSIS IN NON-DIABETIC PATIENTS YIA W Zhu, Y Li (Shanghai, China) 95 PERIODONTITIS-INDUCED INFLAMMATION AND ENDOTOXEMIA INCREASE P1209 VLDL-DERIVED FOAM CELL FORMATION YIA E Kallio, K Hyvärinen, P Kovanen, M Jauhiainen, P Pussinen (Helsinki, Finland) 96 CARDIOVASCULAR RISK MARKERS AND PERIODONTITIS: CASE REPORT P1210 A Monteiro, M Jardini, M Gidlund (São Paulo, Brazil) YIA 97 CARDIOVASCULAR DISEASE PARAMETERS IN PERIODONTITIS P1211 A Monteiro, M Jardini, S Alves, A Neto, M Gidlund (São Paulo, Brazil and São José dos YIA Campos, Brazil) 98 PERIODONTAL DISEASE AND ATHEROSCLEROSIS IN FAMILIAL P1212 HYPERCHOLESTEROLEMIA: A SIGNIFICANT ASSOCIATION WITHOUT YIA APPARENT DOSE-RESPONSE RELATIONSHIP C Vieira, P Cury, I Giuliano, D Calderaro, M Miname, L Martinez, P Yu, D Gualandro, L Bortolotto, R Santos, B Caramelli (São Paulo, Brazil and Campinas, Brazil) 99 ASSOCIATION OF PRECLINICAL ATHEROSCLEROSIS WITH VENOUS P1213 THROMBOEMBOLISM IN PATIENTS WITH HYPERCOAGULABLE STATES O Auzký, L Pagácová, T Šejda, J Piaha (Prague, Czech Republic) 100 MICROPARTICLES BEFORE AND AFTER ANGIOPLASTY OF ILIAC ARTERY P1214 STENOSIS C Bergmark, C Jung, E Jan (Stockholm, Sweden) 101 INTIMA-MEDIA THICKNESS OF CAROTID AND FEMORAL ARTERIES IN P1215 POSTMENOPAUSAL WOMEN WITH SUBCLINICAL HYPOTHYROIDISM T Kurtanidze, N Kakauridze, N Nikolaishvili (Tbilisi, Georgia) 102 LIPOPROTEIN(A): A CAUSE OF RESTENOSIS AFTER INFRAINGUINAL P1216 PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY YIA L Laghi, F Giovanetti, S D’Addato, M Gargiulo, A Stella, C Borghi (Bologna, Italy) 103 ASSOCIATION OF PERIPHERAL ARTERIAL DISEASE AND CAROTID P1217 ATHEROSCLEROSIS: A KYUSHU OKINAWA POPULATION STUDY (KOPS) H Ohnishi, Y Sawayama, S Maeda, T Koga, H Mukae, N Furusyo, J Hayashi (Fukuoka, Japan) 104 ROSUVASTATIN REDUCES INTIMA-MEDIA THICKNESS IN 45 P1218 HYPERCHOLESTEROLEMIC SUBJECTS WITH ASYMPTOMATIC CAROTID ARTERY DISEASE G Riccioni, N Vitulano, A Zanasi, B Mancini, N D’Orazio (Manfredonia, Italy, Rome, Italy, Foggia, Italy and Chieti, Italy) 105 PATENCY LENGTH PREDICTORS IN FEMOROPOPLITEAL BYPASSES P1219 I Mirkovic, F Rozman (Pula, Croatia)

YIA - Young Investigators Award Nominee 152 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 106 PHARMACOLOGIC REDUCTION OF FACTOR XIII ACTIVITY AND P1220 FIBRINOGENEMIA IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE R Flore, A Santoliquido, A Lupascu, MA Zocco, A Di Giorgio, L Santoro, EC Lauritano, P Tondi (Rome, Italy) 107 ASSESSMENT OF IN VITRO SIMVASTATIN EFFECT ON INFLAMMATORY P1221 MARKERS OF MONOCYTES CULTURED CELLS IN CRITICALLY ILL PATIENTS YIA WITH ACUTE KIDNEY INJURY G Ferrari, B Quinto, K Queiroz, J Monte, M Durão, M Cendoroglo, M Dalboni, O Santos, M Batista (Sao Paulo, Brazil) 108 STATIN PREVENT ACUTE KIDNEY INJURY IN ICU SETTING P1222 M Dalboni, M Oliveira, R Narciso, J Monte, M Durão, B Quinto, M Cendoroglo, O Santos, M Batista (Sao Paulo, Brazil) 109 GLOMERULAL FILTRATION RATE IN YOUNG POST-MYOCARDIAL P1223 INFARCTION PATIENTS CORRELATES WITH ENDOTHELIAL DYSFUNCTION, INTIMA MEDIA THICKNESS AND hsCRP B Erzen, M Šabovic, P Poredoš (Ljubljana, Slovenia) 110 STATINS ARE BENEFICIAL FOR THE PRIMARY PREVENTION OF P1224 CARDIOVASCULAR DISEASE IN HEMODIALYSIS PATIENTS YIA W Haykal, O Kuryata (Beirut, Lebanon and Dnepropetrovsk, Ukraine) 111 CARDIO-ANKLE VASCULAR INDEX PREDICTS CHRONIC KIDNEY DISEASE IN P1225 A JAPANESE POPULATION D Maebuchi, Y Kubota, Y Suzuki, T Ono, S Ishii, Y Ikegami, J Fuse, M Sakamoto, Y Momiyama (Tokyo, Japan) 112 MALNUTRITION, INFLAMMATION AND ATHEROSCLEROSIS INCREASE P1226 MORTALITY OF HEMODIALYSED (HD) PATIENTS E Mistrík, V Bláha, S Dusilová-Sulková, C Andrýs, M Bláha, L Sobotka (Hradec Kralove, Czech Republic) 113 INTERVENTION IMPROVES LEVELS OF HDL FOLLOWED BY DECREASE IN P1227 MCP-1 AND INCREASED TWO-YEAR SURVIVAL OF HEMODIALYZED (HD) YIA PATIENTS E Mistrik, V Blaha, S Dusilova-Sulkova, M Kalousova, C Andrys (Hradec Kralove, Czech Republic and Prague, Czech Republic) 114 THE SIGNIFICANCE OF THE METABOLIC SYNDROME IN THE DEVELOPMENT P1228 OF CHRONIC RENAL DISEASE (CKD) IN NON-DIABETIC OBESE SUBJECTS M Ohni, K Nakajima, Y Hata (Mitaka-shi, Japan, Kohu-shi, Japan and Mito, Japan) 115 CAROTID ATHEROSCLEROSIS IS INDEPENDENTLY ASSOCIATED WITH P1229 ENDOTHELIAL DYSFUNCTION MARKERS AND QUINOLINIC ACID LEVELS IN END-STAGE RENAL DISEASE PATIENTS D Pawlak, T Domaniewski, M Mysliwiec, K Pawlak (Bialystok, Poland) 116 KYNURENINE, QUINOLINIC ACID - THE NEW FACTORS LINKED TO CAROTID P1230 ATHEROSCLEROSIS IN PATIENTS WITH END-STAGE RENAL DISEASE K Pawlak, S Brzosko, M Mysliwiec, D Pawlak (Bialystok, Poland) 117 INFLAMMATORY PROFILE AND BLOOD TRANSFUSION PREDICTS MORTALITY P1231 IN CRITICALLY ILL PATIENTS WITH AKI REQUIRING CONTINUOUS VENO- YIA VENOUS HEMODIAFILTRATION

B Quinto, M Goes, Jr., I Iizuka, J Monte, M Durão, O Santos, M Dalboni, M Cendoroglo, Wednesday, June 17 M Batista (Sao Paulo, Brazil) Poster Sessions 118 INSULIN RESISTANCE, CHRONIC INFLAMMATION AND MUSCLE WASTING IN P1232 END-STAGE RENAL DISEASE PATIENTS ON HEMODIALYSIS Z Rasic-Milutinovic, G Perunicic-Pekovic, L Bokan (Beograd, Serbia)

YIA - Young Investigators Award Nominee 153 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 119 RELATION OF APOLIPOPROTEIN-B TO URINARY ALBUMIN EXCRETION P1233 IN EGYPTIAN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND EARLY DIABETIC NEPHROPATHY R Shafeh, T Abdel-Aaty (Alexandria, Egypt) 120 THE BENEFITS OF LONG-TERM ATORVASTATIN TREATMENT IN PATIENTS P1234 WITH ISCHEMIC STROKE S Chumburidze, N Kiphshidze (Tbilisi, Georgia) 121 LOW LEVELS OF NATURAL ANTIBODIES AGAINST PHOSPHORYLCHOLINE P1235 PREDICT DEVELOPMENT OF STROKE J Frostegård, B Stegmayr, G Hallmans, U de Faire, J Frostegård (Stockholm, Sweden and Umea, Sweden) 122 YOUNG STROKES AND AUTOIMMUNITY P1236 D Mesloub, D Hakem, N Ouadahi, B Mansouri, A Berrah, L Stof (Algiers City, Algeria) YIA 123 GLYCEMIA AND TRIGLYCERIDE LEVELS AS PREDICTING FACTOR OF FEVER P1237 IN PATIENTS AFTER STROKE M Savic, V Jakovljevic, D Nikolic, D Djuric (Belgrade, Serbia and Kragujevac, Serbia) 124 EVALUATION OF PARAMETERS OF GLUTATIONE SYSTEM IN PATIENTS WITH P1238 CHRONIC OBSTRUKTIVE PULMONARY DISEASE IN PHARMACOLOGICAL CORRECTION L Bessonova, N Verlan, Kolesnichenko, Kulinsky, Gubina, Pensionerova, Sergeeva (Irkutsk, Russian Federation) 125 BARRIERS IN MULTIPLE RISK FACTOR MANAGEMENT IN CARDIOVASCULAR P1239 DISEASE A Peracino (Milan, Italy) 126 ATORVASTATIN INCREASES PLASMA VITAMIN E/LDL-CHOLESTEROL AND P1240 COQ10/LDL-CHOLESTEROL RATIOS IN HYPERCHOLESTEROLAEMIC PATIENTS YIA W-L Cheng, C-L Kuo, C-S Liu (Changhua, Taiwan and Taichung, Taiwan)

YIA - Young Investigators Award Nominee 154 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 21 EPIDEMIOLOGY OF CARDIOVASCULAR DISEASE

Poster Board No. Publication No. 127 CARDIOVASCULAR DISEASE RISK PROFILE IN PREDIABETIC INDIVIDUALS IN P1241 A DEVELOPING COUNTRY YC Chia, S Pengal (Kuala Lumpur, Malaysia and Penang, Malaysia) 128 ASSOCIATION BETWEEN BLOOD PRESSURE AND SOME OTHER P1242 CARDIOVASCULAR DISEASE RISK FACTORS IN A LEAN BLACK POPULATION YIA C Ejike (Umuahia, Nigeria) 129 TREATMENT WITH EZETIMIBE AND ORLISTAT OR RIMONABANT IN P1243 OVERWEIGHT/OBESE PATIENTS WITH DYSLIPIDEMIA AND A HISTORY OF STATIN-INTOLERANCE M Florentin, E Liberopoulos, M Kostapanos, E Nakou, M Elisaf (Ioannina, Greece) 130 HIGHLY SENSITIVE C-REACTIVE PROTEIN AND THE FRAMINGHAM RISK P1244 SCORE ARE ASSOCIATED WITH CORONARY DISEASE SEVERITY IN PATIENTS WITH METABOLIC SYNDROME C Monteiro, M Izar, S Brandao, S Fischer, S Barros, A Santos, M Vasco, L Pinheiro, A Carvalho, F Fonseca (São Paulo, Brazil) 131 COMPARISON OF COMPUTED VERSUS DIRECT MEASUREMENT OF LOW- P1245 DENSITY LIPOPROTEIN CHOLESTEROL IN THE ASSESSMENT OF CORONARY YIA HEART DISEASE RISK AMONG PHILIPPINE HEART CENTER PATIENTS D Gadingan, A de Luna, M Orillaza, B Asuncion (Quezon City, Philippines) 132 EPIDEMIOLOGY OF VASCULAR RISK FACTORS AND HEAT SHOCK PROTEINS P1246 IN DYSGLYCEMIA MC Guisasola (Madrid, Spain) 133 NECK CIRCUMFERENCE AS A MEASURE OF CENTRAL OBESITY: P1247 ASSOCIATIONS WITH METABOLIC SYNDROME AND OBSTRUCTIVE SLEEP YIA APNEA SYNDROME BEYOND WALST CIRCUMFERENCE A Onat, G Hergenc, H Yuksel, G Can, E Ayhan, Z Kaya, D Dursunoglu (Istanbul, Turkey and Denizli, Turkey) 134 ASSOCIATIONS OF PLASMA HOMOCYSTEINE LEVEL WITH BRACHIAL-ANKLE P1248 PULSE WAVE VELOCITY, LDL ATHEROGENECITY, AND INFLAMMATION YIA PROFILE IN HEALTHY MEN YJ Hyun, HY Park, J Yun, JY Kim, JS Chae, S-H Lee, JH Lee, Y Jang (Seoul, Korea and Goyang, Korea) 135 HIGH PREVALENCE OF CARDIOVASCULAR RISK FACTORS IN A YOUNG, P1249 APPARENTLY HEALTHY POPULATION OF GREATER BUENOS AIRES, ARGENTINA S Lynch, E Gabe, G Giunta, M Cabello, R Ratto, MI Rodriguez Acuña, A Dos Santos, G Bozovich (Buenos Aires, Argentina)

136 EFFECT OF HYDROSOLUBLE, HIGHLY BIOAVAILBLE COENZYME Q10(Qgel) IN P1250 Wednesday, June 17

PATIENTS WITH STROKE YIA Poster Sessions F Mustufa, R Singh, S Ghosh, S Dube (Moradabad, India) 137 EVOLUTION AND IMPROVEMENT OF HEMATOLOGIC PROFILE IN MORBID P1251 OBESE PATIENTS AFTER BARIATRIC SURGERY E Pardina, R Ferrer, J Baena-Fustegueras, J Fort, R Catalán, R Galard, A Lecube, H Allende, V Vargas, J Peinado-Onsurbe (Barcelona, Spain)

YIA - Young Investigators Award Nominee 155 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 138 OBESITY AND ITS ASSOCIATION WITH CARDIOVASCULAR RISK FACTORS IN P1252 SCHOOLCHILDREN FROM BRAZIL A Pereira, A Guedes, I Verreschi, R Santos, T Martinez (São Paulo, Brazil) 139 Apo B, SMALL-DENSE LDL AND CAROTID ATHEROSCLEROSIS IN P1253 MENOPAUSAL WOMEN M Gentile, P Rubba, P Pauciullo, G Iannuzzo, S Ubaldi, G Marotta, F Jossa, A Mattiello, S Panico (Naples, Italy) 140 THE Hp 2-2 GENOTYPE IS NOT ASSOCIATED WITH PREVIOUS P1254 CARDIOVASCULAR DISEASE OR CAROTID ATHEROSCLEROSIS AMONG 64- YIA YEAR OLD WOMEN WITH TYPE 2 DIABETES M Ryndel, F Olson, C-J Behre, U Prahl-Abrahamsson, C Schmidt, G Bergström, B Fagerberg (Gothenburg, Sweden) 141 LOW BONE MINERAL DENSITY IS NOT ASSOCIATED WITH P1255 ANGIOGRAPHICALLY DETERMINED CORONARY ATHEROSCLEROSIS IN MEN YIA S Beer, C Saely, G Hoefle, P Rein, A Vonbank, M Woess, J Breuss, H Drexel (Feldkirch, Austria and Triesen, Liechtenstein) 142 TYPE 2 DIABETES SIGNIFICANTLY MODULATES THE IMPACT OF TCF7L2 P1256 rs7903146 VARIANT ON THE RISK OF CORONARY ATHEROSCLEROSIS YIA A Muendlein, C Saely, S Rhomberg, G Sonderegger, P Rein, T Winder, S Beer, J Breuss, A Vonbank (Feldkirch, Austria and Triesen, Liechtenstein) 143 BENEFICIAL EFFECT IN HEART RATE VARIABILITY AND IGF-I AFTER P1257 TREATMENT WITH ATORVASTATIN IN HYPERCHOLESTEROLEMIC PATIENTS T Sakai, K Saku (Fukuoka, Japan) 144 IMPACT OF LIFESTYLE MODIFICATION ON CARDIOVASCULAR EVENT IN A P1258 SUBURBAN JAPANESE POPULATION. OKINAWA KYUSHU POPULATION STUDY (KOPS) Y Sawayama, S Maeda, H Ohnishi, N Furusyo, J Hayashi (Fukuoka, Japan) 145 FACTORS ASSOCIATED WITH NONADHERENCE TO LIPID-LOWERING P1259 TREATMENT AND IDENTIFICATION OF BEHAVIORAL PROFILES AMONG HYPERCHOLESTEROLEMIC INDIVIDUALS IN BRAZIL: THE CORE PROJECT J dos Santos, A Sposito, J Faria-Neto, F Fonseca, J Ramires, O Coelho, M Bertolami, R Santos, E Tutihashi, F Cesena (São Paulo, Brazil) 146 ESTIMATING THE PROPORTION OF ADULTS WITH MEASURED P1260 BLOOD CHOLESTEROL, THE PREVALENCE OF SELF-REPORTED HYPERCHOLESTEROLEMIA AND THE RATE OF ADHERENCE TO LIPID- LOWERING TREATMENT IN BRAZIL: THE CORE PROJECT A Sposito, J dos Santos, R Santos, O Coelho, M Bertolami, J Faria-Neto, J Ramires, F Fonseca, E Tutihashi, F Cesena (São Paulo, Brazil) 147 METABOLIC SYNDROME IN ARGENTINA: PREVALENCE IN THE CARDIOLOGIC P1261 CONSULTATION ACCORDING TO DEFINITIONS AND DIAGNOSTIC PERCEPTION N Vainstein, G Cerezo, J Zilberman, M Del Sueldo, D Piskorz, A Vicario (Caba, Argentina and Villa Maria, Argentina) 148 PREVALENCE OF MIXED DYSLIPIDEMIA IN AUSTRALIAN PATIENTS ON LIPID P1262 MODIFYING THERAPY D Colquhoun, D Chirovsky, B Ambegaonkar, M Farris, D Gaur, Y Cui, V Sazonov (Brisbane, Australia, Whitehouse Station, NJ, USA and South Granville, Australia) 149 HORMONAL-METABOLIC ASPECTS OF ATHEROGENIC DYSLIPIDAEMIAS IN P1263 NON-OBESE TYPE II DIABETIC PATIENTS WITH ATHEROSCLEROSIS V Anestiadi (Chisinau, Republic of Moldova)

YIA - Young Investigators Award Nominee 156 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 150 RELATION BETWEEN DOPAMINE AND INSULIN IN HEALTHY, HYPERTENSION P1264 AND TYPE 2 DIABETIC SUBJECTS M Lares, J Castro, F Contreras (Caracas, Venezuela) 151 ENDOTHELIN-1, INSULIN RESISTANCE INDEX AND C-REACTIVE PROTEIN IN P1265 HYPERTENSE DYSLIPIDEMIC PATIENTS: THE ROLE OF VASOACTIVE SYSTEM M Lares, J Castro, F Contreras, G Aure, M Velazco (Caracas, Venezuela) 152 EFFICACY OF SIMVASTATIN AND FENOFIBRATE ASSOCIATION IN P1266 HYPERCHOLESTEROLEMIC, TYPE 2 DIABETIC PATIENTS COMPARED TO MONOTHERAPY G Derosa, S Salvadeo, I Ferrari, E Fogari, R Mereu, P Maffioli, A Cicero (Pavia, Italy and Bologna, Italy) 153 IS THE EGYPTIAN DIET ATHEROGENIC IN T2DM? ROLE OF POSTPRANDIAL P1267 LIPEMIA N Lachine, A Abdel-Rehim, D ElKaffash, K El Nouaem, N Khalifa (Alexandria, Egypt) 154 ANTIDIABETIC AND ANTIHYPERLIPIDEMIC EFFECTS OF TERMINALIA P1268 SUPERBA IN RATS YIA CE Momo, J Oben (Yaounde, Cameroon) 155 CLINICAL EVALUATION OF COGNITIVE DYSFUNCTION IN SENILE TYPE II P1269 DIABETES IN JAPAN H Murakami, N Tamasawa, M Yamashita, K Matsuki, J Tanabe, N Hasegawa, J Matsui, T Suda (Hirosaki, Japan) 156 THE EFFECT OF GLARGINE AND NPH INSULIN IN PATIENTS WITH DIABETES P1270 MELLITUS TYPE 2 L Nechevska, M Nechevski, E Nechevska, B Boskovski (Bitola, Macedonia and Skopje, Republic of Macedonia) 157 LIPID PREDICTORS OF CARDIOVASCULAR EVENTS IN STATIN-TREATED P1271 PATIENTS WITH DIABETES MELLITUS H Drexel, S Aczel, T Marte, A Vonbank, C Saely (Feldkirch, Austria and Triesen, Liechtenstein) 158 IMPAIRED INSULIN SENSITIVITY: LIPID AND VASCULAR REACTIVITY DURING P1272 HORMONAL CONTRACEPTION YIA E Chan, E Krieger, P Paramsothy, B Fish, S Prager, R Knopp (Seattle, WA, USA) 159 THE EFFECTS OF PATCH VERSUS ORAL CONTRACEPTION ON LIPOPROTEINS: P1273 A RANDOMIZED CROSSOVER STUDY YIA E Chan E, E Krieger, P Paramsothy, S Prager, B Fish, R Knopp (Seattle, WA, USA) 160 IMPACT OF AGE AND MENOPAUSAL STATUS ON THE POSTPRANDIAL P1274 TRIACYLGLYCEROL RESPONSE K Jackson, A Smith, P Murray, B O’Malley, A Minihane, C Williams (Reading, UK and Sharnbrook, UK) 161 ESR1 GENETIC VARIANTS, HAPLOTYPES AND THE RISK OF CORONARY P1275 HEART DISEASE IN THE FINNISH POPULATION; A PROSPECTIVE FOLLOW-UP STUDY T Kunnas, K Silander, J Karvanen, V Salomaa, S Nikkari (Tampere, Finland and Helsinki, Finland) 162 THE INFLUENCE OF HORMONAL CONTRACEPTION ON CRP, LIPOPROTEINS P1276 AND BLOOD LIPIDS Wednesday, June 17

V Soska, J Fiala, D Hruba (Brno, Czech Republic) Poster Sessions 163 HDL-PARAOXONASE AND MEMBRANE LIPID PEROXIDATION: A COMPARISON P1277 BETWEEN HEALTHY SUBJECTS AND OBESE PATIENTS V Bicchiega, S Masciangelo, T Bacchetti, G Ferretti (Piancavallo, Italy and Ancona, Italy)

YIA - Young Investigators Award Nominee 157 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 164 A COMMON CETP HAPLOTYPE IS A STRONG DETERMINANT OF HDL-C P1278 CONCENTRATIONS IN A HIGH CARDIOVASCULAR RISK MEDITERRANEAN POPULATION AND DOES NOT INTERACT WITH ALCOHOL CONSUMPTION, TOBACCO SMOKING OR DIETARY FAT INTAKE D Corella, P Guillem-Saiz, J Gonzalez, C Saiz, M Guillen (Valencia, Spain) 165 A SIMPLE AND PRECISE METHOD FOR MEASURING HDL-CHOLESTEROL P1279 SUBFRACTIONS, AND ITS CLINICAL SIGNIFICANCE T Hirano, S Koba, A Tanaka, T Taira, Y Ito (Tokyo, Japan and Sakado, Japan) 166 COMPARISON OF DECREASE IN PLASMA CHOLESTEROL AND OXIDIZED LDL P1280 IN 3 LDL SUBFRACTIONS AFTER 6 MONTHS OF TREATMENT WITH LOW-DOSE ROSVASTATIN Y Homma, K Homma, M Igarashi, Y Morita, H Yamaguchi, R Miyano, M Matsuda, T Tanigaki, Y Shiina (Isehara, Japan and Shinjuku, Japan) 167 DEVELOPMENT OF A NOVEL HOMOGENEOUS ASSAY FOR QUANTIFICATION P1281 OF SMALL DENSE LDL CHOLESTEROL Y Ito, M Fujimura, M Ohta, T Hirano (Tokyo, Japan) 168 CHOLESTEROL - A EPIDEMIOLOGICAL STUDY IN CHILDREN AND P1282 ADOLESCENTS A Pereira, T Martinez, L Vieira (São Paulo, Brazil) 169 SPECIFIC Lp(a) APHERESIS BY “Lp(a) LIPOPAK” COLUMNS - UNIQUE P1283 APPROACH FOR EFFECTIVE Lp(a) ELIMINATION S Pokrovsky, O Afanasieva, M Ezhov, I Adamova, G Konovalov, S Kipor (Moscow, Russian Federation) 170 RELATIONSHIP BETWEEN LOW LDL-C LEVELS AND APOLIPOPROTEIN B P1284 CONCENTRATIONS IN A HEALTHY POPULATION FROM ARGENTINA D Siniawski, W Masson, P Sorroche, W Scordo, J Krauss, A Cagide (Buenos Aires, Argentina) 171 ADULT TREATMENT PANEL III METABOLIC SYNDROME CRITERIA MORE P1285 STRONGLY THAN INTERNATIONAL DIABETES FEDERATION CRITERIA YIA PREDICT THE INCIDENCE OF TYPE 2 DIABETES IN ANGIOGRAPHIED CORONARY PATIENTS H Drexel, A Vonbank, P Rein, S Beer, S Aczel, T Marte, C Saely (Feldkirch, Austria and Triesen, Liechtenstein) 172 THE ROLE OF LIPOPROTEIN LIPASE ACTIVITY, HYPERINSULINEMIA AND P1286 FREE FATTY ACIDS IN GENESIS OF DYSLIPIDEMIAS E Ageeva, Y Frolova, A Denisenko (Saint-Petersburg, Russian Federation) 173 INSULIN RESISTANCE PREDICTS ATHEROSCLEROSIS REGARDLESS OF P1287 METABOLIC SYNDROME B Bale, A Doneen, D Feng (Lubbock, TX, USA and Spokane, WA, USA) 174 EVIDENCE OF REGRESSION OF ATHEROSCLEROSIS IN MSCT IMAGING IN P1288 CASES WITH METABOLIC SYNDROME AND PREDIABETIC STATES WITH AGENTS PRIMARILY KNOWN FOR METABOLIC CONTROL D Basu, A Bhargava (Kolkata, India) 175 PREVALENCE OF METABOLIC SYNDROME AND ITS INDIVIDUAL P1289 COMPONENTS CHARACTERISTICS IN POPULATION OF CENTRAL SERBIA YIA I Burazor, N Vukadinovic, M Burazor (Nis, Serbia and Krusevac, Serbia) 176 INCREASE IN THE PREVALENCE OF METABOLIC SYNDROME ASSOCIATED TO P1290 WEIGHT GAIN IN A WORKING POPULATION. ICARIA STUDY (IBERMUTUAMUR CARDIOVASCULAR RISK ASSESSMENT) A Fernández-Meseguer, M Cabrera, J Monsonis-Artero, J Pinto-Blazquez, J Martín- Barallat, J Gelpi-Méndez, L Quevedo-Aguado (Madrid, Spain)

YIA - Young Investigators Award Nominee 158 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 177 THE FUNCTIONAL AND COMPOSITIONAL PROPERTIES OF LIPOPROTEINS ARE P1291 ALTERED IN PATIENTS WITH METABOLIC SYNDROME K-H Park, D-G Shin, J-R Kim, K-H Cho (Gyeongsan, Korea) 178 A DIETARY EDUCATION PROGRAM INVOLVING THE GENERAL POPULATION P1292 BALANCES THE EFFECTS OF MENOPAUSE ON CARDIOVASCULAR RISK YIA FACTORS AND METABOLIC SYNDROME INCIDENCE: DATA FROM THE BRISIGHELLA HEART STUDY A Cicero, A Dormi, A Gaddi, C Borghi (Bologna, Italy) 179 PLASMA PHYTOSTEROLS AND METABOLIC SYNDROME. CROSS-SECTIONAL P1293 STUDY IN DYSLIPIDEMIC PATIENTS AND HEALTHY SUBJECTS M Cofan, V Escurriol, A Garcia-Otin, C Moreno-Iribas, N Larrañaga, M Tormo, F Civeira, E Ros (Barcelona, Spain, Zaragoza, Spain, Pamplona, Spain, Gipuzkoa, Spain and Murcia, Spain) 180 THE RELATION BETWEEN ADIPOKINES, ADIPONECTIN-LEPTIN RATIO AND P1294 THE METABOLIC SYNDROME R Dinu, S Popa, C Stanciulescu, E Mota, M Mota (Craiova, Romania) 181 CRITICAL ANALYSIS OF DIFFERENT DIAGNOSTIC CRITERIA OF ABDOMINAL P1295 CIRCUMFERENCE IN A BRAZILIAN POPULATION YIA E Faludi, A Tome, A Faludi, D Araujo, H Zatz, Y Nakamura, M Atanazio, M Bertolami, R Souza (São Paulo, Brazil) 182 METABOLIC SYNDROME EPIDEMIOLOGY BASED ON SOCIOECONOMIC STATUS: P1296 CROSS SECTIONAL STUDY AMONG IRANIAN ADULT POPULATION (IHHP Study) YIA M Gharipour, N Sarrafzadegan, Z Siadat, M Maghroun, A Abdolvand (Isfahan, Islamic Republic of Iran) 183 THE LOW SERUM MAGNESIUM OF METABOLIC SYNDROME IS ASSOCIATED P1297 WITH INCREASED INTRACELLULAR MAGNESIUM RATHER THAN YIA DEFICIENCY V Gourineni, G Nathanson, M Wolfe, S Volpe, D Rader, R Dunbar (Philadelphia, PA, USA) 184 IMPACT OF BODY WEIGHT REDUCTION ON THE RISK FOR METABOLIC P1298 SYNDROME P Hlubik, H Stritecka, J Hlubik (Hradec Kralove, Czech Republic and Prague, Czech Republic) 185 THE “HYPERTRIGLYCERIDEMIC WAIST” PHENOTYPE ASSOCIATED WITH A P1299 DECREASED APOLIPOPROTEIN AV LEVEL YIA X-S Huang, S-P Zhao, M Hu, L Bai, W Zhao (Changsha, China) 186 BORDERLINE METABOLIC SYNDROME: NEW RISK FACTORS LEVELS P1300 S D’Addato, L Laghi, E Tartagni, C Borghi, A Dormi (Bologna, Italy) YIA 187 IMPLICATION OF METABOLIC SYNDROME COMBINED IN HYPERTENSIVE P1301 PATIENTS H-Y Lee, C-H Kim (Seoul, Korea and Sungnam, Korea) 188 METABOLIC SYNDROME IN DYSLIPIDEMIA CONSULTANTS IN ADULT P1302 POPULATION OF HEALTH CENTER OF GASTOUNI I Lentzas, V Garmiri, G Matzouranis, E Chatzopoulou, A Katsanaki, I Georgiopoulou, S Adaos (Gastouni, Greece, Evinochori, Greece and Krya Vrysi, Greece) 189 METABOLICALLY OBESE PATIENTS WITH NORMAL WEIGHT HAVE GREATER P1303 Wednesday, June 17

DEGREE OF CARDIOVASCULAR RISKS THAN METABOLICALLY HEALTHY BUT Poster Sessions OBESE PATIENTS I Lentzas, V Garmiri, A Katsanaki, G Tsiros, G Matzouranis, P Panagopoulos, E Chatzopoulou (Pyrgos, Greece, Evinochori, Greece and Krya Vrysi, Greece)

YIA - Young Investigators Award Nominee 159 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 190 THE RELEVANCE OF CARDIOMETABOLIC RISK FACTORS AS PREDICTORS OF P1304 THE METABOLIC SYNDROME P Lindqvist, V Sundh, C Björkelund, C Bengtsson (Gothenburg, Sweden) 191 WAIST TO HEIGHT RATIO IS A HIGHLY SENSITIVE INDEX FOR THE P1305 METABOLIC SYNDROME IN A MEDITERRANEAN POPULATION G Mombelli, A Zanaboni, S Gaito, C Sirtori (Milan, Italy) 192 CIRCULATING ADIPOCYTE-FATTY ACID BINDING PROTEIN LEVELS ARE P1306 CONTRIBUTED BY SUBCUTANEOUS FAT AREA BUT NOT INTRA-ABDOMINAL FAT AREA IN JAPANESE POPULATION K Nakaya, M Ayaori, M Ogura, H Kondo, S Takiguchi, E Yakushiji, Y Terao, M Sasaki, K Ikewaki (Tokorozawa, Japan) 193 L-ARGININE DOES NOT IMPROVE ENDOTHELIAL FUNCTION IN PATIENTS P1307 WITH METABOLIC SYNDROME YIA A Ravani, M Amato, S Castelnuovo, B Frigerio, V Cavalca, P Werba, I Squellerio, E Tremoli, D Baldassarre (Milan, Italy) 194 EZETIMIBE/SIMVASTATIN (E/S) VS ATORVASTATIN (A) IN PATIENTS WITH P1308 HYPERCHOLESTEROLEMIA (HC) AND METABOLIC SYNDROME (MetS) GROUPED BY PRESENCE OF ATHEROSCLEROTIC VASCULAR DISEASE (AVD) J Robinson, C Ballantyne, S Grundy, W Hsueh, H Parving, J Rosen, A Shah, M Hanson, J Tomassini, A Tershakovec (Iowa City, IA, USA, Houston, TX, USA, Dallas, TX, USA, Copenhagen, Denmark, Coral Gables, FL, USA and Upper Gwynedd, PA, USA) 195 CARDIO-METABOLIC RISK FACTORS OF SUBCLINICAL HYPOTHYROIDISM IN P1309 WOMAN WITH METABOLIC SYNDROME V Romanov, O Mitchenko, A Logvinenko, I Chulaevskaya (Kiev, Ukraine) 196 METABOLIC SYNDROME AND VASCULAR EVENTS IN GERIATRIC CORONARY P1310 PATIENTS YIA S Aczel, C Saely, H Drexel (Feldkirch, Austria and Triesen, Liechtenstein) 197 THE METABOLIC SYNDROME, ANGIOGRAPHICALLY DETERMINED STABLE P1311 CORONARY ARTERY DISEASE, AND SUBCLINICAL INFLAMMATION YIA S Beer, P Rein, C Saely, A Vonbank, H Drexel (Feldkirch, Austria and Triesen, Liechtenstein) 198 METABOLIC SYNDROME PREVALENCE AMONG ADOLESCENTS ACCORDING P1312 TO 3 PEDIATRIC DEFINITIONS YIA S Schoppen, P Riestra, L López-Simón, H Ortega, C Garces (Madrid, Spain) 199 THE METABOLIC SYNDROME ACCORDING TO THE NEW IDF DEFINITION IN P1313 GERMAN AND IRANIAN YOUTH P Schwandt, R Kelishadi, G Haas, E Liepold (Muenchen, Germany and Isfahan, Islamic Republic of Iran) 200 ROLE OF HYPERINSULINEMIA IN THE DEVELOPMENT OF CARDIOVASCULAR P1314 DISORDERS IN PATIENTS WITH METABOLIC SYNDROME N Srojidinova (Tashkent, Uzbekistan) 201 ASSOCIATION OF METABOLIC SYNDROME AND CARDIOVASCULAR DISEASE P1315 J Suwa, S Hiramatsu (Tokyo, Japan) 202 INFLAMMATORY STATUS IN METABOLIC SYNDROME AND CENTRAL P1316 OBESITY TS Tengku Ismail, N Sayyedah, R Taib, K Yusoff, M Osman, S Muid, H Nawawi (Shah Alam, Malaysia) 203 METABOLIC SYNDROME AND CARDIOVASCULAR MORTALITY IN FRAIL P1317 ELDERLY PEOPLE O Vasovic (Belgrade, Serbia)

YIA - Young Investigators Award Nominee 160 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 204 LIPID RATIOS AND RISK FOR METABOLIC SYNDROME P1318 D Vaz, G Rocha, I Palma, F Borges, J Oliveira (Oporto, Portugal) 205 INSULIN RESISTANCE IN NON-DIABETIC SUBJECTS PREDICTS CORONARY P1319 ARTERY DISEASE OR CORONARY ARTERY DISEASE EQUIVALENCE B Bale, A Doneen, D Feng (Lubbock, TX, USA and Spokane, WA, USA) 206 REDUCING CARDIOMETABOLIC RISK IN DIABETES: WAIST CIRCUMFERENCE, P1320 ITS ASSOCIATION WITH MARKERS OF COAGULATION AND INFLAMMATION AMONG DIABETIC WOMEN IN SERBIA Z Burazor, I Burazor, M Pesic, M Burazor, N Burazor (Nis, Serbia) 207 STUDY OF DYSLIPAEDEMIC PROFILE IN TYPE 2 DIABETES PATIENTS WITH P1321 INSULIN RESISTANCE YIA S Chichilli (Sai Nagara, Anantapur, India) 208 ASSOCIATION OF FTO WITH ANTHROPOMETRIC AND BIOCHEMICAL P1322 VARIABLES IN THE MEDITERRANEAN POPULATION AND ITS MODULATION BY PHYSICAL ACTIVITY P Carrasco, J Sorli, C Ortega-Azorin, O Coltell, O Portoles, D Corella (Valencia, Spain and Castellon, Spain) 209 EFFECT OF METFORMIN ON LIPOPROTEIN PARTICLE CONCENTRATION IN P1323 PEDIATRIC PATIENTS WITH OBESITY AND DYSLIPIDEMIA T Dall, M Vasudevan, C Ballantyne (Delafield, WI, USA and Houston, TX, USA) 210 FRAMINGHAM RISK SCORING UNDERESTIMATES CARDIOVASCULAR RISK P1324 ASSOCIATED WITH INSULIN RESISTANCE A Doneen, B Bale, D Feng (Spokane, WA, USA and Lubbock, TX, USA) 211 COMPARASION OF FASTING GLUCOSE TEST AND GLUCOSE TOLERANCE P1325 TEST IN DIABETES DIAGNOSE IN A BRAZILIAN POPULATION A Faludi, D Araujo, H Zatz, E Faludi, A Tome, Y Nakamura, R Souza, M Bertolami (São Paulo, Brazil, and São Jose Rio Preto, Brazil) 212 THE EFFECTS OF PIOGLITAZONE ON POSTPRANDIAL CENTRAL BLOOD P1326 PRESSURE REGULATION IN TYPE 2 DIABETES J-I Funada, Y Takata, N Morioka, H Hashida, H Okayama, T Iwata (Toon, Japan) 213 COMPARISON OF LIPID, METABOLIC PROFILE AND NUTRITIONAL INTAKE P1327 PATTERN BETWEEN THOSE WITH AND WITHOUT INTESTINAL OBESITY WITH NORMAL BMI ~SAPPORO LIFE-STYLE STUDY~ N Kishimoto, I Sakuma, K Okita, A Kawaguchi (Hokkaido, Japan, Sapporo, Japan and Ebetsu, Japan) 214 EVALUATION OF RENAL FUNCTION AND PROTEINURIA BASED ON MASS P1328 HEALTH EXAMINATIONS IN YOUNG JAPANESE OBESE ADULTS K Matsushita, G Yasuda, M Shouda (Yokohama, Japan) 215 LEPTIN, GLUCOSE METABOLISM AND CHRONIC MILD ALCOHOL INTAKE IN P1329 PATIENTS WITH CORONARY HEART DISEASE O Mayer, Jr., J Simon, J Hrbkova (Plzen, Czech Republic) 216 BIOAVAILABILITY OF 51Cr FROM PHARMACEUTICAL CHROMIUM P1330 COMPOUNDS IN RATS P Nielsen, K Kottwitz, N Laschinsky, G Coxilha, N Friedrich, R Fischer (Hamburg, Germany)

217 STRONG ASSOCIATION BETWEEN PERIODONTAL DISEASE AND OBESITY P1331 Wednesday, June 17 AMONG BRAZILIANS Poster Sessions L Nucci da Silva, C Gun, J Simone (São Paulo, Brazil) 218 NON-OBESE PERSONS: OUT OF WEIGHT RISK? P1332 LM Perez Perez (Havana, Cuba)

YIA - Young Investigators Award Nominee 161 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 219 PRE-OBESITY, IN PATIENTS WITH DM TYPE 2, IS A RISK FACTOR FOR P1333 HYPERINSULINISM LM Perez Perez (Havana, Cuba) 220 CORRELATION BETWEEN ADIPONECTIN-LEPTIN RATIO, ADIPOKINES P1334 AND INSULIN RESISTANCE IN PATIENTS WITH TYPE 2 DIABETES AND PREDIABETES S Popa, R Dinu, C Stanciulescu, E Mota, M Mota (Craiova, Romania) 221 SERUM LEVELS OF HUMAN ANGPTL4 IN A NORMAL FINNISH POPULATION P1335 SAMPLE ARE ASSOCIATED WITH SERUM GLUCOSE AND METABOLIC RATE YIA M Robciuc, M Jauhiainen, C Ehnholm (Helsinki, Finland) 222 THE INCIDENCE OF OBESITY AND OTHERS CARDIOVASCULAR RISK P1336 FACTORS ASSOCIATED AT THE MOROCCAN POPULATION R Saïle, F Essiarab, J Jarir, H Taki, N Ghalim (Casablanca, Morocco) 223 PREVALENCE OF IMPAIRED GLUCOSE METABOLISM IN INDIVIDUALS WITH P1337 PERIPHERAL ARTERIAL DISEASE YIA P Rein, S Beer, C Saely, A Vonbank, H Drexel (Feldkirch, Austria and Triesen, Liechtenstein) 224 IMPAIRED GLUCOSE TOLERANCE STRONGLY AND SIGNIFICANTLY P1338 INCREASES THE RISK OF FUTURE VASCULAR EVENTS AMONG ANGIOGRAPHIED CORONARY PATIENTS C Saely, H Sourij, C Saely, H Jahnel, R Zweiker, G Hoefle, T Wascher, H Drexel (Graz, Austria, Feldkirch, Austria and Triesen, Liechtenstein) 225 BODY MASS INDEX AND WAIST CIRCUMFERENCE AS PREDICTORS OF THE P1339 INCIDENCE OF TYPE 2 DIABETES AMONG ANGIOGRAPHIED CORONARY YIA PATIENTS C Saely, S Beer, P Rein, A Vonbank, S Aczel, T Marte, H Drexel (Feldkirch, Austria and Triesen, Liechtenstein) 226 LIFESTYLE AND INSULIN RESISTANCE IN YOUTH: THE PEP FAMILY HEART P1340 STUDY P Schwandt, T Bertsch, G Haas (Munich, Germany and Nürnberg, Germany) 227 EVALUATION OF SERUM LEPTIN IN HEALTHY SUBJECTS P1341 I Silosi (Craiova, Romania) YIA 228 INCREASED RISK OF TYPE 2 DIABETES WITH NAPPING: THE GUANGZHOU P1342 BIOBANK COHORT STUDY (GBCS) K-BH Lam, CQ Jiang, G Thomas, T Arora, WS Zhang, S Taheri, P Adab, TH Lam, KK Cheng (Birmingham, UK, Guangzhou, China and Hong Kong, China) 229 THE OPTIMAL CUTOFFS OF ANTHROPOMETRIC FACTORS FOR P1343 HYPERGLYCEMIA, HYPERTENSION AND DYSLIPIDEMIA FOR TAIWANESE POPULATION C-H Tseng, C-K Chong, C-J Chen (Taipei, Taiwan and Taoyuan, Taiwan) 230 CARDIOVASCULAR RISK MARKERS IN GYPSY POPULATION OF SLOVAKIA P1344 M Valachovicova, M Krajcovicova- Kudlackova, V Spustova, P Blazicek, A Madaric, E YIA Ginter (Bratislava, Slovak Republic) 231 ADIPONECTIN-MEDIATED ROLE OF ROSIGLITAZONE IN IMPROVING INSULIN P1345 RESISTANCE FOR OVARIECTOMIZED FEMALE SPRAGUE-DAWLEY RATS G Long, B Hu, G Wang, L Yang (Chongqing, China and Hengyang, China)

YIA - Young Investigators Award Nominee 162 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 232 CHANGES OF SERUM LEVELS OF TOTAL AND HIGH MOLECULAR P1346 ADIPONECTINS IN PRETERM INFANTS DURING GROWTH AFTER PRETERM BIRTH T Yoshida, H Nagasaki, Y Asato, K Takata, T Ohta (Okinawa, Japan and Hiroshima-City, Japan) 233 LIPID DISORDERS AND OTHER RISK FACTORS IN ELDERLY MEN OF TALLINN, P1347 (2002-2004) J Abina, M Saava, P Laane, L Tchaiko (Tallinn, Estonia) 234 RISK FACTORS AND CUTANEOUS MARKERS OF CORONARY ARTERY DISEASE P1348 IN YOUNG IN NORTH INDIAN POPULATION YIA S Dwivedi, A Aggarwal (Delhi, India) 235 DIFFERENCES IN APOLIPOPROTEIN LEVELS IN RACIAL/ETHNIC GROUPS. AN P1349 ANALYSIS FROM PROVE IT-TIMI 22 A Armani, J Qin, C Cannon, TIMI Study Group (Boston, MA, USA) 236 OVEREXPRESSION OF MYELOPEROXIDASE IN CHILDREN WITH P1350 HYPERCHOLESTEROLEMIA S Basili, P Pignatelli, L Loffredo, F Martino, R Carnevale, F Violi (Rome, Italy) 237 FRUIT AND VEGETABLE INTAKE IS ASSOCIATED WITH CORONARY HEART P1351 DISEASE RISK AND INFLAMMATION IN OLDER PUERTO RICANS YIA S Bhupathiraju, K Tucker, P Bakun (Boston, MA, USA) 238 BIRTHWEIGHT AND OBESITY IN CHILDHOOD P1352 H Bilianou, C Festeridou, S Makrygiannis, C Voyatzidis, C Ritsatos, G Fountakis, N Tellis, E Adamopoulou, S Foussas (Pireas, Greece and Heraklion, Greece) 239 BIRTH YEAR AND THE PREVALENCE OF CARDIOVASCULAR DISEASE P1353 K Cruickshanks, W Zhan, D Nondahl, B Klein, R Klein, F Nieto, J Pankow (Madison, WI, USA and Minneapolis, MN, USA) 240 THE IMPACT OF LIPID LOWERING TREATMENT ON THE NATURAL HISTORY P1354 OF FAMILIAL HYPERCHOLESTEROLEMIA IN CHILDREN AND ADOLESCENTS OVER THE LAST 30 YEARS A Elis, A Evan (Kfara-Saba, Israel and Cincinnati, OH, USA) 241 EARLY ATHEROSCLEROSIS SIGNAL IN CHILDHOOD AND ADOLESCENTS IN P1355 HAVANA, CUBA J Fernandez-Britto, M Ferrer, A Armisen (Havana, Cuba) 242 CORONARY RISK FACTOR PROFILE AND PROGNOSTIC FACTORS FOR YOUNG P1356 JAPANESE PATIENTS UNDERGOING CORONARY REVASCULARIZATION Y Furukawa, N Ehara, T Kita, T Kimura (Kobe, Japan and Kyoto, Japan) 243 CHRONIC HELICOBACTER PYLORI INFECTION AFFECTS LIPID METABOLISM P1357 BY ELEVATING LDL AND SMALL DENSE LDL (SD-LDL-C): A KYUSHU OKINAWA POPULATION STUSY (KOPS) N Furusyo, T Koga, M Ai, S Otokozawa, H Mukae, S Maeda, Y Sawayama, B Asztalos, E Schaefer, J Hayashi (Fukuoka, Japan and Boston, MA, USA) 244 IS INSULIN RESISTANCE IN ADOLESCENTS AFFECTED BY AGE AND GENDER? P1358 G Haas, T Bertsch, P Schwandt (Muenchen, Germany and Nuernberg, Germany) 245 CVD RISK FACTORS AND LIFESTYLE IN TURKISH MIGRANTS AND RESIDENTS P1359 IN NUREMBERG AND ISTANBUL: THE PEP FAMILY HEART STUDY

G Haas, A Onat, M Agirbasli, P Schwandt (Muenchen, Germany and Istanbul, Turkey) Wednesday, June 17 Poster Sessions 246 RISK FACTOR PROFILE FOR MYOCARDIAL INFARCTION IN PATIENTS UNDER P1360 45 YEARS N Antonijevic, M Kocica, B Jakovljevic, A Beletic, V Kanjuh (Belgrade, Serbia)

YIA - Young Investigators Award Nominee 163 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 247 SMALL DENSE LDL CHOLESTEROL LEVELS PREDICT SUBCLINICAL P1361 ATHEROSCLEROSIS IN A JAPANESE POPULATION: A KYUSHU OKINAWA POPULATION STUDY (KOPS) T Koga, N Furusyo, M Ai, S Otokozawa, H Mukae, H Ohnishi, S Maeda, Y Sawayama, B Asztalos, E Schaefer, J Hayashi (Fukuoka, Japan and Boston, MA, USA) 248 AN IMPACT OF CAROTID ULTRASONIC PLAQUE NUMBER (PN) ON VASCULAR P1362 MORTALITY IN CHRONIC KIDNEY DISEASE (CKD): A KYUSHU OKINAWA POPULATION STUDY (KOPS) S Maeda, N Furusyo, T Koga, H Ohnishi, H Mukae, Y Sawayama, J Hayashi (Fukuoka, Japan) 249 HORTON’S GIANT CELL ARTERITIS: REVIEW OF 11 CASES P1363 D Mesloub, D Hakem, M Boucelma, N Ouadahi, A Berrah, N Djenane (Algiers City, YIA Algeria) 250 PATIENTS WITH PREMATURE CARDIOVASCULAR DISEASE HAVE A LESS P1364 WELL PROTECTED VASCULATURE DUE TO A DIMINISHED GLYCOCALYX YIA VOLUME, AS COMPARED TO HEALTHY CONTROLS T Mulders, M Avesaat, J Teeffelen, H Vink, S Pinto-Sietsma (Maastricht, The Netherlands and Amsterdam, The Netherlands) 251 A POSITIVE FAMILY HISTORY FOR CARDIOVASCULAR DISEASE IDENTIFIES P1365 PATIENTS PRONE TO DEVELOP RECURRENT ARTERIAL THROMBOTIC EVENTS T Mulders, L Maurissen, Z Meyer, M Hameeteman, C van der Donk, A Kroon, I Ferreira, C Stehouwer, T Hackeng, S-J Pinto-Sietsma (Maastricht, The Netherlands and Amsterdam, The Netherlands) 252 WILD SCREENING FOR HIGH PLASMA CHOLESTEROL IN PUBLIC AREAS P1366 K Retterstøl, C Alm (Oslo, Norway) 253 ARE RISK FACTORS FOR CHD AND ISCHEMIC STROKE SIMILAR? DUBBO P1367 STUDY OF SENIOR AUSTRALIANS L Simons, J Simons, Y Friedlander, J McCallum (Sydney, Australia, Jerusalem, Israel and Melbourne, Australia) 254 PLASMATIC LEVELS OF APOLIPOPROTEINS IN A LOW RISK POPULATION. P1368 INFLUENCE OF AGE, GENDER AND BODY MASS INDEX P Sorroche, D Siniawski, W Masson, L Casañas, W Scordo (Buenos Aires, Argentina) 255 LIPID TETRAD AND LIPID PENTAD INDEX IN EVALUATION OF LIPID RISK P1369 PROFILE IN SCHOOLCHILDREN FROM SERBIA S Spasic, N Bogavac-Stanojevic, J Kotur-Stevuljevic, N Spasic (Belgrade, Serbia) 256 RISK OF DEVELOPMENT CARDIOVASCULAR DISEASES IN CZECH FORCES P1370 H Stritecka, P Hlubik (Hradec Kralove, Czech Republic) YIA 257 DIFFERENCES IN RISK FACTORS ACCORDING TO FAMILY HISTORY OF P1371 CARDIOVASCULAR DISEASE IN 40 YEARS OLD SLOVAK POPULATION B Vohnout, J Gasparovic, L Fabryova, S Wsolova, K Raslova (Bratislava, Slovak Republic) 258 MUTATIONS IN HFE CAUSING HEMOCHROMATOSIS ARE ASSOCIATED WITH P1372 PRIMARY HYPERTRIGLYCERIDEMIA M Solanas, R Mateo-Gallego, P Calmarza, E Jarauta, A Bea, F Civeira (Zaragoza, Spain)

YIA - Young Investigators Award Nominee 164 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 22 GENETICS

Poster Board No. Publication No. 259 LIPOPROTEIN LIPASE DEFICIENCY: NOVEL MUTATIONS IN AN INDIAN INFANT P1373 S Nampoothiri, V Sunitha, A Schwentek, M Hoffmann (Cochin, India and Freiburg, Germany) 260 THE EFFECT OF LPL PVUII POLYMORPHISM ON THE PREVALENCE OF KOREA P1374 METABOLIC SYNDROME E Shin, H Oh, M Park, K Kim, S Park, S Kim, M Lee (Seongbuk-gu, Korea, Songdo-dong, Yeonsu-ku, Korea and Samsung-dong,Gangnam-gu, Korea) 261 OXIDATIVE DAMAGE OF MITOCHONDRIAL DNA IN LEUKOCYTES IS P1375 ASSOCIATED WITH PROGRESSION OF METABOLIC SYNDROME YIA H-M Lin, T-T Lin, C-L Kuo, C-S Liu (Changhua, Taiwan) 262 A LOW MITOCHONDRIAL DNA COPY NUMBER OF LEUKOCYTES ARE P1376 ASSOCIATED WITH PROGRESSION OF METABOLIC SYNDROME C-S Liu, W-L Cheng, C-S Huang, H-M Lin (Changhua, Taiwan) 263 Arg16Gly OF THE b2-ADRENOCEPTOR POLYMORPHISM PREDICTS THE ONSET P1377 OF DYSLIPIDEMIA THROUGH INSULIN RESISTANCE (IR) IN NORMOTENSIVE MEN K Masuo, H Rakugi, T Ogihara, M Tuck (Melbourne, Australia, Suita, Japan and Sepulveda, CA, USA) 264 SERUM APOLIPOPROTEIN B-48 LEVEL IS CORRELATED WITH CAROTID P1378 INTIMA-MEDIA THICKNESS (IMT) IN SUBJECTS WITH NORMAL SERUM TRIGLYCERIDE LEVEL K Nakatani, T Sugimoto, M Inagaki, K Tsubakio-Yamamoto, D Masuda, T Ohama, Y Nakagawa-Toyama, M Nishida, M Ishigami, S Yamashita (Suita, Japan, Osaka, Japan and Toyonaka, Japan) 265 HYPERTRIGLYCERIDEMIA/HYPERACIDEMIA: A CAUSE AND CONSEQUENCE P1379 OF HYPERINSULINISM/INSULIN RESISTANCE LM Perez Perez (Havana, Cuba) 266 ARTERIAL STIFFNESS IS INDEPENDENTLY ASSOCIATED WITH INTERLEUKIN- P1380 18 AND COMPONENTS OF THE METABOLIC SYNDROME M Trøseid, T Weiss, I Seljeflot, H Arnesen (Oslo, Norway) 267 IDENTIFICATION OF COMPOUND HETEROZYGOUS DEFICIENCY WITH A P1381 NOVEL LARGE DELETION AND Y61X OF THE LIPOPROTEIN LIPASE GENE IN THE JAPANESE SUBJECT A Takagi, M Nagano, T Iwanaga, N Ito, H Hattori, T Egashira, Y Ikeda (Suita, Japan and Saitama, Japan) Wednesday, June 17 Poster Sessions

YIA - Young Investigators Award Nominee 165 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 23 IMAGING OF CARDIOVASCULAR DISEASE

Poster Board No. Publication No. 268 ABSENCE OF CORONARY ARTERY CALFICATION IS ASSOCIATED WITH LOW P1382 PREVALENCE OF CORONARY LUMINAL OBSTRUCTION EVALUATED BY YIA COMPUTER TOMOGRAPHY ANGIOGRAPHY E Faludi, M Atanazio, L Mangili, M Miname, A Marte, R Moraes, C Rochitte, R Santos (São Paulo, Brazil) 269 TU CORAZÓN Y MI PASIÓN P1383 M Hernandez-Leveille, J Osborne (Arlington, TX, USA) 270 VASCULAR RISK FACTORS AND PREVALENCE OF CEREBRAL ARTERY P1384 CALCIFICATION IN PATIENTS WITH ACUTE ISCHEMIC STROKE K-Y Park (Seoul, Korea) 271 CORONARY OBSTRUCTIONS IN ASYMPTOMATIC FAMILIAL P1385 HYPERCHOLESTEROLEMIA SUBJECTS ARE RELATED TO ACHILLES TENDON YIA XANTHOMAS AND CORONARY CALCIFICATION M Miname, L Martinez, J Parga, F Ávila, W Salgado, A Chacra, C Rochitte, R Santos (São Paulo, Brazil) 272 LOWERING OF HbAIc IS ASSOCIATED WITH LESS PROGRESSION OF P1386 CORONARY ATHEROSCLEROSIS O Bayturan, M Shao, A Lavoie, K Wolski, P Schoenhagen, S Kapadia, E Tuzcu, S Nissen, S Nicholls (Cleveland, OH, USA) 273 INCREASED ATHEROSCLEROTIC PLAQUE BURDEN IN ANGIOGRAPHICALLY P1387 NEAR-NORMAL CORONARY SEGMENTS IN PATIENTS WITH SIGNIFICANT CORONARY ARTERY DISEASE T Higashikata, T Kaneda, H Kato, K Ueda (Komatsu, Japan) 274 FREQUENCY OF A NEWLY FORMED YELLOW NEOINTIMA AFTER SIROLIMUS- P1388 ELUTING STENT IMPLANTATION. ANGIOSCOPIC FINDINGS H Kawakami, A Oshita, T Kono, S Shigemi, H Matsuoka (Imabari, Japan)

YIA - Young Investigators Award Nominee 166 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 24 LIPOPROTEIN METABOLISM

Poster Board No. Publication No. 275 TIP47 IS INVOLVED IN MACROPHAGE FOAM CELL FORMATION P1389 I Buers, O Hofnagel, S Lorkowski, H Robenek (Muenster, Germany and Jena, Germany) YIA 276 DESIGN OF THE DEFINE TRIAL: DETERMINING THE EFFICACY AND P1390 TOLERABILITY OF CETP INHIBITION WITH ANACETRAPIB C Cannon, H Dansky, M Davidson, A Gotto, E Brinton, A Gould, M Stepanavage, S Liu, S Shah, J Rubino, P Gibbons, A Hermanowski-Vosatka, B Binkowitz, Y Mitchel, P Barter (Boston, MA, USA, Rahway, NJ, USA, Chicago, IL, USA, New York, NY, USA, Salt Lake City, UT, USA and Sydney, Australia) 277 INTER- AND INTRA-PARTICLE HETEROGENEITY IN APOA-I/ P1391 PHOSPHATIDYLCHOLINE/CHOLESTERYL ESTER COMPLEXES DETERMINES CETP ACTIVITY A Dergunov, G Dobretsov (Moscow, Russian Federation) 278 EFFECTS OF THE CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR P1392 ANACETRAPIB ON LIPOPROTEIN SUBFRACTIONS R Krauss, K Wojnoonski, JC Geaney, R Kimberlin, A Johnson-Levonas, J Luk, R Krishna, J Wagner, M Anderson (Oakland, CA, USA, Evansville, IN, USA and Rahway, NJ, USA) 279 ANTHOCYANIN SUPPLEMENTATION IMPROVES THE SERUM LDL-C AND HDL- P1393 C LEVELS ASSOCIATED WITH CETP INHIBITION IN DYSLIPIDEMIC SUBJECTS W Ling, M Xia, Y Yang (Guangzhou, China) 280 SIMULTANEOUS TRANSFER OF LIPIDS TO HDL IN CHILDREN, ADOLESCENTS P1394 AND YOUNG ADULTS J Oba, R Maranhao (São Paulo, Brazil) 281 EFFECT OF CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) DEFICIENCY P1395 ON HDL COMPOSITION AND FUNCTION YIA P McPherson, I Young, P Nicholls, C McMaster, J McEneny (Belfast, UK) 282 REGULATION OF CHOLESTERYL ESTER TRANSFER PROTEIN EXPRESSION P1396 BY NATURAL AND SYNTHETIC LIGANDS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS H Raposo, P Patricio, H Oliveira (Campinas, Brazil) 283 CHOLESTEROL ESTER, FREE CHOLESTEROL, TRIGLYCERIDE AND P1397 PHOSFOLIPID TRANSFERRING TO THE HDL PARTICLE IN FAMILIAL HYPERCHOLESTEROLEMIA L Martinez, R Santos, M Miname, L Bortoloto, R Maranhão (São Paulo, Brazil) 284 EFFECT OF CITRUS LIMON BURM F. ON LDL AND OX-LDL AFFINITY TO THEIR P1398 RECEPTORS IN RABBITS WITH ATHEROGENIC DIET M Boshtam, G Naderi, J Moshtaghian (Isfahan, Islamic Republic of Iran) 285 Withdrawn P1399 Wednesday, June 17

286 CHARACTERIZATION OF THE LOW DENSITY LIPOPROTEIN RECEPTOR P1400 Poster Sessions GENE (LDLR) MUTATIONS IN GREEK FAMILIES WITH FAMILIAL YIA HYPERCHOLESTEROLEMIA (FH) V Mollaki, N Mavroidis, E Laios, E Koniari, A Nikola, E Tsoutsou, A Skouma, E Drogari (Athens, Greece)

YIA - Young Investigators Award Nominee 167 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 287 INTRACELLULAR PROCESSING AND ORGANIZATION OF RECEPTOR P1401 COMPLEX AMONGST LDL RECEPTOR, INSULIN RECEPTOR AND RAP YIA G Ramakrishnan, N Chandra (New Delhi, India) 288 ROLE OF PPAR-g IN THE MODULATION OF CD36 AND FcgRII INDUCED BY P1402 MODIFIED LDL DURING THE DIFFERENTIATION OF THE MONOCYTIC THP-1 YIA CELLS F Rios, S Jancar, I Melo, M Gidlund (São Paulo, Brazil)

YIA - Young Investigators Award Nominee 168 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 25 NUTRITION AND LIFESTYLE

Poster Board No. Publication No. 289 THE EFFECT OF BENIFUKI GREEN TEA ON LDL OXIDIZATION P1403 K Murakami, Y Kishimoto, M Iizuka, E Saita, K Suzuki, M Toyozaki, M Nagai, N Sugihara, K Takenaka, C Taguchi, T Kido, M Tani, K Kondo (Tokyo, Japan) 290 A ROLE OF ION CHANNELS IN RELAXATION OF RAT MESENTERIC ARTERY P1404 INDUCED BY RESVERATROL YIA A Novakovic, L Gojkovic Bukarica, V Kanjuh (Belgrade, Serbia) 291 ASSOCIATION OF ANTIOXIDANT FOOD AND BEVERAGE INTAKES WITH P1405 CORONARY ARTERY DISEASE IN JAPANESE PATIENTS R Ohmori, Y Momiyama, R Kato, H Taniguchi, F Ohsuzu (Utsunomiya, Japan, Tokyo, Japan and Saitama, Japan) 292 EFFECT OF COFFEE ON FLOW-MEDIATED VASODILATATION OF THE P1406 BRACHIAL ARTERY M Toyozaki, Y Kishimoto, M Iizuka, E Saita, K Suzuki, M Nagai, K Murakami, N Sugihara, K Takenaka, T Kido, C Taguchi, M Tani, K Kondo (Tokyo, Japan) 293 COFFEE INTAKE ENHANCES HDL-MEDIATED CHOLESTEROL EFFLUX FROM P1407 MACROPHAGES YIA H Uto-Kondo, M Ayaori, M Ogura, K Nakaya, S Takiguchi, E Yakushiji, Y Terao, M Sasaki, F Ohsuzu, K Ikewaki (Tokorozawa, Japan) 294 IMPACTS OF FEEDING BEHAVIOR IN CARDIOVASCULAR RISK ACCORDING TO P1408 CENTRAL OBESITY I Pimentel, C Gracia, C Silva, R Costa, L Piegas (São Paulo, Brazil) 295 THE EFFECT OF THREE DIETARY INTERVENTIONS ON PAI-1 AMONG P1409 METABOLIC SYNDROME SUBJECTS J Reid, R Mukhtar, H Fishlock, G Taylor, J Reckless (Bath, UK, Bristol, UK and Solihull, UK) 296 EFFECT OF WEIGHT REDUCTION WITH NON-PHARMACOLOGICAL P1410 TREATMENT IN METABOLIC AND INFLAMATORY BIOMARKERS ASSOCIATED TO ATHEROSCLEROTIC DISEASE R Santos, J Freitas, M Macedo, I Rebelo (Porto, Portugal) 297 DIETARY PULSES IMPROVE GLYCEMIC CONTROL: A META-ANALYSIS OF P1411 RANDOMIZED CONTROLLED EXPERIMENTAL TRIALS YIA J Sievenpiper, C Kendall, A Esfahani, J Wong, A Carleton, R Bazinet, D Jenkins (Toronto, ON, Canada) 298 L-CARNITINE INHIBITS CYCLIC STRAIN-INDUCED ENDOTHELIN-1 P1412 EXPRESSION THROUGH A PROSTACYCLIN-MEDIATED PATHWAY WITHIN VASCULAR ENDOTHELIAL CELLS J-C Liu, H-H Chao, C-H Chen, J-J Chen, T-H Cheng (Taipei, Taiwan and Taichung,

Taiwan) Wednesday, June 17 Poster Sessions 299 LUPIN SEED CONGLUTIN g LOWERS GLUCOSE IN RATS AND INCREASES HEP P1413 G2 CELL GLUCOSE CONSUMPTION M Lovati, C Manzoni, S Castiglioni, M Duranti (Milano, Italy)

YIA - Young Investigators Award Nominee 169 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 300 BETA CASEIN A1 IS A POSSIBLE RISK FACTOR FOR ATHEROSCLEROSIS P1414 A Steinerova, J Racek, M Korotvicka, F Stozicky (Pilsen, Czech Republic) 301 A NEW INSIGHT INTO RESVERATROL AS AN ATHEROPROTECTIVE P1415 COMPOUND: INHIBITION OF LIPID PEROXIDATION AND ENHANCEMENT OF CHOLESTEROL EFFLUX H Berrougui, G Grenier, G Drouin, A Khalil (Sherbrooke, QC, Canada and Beni Mellal, Morocco) 302 OLIVE OIL PHENOLS MODULATE THE EXPRESSION OF METALLOPROTEINASE P1416 9 IN A MONOCYTIC CELL LINE BY ACTING ON NF-kB SIGNALLING M Dell’Agli, R Fagnani, G Galli, O Maschi, F Gilardi, S Bellosta, M Crestani, E Bosisio, E De Fabiani, D Caruso (Milan, Italy) 303 ACUTE PLATELET THROMBUS FORMATION IN STENOSED MONKEY CAROTID P1417 ARTERIES IS INHIBITED BY BOTH ASPIRIN AND PURPLE GRAPE JUICE; RENEWED BY IV EPINEPHRINE AFTER ASPIRIN BUT NOT AFTER ORAL GRAPE JUICE J Folts (Madison, WI, USA) 304 GRAPE FLAVONOIDS, IN Provex CV® DECREASE THE INFLAMMATORY P1418 RESPONSE CAUSED BY SECRETORY PHOSPHOLIPASE A2 ACTIVITY IN RATS F Tsao, B Culver, J Pierre, K Meyer, J Folts (Madison, WI, USA) 305 THE EFFECTS OF SPIRULINA PLATENSIS ON EXPERIMENTAL ATHEROGENESIS P1419 P Nachtigal, M Slanarova, S Micuda, E Brcakova, L Vitek (Hradec Kralove, Czech YIA Republic and Prague, Czech Republic) 306 EVENING PRIMROSE (OENOTHERA PARADOXA) DEFATTED SEED EXTRACT P1420 INHIBIT NEUTRAL ENDOPEPTIDASE (NEP) ACTIVITY IN NEUTROPHILS ISOLATATE FROM HEALTHY SUBJECTS AND FROM PATIENTS WITH AMI A Kiss, K Filipiak, G Opolski, M Naruszewicz (Warsaw, Poland) 307 THE THIRD NATURAL ROAD TO FIGHT HYPERCHOLESTEROLEMIA P1421 R Volpe, R Gavita, MC Grassi, J Pille (Rome, Italy) 308 CARNOSIC ACID & URSOLIC ACID (ORIGANUM MAJORANA L.) PREVENT P1422 ATHEROSCLEROSIS CAUSED BY OBESITY: SUPPRESSION OF LEPTIN- INDUCED PROLIFERATION IN VASCULAR SMOOTH MUSCLE CELLS Y-M Yu, Y-W Tzeng (Tainan, Taiwan and Taichung, Taiwan) 309 INHIBITION ABILITY OF FRUCTOSE MEDIATED APOLIPOPROTEIN A-I P1423 GLYCATION AND COPPER MEDIATED LDL OXIDATION BY CULINARY HERBS AND SPICES SH Jeon, K-H Park, K-H Cho (Gyeongsan, Korea) 310 PYRIDOXINE IMPROVES PLATELET NITRIC OXIDE SYNTHASE DYSFUNCTION P1424 CAUSED BY ADVANCED GLYCATION END PRODUCTS Y Ji (Nanjing, China) 311 ANTI-INFLAMMATORY AND ANTI-OXIDATIVE EFFECTS OF VITAMIN E- P1425 COATED MEMBRANE DIALYZER IN CHRONIC HEMODIALYSIS PATIENTS D Kirmizis, A Papagianni, A-M Belechri, G Efstratiadis, E Alexopoulos, D Memmos (Thessaloniki, Greece) 312 PRO-OXIDANT EFFECTS OF A & G TOCOPHEROL DURING HDL OXIDATION P1426 N Nadeem, J Woodside, I Young, J McEneny (Belfast, UK) 313 EFFECTS OF SWEET POTATO (IPOMOEA BATATAS L.) LEAVES ON LDL P1427 OXIDATION AND ROS PRODUCTION M Nagai, Y Kishimoto, M Iizuka, E Saita, K Suzuki, M Toyozaki, K Murakami, N Sugihara, K Takenaka, C Taguchi, T Kido, M Tani, K Kondo (Tokyo, Japan)

YIA - Young Investigators Award Nominee 170 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Board No. Publication No. 314 ASSOCIATIONS OF SERUM LYCOPENE CONCENTRATION WITH BRACHIAL- P1428 ANKLE PULSE WAVE VELOCITY AND MARKERS OF OXIDATIVE STRESS AND YIA INFLAMMATION JK Paik, HY Yeo, HJ Kim, JY Park, HH Lim, JH Lee, Y Jang, JH Lee (Seoul, Korea) 315 THE ANTIOXIDANT ACTIVITIES OF PERILLA FRUTESCENS AGAINST LDL P1429 OXIDATION IN VITRO AND IN VIVO E Saita, Y Kishimoto, M Iizuka, K Suzuki, M Toyozaki, M Nagai, K Murakami, N Sugihara, K Takenaka, M Tani, K Kondo (Tokyo, Japan) 316 CHITOSAN SELECTIVELY REDUCES n-6 FATTY ACID ABSORPTION AND P1430 DECREASES PLASMA AND LIVER n-6/ n-3 RATIO IN GUINEA PIGS YIA J Santas, M Rafecas (Barcelona, Spain) 317 EFFECTS OF RED BEET ON LDL OXIDATION AND REACTIVE OXYGEN SPECIES P1431 (ROS) PRODUCTION N Sugihara, Y Kishimoto, M Iizuka, E Saita, K Suzuki, M Toyozaki, M Nagai, K Murakami, K Takenaka, M Kamiyama, M Tani, K Kondo (Tokyo, Japan and Nagano, Japan) 318 THE EFFECT OF LYCHEE FRUIT-DERIVED POLYPHENOL ON LDL OXIDATION P1432 AND MATRIX METALLOPROTEINASE ACTIVATION K Suzuki, Y Kishimoto, M Iizuka, E Saita, M Toyozaki, M Nagai, K Murakami, N Sugihara, K Takenaka, K Kitadate, K Wakame, H Kurata, M Tani, K Kondo (Tokyo, Japan and Sapporo, Japan) 319 EFFECT OF THE BROWN SEAWEED HIZIKIA FUSIFORMIS ON POST PRANDIAL P1433 SERUM LIPID RESPONSES IN HEALTHY HUMAN SUBJECTS K Takenaka, Y Kishimoto, M Iizuka, E Saita, K Suzuki, M Toyozaki, M Nagai, K Murakami, N Sugihara, C Taguchi, T Kido, K Yazawa, M Tani, K Kondo (Tokyo, Japan) 320 LYCHEE POLYPHENOL INHIBIT LDL OXIDATION AND ADHESION MOLECULE P1434 EXPRESSION IN HUMAN ENDOTHELIAL CELLS M Tani, Y Hirata, Y Kishimoto, M Iizuka, E Saita, K Suzuki, M Toyozaki, M Nagai, K Murakami, K Takenaka, N Sugihara, C Taguchi, T Kido, K Kitadate, K Wakame, M Yoshida, K Kondo (Tokyo, Japan and Sapparo, Japan) 321 EFFECT OF INCREASED CONSUMPTION OF WHOLEGRAIN FOODS ON P1435 BLOOD PRESSURE IN HEALTHY MIDDLE-AGED PEOPLE: A RANDOMISED CONTROLLED TRIAL P Tighe, N Vaughan, G Duthie, J Brittenden, W Simpson, S Duthie, W Mutch, G Horgan, K Wahle, F Thies (Aberdeen, UK) Wednesday, June 17 Poster Sessions

YIA - Young Investigators Award Nominee 171 WEDNESDAY, JUNE 17, 2009 • POSTER AREA - EXHIBIT HALL C

Poster Viewing: 8:30 AM - 6:15 PM

Poster Discussion: 10:00 AM - 10:30 AM 12:30 PM - 1:30 PM 3:00 PM - 3:30 PM

POSTER SESSION 26 PHARMACOLOGY OF CARDIOVASCULAR DISEASE

Poster Board No. Publication No. 322 EFFECT OF PIOGLITAZONE ON HDL, INSULIN AND ADIPONECTIN P1436 CONCENTRATIONS IN YOUNG WOMEN WITH UNCOMPLICATED SYSTEMIC YIA LUPUS ERYTHEMATOSUS J Juárez, R Posadas, A Medina, N Caracas, G Cardoso, E Mendoza, M Goycochea, L Silveira, C Posadas (Mexico City, Mexico) 323 VARIABLE RESPONSES OF HIGH DENSITY LIPOPROTEIN CHOLESTEROL P1437 LEVELS TO STATIN THERAPY: INITIAL DROPS AND LONG TERM CHANGES IN POOR RESPONDERS S-H Kim, M-K Kim, H-Y Lee, W-Y Chung, J-H Zo, M-A Kim, H-S Kim, C-H Kim, D-W Sohn, B-H Oh, Y-B Park, Y-S Choi (Seongnam and Seoul, Republic of Korea) 324 REVERSE CHOLESTEROL TRANSPORT (RCT) IN HAMSTERS AND IN HUMAN P1438 APOAI EXPRESSING MICE: EFFECT OF DYB186LC J Luchoomun, J Voogt, G Lindwall, S Killion, T Hirst, H Kempen, M Hellerstein, S Turner (Emeryville, CA, USA, Berkeley, CA, USA and Basel, Switzerland) 325 THE HUMAN PARAOXONASE-1 (PON1) PHENOTYPE MODIFIES THE EFFECT OF P1439 STATINS ON PON1 ACTIVITY AND LIPID PARAMETERS G Paragh, H Mirdamadi, M Harangi, F Sztanek, Z Derdak, A Kassai, I Seres (Debrecen, Hungary and Providence, RI, USA) 326 NANSHETENG, A TRADITIONAL CHINESE HERB INCREASES THE LEVEL AND P1440 ANTI-ATHEROSCLEROTIC FUNCTION OF HIGH DENSITY LIPOPROTEIN IN MICE FED WITH HIGH FAT HIGH CHOLESTEROL DIET S Qin, H Sang, Y Zhang, J Wang, X Chen (Taian, China and Philadelphia, PA, USA) 327 EFFECTS OF FIBRATES ON IN VIVO MACROPHAGE-SPECIFIC REVERSE P1441 CHOLESTEROL TRANSPORT IN MICE YIA N Rotllan, L Calpe-Berdiel, F Blanco-Vaca, JC Escolà-Gil (Barcelona, Spain) 328 EFFECT OF PPARd TREATMENT ON PATHWAYS OF REVERSE CHOLESTEROL P1442 TRANSPORT S Turner, J Voogt, J Luchoomun, D Villegas, K Place, A Guo, Y Lu, H Mohammed, S Killion, M Hellerstein (Emeryville, CA, USA and Berkeley, CA, USA) 329 LONG-TERM EFFECT OF COMBINATION EZETIMIBE/SIMVASTATIN + P1443 EXTENDED-RELEASE NIACIN (E/S+N) ON LIPOPROTEIN SUBCLASSES IN PATIENTS WITH HYPERLIPIDEMIA (HL) S Fazio, J Guyton, A Polis, A Adewale, J Tomassini, A Tershakovec (Nashville, TN, USA, Durham, NC, USA and N Wales, PA, USA) 330 ASPIRIN IN ADDITION TO NIACIN PROMOTES A MORE RAPID TOLERANCE TO P1444 FLUSHING R Thakkar, H Punzi, M Davidson, P Jiang, R Padley (Abbott Park, IL, USA, Dallas, TX, USA and Chicago, IL, USA)

YIA - Young Investigators Award Nominee 172 THURSDAY, JUNE 18, 2009

PLENARY SESSION IV AUDITORIUM

Other Lipid Modifying Treatments for Atherosclerosis Chairs: J-C Fruchart (Loos, France), M Krieger (Cambridge, MA, USA), SJ Robins (Framingham, MA, USA), AG Olsson (Bromma, Sweden)

Time Presentation Publication No. 8:00 AM - 8:20 AM TREATMENT STRATEGIES TO ENHANCE REVERSE 1445 CHOLESTEROL TRANSPORT AR Tall (New York, NY, USA) 8:20 AM - 8:30 AM COMMENTARY - J-C Fruchart (Loos, France) 8:30 AM - 8:50 AM THERAPY WITH PPAR AGONISTS: USE IN THE 1446 MANAGEMENT AND PREVENTION OF VASCULAR DISEASE IN DIABETES A Keech (Sydney, Australia) 8:50 AM - 9:00 AM COMMENTARY - SJ Robins (Framingham, MA, USA) 9:00 AM - 9:20 AM OTHER LIPID MODIFYING TREATMENTS FOR 1447 ATHEROSCLEROSIS JJP Kastelein (Amsterdam, The Netherlands) 9:20 AM - 9:30 AM COMMENTARY - AG Olsson (Bromma, Sweden) 9:30 AM - 9:50 AM THERAPIES AFFECTING HDL 1448 Thursday,

PJ Barter (Sydney, Australia) June 18 9:50 AM - 10:00 AM COMMENTARY AND CONCLUSIONS - M Krieger (Cambridge, MA, USA)

*Abstract not available at the time of publication 173 YIA - Young Investigators Award Nominee THURSDAY, JUNE 18, 2009

CLINICAL SYMPOSIUM VII AUDITORIUM

Use of Anion Exchange Resins for Lipid and Diabetes Therapy Chair: WV Brown (Atlanta, GA, USA)

Time Presentation Publication No. 10:30 AM - 10:55 AM RESULTS OF THE LIPID RESEARCH CLINICS PRIMARY 1449 PREVENTION TRIAL WV Brown (Atlanta, GA, USA) 10:55 AM - 11:20 AM USE OF COMBINED LIPID LOWERING AND GLUCOSE 1450 LOWERING THERAPY IN DIABETES MELLITUS HN Ginsberg (New York, NY, USA) 11:20 AM - 11:45 AM USE OF ANION EXCHANGE RESINS FOR COMBINED 1451 LIPID AND GLUCOSE CONTROL RB Goldberg (Miami, FL, USA) 11:45 AM - 12:00 PM CONCLUDING REMARKS - WV Brown (Atlanta, GA, USA)

*Abstract not available at the time of publication 174 YIA - Young Investigators Award Nominee THURSDAY, JUNE 18, 2009

WORKSHOP VII-1 BALLROOM B

Intervention Studies: Therapies to Enhance Reverse Cholesterol Transport Chairs: HB Brewer, Jr. (Washington, DC, USA), NCW Wong (Calgary, AB, Canada)

Time Presentation Publication No. 10:30 AM - 10:45 AM UPDATE ON THE ROLE OF HDL INFUSIONS IN THE 1452 TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASE HB Brewer, Jr. (Washington, DC, USA) 10:45 AM - 11:00 AM RVX-208 A SMALL MOLECULE INCREASES APOA- 1453 I, PRE β-HDL, AND FUNCTIONALITY OF HDL IN HUMANS A Gordon, R Jahagirdar, J Johansson, F Chiacchia, H Hansen, G Wagner, D Bailey, L Krimbou, J Genest, Jr., NCW Wong (San Francisco, CA, USA, Calgary, AB, Canada and Montreal, QC, Canada) 11:00 AM - 11:15 AM Artpep™ INJECTIONS FOR STABILIZATION AND 1454 REDUCTION OF ATHEROSCLEROSIS J Bielicki, H Zhang, J Johansson, S Azhar (Berkeley, CA, USA, Palo Alto, CA, USA and Danville, CA, USA) 11:15 AM - 11:30 AM CHOLESTERYL ESTER TRANSFER PROTEIN 1455 MODULATES LPS-INDUCED TNF-α PRODUCTION AND FORMS A HOST DEFENSE MECHANISM AGAINST SYSTEMIC INFLAMMATION D Ye, R Hildebrand, J Berbee, W de Haan, M Hoekstra, T Thursday, Van Berkel, P Rensen, M Van Eck (Leiden, The Netherlands) June 18 11:30 AM - 11:45 AM Dyb186lc INCREASES PLASMA apoA-I AND PROMOTES 1456 FECAL STEROL EXCRETION IN HUMAN-apoA-I TRANSGENIC MICE I Zanotti, M Pedrelli, H Kempen, L Calabresi, F Bernini (Parma, Italy, Basel, Switzerland and Milan, Italy) 11:45 AM - 12:00 PM MODIFICATION OF APOLIPOPROTEIN A-I BY 1457 MALONDIALDEHYDE, BUT NOT BY AN ARRAY OF OTHER REACTIVE CARBONYLS, BLOCKS CHOLESTEROL EFFLUX BY THE ABCA1 PATHWAY B Shao, M Oda, J Oram, J Heinecke (Seattle, WA, USA and Oakland, CA, USA) 12:00 PM - 12:15 PM THE 5A apoA-I MIMETIC PEPTIDE DISPLAYS ANTI- 1458 INFLAMMATORY AND ANTIOXIDANT PROPERTIES YIA MEDIATED BY ABCA1 F Tabet, A Remaley, P Barter, K-A Rye, G Lambert (Sydney, Australia and Bethesda, MD, USA)

*Abstract not available at the time of publication 175 YIA - Young Investigators Award Nominee THURSDAY, JUNE 18, 2009

WORKSHOP VII-2 BALLROOM A

Pharmacology and Novel Therapies: Novel Therapies Chairs: M Cuchel (Philadelphia, PA, USA), M Abi Fadel (Paris, France)

Time Presentation Publication No. 10:30 AM - 10:45 AM PCSK9, FROM GENE AND VARIANT TO PROTEIN 1459 AND PHENOTYPE: A NEW THERAPEUTIC TARGET IN HYPERCHOLESTEROLEMIA M Abi Fadel, C Boileau (Paris, France, Beirut, Lebanon and Boulogne, France) 10:45 AM - 11:00 AM LOWERING LDL THROUGH MTP INHIBITION 1460 M Cuchel (Philadelphia, PA, USA) 11:00 AM - 11:15 AM RNAi THERAPEUTICS TARGETING PCSK9 ACUTELY 1461 AND DURABLY LOWER CHOLESTEROL FROM MICE TO NON-HUMAN PRIMATES M Frank-Kamenetsky, T Racie, T Zimmerman, A Akinc, J Wong, R Dorkin, A Grefhorst, N Anderson, M Maier, Y Fan, K Charisse, L Nechev, M Manoharan, A deFougerolles, J Horton, V Kotelianski, K Fitzgerald (Cambridge, MA, USA and Dallas, TX, USA) 11:15 AM - 11:30 AM INTRAVENOUS ADMINISTRATION OF 1462 ERYTHROPOIETIN AT THE TIME OF REPERFUSION DOES NOT REDUCE INFARCT SIZE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WHO UNDERWENT PRIMARY PERCUTANEOUS CORONARY INTERVENTION J-W Suh, D-J Choi, W-Y Chung (Seongnam, Republic of Korea) 11:30 AM - 11:45 AM EPROTIROME: A PHYSIOLOGICAL APPROACH TO 1463 LIPID CONTROL UTILIZING A LIVER SELECTIVE THYROID HORMONE RECEPTOR AGONIST B Angelin, P Ladenson, E Ridgway, I Klein, J Baxter, A Olsson, M Eriksson, B Carlsson, J Kristensen (Stockholm, Sweden) 11:45 AM - 12:00 PM ACTIVATION OF THE CONSTITUTIVE ANDROSTANE 1464 RECEPTOR (CAR) DECREASES PLASMA TRIGLYCERIDES AND LDL CHOLESTEROL LEVELS AND REDUCES ATHEROSCLEROTIC LESIONS IN LDL RECEPTOR-DEFICIENT MICE AL Sberna, M Assem, L Lagrost, D Masson (Dijon, France and Iowa City, IA, USA) 12:00 PM - 12:15 PM EFFECT OF RAPID INFUSION OF LCAT ON HDL 1465 METABOLISM AND ITS POSSIBLE UTILITY FOR YIA ENZYME REPLACEMENT THERAPY X Rousset, B Vaisman, J Stonik, C Duarte, A Remaley (Bethesda, MD, USA)

*Abstract not available at the time of publication 176 YIA - Young Investigators Award Nominee THURSDAY, JUNE 18, 2009

WORKSHOP VII-3 BALLROOM C

Epidemiology of Cardiovascular Disease: Lipoprotein Particles and Heart Disease Chairs: P Alaupovic (Oklahoma City, OK, USA), R Krauss (Oakland, CA, USA)

Time Presentation Publication No. 10:30 AM - 10:45 AM COMPARISON OF PLASMA SMALL DENSE LOW- 1466 DENSITY LIPOPROTEIN-CHOLESTEROL LEVELS IN AMERICANS AND JAPANESE IN FRAMINGHAM AND FUKUOKA M Ai, T Koga, N Furusyo, S Otokozawa, B Asztalos, C White, S Demissie-Banjaw, LA Cupples, K Nakajima, J Hayashi, E Schaefer (Boston, MA, USA and Fukuoka, Japan) 10:45 AM - 11:00 AM CONCEPT OF APOLIPOPROTEIN-DEFINED PLASMA 1467 LIPOPROTEINS P Alaupovic (Oklahoma City, OK, USA) 11:00 AM - 11:15 AM A NEW ASPECT OF HDL REMODELING 1468 B Asztalos (Boston, MA, USA) 11:15 AM - 11:30 AM DEVELOPMENT AND CLINICAL SIGNIFICANCE 1469 OF SIMPLE ASSAY FOR SMALL DENSE LDL- CHOLESTEROL T Hirano, S Koba, Y Ito (Tokyo, Japan) 11:30 AM - 11:45 AM SHOULD APOB OR LDL PARTICLE CONCENTRATION 1470 REPLACE STANDARD LIPIDS FOR PRIMARY PREVENTION FOR CVD?

S Mora (Boston, MA, USA) Thursday, June 18 11:45 AM - 12:00 PM GENETIC REGULATION OF ALTERNATIVE SPLICING 1471 OF HMGCOA REDUCTASE IS ASSOCIATED WITH VARIATION IN LDL RESPONSE TO STATIN TREATMENT M Medina, L Mangavite, R Krauss (Oakland, CA, USA) 12:00 PM - 12:15 PM ApoC-III CONTAINING LIPOPROTEINS AND RISK OF 1472 CORONARY HEART DISEASE YIA C Mendivil, E Rimm, J Furtado, S Chiuve, F Sacks (Boston, MA, USA) 12:15 PM - 12:30 PM PCSK9 IN YOUTH 1473 A Baass, G Dubuc, M Lambert, J Davignon (Montreal, QC, YIA Canada)

*Abstract not available at the time of publication 177 YIA - Young Investigators Award Nominee THURSDAY, JUNE 18, 2009

WORKSHOP VII-4 ROOM 302

Genetics: Gene-Environment-Drug Interactions Chairs: H Roche (Dublin, Ireland), JM Ordovas (Boston, MA, USA)

Time Presentation Publication No. 10:30 AM - 10:45 AM THE ANTIPLATELET EFFECT AN ADP-RECEPTOR 1474 ANTAGONIST CLOPIDOGREL IS WEAKER FOR JAPANESE PATIENTS PROBABLY DUE TO FREQUENT CYP2C19 POLYMORPHISM T Kita, T Jinnai, T Makiyama, H Horiuchi, T Kimura (Kobe, Japan and Kyoto, Japan) 10:45 AM - 11:00 AM NUTRIGENOMICS: TOWARDS PERSONALIZATION 1475 OF DIETARY RECOMMENDATIONS FOR CVD PREVENTION JM Ordovas (Boston, MA, USA) 11:00 AM - 11:15 AM DIETARY FATS, INFLAMMATION AND INSULIN 1476 RESISTANCE-INSIGHTS FROM LIPGENE STUDY H Roche, J Ferguson, P Perez-Martinez, J Lovegrove, C Drevon, C Defoort, E Blaak, A Dembinska-Kiec, B Karlström, J López-Miranda (Dublin, Ireland, Cordoba, Spain, Reading, UK, Oslo, Norway, Marseille, France, Maastricht, The Netherlands, Kraków, Poland and Uppsala, Sweden) 11:15 AM - 11:30 AM ADIPONECTIN (ADIPOQ) GENE POLYMORPHISMS 1477 AND ADIPONECTIN LEVELS IN OBESE WITH AND WITHOUT CARDIOMETABOLIC RISK FACTORS P Henneman, R Maaijen, A Fogteloo, K Willems van Dijk, R Frants, A Smelt (Leiden, The Netherlands) 11:30 AM - 11:45 AM ENVIRONMENTAL RISK FACTORS LEADING 1478 TO HYPERTRIGLYCERIDEMIA (HTG) AND ASSOCIATION WITH ISCHEMIC HEART DISEASE (IHD) ON HETEROZYGOUS LIPOPROTEIN LIPASE (LPL) DEFICIENCY IDENTIFIED IN THE GENERAL POPULATION OF JAPANESE: THE SUITA STUDY Y Ikeda, A Takagi, N Iwai, Y Kokubo, H Tomoike (Suita, Japan) 11:45 AM - 12:00 PM POLYMORPHISMS AT BCL7B-TBL2-MLXIPL LOCUS 1479 INTERACT WITH DIETARY UNSATURATED FA TO YIA MODULATE BMI AND LIPIDS Y-C Lee, D Arnett, M Tsai, E Kabagambe, R Straka, M Province, P An, M Garaulet, J Shen, M Junyent, C-Q Lai, L Parnell, I Borecki, J Ordovas (Boston, MA, USA, Birmingham, AL, USA, Minneapolis, MN, USA, St. Louis, MO, USA and Murcia, Spain) 12:00 PM - 12:15 PM INFLUENCE OF ABCA1 PROMOTER HAPLOTYPES ON 1480 A NOVEL R1068H MUTATION YIA R Brace, M Williams, D Sviridov, N Mukhamedova, S McCormick (Dunedin, New Zealand and Melbourne, Australia) 12:15 PM - 12:30 PM COMPUTATIONAL IDENTIFICATION OF HUMAN DIET- 1481 RESPONSIVE GENETIC VARIANTS L Parnell, C-Q Lai, J Ordovas (Boston, MA, USA)

*Abstract not available at the time of publication 178 YIA - Young Investigators Award Nominee THURSDAY, JUNE 18, 2009

WORKSHOP VII-5 ROOM 312

Nutritional Studies: Dietary Constituents Part II Chairs: ML Ricketts (Gainesville, FL, USA), D Grassi (L’Aquila, Italy)

Time Presentation Publication No. 10:30 AM - 10:45 AM NUCLEAR HORMONE RECEPTORS AS MEDIATORS 1482 OF DIETARY CONSTITUENT – INDUCED METABOLIC CHANGES ML Ricketts (Gainesville, FL, USA) 10:45 AM - 11:00 AM FLAVONOIDS, ATHEROSCLEROSIS AND 1483 CARDIOVASCULAR PROTECTION D Grassi (L’Aquila, Italy) 11:00 AM - 11:15 AM DIETARY SALT REDUCTION HAS A BENEFICIAL 1484 EFFECT ON FLOW MEDIATED DILATATION IN HUMAN SUBJECTS J Keogh, K Dickinson, P Clifton (Adelaide, Australia) 11:15 AM - 11:30 AM SELF-REPORTED VITAMIN E SUPPLEMENT USE WAS 1485 POSITIVELY ASSOCIATED WITH ATHEROSCLEROSIS YIA PROGRESSION IN POSTMENOPAUSAL WOMEN WITH ESTABLISHED HEART DISEASE F Imamura, D Herrington, P Jacques, A Lichtenstein (Boston, MA, USA and Winston-Salem, NC, USA) 11:30 AM - 11:45 AM ASTAXANTHIN ADMINISTRATION AMELIORATES 1486 SERUM LIPID AND ADIPONECTIN LEVELS IN

SUBJECTS WITHIN MILD HYPERLIPIDEMIA: Thursday, June 18 A RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED STUDY H Yoshida, H Yanai, K Ito, N Sato, N Tada (Kashiwa, Japan) 11:45 AM - 12:00 PM CONTROLLED CLINICAL STUDY ON A NEW DIETARY 1487 SUPPLEMENT ACTIVE ON CHOLESTEROL AND TRIGLYCERIDES IN CV RISK AND METABOLIC SYNDROME CONTROL B Trimarco, C Benvenuti (Naples, Italy and Monza, Italy) 12:00 PM - 12:15 PM EPIGALLOCATECHIN GALLATE LOWERS 1488 CHOLESTEROL IN THE CHOLESTEROL-FED RABBIT BY UPREGULATING THE LDL RECEPTOR AND INHIBITING CHOLESTEROL SYNTHESIS AT THE LEVEL OF SQUALENE EPOXIDASE N Naumovski, P Roach (Ourimbah, Australia) 12:15 PM - 12:30 PM MAT1A VARIATION ASSOCIATED WITH 1489 HYPERTENSION, STROKE, AND DNA DAMAGE IN THE YIA BOSTON PUERTO RICANS: MODULATION BY PLASMA

VITAMIN B6 AND FOLATE STATUS C-Q Lai, K Tucker, L Parnell, J Shen, D Warodowichit, Y-C Lee, J Crott, J Ordovas (Boston, MA, USA)

*Abstract not available at the time of publication 179 YIA - Young Investigators Award Nominee THURSDAY, JUNE 18, 2009

WORKSHOP VII-6 ROOM 304

Imaging of Atherosclerosis: Quantitative Coronary Angiography and IVUS Chairs: J-C Tardif (Montreal, QC, Canada), CM Ballantyne (Houston, TX, USA)

Time Presentation Publication No. 10:30 AM - 10:45 AM QCA VERSUS IVUS: WHAT ARE THE DIFFERENCES IN *1490 WHAT WE MEASURE AND DON’T MEASURE? CM Ballantyne (Houston, TX, USA) 10:45 AM - 11:00 AM AIM-HIGH: RATIONALE, METHODS AND PROGRESS *1491 OF AN HDL-C-RAISING TRIAL IN HIGH-RISK PATIENTS BG Brown (Seattle, WA, USA) 11:00 AM - 11:15 AM ATHEROSCLEROSIS REGRESSION AND IMAGING 1492 J-C Tardif (Montreal, QC, Canada) 11:15 AM - 11:30 AM FACTORS INFLUENCING PROGRESSION OF 1493 CORONARY ATHEROSCLEROSIS SJ Nicholls (Cleveland, OH, USA) 11:30 AM - 11:45 AM ALBUMINURIA, THE GLOMERULAR FILTRATION 1494 RATE, AND ANGIOGRAPHICALLY DETERMINED YIA CORONARY ATHEROSCLEROSIS P Rein, C Saely, L Risch, U Neyer, A Vonbank, S Beer, H Drexel (Feldkirch, Austria and Triesen, Liechtenstein) 11:45 AM - 12:00 PM ATHEROSCLEROTIC PROGRESSION AND 1495 REMODELING IN ARTERIES WITH MINIMAL YIA ANGIOGRAPHIC DISEASE A Lavoie, O Bayturan, A Hsu, K Wolski, E Tuzcu, S Nissen, S Nicholls (Cleveland, OH, USA) 12:00 PM - 12:15 PM DIFFERENT PATTERNS OF ARTERIAL REMODELING 1496 AND CALCIFICATION ASSOCIATED WITH YIA ATHEROSCLEROSIS IN CORONARY AND PERIPHERAL VASCULAR TERRITORIES P Bishop, K King, T Crowe, O Bayturan, L Feiten, D Brennan, D Clair, V Kashyap, S Nicholls (Cleveland, OH, USA)

*Abstract not available at the time of publication 180 YIA - Young Investigators Award Nominee THURSDAY, JUNE 18, 2009

WORKSHOP VII-7 ROOM 310

Lipoprotein Metabolism: Reverse Cholesterol Transport and HDL Metabolism Chairs: H Greten (Hamburg, Germany), VI Zannis (Boston, MA, USA)

Time Presentation Publication No. 10:30 AM - 10:45 AM CORRECTION OF REDUCED ABCA1 EXPRESSION 1497 FAILS TO CORRECT apoA-I-MEDIATED CHOLESTEROL EFFLUX FROM INTIMAL-TYPE ARTERIAL SMOOTH MUSCLE CELLS G Francis, H Choi, M Rahmani, B McManus, T Chan (Vancouver, BC, Canada) 10:45 AM - 11:00 AM ROLE OF APOLIPOPROTEIN E IN TRIGLYCERIDE 1498 HOMEOSTASIS AND THE BIOGENESIS OF HDL V Zannis, K Drosatos, K Kypreos, A Vezeridis, A Chroni (Boston, MA, USA) 11:00 AM - 11:15 AM ALTERED DISTRIBUTION OF CHOLESTERYL ESTERS 1499 AMONG APOPROTEIN-DEFINED LIPOPROTEIN SUBCLASSES DURING CHOLESTERYL ESTER TRANSFER (CET) IN TYPE 1 DIABETES (T1D) J Bagdade, D Lee, P Alaupovic (Portland, OR, USA and Oklahoma City, OK, USA) 11:15 AM - 11:30 AM TRANSCRIPTIONAL REPRESSION OF THE HUMAN 1500 ATP BINDING CASSETTE TRANSPORTER A1 (ABCA1) GENE BY THE WINGED-HELIX/FORKHEAD TRANSCRIPTION FACTOR FOXA2 Thursday, E Thymiakou, D Kardassis (Heraklion, Greece) June 18

11:30 AM - 11:45 AM P2Y13 ADP-RECEPTOR IS CRITICAL FOR REVERSE 1501 CHOLESTEROL TRANSPORT YIA A Fabre, C Malaval, A Ben Addi, J-M Boeynaems, B Perret, B Robaye, L Martinez (Toulouse, France and Brussels, Belgium) 11:45 AM - 12:00 PM THE EFFECT OF TOTAL BODY ABCG1-DEFICIENCY 1502 ON LESION DEVELOPMENT DEPENDS ON THE STAGE YIA OF ATHEROGENESIS I Meurs, B Lammers, R Out, R Hildebrand, M Hoekstra, T Van Berkel, M Van Eck (Leiden, The Netherlands) 12:00 PM - 12:15 PM GENETIC LOCI SHOW INVERSE EFFECTS ON PLASMA 1503 PHYTOSTEROLS IN MICE YIA R Baber, D Teupser, U Ceglarek, J Breslow, J Thiery (Leipzig, Germany and New York, NY, USA) 12:15 PM - 12:30 PM SCAVENGER RECEPTOR CD36 MEDIATES HEPATIC 1504 UPTAKE OF HDL-ASSOCIATED CHOLESTERYL ESTERS IN MICE M Brundert, J Heeren, M Merkel, R Ramakrishnan, K Moore, F Rinninger (Hamburg, Germany, New York, NY, USA and Boston, MA, USA)

*Abstract not available at the time of publication 181 YIA - Young Investigators Award Nominee THURSDAY, JUNE 18, 2009

WORKSHOP VII-8 ROOM 311

Basic Science and Vascular Biology: Inflammation and Atherosclerosis Chairs: B Lamarche (Quebec, QC, Canada), I Jialal (Davis, CA, USA)

Time Presentation Publication No. 10:30 AM - 10:45 AM THE ROLE OF C-REACTIVE PROTEIN IN 1505 ATHEROTHROMBOSIS I Jialal (Davis, CA, USA) 10:45 AM - 11:00 AM INTRAVASCULAR KINETICS OF C-REACTIVE 1506 PROTEIN AND THEIR RELATIONSHIPS WITH FEATURES OF THE METABOLIC SYNDROME B Lamarche (Quebec, QC, Canada) 11:00 AM - 11:15 AM LIGHT AND LYMPHOTOXIN INFLUENCE BOTH LIPID 1507 METABOLISM AND ATHEROSCLEROSIS C Reardon, G Getz (Chicago, IL, USA) 11:15 AM - 11:30 AM ADIPONECTIN ENHANCES REVERSE CHOLESTEROL 1508 TRANSPORT THROUGH DE NOVO HEPATIC HDL SYNTHESIS AND APOA-I-MEDIATED CHOLESTEROL EFFLUX FROM MACROPHAGES VIA ABCA1- DEPENDENT PATHWAY S Yamashita, K Tsubakio-Yamamoto, T Ohama (Suita, Japan) 11:30 AM - 11:45 AM IL-1 MODULATES BLOOD PRESSURE IN MICE AND 1509 MAN S Francis, J Chamberlain, Z Brookes, G Shaw, N Alp, J Rogus, K Kornman, D Crossman (Sheffield, UK, Oxford, UK, and Boston, MA, USA) 11:45 AM - 12:00 PM ROLE OF 3β-HYDROXYSTEROID-Δ24 REDUCTASE IN 1510 MEDIATING THE ANTI-INFLAMMATORY EFFECTS OF HIGH-DENSITY LIPOPROTEINS IN ENDOTHELIAL CELLS E Liong, K McGrath, J Tan, X-H Li, V Dy, P Barter, K Rye, A Heather (Sydney, Australia and Melbourne, Australia) 12:00 PM - 12:15 PM IDENTIFICATION OF AN UP-REGULATED ANTI- 1511 APOPTOTIC GENE NETWORK IN THE INTERNAL YIA THORACIC ARTERY COMPARED TO THE RADIAL ARTERY M Krane, S Dummler, M Dreßen, H Lahm, C Tesche, S Wildhirt, B Voss, C Badiu, R Lange, R Bauernschmitt (Munich, Germany) 12:15 PM - 12:30 PM CYTOKINE DIFFERENTIATION PATTERN IN PATIENTS 1512 WITH ST-ELEVATION MYOCARDIAL INFARCTION YIA (STEMI) ASSOCIATED WITH HIGH LEVELS OF CIRCULATING INTELEUKIN (IL)-6 E Ammirati, N Cristell, C Cannistraci, V Vecchio, A Paganoni, L Sangalli, A Palini, A Monello, M Banfi, N Uren, A Manfredi, D Cianflone, A Maseri (Milan, Italy and Edinburgh, UK)

*Abstract not available at the time of publication 182 YIA - Young Investigators Award Nominee THURSDAY, JUNE 18, 2009

CLINICAL SYMPOSIUM VIII AUDITORIUM

Combined Risk Factor Treatment: Lipids, Diabetes, Hypertension, and Smoking Chair: JD Brunzell (Seattle, WA, USA), C Oncken (Farmington, CT, USA)

Time Presentation Publication No. 1:30 PM - 1:55 PM STATIN THERAPY IN DIABETES 1513 PN Durrington (Manchester, UK) 1:55 PM - 2:20 PM COMBINED STATIN - ANTI HYPERTENSIVE THERAPY 1514 PS Sever (London, UK) 2:20 PM - 2:45 PM SMOKING CESSATION 1515 C Oncken (Farmington, CT, USA) 2:45 PM - 3:00 PM LIPID AND GLUCOSE TARGETS IN DIABETES AND 1516 FAMILIAL COMBINED HYPERLIPIDEMIA JD Brunzell (Seattle, WA, USA)

MASTER SESSION VII BALLROOM B

High Density Lipoprotein Metabolism and Premature Heart Disease

Time Presentation Publication No. 1:30 PM - 2:15 PM HIGH DENSITY LIPOPROTEIN METABOLISM AND 1517 Thursday,

PREMATURE HEART DISEASE June 18 EJ Schaefer (Boston, MA, USA) 2:!5 PM - 2:30 PM COMMENTARY - HB Brewer, Jr. (Washington, DC, USA)

MASTER SESSION VIII: LIPOPROTEIN(A) BALLROOM A

Time Presentation Publication No. 1:30 PM - 2:15 PM LIPOPROTEIN (A) 1518 G Utermann, A Brandstaetter, B Jaeger, K Schmidt, H-G Kraft (Innsbruck, Austria) 2:15 PM - 2:30 PM COMMENTARY - SM Marcovina (Seattle, WA, USA)

CLOSING REMARKS AUDITORIUM

Time Presentation Publication No. 3:00 PM CLOSING REMARKS - EJ Schaefer (Boston, MA, USA) AM Gotto, Jr. (New York, NY, USA) PJ Barter (Sydney, Australia)

*Abstract not available at the time of publication 183 YIA - Young Investigators Award Nominee Category Index The numbers refer to the publication number. P=Poster. BASIC SCIENCE CLINICAL STUDIES - Guidelines and Treatment Targets 566, 605, 1047, P151-P155, P626-P628 3-5, 9, 572-576, 593, 1516, P759-P773

BASIC SCIENCE - Animal Models CLINICAL STUDIES - Pharmacoeconomy 145-150, P1115-P1118, P156-P211, P629 P1238-P1239

BASIC SCIENCE - Cellular Lipid Metabolism CLINICAL STUDIES - Pharmacovigilance 16, 625, 1040, 1042, 1043, 1044, 1045, 1046, P212, 102, P1240 P1119-P1148 EPIDEMIOLOGY OF CVD - Biomarkers of CHD Risk BASIC SCIENCE - HDL Proteins and Inflammation 112, 501, 520-522, 524, 525, 588, 589, 1014, P774-P822 1066, 1108, 1110-1113, P1149-P1162 EPIDEMIOLOGY OF CVD - Cardiometabolic Risk BASIC SCIENCE - Inflammation 34, 590, 991, 1067-1070, P324, P1241-P1261 77, 561-563, 618, 1093, 1505-1507, 1509, 1510, 1512, P1163, P630, P706 EPIDEMIOLOGY OF CVD - Diabetic Dyslipidemia 592, 1015, P1262-P1271 BASIC SCIENCE - Lipidomics P1164 EPIDEMIOLOGY OF CVD - Estrogens, Gender Differences and Heart Disease Risk BASIC SCIENCE - Macrophages 1053, 1056, 1058, P1272-P1276 619-624, 1095, P213, P707-734 EPIDEMIOLOGY OF CVD - Gender BASIC SCIENCE - Markers of Inflammation 10, P325 59, 143, 1094, P736-P750 EPIDEMIOLOGY OF CVD - Global Risk Assessment BASIC SCIENCE - Other Vascular Cells 107, 108, 110, 113, 114, P326-P344 499, 564, 1511, P214-P262, P1166 EPIDEMIOLOGY OF CVD - Lifestyle and Worldwide CVD BASIC SCIENCE - Oxidation, Proteomics 6, 42, 586, 987, 988, P345-P356 75, 80-82, P263-P279 EPIDEMIOLOGY OF CVD - Lipoprotein Particles BASIC SCIENCE - Vulnerable Plaque and Heart Disease 60-62, 64-65, 1090-1092, P280-P294 1467, 1469, 1470, 1472, 1473, P823, P824, P1277-P1284

CLINICAL ASPECTS OF CVD - Degenerative Diseases EPIDEMIOLOGY OF CVD - Metabolic Syndrome 66, 615, 999 1071, 1476, P1285-P1318

CLINICAL ASPECTS OF CVD - Heart Failure EPIDEMIOLOGY OF CVD - Obesity, Insulin Resistance, 58, P758, P1167-P1170 and Diabetes 1011-1013, 1016, 1017, 1073, P825, P1319-P1346 CLINICAL ASPECTS OF CVD - Hypertension 523, 994, P295-P299 EPIDEMIOLOGY OF CVD - Special Populations (Youth, Elderly, Ethnicity) CLINICAL ASPECTS OF CVD - Menopause 587, 1072, 1466, P357, P1347-P1371 1055, 1059, P1171-P1173 GENETICS - Dyslipidemias CLINICAL ASPECTS OF CVD - Myocardial Infarction 45, 48, 49, 526, 528-533, 1024, P358, P826-P863 39, 63, 510, 591, 1001, 1462, P300-P314 GENETICS - Familial Combined Hyperlipoproteinemia CLINICAL ASPECTS OF CVD - Obesity, Insulin Resistance, 43, 44, 47, 50, 362, P359-P361 and Diabetes 93, 98, 993, 1006-1007, 1074, P1174-P1188 GENETICS - Genetic Markers of CVD 500, 1078-1081, 1471, 1481, P864-P897 CLINICAL ASPECTS OF CVD - Periodontal Disease P1209-P1212 GENETICS - Genetics of HDL 115-122, 527, 1480, 1517, P363-P372 CLINICAL ASPECTS OF CVD - Renal Diseases 38, 79, 1096, 1097, 1494, P1221-1233 GENETICS - Hypertriglyceridemia and Metabolic Syndrome 1018-1023, 1478, 1479, P1372-P1381 CLINICAL ASPECTS OF CVD - Stroke 1057, 1077, 1489, P1234-P1237 GENETICS - Lipoprotein(a) 17, 1518, P373, P374 CLINICAL ASPECTS OF CVD - Thrombosis P315-P323 IMAGING OF CVD - ABI and Pulse Wave Velocity Testing 127, 132, P375, P376

IMAGING OF CVD - Cardiac Calcium 1034

184 IMAGING OF CVD - CT-scan NUTRITION AND LIFESTYLE - Alcohol, Coffee, Tea, 1035-1039, P1382-P1385 and Chocolate 597, 1482, 1483, P1403-P1407 IMAGING OF CVD - External Ultrasound Imaging 46, 88, 134, 542-547, P898-P911 NUTRITION AND LIFESTYLE - Caloric Restriction and Weight Loss IMAGING OF CVD - IVUS 97, P1408-P1410 89, 992, 1495, 1496, P1386-P1388 NUTRITION AND LIFESTYLE - Carbohydrates IMAGING OF CVD - MRI 95, 1025-1027, P1411 606-611, P912, P913 NUTRITION AND LIFESTYLE - Dietary Cholesterol IMAGING OF CVD - Quantitative Coronary Angiography 534, 539, 1088, 1089, P938, P939 133 NUTRITION AND LIFESTYLE - Dietary Proteins IMAGING OF CVD - Surrogate Endpoints 600, P1412-P1414 131, 541, 548, P377, P378 NUTRITION AND LIFESTYLE - Exercise INTERVENTION STUDIES - Blood Pressure Therapy P940-P946 1000, P379, P380 NUTRITION AND LIFESTYLE - Fatty Acids INTERVENTION STUDIES - Exercise Interventions 51-57, 505, 598, 1028-1030, P447-P466 96 NUTRITION AND LIFESTYLE - Neutraceuticals INTERVENTION STUDIES - HDL Treatments 601, 604, 1031, 1085, 1086, 1487, 1488, P1415-P1422 569, 1454 NUTRITION AND LIFESTYLE - Vitamins, Fibers, INTERVENTION STUDIES - Interventions Affecting and Other Nutrients Glucose Homeostasis 602, 603, 1083, 1084, 1087, 1484-1486, P1423-P1435 997, 998, 1032, P381-P384 PHARMACOLOGY OF CVD - Agents Affecting Cholesterol INTERVENTION STUDIES - Primary and Synthesis and/or Cholesterol Absorption Secondary Prevention 18, 21, 23, 83, 99, 535, 578-585, 1082, 1461, P947-P977 20, 25-30, 52, 503, 504, 508, 516, 517, 570, 577, 989, 1050, 1114, 1449, 1514, P385-P401 PHARMACOLOGY OF CVD - Agents Affecting Triglyceride Secretion INTERVENTION STUDIES - Smoking P978, P979, P980 1519, P914-P918 PHARMACOLOGY OF CVD - HDL Modifying Therapies INTERVENTION STUDIES - Weight Loss 106, 1002, 1063, 1064, 1448, 1453, 1456, 1458, 84, 94, P402 P1436-P1442

LIPOPROTEIN METABOLISM - Hepatic Lipoprotein PHARMACOLOGY OF CVD - Niacin and its Analogues Metabolism 567, 1004, 1005, 1008, 1009, P1443, P1444 67-73, 135, 136, 139, 1504, P403-P408 PHARMACOLOGY OF CVD - Novel Therapies LIPOPROTEIN METABOLISM - Intestinal Lipid 86, 101, 103, 515, 1003, 1450, 1459, 1460, P467-P485 Absorption and Post-prandial Lipoproteins 536-538, 540, P409-P417 PHARMACOLOGY OF CVD - Nuclear Receptor Agonists 512, 514, 518, 1463, 1464, P981-P986 LIPOPROTEIN METABOLISM - Lipid Transfer Proteins 142, 614, 1062, 1455, 1499, 1503, P1389-P1397 PHARMACOLOGY OF CVD - Pharmacogenetics 32, 33, 35-37, 1474, P486-P488 LIPOPROTEIN METABOLISM - Lipolytic Enzymes 552, 616, 617, P919, P920 PHARMACOLOGY OF CVD - Polypharmacy P489-P491 LIPOPROTEIN METABOLISM - Lipoprotein Receptors 87, 1098, 1100-1105, P1398-P1402 PHARMACOLOGY OF CVD - Safety of Lipid Modifying Agents LIPOPROTEIN METABOLISM - Metabolism of 85, 100, 104, 105, P492-P497 Triglyceride-Rich Lipoproteins 74, 137-141, 550, 551, 554-556, 613, P921-P937 PHARMACOLOGY OF CVD - Thrombolysis P498 LIPOPROTEIN METABOLISM - Reverse Cholesterol Transport and HDL Metabolism 509, 1041, 1061, 1065, 1457, 1465, 1497, 1498, 1500- 1502, 1508, P418-P446

185 Author Index The numbers refer to the publication number. P=Poster. Aardestrup, I...... P447, P450 Ahnström, J...... P1149 Andrade, J...... P400 Abbink, E...... 577 Ai, M...... 1466, P413, P1357, P1361 Andreasen, A...... P448 Abdalla, D...... P630, P707, P708 Aikawa, E...... 561, 611, P640, P734 Andreasen, J...... 560, P447, P450 Abdel-Aaty, T...... P1233 Aikawa, M...... 561, 1071, P734 Andreev, V...... P327 Abdelkhirane, C...... 591, P326 Aitmagambetova, B...... P1147 Andreeva, E...... P200, P251, P709 Abdel-Rehim, A...... P1267 Akamatsu, S...... P929 Andrys, C...... 1096, P849, P1227 Abdolvand, A...... P1296 Akao, H...... 33, P214, P1171 Anelli, C...... P712 Abe, Y...... P666, P921 Akdim, F...... 104 Anestiadi, V...... P1263 Abela, G...... P156 Akhavan Tabib, A...... P915, P1175 Angelin, B...... 1463 Abelak, K...... P874 Akhvlediani, M...... P632 Anikster, Y...... P832 Abello, F...... P826, P828 Akinc, A...... 1461 Antonijevic, N...... P1360 Abidoye, R...... P938 Akintayo, O...... P1119 Aoyama, T...... P466 Abifadel, M...... 1459 Akopian, M...... P295 Aoyama, T...... P730 Abiko, Y...... P238 Aksoy, H...... P818, P819 Apostolou, F...... P674 Abina, J...... P1347 Alabakovska, S...... P373, P374 Apovian, C...... 93 Abletshauser, C...... P391 Alaupovic, P...... 1467, 1499 Arai, H...... 516 Aboufakher, R...... P737 Alberici, L...... P278 Araki, E...... 624, P719, P721, P981 Abreu-Gonzalez, P...... P302, P303 Alberts, A...... 83 Arana, B...... P493 Abt, M...... 1063 Albino-Teixeira, A...... P184 Araujo, AL...... P400 Aceves, M...... P838 Alegiani, F...... P343 Araujo, D...... P1180, P1295, P1325 Achem, J...... P1119 Alexandre, A...... P398 Arbonés-Mainar, J...... P478 Acher, C...... P812, P822 Alexopoulos, E...... P1425 Arefieva, .T ...... P188 Acquati, S...... P971 Alexopoulos, N...... P784, P808 Armani, A...... P1349 Aczel, S...... P855, P945, P1271, Alfaro-Moreno, E...... P747 Armisen, A...... P1355 P1285, P1310, P1339 Alfthan, G...... P659 Armour, D...... 149 Adab, P...... P1342 Ali, M...... P273, P684 Arnaboldi, L...... P715 Adachi, H...... 508 Alikhassi, H...... P1175 Arnal, C...... P478 Adachi, T...... P228 Alladi, S...... P634 Arnesen, H...... 1030, P1380 Adamkova, V...... P358 Allen, T...... 998 Arnesen, K-E...... P840 Adamopoulou, E...... P1352 Allende, H...... P1251 Arnett, D...... 1479, P370, P857 Adamova, I...... 362, P1283 Allister, E...... 136 Arnhold, R...... P363 Adams, T...... 595 Alm, C...... P1366 Aroche, R...... P821 Adaos, S...... P1302 Almagro, F...... P842 Arora, T...... P1342 Adaramoye, O...... P1119 Almeida, C...... P468 Arrobas, T...... P1179 Addo, J...... P813 Alonge, B...... 134 Arroyo-Espliguero, R...... P1167 Adewale, A...... 31, 1007, P1443 Alonso, R...... 530, 575 Asai, A...... P932 Adiels, M...... 69, P922 Alonso Karlezi, R...... P839 Asato, Y...... P1346 Adlouni, A...... P385, P836 Alp, N...... 1509 Ascaso, J...... P927 Adnan, K...... 591, P326 Alssema, M...... P409 Aseycheva, O...... P897 Adorni, MP...... P371, P716 Altieri, P...... P1120 Asgary, S...... P449, P633 Aerssens, J...... P202 Alvarenga, B...... P398 Asgry, S...... P800 Aerts, J...... P158 Alves, A...... P829 Ashkar, A...... P643 Afanasieva, M...... P807 Alves, MJ...... P946 AshokKumar, M...... P864 Afanasieva, O...... P807, P1283 Alves, S...... P1211 Asmis, R...... P710 Afonso, J...... P184 Aly, A...... P480 Aspelund, T...... 114 Afzelius, M...... P911 Amar, M...... 1065 Assem, M...... 1464 Agardh, H...... P631, P651, P740 Amati, F...... 564 Assmann, G...... 111,1519 Agarwal, A...... 147 Amato, M...... 112, P901, P1307 Asuncion, B...... P1245 Ageeva, E...... P1286 Ambegaonkar, B...... P759, P1262 Asztalos, B...... 1003, 1466, 1468, Aggarwal, A...... P914, P1348 Ammirati, E...... 1512 P369, P1357, P1361 Aggarwal, R...... P914 Ampartzidou, O...... 593, P300 Asztalos, L...... P804 Aggelopoulos, P...... 58, P1168 An, P ...... 1479 Atanazio, M...... P1295, P1382 Agirbasli, M...... P1359 Anagnostopoulou, K...... P827 Atassi-Dumont, M...... 106 Agoston-Coldea, L...... P212 Anand, S...... 990 Atkinson, D...... P925 Agozzino, F...... P298 Andersen, V...... P448, P465 Attia, N...... P422 Agrotis, A...... P690 Anderson, M...... P1392 Aukrust, P...... P683, P692 Ahn, CM...... P384 Anderson, N...... 1461 Aure, G...... P1265 Ahn, CW...... P878 Andersson, R...... P233, P705 Auzký, O...... P1213 Ahn, M-S...... P381 Ando, J...... 510, P301 Avanzas, P...... P303, P1167 Ahn, Y...... P1186 Andrýs, C...... P1226 Avesaat, M...... P1364

186 Ávila, F...... P1385 Barrett, PH...... 1003, P403, P954 Bennet, A...... P873 Aviram, M...... 75 Barrett-Connor, E...... 524, 1057 Bensadoun, A...... 141 Avis, H...... 48 Barrios, E...... P324 Benvenuti, C...... 1487 Axler, O...... P404, P1149 Barros, S...... P1244 Ben-Yehuda, O...... P773 Ayaori, M...... P228, P418, P440, Barsukov, A...... P327 Beraia, M...... P912 P802, P1306, P1407 Bartels, E...... P1121 Berbée, J...... P479, P700, 1455 Ayhan, E...... P1247 Bartelt, A...... 1044, 1102 Berckmans, R...... P242 Aytemir, K...... P818, P819 Barter, P...... 86, 1043, 1066, 1095, Berendschot, T...... 1085 Ayusawa, M...... P921 1111, 1112, 1448, 1458, Berestatskaya, J...... 362 Azadbakht, L...... P449 1510, P290, P655, P964, Berge, K...... 1031 Azanjac, A...... P172 P965, P1151, P1154, Berglund, G...... 34, P777 P1202, P1390 Azhar, S...... 1454 Berglund, L...... P739 Barthwal, M...... P157, P1117 Aznaouridis, K...... 132, P359 Bergmann, S...... P363, P402 Bartorelli, A...... P315 Böhm, F...... P1184, P1199 Bergmark, C...... P1214 Bartusch, M...... P655 Bülow, R...... P447, P450 Bergström, G...... P288, P905, P1254 Barudzic, N...... P172 Baass, A...... 1473 Bergström, I...... P744 Basart, D...... 104 Baber, R...... 1503, P467 Bergstrom, G...... P345 Basart, H...... P213 Bacchetti, T...... P1277 Berisha, S...... 1079 Basili, S...... P318, P1350 Back, D...... P714 Berliner, S...... P691, P754 Basu, D...... P865, P1288 Backes, J...... P1162 Berne, G...... P740 Batellino, N...... P1174 Backteman, K...... P757 Bernini, F...... 120, 1456, P371, P446, P716 Batellino, T...... P1174 Badeau, R...... 1056 Berrah, A...... P898, P1236, P1363 Batista, M...... P635, P675, P676, P743, Badimon, J...... 605 Berrougui, H...... P1160, P1415 P1221, P1222, P1231 Badiu, C...... 1511 Bertato, M...... 1015 Batsell, R...... P750, P756, P809 Bae, H-S...... P395 Berthold, H...... 585, P1164 Battelino, N...... P1197 Baek, S...... P1186 Bertolami, M...... P1180, P1259, P1260, Battelino, T...... P1197 Baena-Fustegueras, J...... P1251 P1295, P1325 Bauer, K...... 522 Baer, A...... P469, P471 Bertsch, T...... P1340, P1358 Bauernschmitt, R...... 1511 Baetta, R...... P715 Bess, R...... P737 Bauersachs, J...... 563 Bagdade, J...... 1499, P628 Bessonova, L...... P1238 Baumeister, J...... P202 Baglioni, P...... P942 Betteridge, J...... 993, P753, P1203 Baxter, J...... 1463 Bahonar, A...... P1175 Beutner, F...... 1080, P467, P776 Bays, H...... 103, 515, P823, P948, Bhargava, A...... P1288 Bai, L...... 1059, P171, P978, P1299 P949, P950 Bhatia, S...... P824 Baiano, A...... 1074 Bayturan, O...... 1495, 1496, P1386 Bhatt, D...... 1067 Baida, S...... 362 Bazinet, R...... P1411 Bhupathiraju, S...... P1351 Bailey, D...... 1453 Bea, A...... 46, P360, P1372 Bicchiega, V...... P1277 Bailey, K...... 130 Beaslas, O...... P711 Biedzka-Sarek, M...... P637 Bailey, P...... P763 Bech, N...... 1063 Bielicki, J...... 1454 Bairaktari, E...... P933 Beck, K...... 81 Bielorai, B...... P386 Bakker, A...... P774 Bedford, D...... P780 Bietrix, F...... P158 Bakun, P...... P1351 Bedi, R...... P902 Biganzoli, E...... P304 Balakrishnan, K...... 616 Beer, S...... 1494, P855, P886, P887, P906, Balavadze, M...... P632 P945, P1255, P1256, P1285, P1311, Bilianou, H...... P300, P1352 Baldassarre, D...... 112, 543, P775, ...... P1337, P1339 Bilici, A...... P665 P899, P901, P1307 Behre, CJ...... P735 Bilkis, V...... P498 Bale, B...... 113, P1287, P1319, P1324 Behre, C-J...... P1254 Binkowitz, B...... P1390 Baliga, V...... P490 Beigneux, A...... 141 Binz, C...... 1067 Ballantyne, C...... 502, 1049, 1490 Beilin, L...... P272 Bird, S...... P773, P948, P949 Ballantyne, CM...... 31, 582, P947, Beisiegel, U...... 140, 549, P656, P1196 Bishop, P...... 1496 P966, P967, P1308, P1323 Bekkers, M...... P482 Björkbacka, H...... P638, P699, P706, P777 Banchs, H...... P1120 Belechri, A-M...... P1425 Björkelund, C...... P1304 Bandaru, VCSS...... P634 Beletic, A...... P1360 Bláha, M...... P951, P1226 Banfi, .C ...... P263 Bell, T...... 145 Bláha, V...... P1226 Banfi, M...... 1512 Blé, J...... P955 Bell III, T...... 53 Bangit, J...... P750, P756, P809 Bellomo, G...... P304 Blaak, E...... 1476 Bao, Y...... P472 Bellosta, S...... P712, P715, P1416 Blaha, M...... P849 Baracco, V...... P826, P828 Belton, O...... P235 Blaha, V...... 1096, P849, P951, P1227 Barbosa, D...... P420 Beltowski, J...... P1150 Blair, S...... P1176 Barcella, S...... P263 Belzunce, M...... P291 Blanco-Colio, L...... P678 Barco, A...... P1179 Ben Addi, A...... 1501 Blanco-Vaca, F...... P1441 Bardymova, T...... P264, P265 Benchimol, D...... P867 Blasi, C...... P736 Barranquero, C...... P478 Bengtsson, C...... P1304 Blazicek, P...... P1344 Barrenetxe, J...... P291 Bengtsson, D...... P636, P699 Bleda, D...... P1195 Barrett, H...... 72, 94, 135, 139, P419, P432 Benmeziane, S...... P898 Blevins, J...... P764

P=Poster 187 Blocher, J...... P945 Brennan, D...... 1496 Cai, M...... P211 Bloedon, L...... 103, P469, P471 Breslow, J...... 1503 Cai, S...... P151, P152 Boban, D...... P443 Breuss, J...... P1255, P1256 Caidahl, K...... 1077, P629, P779 Boban, P...... P1163 Brinkworth, G...... 95 Calabresi, L...... 116, 120, 1456 Bobik, A...... P690 Brinton, E...... 597, 598, P1390 Calabresi, L...... P371 Bochdansky, T...... P945 Brioschi, M...... P263 Calderaro, D...... P1212 Boekholdt, M...... P810 Brisson, D...... 554, 1017, 1024, P848 Calmarza, P...... P360, P1372 Boekholdt, S...... P895 Brites, F...... P957, P1177 Calpe-Berdiel, L...... P1122, P1441 Boero, L...... P1177 Brito, V...... P821 Calvayrac, O...... P748 Boeynaems, J-M...... 1501 Brittenden, J...... P1435 Camargo, A...... P931 Boffito, M...... P714 Bro, S...... P185, P186 Camargo, N...... P398 Bogani, P...... P315 Brochot, A...... P451 Cambillau, M...... P422 Bogavac-Stanojevic, N...... P1369 Broekhuizen, L...... P215 Camera, M...... P315, P316 Bogorad, R...... P810 Brookes, Z...... 1509 Campos, H...... 42, 586 Bogsrud, M...... 102 Brousseau, M...... 115 Can, G...... P1247 Boguszewski, A...... P737 Brouwer, I...... 51, 54 Canavesi, M...... P712, P715 Boileau, C...... 1459 Brovkin, A...... P881 Cannistraci, C...... 1512 Boitsov, S...... P847 Brown, A...... 601 Cannon, C...... P1349, P1390 Bokan, L...... P1232 Brown, G...... 568, 1491 Canpolat, U...... P819 Bolego, C...... 1055 Brown, M...... 16 Capozzi, A...... P639 Bollekens, J...... P202 Brown, W...... 1449 Capuzzi, D...... 27, P963 Bolmall, C...... P490 Bruckert, E...... 577, 1089 Caracas, N...... P1436 Bolton, J...... P866 Bruckner, P...... P183 Caracas-Portilla, N...... P434 Bond, D...... 546 Brundert, M...... 1504 Caramelli, B...... P1212 Bongo, A...... P304 Brunner, S...... 1094 Cardellini, M...... 564, P1181, P1182 Bonnet, J...... P867 Bruns, O...... 140, P928 Cardona, F...... P923 Borén, J...... 69, 70, 625, P727, P922, P1164 Brunzell, J...... 1516 Cardoso, G...... P1436 Boracchi, P...... P304 Bryan Brewer, H...... 126, 1452 Cardoso, L...... P420 Borai, A...... P805 Brzosko, S...... P1230 Cardoso-Saldaña, G...... P434 Borbas, B...... P1193 Buchwald, H...... 98, 594 Cariolou, M...... P834, P835 Borecki, I...... 1479 Buci, L...... P971 Carleton, A...... P1411 Borges, F...... P1205, P1318 Buckley, J...... 95 Carli, F...... P784, P808 Borghi, C...... P1216, P1292, P1300 Budzyn, K...... 562 Carlson, J...... P777 Bortoloto, L...... P1397 Bueno, H...... P652, P653 Carlsson, B...... 1463 Bortolotto, L...... P1212 Bueno Garcia, M...... P693 Carmena, R...... 1012 Bosa-Ojeda, F...... P303 Buers, I...... P1389 Carnevale, R...... P687, P1350 Boscá, L...... P630, P708, P707 Bujo, H...... 516, P216 Carnicer, R...... P478 Boshtam, M...... P1118, P1398 Bulgarelli, A...... P468 Caron, S...... 72 Bosilkova, G...... P1169 Bullano, M...... P332 Carr, J...... 610 Bosisio, E...... P1416 Bult, H...... 1092, P203 Carrasco, P...... P1322 Boskovski, B...... P1270 Buravkova, L...... P200, P251 Carrilho, A...... P420 Boström, P...... 625 Burazor, I...... P778, P1289, P1320 Caruso, D...... P795, P1416 Botez, G...... 1103, P1141 Burazor, M...... P778, P1289, P1320 Carvalho, A...... P169, P751, P1244 Bots, M...... P952, P953 Burazor, N...... P778, P1320 Carvalho, LS...... P400 Bottos, J...... P169 Burazor, Z...... P1320 Carvalho, M...... P1124 Boucelma, M...... P1363 Burillo, E...... 46, P360, P421 Carvalho-Oliveira, R...... P652, P653 Bouchard, L...... P848 Burke, G...... P903 Casañas, L...... P325, P918, P1368 Boudot, C...... P218 Burke, V...... P272 Casagrande, V...... 564 Boudoulas, H...... P481 Burnett, J...... 623, P846 Casas, J...... 527, 1078, P813 Bouhali, T...... P848 Bursill, C..... 1095, 1111, 1112, P1151, P1154 Casella-Filho, A...... P940, P941 Bourbon, M...... P829, P830 Busabaratana, M...... P896 Caslake, M...... P753, P780 Bourghardt, J...... P159 Businaro, R...... P217 Cassano, C...... 81 Bouzifi, ...... S P898 Butenhoff, J...... P980 Cassina, A...... P279 Boyanovsky, B...... 621 Buttari, B...... P217, P639 Cassis, L...... 994 Bozovich, G...... P1249 Bzowska, M...... P742 Castanho, V...... 1058 Brace, R...... 1480 Câmara, N...... P199 Castelnuovo, S...... P899, P901, P1307 Brambilla, M...... P315, P316 Caamaño, J...... P885, P888 Castiglioni, S...... 600, P1413 Brandao, S...... P751, P1244 Cabella, C...... P913 Castilho, G...... P713 Brandrup-Wognsen, G...... P964, P965 Cabello, M...... P1249 Castilho, L...... 547, P942 Brandstaetter, A...... 1518 Cabre, A...... P927 Castilho, R...... P279 Braunwald, E...... 1051 Cabrera, M...... P1290 Castillo-Rojas, L...... P764 Brazier, M...... P218 Cadenas, E...... P1127 Castro, A...... P924 Brcakova, E...... P181, P1419 Cagide, A...... P325, P918, P1284 Castro, J...... P1264, P1265 Brendel, D...... P467 Cagnin, A...... 615 Castro, L...... 1095, P1151

P=Poster 188 Castro-Chavez, F...... P252 Chen, H-J...... 1073 Christensen, J...... P448, P465 Catalán, R...... P1251 Chen, J-H...... P791 Christoffersen, C...... P404 Catanozi, S...... 57, 509, P686 Chen, J-J...... P1412 Christopher, R...... P880 Caudrillier, A...... P218 Chen, J-S...... P220 Chroni, A...... 1498 Caulfield, .M ...... 34 Chen, J-W...... 1039, P155, P220, P266, Chrysohoou, C...... 58, P337, P361, P803, Cavalca, V...... P795, P1307 P379, P1166 P1168 Cazita, P...... 57 Chen, K...... 540 Chu, N-F...... P831 Cederholm, J...... 592 Chen, L...... 500 Chu, T...... 36, P486, P487 Ceglarek, U...... 1503, P467 Chen, M-F...... 609 Chulaevskaya, I...... P1309 Celebi, G...... 96, P973 Chen, R...... P260 Chulajevska, I...... P296 Cella, P...... 1035 Chen, S...... P151 Chumark, P...... P1399 Cenarro, A...... P291, P360, P462 Chen, W...... P703 Chumburidze, S...... P1234 Cendoroglo, M...... P743, P1221, P1222, Chen, W-C...... P221 Chung, DK...... P626 P1231 Chen, X...... P1440 Chung, I-M...... P161, P162 Cepova, J...... P883 Chen, Y...... P190, P209 Chung, N...... P390 Cerezo, G...... 1000, P1178, P1261 Chen, Y-H...... P221 Chung, R...... 601, 1031 Cesena, F...... P940, P941, P1259, P1260 Chen, Y-L...... P221 Chung, WY...... P457, 1462, P1437 Ceska, R...... P358, P372 Chen, Z...... 27 Churchill, G...... 122 Cha, BS...... P878 Chen, Z-J...... P267 Cianflone, .D ...... 1512 Chabert, M...... 1023 Cheng, C...... P310 Cianflone, .K ...... 74, 146 Chacra, A...... P1385 Cheng, KK...... P1342 Ciardi, L...... P304 Chae, JS...... P1248 Cheng, T-H...... P222, P1412 Cicero, A...... P346, P782, P1266, P1292 Chagas, A...... P940, P941 Cheng, W-L...... P1240, P1376 Cifkova, R...... 590 Chainani-Wu, N...... 588, P781 Cheng, XW...... 79, P280, P730 Cignarella, A...... 1055 Chalikias, G...... P481 Cherian, KM...... P864 Cingoz, F...... P665 Chamberlain, J...... 1509 Cherki, M...... P385 Cintra, R...... P400 Chan, D...... 94, P403, P412, P419, P432, Chern, C-L...... 1039 Civeira, F...... 44, 46, P291, P360, P462, P954, P986 Chew, G...... P986 P838, P842, P927, P1293, P1372 Chan, E...... P1272, P1273 Chia, YC...... P328, P1241 Clair, D...... 1496 Chan, J...... P825 Chiacchia, F...... 1453 Clarke, D...... P935 Chan, P...... P290 Chiang, A-N...... P267 Clarke, R...... 1005 Chan, T...... 1497 Chiang, C-W...... 574, 589 Clifton, P...... 95 Chan, W-H...... P255 Chiang, K-H...... P266 Clifton, P...... 1484 Chandra, N...... P1201, P1401 Chichilli, S...... P1321 Clouse, M...... 1033 Chang, C...... P1131 Chien, K...... 1072 Coe, J...... 507 Chang, H-Y...... 1073 Chiesa, G...... P913 Coelho, O...... P1259, P1260 Chang, K...... P640 Chimini, G...... P1122 Cofán, M...... P462, 544, P842, P927, P1293 Chang, S...... P980 Chin-Dusting, J...... 1042 Cohen, G...... P737 Chang, T-Y...... P1131 Chinetti, G...... P724 Cohen, H...... P386, P832 Chang, W-C...... P641 Chiodini, P...... 1074 Cohn, J...... 550, 601, 1031, P290 Chang, WH...... P255 Chiou, K...... P310 Cokkinos, D...... 593, P300, P827 Chang, Y-C...... P221 Chirovsky, D...... P1262 Collins, D...... 115 Chang, Y-T...... P219 Chiu, T-Y...... 1039 Collinson, E...... 81 Channer, K...... P667 Chiu, W-C...... P267 Collot-Teixeira, S...... P714 Chantepie, S...... 80, 82, 106 Chiuve, S...... 1071, 1472 Colombo, G...... P316 Chantzichristos, V...... P276 Cho, G-Y...... P875 Colquhoun, D...... P1262 Chao, H-H...... P1412 Cho, K-H...... P1291, P1423 Coltell, O...... P1322 Chapman, K...... 149 Cho, SK...... P489 Conard, S...... P823, P948, P949 Chapman, M...... 80, 82, 106, 1107 Cho, Y-S...... P160 Conde, H...... P821 Charalambous, A...... 579 Choe, H...... P381 Constance, C...... P773 Charisse, K...... 1461 Choi, CU...... 1038 Contreras, F...... P1264, P1265 Charlton, F...... 1008 Choi, D...... P390 Cook, N...... 107 Chasman, D...... 32 Choi, D-J...... 1462 Cooney, J...... P780 Chatterjee, S...... P798 Choi, H...... 1497 Cooper, J...... 522, P753, P794, P874 Chattopadhyay, P...... P293 Choi, J...... P232, P626, P1152 Cooper, M...... 998 Chatzikyriakou, S...... P481 Choi, J-H...... P685 Corbella, E...... 129 Chatzizisis, Y...... P285, P286, P1115 Choi, JY...... P154 Corella, D...... P1278, P1322 Chatzopoulou, E...... P1189, P1302, P1303 Choi, Y...... 515, P1186 Corrêa-Giannella, ML...... P1133 Chavez, A...... 1016 Choi, Y-J...... P875 Corsini, A...... 21, P223, P712, P715, Chayama, K...... P236 Choi, YS...... P457 P716 Chen, B-S...... P815 Choi, Y-S...... P1437 Cortés, V...... 147 Chen, C-H...... P222, P255, P1412 Chong, C-K...... P1343 Cortese, C...... 1089 Chen, C-J...... P267, P1343 Chow, WS...... P1203 Coskun, A...... P285, P286, P1115 Chen, H...... 610 Christen, T...... 611 Costa, R...... P1408

P=Poster 189 Costa, S...... P716 de Beer, F...... P1157 Di Santo, S...... P687 Couturier, M...... 82 De Beer, M...... 1108, P1157 Diakou, M...... P834, P835 Covelli, D...... P1190 de Boer, O...... P483, P644, P645 Diakoumakou, O...... P827 Cox, C...... P235 De Caterina, R...... P646, P1140 Dickinson, K...... 1484 Cox, D...... 1057 De Fabiani, E...... P1416 Diffenderfer, M...... 139, 1003, P413 Coxilha, G...... P1330 de Faire, U...... P872, P873, P1235 Dikshit, M...... P157, P1117 Crespo, M...... P1120 de Faria, E...... 547, 1058, P738 Dimitriou, A...... P276, P322 Crestani, M...... P1416 De Francesco, A...... P712 Dinu, R...... P1294, P1334 Criqui, M...... 127 De Gendt, K...... P159 Djenane, N...... P1363 Cristell, N...... 1512 de Graaf, A...... P934 Djuric, D...... P163, P172, P1237 Croft, K...... P732 de Graaf, J...... 43, 47 Do Thi, NP...... P867 Crossman, D...... 1509 De Groot, E...... 541, 608, P378 Doan, D...... P737 Crott, J...... 1489 de Haan, W...... 533, 1455 Dobretsov, G...... P1391 Crouse, J...... 88, 610, P952, P953 De Haan, W...... P982 Docenko, Y...... P807 Crowe, T...... 1496 de Jong, A...... 1087 Dogan, S...... P953 Cruickshanks, K...... P812, P822, P1353 de Kleijn, D...... P483 Dogru, T...... 96, P973 Cruz, C...... P793 de Lorenzo, F...... P714 Doi, M...... P376 Cruz-Teno, C...... P930, P931 de los Santos, A...... P295 Domagala, T...... P1155 Cuchel, M...... 1460, P469, P471 de Luna, A...... P1245 Domaniewski, T...... P1229 Cucinotta, D...... P369 De Metrio, M...... P316 Domeij, H...... P648 Cui, W...... 146 De Meyer, G...... 1092, P203 Domenech, M...... 544 Cui, Y...... P1262 de Roos, B...... 1029 Dominguez-Rodriguez, A...... P302, P303 Culver, B...... P1418 de Vries, J...... P483 Donath, M...... 1013 Cuniberti, L...... P957, P1177 de Vries, M...... 1091 Doncheva, N...... P452 Cupples, L...... 115 de Vries-van der Weij, J...... 142, 533 Doneen, A...... 113, P1287, P1319, P1324 Cupples, LA...... 1466 de Winther, M...... P187 Donoghoe, M...... P496 Curtiss, L...... 143 Debenham, S...... P895 Dorent, R...... P223 Cury, P...... P1212 Decasper, S...... P268, P281 Dorighello, G...... P274 Cynis, H...... P642, P689 Deckelbaum, R...... 1028, P456 Dorkin, R...... 1461 Czesnikiewicz-Guzik, M...... P742 Dedoussis, G...... P868 Dormi, A...... P1292, P1300 D’Addato, S...... P1216, P1300 Dedov, I...... P264 Dos Santos, A...... P1249 D’Agostino, Sr., R...... 108 Deeb, R...... P670 dos Santos, J...... P1259, P1260 D’Orazio, N...... P1218 deFaire, U...... P779 Dotsenko, O...... P224 D’Souza, W...... 1042 Defesche, J...... 48, 526, 531, P365, P841, Doumori, T...... P969 Díaz, J...... P955 P870 Doyle, R...... P950 Díaz, JL...... 575 Defoort, C...... 1476, P930 Dreßen, M...... 1511 Dühring, S...... 1093 deFougerolles, A...... 1461 Drenos, F...... 522, 527, 1078 Dabelea, D...... 1019 DeFronzo, R...... 1016 Drevon, C...... 1476 Dadoo, O...... P643 Degirolamo, C...... 53 Drexel, H...... 1494, P855, P886, Dahlbäck, B...... 614, P404, P1149, P419 Deguchi, J-O...... P734 P887, P906, P945, P1255, P1271, Dai, X...... P152 Dekker, J...... 525, P409, P817 P1285, P1310, P1311, P1337, Daida, H...... P392, P1183 Del Sueldo, M...... 1000, P1178, P1261 P1338, P1339 Dainese, L...... P795 Delgado-Lista, J...... P931 Drogari, E...... P856, P1400 Dakam, W...... P1116 Dell’Agli, M...... P1416 Drosatos, K...... 1498, P1123 Dalboni, M...... P743, P1221, P1222, P1231 Dembinska-Kiec, A...... 555, 1476 Drouin, G...... P1415 Dall, T...... P1323 Demissie, S...... 115 Du, D...... P484 Dallinga-Thie, G...... 141, 552, P423, P810, Demissie-Banjaw, S...... 1466 Duan, Z...... P963 P895, P924 Demosky, S...... P437 Duarte, C...... 1465 DaLuz, P...... P940, P941 Demuth, H-U...... P642, P689 Dube, S...... P1250 Damås, J...... P692 Denisenko, A...... P1286 Dubuc, G...... 1473 Damm, P...... P404 Derdak, Z...... P1439 Duffy, D...... P469 Dana, S...... P314 Derdemezis, C...... P956 Duivenvoorden, R...... 541, 608 Daniels, K...... 148 Dergunov, A...... P1153, P1391 Dullaart, R...... P895 Dansky, H...... P1390 Derks, M...... 1063 Dummler, S...... 1511 Daugherty, A...... 994 Derosa, G...... P782, P783, P1266 Dunér, P...... P699 Davidson, M...... 103, 505, 1009, 1014, Descamps, O...... P833 Dunbar, R...... P469, P471, P1297 P470, P1390, P1444 Després, J-P...... 84 Durão, M...... P743, P1221, P1222, P1231 Davidson, W...... 80 Dethlefsen, C...... P455 Duranti, M...... 600, P1413 Davidson, S...... 1107 Deuchar, G...... 149 Durrington, P...... 577, 1011, 1513 Davidsson, P...... P288 Deveci, O...... P818, P819 Dursunoglu, D...... P1247 Davies, G...... P759 Di Bartolo, B...... 1111, P1154 Dusilová-Sulková, S...... P1226, 1096, Davignon, J...... 25, 1473 Di Benedetto, A...... P369 P951, P1227 Davis, H...... 578 Di Giorgio, A...... P1220 Duthie, G...... P1435 De Beer, F...... 1108 Di Marzo, V...... 69 Duthie, S...... P1435

P=Poster 190 Dwivedi, S...... P914, P1348 Faas, F...... P761 Filipiak, K...... P1420 Dy, V...... 1510, P655 Fabiani, F...... P1179 Filippatos, T...... P933, P956 Dyer, A...... P903 Fabre, A...... 1501 Fiocchi, F...... P808 Dzhekova-Stojkova, S...... P1169 Fabryova, L...... P1371 Fischer, R...... P1330 Edelman, E...... P681, P1115 Facchiano, F...... P639 Fischer, S...... P751, P1244 Eekhoff, E...... P409 Fafunso, M...... P1119 Fisette, A...... 74 Efendic, S...... P1199 Fagerberg, B...... P288, P289, P345, Fish, B...... P1272, P1273 Efstratiadis, G...... P1425 P735, P905, P1254 Fisher, E...... 1040 Eftekhari, S...... P233 Fagnani, R...... P1416 Fishlock, H...... P1409 Efthimiadis, A...... P382 Faine, L...... P630, P707, P708 Fiskesund, R...... P1235 Efthimiadis, I...... P382 Fajkusova, L...... P837 Fitzgerald, K...... 1461 Egashira, K...... 65, P182 Faludi, A...... P1180, P1295, P1325 Fleg, J...... 1050 Egashira, T...... P1381 Faludi, E...... P1180, P1295, P1325, P1382 Fletcher, C...... P714 Egido, J...... P678, P679 Fan, W...... P226, P240 Flore, R...... P1220 Ehara, N...... P1356 Fan, Y...... 1461 Florentin, M...... P383, P1243 Ehnholm, C...... 614, P1335 Fan, Y-M...... P869 Flores, D...... P762 Ehresman, D...... P980 Fang, X-Z...... P815 Florkowski, C...... P497 Eilertsen, K-E...... P164 Farah, M...... P169 Fogari, E...... P1266 Eisenreichova, S...... P882 Faria-Neto, J...... P1259, P1260 Fogari, R...... P783 Ejike, C...... P1242 Farris, M...... P1262 Fogteloo, A...... 1477 Eklund, C...... 131, P900, P911 Farsky, S...... P630 Folco, E...... 64 Ekroos, K...... 70, 105, 585, P1164 Favaloro, R...... P957 Folkersen, L...... P651, P740 Ekstrand, J...... P629 Favari, E...... 120, P371, P716 Folli, F...... 1016, P1181 El Kattouti, A...... P317 Fayyad, R...... P824 Folts, J...... P1417, P1418 El Messal, M...... P385, P836 Fazio, S...... 1006, 1007, P1443 Fong, L...... 141 El Nouaem, K...... P1267 Fedacko, J...... 604, P396 Fonseca, F...... P169, P688, P751, P1244, Eliasson, B...... 592 Fedackova, P...... 604 P1259, P1260 Elis, A...... P760, P1354 Federici, M...... 564, 1016, P1181, P1182 Foody, J...... 10 Elisaf, M...... P383, P441, P674, P834, Feeman, Jr., W...... P329, P330 Ford, E...... 1070 P835, P933, P956, P1243 Feiten, L...... 1496 Ford, I...... 535 ElKaffash, D...... P1267 Feldman, C...... P285, P286, P1115, P295 Foris, G...... P239, P1137 Else, P...... P463, P464 Feng, D...... 113, P153, P225, P226, P1287, Forrest, K...... 621 Elvevoll, E...... P164 P1319, P1324 Forssell, C...... P287 Emmanuel, C...... P864 Feng, D-M...... P229 Fort, J...... P1251 Endo, A...... 17 Ferderbar, S...... P630, P707 Fouchier, S...... 48, P841, P870 Engstrom, G...... 34 Ferguson, J...... 1476 Fountakis, G...... P1352 Enzan, H...... P658 Ferin, R...... P331 Fournier, N...... P422 Ercin, C...... 96, P973 Ferkany, J...... 538 Foussas, S...... 593, P300, P1352 Erdem, G...... 96, P973 Fernández-Meseguer, A...... P1290 Fox, K...... P332 Erdembileg, A...... P739 Fernández-Vizarra, P...... P679 Fragopoulou, E...... P803 Eriksson, E...... P249, P647 Fernandez, I...... P242 Franceschini, G...... 116, 120, P371 Eriksson, M...... 577, 592, 1463 Fernandez-Britto, J...... P1355 Francis, G...... 1497 Eriksson, P...... 64, 1068 Ferns, G...... P805 Francis, S...... 1509, P640 Ernerudh, J...... P757 Ferré, R...... P924 Francisco, V...... P829 Ernst, J...... 1093 Ferrari, G...... P1221 Franco, D...... P628 Er-Rachdi, L...... P843 Ferrari, I...... P782, P783, P1266 Franek, T...... P883 Ertl, G...... 563 Ferraro, S...... P304 Frank, J...... P737 Erzen, B...... P1223 Ferre, R...... P927 Frank-Kamenetsky, M...... 1461 Escobales, N...... P1120 Ferreira, F...... 57 Franssen, R...... 141, P423 Escolà-Gil, JC...... P1441 Ferreira, I...... P1365 Frants, R...... 1477 Escurriol, V...... P1293 Ferrer, M...... P1355 Fredrikson, G...... P699, P706, P777 Esfahani, A...... P1411 Ferrer, R...... P1251 Freiberger, T...... P837 Esmaillzadeh, A...... P449 Ferretti, G...... P1277 Freidig, A...... P934 Esnouf, M...... 522 Ferri, N...... P223, P715 Freitas, J...... P1410 Espirito Santo, Í...... 1058 Ferrières, J...... 574 Frenda, S...... 588, P781 Essiarab, F...... P1336 Ferro, D...... P318 Friedlander, Y...... P1367 Eto, H...... P166 Festeridou, C...... P1352 Friedrich, N...... P1330 Evan, A...... P1354 Fiala, J...... P1276 Frigerio, B...... P901, P1307 Evans, G...... P952, P953 Fiddyment, S...... 46, P421, P838 Frikke-Schmidt, R...... 119, 1081, P894 Evdokimova, M...... P897 Figueiredo, J...... P640 Frochot, V...... 1023 Evranos, B...... P818 Figueiredo-Neto, A...... P751 Froemming, G...... P273, P684 Ewing, M...... 1091 Figueroa, Y...... P1120 Frohlich, J...... P820 Eyigun, C...... P665 Filep, J...... P701 Frolova, Y...... P1286 Ezhov, M...... P807, P1283 Fili, P...... P868 Frostegård, A...... P648, P649

P=Poster 191 Frostegård, J...... P648, P649, P779, P1235 Garcia-Otin, A...... P927, P1293 Ginter, E...... P1344 Fruchart, J...... 1520 Garcia-Otin, A-L...... P421 Giovanetti, F...... P1216 Fryirs, M...... 1043 Garcia-Rios, A...... P931 Giovannini, M...... P346 Fuentes, F...... 530 Gracia-Sancho, J...... 558 Girman, C...... P409 Fuentes Jimenez, F...... P839 Gardiner, P...... P799 Giuliano, I...... P1212 Fujii, M...... 1045 Gareus, R...... P187 Giunta, G...... P957, P1177, P1249 Fujimoto, M...... P725 Garg, A...... 147 Glaros, E...... P405 Fujimoto, S...... P962 Garg, M...... 1086 Glass, A...... P443 Fujimura, M...... P1281 Gargiulo, M...... P1216 Glaveckaite, S...... P356 Fujioka, Y...... P411, P920, P962 Garmiri, V...... P1189, P1302, P1303 Go, Y...... P375 Fujita, M...... P408, P417 Garner, B...... P405 Godreau, A...... P903 Fujita, Y...... P741 Garrido, D...... P295 Goes, Jr., M...... P1231 Fujiu, K...... P650 Gascón, S...... P478 Goffin, .V ...... P242, P810 Fujiwara, Y...... P1131 Gasparovic, J...... P1371 Goh, CW...... P384 Fukamachi, I...... P919 Gatfosse, M...... P212 Gojkovic Bukarica, L...... P1404 Fukao, K...... P1183 Gatti, R...... P716 Golabek, I...... P930 Fukuda, N...... P238 Gaudet, D...... 554, 1017, 1024, P848 Goldberg, A...... 517 Fukumoto, T...... P902 Gaur, D...... P1262 Goldberg, R...... 1451 Fukumoto, Y...... P682 Gaus, K...... 623 Goldmann, R...... P837 Fukuo, K...... P892 Gavita, R...... P1421 Goldstein, J...... 16 Fukushima, M...... 516 Gavrisheva, N...... 64 Gollub, S...... 50 Fuller, M...... P165 Gazi, I...... P674 Gomaraschi, M...... 120, P371 Funada, J-I...... P1326 Gazzard, B...... P714 Gomez, M...... P638 Funari Ferri, L...... P871 Geaney, JC...... P1392 Gomez Rosso, L...... P957, P1177 Furtado, J...... 1472, P937 Geller-Rhomberg, S...... P886, P887 Gomez-Luna, MJ...... P930 Furukawa, Y...... P367, P1356 Gelpi-Méndez, J...... P1290 Gomita, K...... 63 Furusyo, N...... 587, 1466, P768, P1217, Genco, C...... P167 Gong, J...... 1069 P1258, P1357, P1361, P1362 Genest, J...... 3 Gonon, A...... P308, P1199, P305 Fuse, J...... P1225 Genest, Jr., J...... 1453 Gonzàlez, M...... P924 Futami-Suda, S...... P910 Geng, Y-J...... 999, P282 Gonzalez, C...... P1179 Góes, M...... P743 Gentile, M...... 1074, P1253 Gonzalez, J...... P1278 Gómez-Guerrero, C...... P679 George, J...... P496 Goodall, A...... P213 Gabe, E...... P1249 George, P...... P497 Gopalan, R...... P283 Gabriel, S...... 115 Georgiopoulou, I...... P1302 Goran, U...... P908 Gabrielsen, A...... P631, P651, P740 Georgiou, N...... 546 Gorchakova, T...... P387, P904 Gachechiladze, D...... P632 Georgoula, M...... P956 Gordon, A...... 1453 Gaddi, A...... P346, P1292 Gerdes, N...... 150, 560, P677 Gordon, B...... 37 Gadi, R...... P469, P471 Gertow, K...... P316 Gordon, M-J...... 1029 Gadingan, D...... P1245 Getz, G...... 1507 Gords, P...... P928, 1102 Gagliardi, L...... P971 Geurts, P...... 1113 Gorshkova, I...... P925 Gaion, RM...... 1055 Ghalim, N...... P843, P1336 Gorshunska, M...... P1187, P1188 Gaito, S...... P1305 Gharipour, M...... P1296 Gorzalczany, S...... P936 Galard, R...... P1251 Ghosh, S...... P1250 Gosho, M...... P493 Galli, G...... P1416 Gialeraki, A...... P884 Goswami, N...... P763 Galli, S...... P263 Gianarkis, D...... P762 Goto, H...... P189, P693, P1124 Gambhir, S...... P480 Giandalia, A...... P369 Gotoh, T...... P789 Gamble, J...... 81 Gibbons, P...... P1390 Gotto, A...... P1390 Gan, L-M...... 131, P900, P911 Gibney, J...... P1176 Gotto, Jr., A...... 14, P670 Gan, S...... P954 Gibson, C...... P1162 Goudevenos, I...... P322 Gandelman, K...... P492 Gibson, R...... P463, P464 Gould, A...... P1390 Ganji, S...... P1156 Gibson III, F...... P167 Gouni-Berthold, I...... 585, P1164 Gao, S...... P900 Gidding, S...... 1070 Gourineni, V...... P1297 Garaulet, M...... 1479 Gidlund, M...... P189, P199, P693, P738, Gouverneur, M...... P215 Garcés, C...... P368 P751, P1124, P1210, Goycochea, M...... P1436 García-Otín, Á...... P462 P1211, P1402 Grüner, S...... 563 García-Otín, Á-L...... P838 Gielen, S...... 1080, P776 Graaf, J...... 43 Garces, C...... P364 Gigante, B...... P872, P873 Graaff, R...... P377 Garces, C...... P1312 Gijbels, M...... P187 Gracheva, E...... P709 Garcia, A...... P420 Gilabert, R...... 544, P842 Gracia, C...... P1408 Garcia, B...... P335 Gilardi, F...... P1416 Grady, D...... 1057 Garcia, M...... P652, P653 Gilchrist, S...... 602 Graesdal, A...... P840 Garcia, R...... P279 Gimbrone, M...... 499 Granata, A...... P223, P715, P716 García-Cardeña, G...... 558 Gin, P...... 141 Grande, P...... 119, 1081 Garcia Rios, A...... P839 Ginsberg, H...... 68, 1450 Grandi, E...... P346

P=Poster 192 Grandy, S...... P332 Halvorsen, B...... P683, P692 Henry, R...... 525 Grassi, D...... 1483 Hamada, N...... P166 Her, A-Y...... P390 Grassi, MC...... P1421 Hamamoto, Y...... P962 Heras, B...... P707, P708 Greene, M...... P879, P1134 Hameeteman, M...... P1365 Hergenc, G...... P1247 Grefhorst, A...... 1461 Hamiel, O...... P386 Herlitz, H...... P735 Gregg, R...... 85 Hamilton, J...... P167 Herman, A...... 1092, P203 Grenier, G...... P1415 Hamilton, S...... P986 Herman, D...... 121 Griffin, M...... 546 Han, A...... 1069 Hermanowski-Vosatka, A...... P1390 Griinari, M...... 1031 Han, K...... P1186 Hermansson, A...... P663 Grion, C...... P420 Han, SJ...... P878 Hernandez-Baldomero, I...... P302 Grobbee, D...... P952 Hanasaki, H...... P892 Hernandez-Leveille, M...... P1383 Grobee, D...... P953 Hansen, H...... 1453 Herrington, D...... 1485 Groen, A...... 536, 580, P158, P444 Hansen, U...... P183 Hertecant, J...... 141 Grundy, S...... 31, 573, 582, P947, P966, Hanson, M...... P773, P823, P1308 Hiemstra, P...... P700 P967, P1308 Hansson, G...... 64, 150, 560, P663, HIFMECH Consortium ...... P794 Grynberg, A...... P422, P451, P460 P664, P677 Higashikata, T...... P1387 Gualandro, D...... P1212 Hara, M...... P921 Higuchi, M...... P468, P476 Guaraldi, G...... P784, P808 Harada, T...... P932 Hiki, M...... P392, P1183 Guardamagna, O...... P826, P828 Harada-Shiba, M...... 516, P388, P389 Hilaire, L...... 1035 Guardiola, M...... P924 Harangi, M...... P1439 Hildebrand, R...... 620, 622, 1455, 1502, Guarino, A...... P795 Harats, D...... P386, P832 P1122 Guarner, V...... P196 Harris, W...... P755 Hilge, R...... P258 Gubina, ...... P1238 Hartford, M...... P779 Hilton, D...... 1042 Gudbjörnsdottir, S...... 592 Hartwich, J...... 555, P930 Hingorani, A...... 527, 1078, P813 Gudnason, V...... 114 Hasegawa, G...... P752 Hiramatsu, S...... P1315 Guedes, A...... P1252 Hasegawa, N...... P1269 Hirano, T...... 1469, P179, P1279, P1281 Guerci, B...... P422 Hasegawa, T...... P944 Hiraoka, S...... P246 Guevara, E...... P957 Hashida, H...... P1326 Hirata, K...... P962 Gui, Y...... P977 Hashimoto, H...... P919 Hirata, K-I...... P243, P248 Guillén, N...... P478 Hashimoto, N...... 76 Hirata, Y...... 510, 603, P197, P301, P1434 Guillem-Saiz, P...... P1278 Hata, Y...... P461, P1228 Hirayama, N...... P194, P195 Guillen, M...... P1278, P451 Hatsukami, T...... 610 Hirohata, S...... P376, P657 Guisasola, MC...... P1246 Hattori, H...... P1381 Hirose, K...... P1183 Gullestad, L...... P692 Havekes, L...... 533, P201, P479, P700, Hirowatari, Y...... P454, P1145 Gun, C...... P1331 P934, P980, P982 Hirschfeldova, K...... P358, P372 Guo, A...... P1442 Havekes, LM...... 142 Hirst, T...... P1438 Guo, F...... P226, P229, P240 Havel, P...... 1025, P407 Hisada, T...... P228 P440 Guo, L...... 623 Hayashi, C...... P167 Hiukka, A...... 70 Guo, S...... P963 Hayashi, E...... P245 Hjerpe, C...... P663, P664 Gurgel, A...... P341, P399 Hayashi, J...... 587, 1466, P768, P1217, Hlubik, J...... P1298 Gustafsson, T...... 1068, P905 P1258, P1357, P1361, P1362 Hlubik, P...... P1298, P1370 Guthrie, R...... 1014 Hayashida, K...... 521 Ho, Y-Y...... P825 Guyton, J...... 1006, 1007, P1443 Hayden, M...... P483 Hobbs, R...... 570 Guzik, T...... 562 Haykal, W...... P1224 Hodis, H...... 1052, P1127 Guzik, T...... P742 He, J P673 Hoefle, G...... P1255, P1338 Gylling, H...... 534, 537, 583, 585, 1082 He, X...... P207 Hoekstra, M...... 73, 518, 620, 622, 1455, Høyer-Hansen, G...... P289 Heather, A...... 1043, 1066, 1111, 1510, 1502, P982 Ha, J-W...... 1001, P390 P168, P655, P1154 Hof, D...... P268, P281 Haas, B...... 49 Hedblad, B...... 34 Hoffmann, M...... P391, P1373 Haas, G...... P1313, P1340, P1358, P1359 Hedin, U...... 1077, P219, P249, P629, Hoffmann, T...... P642 P631, P740 Haas, J...... 1105 Hofnagel, O...... P1389 Heeren, J...... 140, 549, 556, 1044, 1102, Habets, K...... P1122 Holanda, C...... P1133 1504, P656, P928 Hackeng, T...... P1365 Holdfeldt, P...... P905 Heffernan, K...... P338, P339, P916, P943 Hacking, D...... 1042 Holdt, L...... 1080, 1093 Hegele, R...... 136, 1021 Haeggström, J...... P648, P649 Hollak, C...... P365 Heine, R...... 525, P817 Haghjooy Javanmard, S...... P227 Holland, C...... P282 Heinecke, J...... 1109, 1457 Hagiata, S...... P704 Holleboom, A...... P365 Helfenstein, T...... P169, P688 Hagita, S...... P654 Holme, I...... 28, P824 Hellerstein, M...... P443, P1438, P1442 Hagiwara, N...... 63 Holst, J...... P409 Hellgren, L...... P1121 Hajjar, D...... 987, P670 Holven, K...... P683 Helmbold, A...... P764 Hakem, D...... P898, P1236, P1363 Homma, K...... 1097, P1280 Helou, R...... P1190 Hallenberger, S...... P202 Homma, S...... P944 Hendrikse, F...... 1085 Hallikainen, M...... 537, 583 Homma, T...... P245 Henneman, P...... 1477 Hallmans, G...... P1235 Homma, Y...... 1097, P1280 Henriquez, R...... P790

P=Poster 193 Hong, B...... P438, P445, P472 Hutri-Kahonen, N...... P869 Itoh, K...... P733 Hong, E...... P170 Hutten, B...... 48, 536, 576, 580, 1024, Itou, T...... P969 Hong, SJ...... P384 P378, P810, P841 Ittrich, H...... 140 Hopkins, P...... 45, 548 Hwalla, N...... 1023 Iwai, N...... 1478 Horan, M...... 1468 Hwang-Levine, J...... P1127 Iwanaga, T...... P1381 Horgan, G...... P1435 Hyodo, S...... P944 Iwata, F...... P921 Horinek, A...... P358 Hyon, M...... P1186 Iwata, T...... P1326 Horiuchi, H...... 1474 Hyry, M...... 64 Izar, M...... P169, P688, P751, P1244 Horng, H-E...... 609 Hyun, YJ...... P1248 Jönsson, S...... P705, P744 Horrevoets, A...... 59, P483 Hyvärinen, K...... P659, P1209 Jackson, C...... P290 Horton, J...... 147, 1461 Hyvönen, M...... 617 Jackson, K...... P459, P935, P1274 Horvath, K...... P369 Iannuzzo, G...... P1253 Jackuliakova, D...... P820 Hosokawa, T...... P658 Ibarra-Sanchez, M...... P747 Jacques, P...... 1485 Hou, H...... P211 Iborra, R...... P1133 Jaeger, B...... 1518 Hou, Y...... P254, P323 Ide, N...... P258, P1165 Jaffer, F...... P640 Hounslow, N...... P770 Iekushi, K...... P261 Jahagirdar, R...... 1453 Houttuijn Bloemendaal, F...... 1090 Iftimie, S...... P924 Jahangiri, A...... P1157 Hovingh, GK...... 121 Igarashi, M...... 1097, P1280 Jahangiri, M...... P224 Howard, B...... 52, 1050 Ihara, S...... P169, P688 Jahnel, H...... P1338 Howard, W...... 1050 Iiyama, M...... P375 Jakobs, C...... 525 Hoylaerts, M...... P164 Iizuka, I...... P743, P1231 Jakobsen, M...... P767 Hrbkova, J...... P1329 Iizuka, M...... 603, P695, P717, P722, Jakovljevic, B...... P1360 Hrncic, D...... P163 P1403, P1406, P1427, P1429, Jakovljevic, V...... P172, P1237 Hruba, D...... P1276 P1431, P1432, P1433, P1434, Jakulj, L...... 536, 580 Hsieh, C-L...... P255 Ikeda, Y...... 1478, P1381 Jan, E...... P1214 Hsu, A...... 1495 Ikegami, Y...... P1225 Jancar, S...... P1402 Hsu, J...... 1079 Ikewaki, K...... 137, P228, P418, P440, Jang, Y...... P390, P1248, P1428 Hsueh, W...... 31, 582, P947, P966, P802, P1306, P1407 Jansen, E...... P1187, P1188 P967, P1308 Iliopoulos, D...... P1123 Janssen, A...... 1024 Hu, B...... P1206, P1345 Ilyinskaya, O...... P188 Januszek, R...... P1155 Hu, L...... 533, P280, P700 Imagawa, M...... 1045, 1104 Jaramillo, P...... P885, P888 Hu, M...... 36, 1059, P486, P487, P1299 Imaizumi, T...... P428 Jarasuniene, D...... P498 Hu, W...... P260, P485 Imamura, F...... 1485 Jarauta, E...... 46, P360, P927, P1372 Hu, Y-W...... P983, P1125, P1126, P1132, Imholz, B...... 577 Jardini, M...... P1210, P1211 P1135, P1142, P1143 IMPROVE Study Group..... 112, P775, P899 Jargin, S...... P473, P958 Hua, X...... P648, P649 Inada, N...... P274, P1139 Jarinova, O...... 500 Huang, A...... P1146 Inagaki, M...... P410, P416, P430, Jarir, J...... P1336 P749, P862, P1378 Huang, C-C...... P379 Jasiewicz-Honkisz, B...... P742 Inagaki, N...... P962 Huang, C-S...... P1376 Jauhiainen, M...... 529, 614, 1056, P435, Huang, C-Y...... P696 Inagaki, Y...... P493 P637, P659, P1209, P1335 Huang, F...... P170 Inazu, A...... 66, 532, P851, P852, P859, Jelic-Ivanovic, Z...... P786 P860, P919, P979 Huang, G-H...... P822 Jenkins, A...... P986, P1202 Inoue, A...... P280 Huang, H...... P204 Jenkins, D...... 1026, P1411 Inoue, N...... P1183 Huang, L...... P211, P1148 Jensen, E...... 1007, P823 Insull, W...... P333 Huang, P...... 563, P306 Jensen, G...... P787 Investigators of the PSFH, ...... P829 Huang, P-H...... P155, P1166 Jensen, M...... P787 Ippoliti, A...... 564, P1181, P1182 Huang, S...... P306 Jeon, HJ...... P685 Ireland, H...... 522 Huang, T...... P453 Jeon, SH...... P1423 Isabelle, M...... P1160 Huang, W...... P310 Jeong, SJ...... P685 Ishibashi-Ueda, H...... 39 Huang, X-S...... 1059, P171, P785, P978, Jessup, W...... 622, 623, P732 Ishigami, M...... P410, P416, P430, P749, P1299 Jha, H...... P745 P862, P926, P1378 Huang, Y...... 566, P307 Ji, A 1108, P1157 Ishii, I...... P250, P718 Hubacek, J...... P358, P372, P882 Ji, HS...... 133 Ishii, N...... 624, P682, P719, P721, P981 Hueb, W...... P871 Ji, J P260 Ishii, S...... P1225 Huff, M...... 136 Ji, S-R...... P701 Ishikado, A...... P660 Huijgen, R...... 576, 577, P841, P870 Ji, Y P1424 Ishikawa, K...... P902 Hultgardh, A...... P186 Jia, D...... P253 Ishikawa, S...... P789 Hulthe, J...... P288, P905 Jialal, I...... 1505 Ishikawa, T...... P417 Humphries, S...... 522, 527, 1078, P753, Jiang, CQ...... P1342 Itabe, H...... P725 P794, P833, P874 Jiang, M...... P216 Ito, K...... 39, 1486, P454, P1145 Hunt, T...... P493 Jiang, P...... 1009, P333, P1444 Ito, N...... P1381 Hurme, R...... 105, 585, P1164 Jiang, S...... P752 Ito, T ...... P194, P195 Husche, C...... 1088 Jiang, T...... P254, P323 Ito, Y...... 39, 1469, P1279, P1281 Hussein, H...... 106 Jiang, W...... P438

P=Poster 194 Jiang, Z...... P173, P174, P225, P240, P284, Kamel, S...... P218 Kawakami, A...... P666 P307, P474, P661, P662, P720, P959, Kamili, A...... 601, 1031 Kawakami, H...... P1388 P1128, P1129, P1158 Kaminnyi, A...... P271 Kawano, H...... P494 Jiang, Z-S...... P229 Kamisaka, Y...... P725 Kawano, M...... P367 Jimenez-Gomez, Y...... P930 Kamiyama, K...... P406 Kawashiri, M-A...... 66, 532, P851, P852, Jimenez-Sosa, A...... P302 Kamiyama, M...... P1431 P859, P860, P919, P979 Jinnai, T...... 1474 Kanda, J...... 38 Kaya, B...... P818, P819 Jirsa, M...... P175, P1130 Kane, J...... 37 Kaya, Z...... P1247 Jo, S-H...... P875 Kaneda, T...... P1387 Kayaba, K...... P789 Jochemsen, B...... P377 Kang, DG...... P489 Kazakou, P...... P441 Joensen, A...... P455 Kang, ES...... P878 Keber, I...... P1174, P1197 Johansson, D...... P663, P664 Kang, I...... P424 Keech, A...... 1446 Johansson, J...... 1453, 1454 Kang, M...... 133 Keech, T...... P496 Johnson-Levonas, A...... P1392 Kang, S-M...... P390 Kelishadi, R...... P350, P1313 Jokiranta, S...... P637 Kang, Y...... P173 Kelly, D...... P667 Jonas, M...... P285, P286, P1115 Kanic, V...... P319 Kelly, E...... 1085 Jonasson, L...... P672, P744, P757 Kanjuh, V...... P1360, P1404 Kelly, M...... 517, 1014 Jones, P...... 517, 1083 Kanou, M...... P960 Kemp, C...... 588, P781 Jones-Burton, C...... P773 Kapadia, S...... P1386 Kempen, H...... 1456, P1438 Jongjirasiri, S...... P896 Kapanadze, K...... P765 Kendall, C...... 1026, P1411 Joosten, L...... P731 Karachentsev, I...... P1187, P1188 Keogh, J...... 95, 1484 Jorge-Galarza, E...... P434 Karaduman, M...... P665 Kerzner, B...... 515 Joshi, S...... P495 Karas, R...... 1009, 1054, P338, P339, Ketelhuth, D...... 560, P1124 Jossa, F...... P1253 P916, P943 Kettani, A...... P836, P843 Josselin, E...... P1122 Karasek, D...... P820 Khachigian, L...... 81, P668 Jou, S-H...... P876 Kardakaris, R...... P187 Khalifa, N...... P1267 Jovanova, S...... P373 Kardas, P...... P347, P766 Khalil, A...... P385, P1160, P1415 Juárez, J...... P1436 Kardassis, D...... 119, 1081, 1500 Khaw, K-T...... P810, P895 Juarez, I...... P955 Karlöf, E...... P249, P629 Khmelnitskaya, K...... P230 Juarez-Rojas, JG...... P434 Karlsson, M...... 524 Kholoosi, E...... P314 Judström, I...... P425 Karlsson, T...... P779 Khoo, C...... P937 Jukema, J...... 574, 1091, P982 Karlström, B...... 1476 Khosravi, A...... P746, P915 Jukema, JW...... 35 Karnialiuk, D...... P309 Khoury, D...... 1023 Jung, C...... P308, P1184, P1214 Karpf, D...... 515 Khouzami, V...... P357 Jung, IH...... P685 Karvanen, J...... P1275 Khunawat, P...... P1399 Jung, U...... 1028 Kasai, T...... P394 Kiani Mehr, G...... P746 Jung, UJ...... P456 Kashirina, S...... P709 Kiba, H...... P733 Jung, W-S...... P395 Kashiwagi, A...... P660 Kido, T...... 603, P695, P722, P1403, Junyent, M...... 544,1479, P366, P370, 462, Kashyap, M...... 567, 1002, 1009, P1156 P1406, P1427, P1433, P1434 P842, P857, P877 Kashyap, V...... 1496 Kiec-Wilk, B...... 555, P930 Juodelis, T...... P356 Kaski, JC...... P481, P1167 Kiene, V...... P945 Juonala, M...... P869 Kaspruk, G...... P296 Kikuchi, J...... P367 Juturu, V...... P1185 Kassai, A...... P1439 Kikuchi, R...... P730 Käkelä, R...... P659 Kastelein, J...... 22, 48, 104, 141, 536, 541, Kile, B...... 1042 Kabagambe, E...... 1479 552, 576, 577, 580, 608, 1024, Killion, S...... P1438, P1442 Kabakci, G...... P818, P819 1090, 1447, P213, P242, P365, Kim, CH...... P457 Kabiri, N...... P633 P378, P423, P475, P810, P841, Kim, C-H...... P1301, P1437 Kagimoto, S...... P962 P863, P870, P895 Kim, C-K...... P161 Kagota, S...... P269 Kastorini, C-M...... 58, P1168 Kim, D...... P1186 Kahonen, M...... P869 Katan, M...... 51, 54 Kim, DY...... 523 Kajii, E...... P789 Kateifides, .A...... 119 Kim, D-Y...... P685 Kajinami, K...... 33, P214, P1171 Kathiresan, S...... 34, 1075 Kim, E...... P736 Kakauridze, N...... P939, P1215 Kathrein, T...... P906 Kim, EJ...... 1038 Kakino, A...... P741 Katliorius, R...... P498 Kim, E-J...... P160 Kaklamanis, L...... 579 Kato, H...... P1387 Kim, HC...... P788 Kalantzi, K...... P322 Kato, L...... P942 Kim, HJ...... P875, P878, P1428, P457 Kallio, E...... P1209 Kato, M...... P902 Kim, H-S...... P875, P1186, P1437 Kalogeropoulos, N...... 55 Kato, R...... P797, P1405 Kim, J...... P162, P232, P1152 Kalopissis, A...... 1023 Katsanaki, A...... P1189, P1302, P1303 Kim, J-R...... P1291 Kalousova, M...... 1096, P1227, Katsuda, S...... P851 Kim, JW...... 1038 Kaloyianni, M...... P726 Kauhanen, D...... 105 Kim, JY...... P154, P626, P1248 Kamanna, V...... 1002, P1156 Kaul, S...... P634 Kim, J-Y...... P381 Kamath, P...... 56 Kawaguchi, A...... P1327 Kim, K...... P424, P1152, P1374 Kamath, S...... 1016 Kawai, Y...... P214 Kim, KC...... 133

P=Poster 195 Kim, K-I...... P160 Kocica, M...... P1360 Kouba, E...... 610 Kim, K-S...... P348 Kockx, M...... 623 Koukou, E...... P769 Kim, MA...... P457 Kodama, T...... 1098, P752 Kourounakis, A...... 579 Kim, M-A...... P1437 Koelle, P...... P258 Kourounakis, P...... 579 Kim, M-K...... P1437 Koenig, W...... 501 Koutete, D...... P769 Kim, P...... P671 Koga, T...... 1466, P768, P1217, P1357, Kovanen, P...... 617, P425, P659, P1209 Kim, S...... 424, 1374 P1361, P1362 Kovar, J...... P175, P1130 Kim, S-G...... P875 Koh, P...... 998 Kowaltowski, A...... P278 Kim, SH...... P457, P878 Koistinen, K...... 105 Kozlowska-Wojciechowska, M...... P380, Kim, S-H...... P1186, P1437 Koivuniemi, A...... 617 P1170 Kim, TS...... 23 Koizumi, J...... 532 Kraemer, F...... 1045 Kim, W...... 348, P348, 405 Kokubo, Y...... 1478 Kraft, H-G...... 1518 Kim, Y...... 186 Kolesnichenko, ...... P1238 Kraft, R...... 610 Kim, Y-M...... P161 Kolesnichenko, L...... P265, P270 Krajcovicova- Kudlackova, M...... P1344 Kimberlin, R...... P1392 Kolesnikova, L...... P264 Kralova Lesna, I...... P433 Kimura, H...... 1045 Koliakos, G...... P726 Krane, M...... 1511 Kimura, T...... 1045, 1104, 1474, P1356 Kollias, G...... P187 Krasova, N...... P1187, P1188 Kindt, I...... 576, P841, P845 Kolovou, G...... P827, P868 Krauss, J...... P325, P918, P1284 King, K...... 1496 Kolovou, V...... P827 Krauss, R...... 34, 515, 1471, P1392 Kinoshita, H.....624, P719, P721, P981, P417 Komindr, S...... P896 Krauze, J...... P889 Kiortsis, D...... P956 Komiyama, Y...... P261 Kravchun, N...... P1187, Kiphshidze, N...... P1234 Koncsos, P...... P1198 P1188 Kipor, S...... P1283 Kondo, H...... P802, P1306 Kremastinos, D...... P884 Kipshidze, N...... P765 Kondo, K...... 603, P695, P717, P722, P1403, Krempf, M...... 1067 Kirmizis, D...... P1425 P1406, P1427, P1429, P1431, Krettek, A...... P159 Kirsch, M...... P321 P1432, P1433, P1434, Krieger, E...... P1272, P1273 Kis, I ...... P239 Kondo, S...... P960 Krieger, J...... P871 Kishimoto, N...... P968, P1327 Koniari, E...... P856, P1400 Krieger, M...... 87, 148 Kishimoto, Y...... 603, P695, P717, P722, Konishi, M...... 1037 Krimbou, L...... 1453 P1403, P1406, P1427, P1429, Kono, M...... P436 Kris-Etherton, P...... 1084 P1431, P1432, P1433, P1434 Kono, T...... P1388 Krishna, R...... P1392 Kiss, A...... P1420 Konovalov, G...... 362, P1283 Krishnan, U...... P213 Kita, T...... 516, 521, 1474, P1356 Konstantinidis, D...... P726 Krisinger, M...... 614 Kitada, M...... P250, P718 Kontush, A...... 80, 82, 106, 1107 Kristensen, J...... 1463 Kitadate, K...... 603, P1432, P1434 Konya, G...... P239, P1137 Kritharides, L...... 623 Kitahara, M...... P718 Kooistra, T...... 142 Krneta, M...... P344 Kitakaze, M...... 76 Koolwijk, P...... 1090 Krook, A...... P1199 Kitamura, Y...... P458 Korbut, R...... 562, P742 Kroon, A...... P1365 Kitaoka, H...... P375 Kordalis, A...... P769 Krstevska, M...... P1169 Kitayama, M...... P214 Kornman, K...... 1509 Kruijt, JK...... 73 Kiyanagi, T...... P392, P1183 Korotvicka, M...... P961, P1414 Kuaschi, S...... P376 Kiyooka, T...... P394 Korporaal, S...... 1101 Kubar, A...... P665 Klegerman, M...... P282 Korstanje, R...... 114 Kubota, Y...... P1225 Klein, B...... P812, P822, P822, P1353 Kortsaris, A...... P481 Kugiene, R...... P498 Klein, I...... 1463 Koseki, H...... P246 Kuhlencordt, P...... 563 Klein, R...... P812, P822, P1353 Koshiyama, H...... P962 Kuhlisch, E...... P363 Klingenberg, R...... 150 Koskinas, K...... P285, P286, P1115 Kuiper, J...... 1101 Klishade, R...... P915 Kostakou, P...... P827 Kuivenhoven, J...... 118, 1101, P365, P423, Knapp, H...... 517 Kostapanos, M...... P383, P933, P1243 P475 Knopp, R...... P1272, P1273 Kostara, C...... P933 Kuivenhoven, J-A...... 1113 Knowlton, A...... P736 Kostka, H...... P363 Kukharchuk, V...... P271, P847, P970 Ko, C-N...... P395 Kostopoulos, C...... P231, P247 Kulinsky, ...... P1238 Ko, Y-G...... P390 Kostulas, N...... P680 Kullo, I...... 130 Koba, S...... 1469, P1279 Kotake, H...... P932 Kumari, M...... 527 Kobayashi, H...... P292, P725 Kotani, K...... P367, P789 Kume, A...... P392, P1183 Kobayashi, J...... 66, 532, P851, P852, Kotaska, K...... P883 Kume, N...... 521, P962 P859, P860, P919, P979 Kotelevtsev, Y...... 149 Kumon, Y...... P658 Kobayashi, S...... P243 Kotelianski, V...... 1461 Kunimatu, M...... P969, P269 Kobayashi, T...... P194, P195, P658 Kotkina, T...... P847 Kunnas, T...... P1275 Kobayashi, Y...... P394 Kotsaki, E...... P187 Kuo, C-L...... P891, P1240, P1375 Kobbelgaard, L...... P767 Kottwitz, K...... P1330 Kuo, F...... P310 Kobling, T...... P239, P1137 Kotula-Horowitz, K...... P1155 Kurabayashi, M...... P771, P772 Kocher, O...... 148 Kotur-Stevuljevic, J...... P786, P1369 Kurata, H...... P722, P1432, Kocherla, M...... 37 Kou, W-R...... 27 Kurata, T...... P1183

P=Poster 196 Kureishi-Bando, Y...... P176 Lansberg, P...... P845 Leon, A...... 615 Kuromori, Y...... P921 Lanska, V...... P358, P882 Leonard, D...... P879 Kurtanidze, T...... P939, P1215 Laothamatas, J...... P896 Lerario, A...... 1015 Kurth, J...... P202 Lares, M...... P1264, P1265 Leszczynska-Golabek, I...... 555 Kuruvilla, S...... 616 Larner, C...... P790 Leu, H-B...... P379 Kuryata, O...... P1224 LaRosa, J...... 26 Levels, J...... 1113 Kusachi, S...... P657 Larrañaga, N...... P1293 Levy, A...... 520 Kusano, J...... P417 Larsson, M...... 556 Levy, D...... 995 Kuusisto, J...... 537 Laschinsky, N...... P1330 Li, C ...... 81, 1070, P262 Kuuzya, M...... P280 Laskey, R...... P492 Li, D ...... P453 Kuvin, J...... P338, P339, P916, P943 Lasrich, D...... P656 Li, F ...... P698 Kuzuya, M...... 79 Lasunción, MA...... P368 Li, H ...... P234 Kvantaliani, T...... P669 Lattanzi, A...... P784 Li, J-J...... 27 Kwiterovich, P...... 1070, P357 Laurila, P-P...... 529 Li, K ...... 1069 Kwoh, T...... 104 Laurindo, F...... P713 Li, L 1...... 112, P485 Kwon, BS...... P685 Lauritano, EC...... P1220 Li, L-H...... P256, P974, P975, P976 Kwon, S...... 545 Lauro, R...... 564, P1181, P1182 Li, M...... 540, P1159 Kyaw Tun, T...... P1176 Lavant, E...... P777 Li, Q ...... P211 Kyle, R...... P732 Lavoie, A...... 1495, P1386 Li, S ...... P963 Kypreos, K...... 1498 Lawn, R...... 1047 Li, W...... P233, P287, P672, P705, P744 Lähdesmäki, K...... 617 Lazarevic, A...... P344 Li, X-D...... P815 López-Franco, Ó...... P678, P679, Lazaro, I...... P927 Li, X-H...... 1066, 1510, P655 López-Miranda, J...... 1476 Lazzerini, G...... P646 Li, X-X...... P983, P1125, P1126, P1132, López-Parra, V...... P679 Leander, K...... P872 P1135, P1142, P1143 López-Simón, L...... P364, P368, P1312 Lecic, N...... P917 Li, Y ...... P262, P323, P985, P1208 Lütjohann, D...... 1088 Lecube, A...... P1251 Li, Z ...... 73, 518, P484, P985 Laakso, M...... 49, 537 Leduc, M...... 122 Liang, C...... P259 Laaksonen, R...... 105, 585, P1164 Lee, B...... P232, P1152 Liao, C...... 1072 Laane, P...... P1347 Lee, B-S...... P154, P626 Liao, D...... P277, P723 Laaribi, O...... P334 Lee, C-H...... P255 Liao, J...... P266, P730, P791 Laatsch, A...... 549, P928 Lee, C-K...... 545 Liao, Q...... P673, P1207 Labrie, F...... 524 Lee, D...... 1499 Libby, P...... 64, 561, 611, 1048, 1071 Labudovic, D...... P373, P374 Lee, E-H...... 545 Liberopoulos, E...... P383, P674, P1243 Lachine, N...... P1267 Lee, HC...... P878 Lichtenstein, A...... 7, 535, 598, 1485 Laclaustra, M...... P370 Lee, HY...... P457 Liepold, E...... P1313 Lacorte, J-M...... 1023 Lee, H-Y...... P1301, P1437 Ligabue, G...... P784 Lacour, B...... P460 Lee, I-W...... P395 Ligabue, G...... P808 Ladenson, P...... 1463 Lee, J...... P232, P232, P1152 Lim, D...... P1186 Laghi, L...... P1216, P1300 Lee, JH...... P1248, P1428, P1428 Lim, DS...... P384 Lagor, W...... 80 Lee, JWY...... P154 Lim, HE...... 1038 Lagrost, L...... 1464 Lee, J-Y...... P154, P626 Lim, HH...... P1428 Lahl, K...... 150 Lee, K-H...... P381 Lima, M...... P331 Lahm, H...... 1511 Lee, K-M...... P384 Limbourg, T...... 1067 Lahrach, H...... P843 Lee, M...... P424, P1374 Lin, B...... P697, P891 Lai, C...... P370 Lee, MN...... P685 Lin, C-P...... 1039 Lai, C...... P857 Lee, MR...... P685 Lin, C-P...... P221 Lai, C-Q...... 1479, 1481, 1489, P366, P877, Lee, R...... P773 Lin, F-H...... P831 Laios, E...... P856, P1400 Lee, S...... P179, P424 Lin, F-Y...... P155, P696 Laitinen, S...... P659 Lee, S-H...... 1001, P381, P390, P1248 Lin, H-M...... P1375, P1376 Laletin, V...... P270 Lee, SU...... P489 Lin, J...... 582, 1006, P947, P948, P966, P967 Lam, K-BH...... P1342 Lee, V...... 36 Lin, S...... P310 Lam, TH...... P1342 Lee, W...... P671 Lin, S-J...... P155, P220, P266, P379, Lamarche, B...... 1506 Lee, Y...... 1072, P671 P696, P1166 Lambert, G...1458, P403, P844, P986, P1202 Lee, Y-C...... 1479, 1489, P877 Lin, S-Y...... P267 Lambert, M...... 1473 Lee-Rueckert, M...... P425 Lin, T-T...... P876, P1375 Lameris, J...... 608 Lehtimaki, T...... P869 Lin, Y-C...... P255 Lammers, B...... 518, 622, 1502 Lei, D...... P206, P207, P208 Lindén, D...... P482 Lamon, B...... P670 Lei, X...... P1131 Lindahl, C...... P824 Lamon-Fava, S...... 1003, P413 Leinonen, M...... P659 Lindahl, U...... P482 Lanas, C...... P885 Leite, AC...... P279 Lindegaard, M...... P404 Lanas, F...... P885, P888 Leiter, L...... P823, P948, P949 Lindholm, M...... P638 Landis, S...... P739 Lekakis, J...... P884 Lindner, H...... 1105 Lange, R...... 1511 Lemkes, B...... P215 Lindqvist, P...... P1304 Langford, C...... P213 Lentzas, I...... P1189, P1302, P1303 Lindstedt, E...... P482

P=Poster 197 Lindwall, G...... P1438 Ludwig, D...... 1027 Makiyama, T...... 1474 Ling, H...... P723 Luetjohann, D...... 581, P972 Makrygiannis, S...... 593, P300, P1352 Ling, W...... P1393 Lui, MY...... P825 Malaval, C...... 1501 Liong, E...... 1510, P168, P655 Luk, J...... P1392 Malczewska-Malec, M...... 555, P930 Liontou, C...... 58, P1168 Lukes, J...... P820 Malheiros, D...... P653 Lishner, M...... P760 Lukito, W...... P811 Mallat, Z...... 557 Littlejohn, T...... P470 Lund, K...... 1077, P629 Mallavia, B...... P679 Littlejohn III, T...... 515 Lundberg, A...... 560, P677 Mallen, M...... P842 Liu, B...... P152 Lundberg, J...... P308 Malt, U...... 102 Liu, C...... P209, P310 Lundbom, N...... 69 Malyshev, P...... P847 Liu, C-S... P876, P891, P1240, P1375, P1376 Lundbye-Christensen, S...... P447 Mamoto, R...... P411, P920 Liu, G...... P177 Lundegaard, C...... 119 Manabe, I...... 1046, P650 Liu, H...... P206, P208 Lund-Katz, S...... P436 Mancini, B...... P1218 Liu, J...... P438 Lundman, P...... 1068 Mandalia, S...... P714 Liu, J-C...... P222, P1412 Luo, L...... P254, P323, P484 Manea, A...... 1103 Liu, J-L...... P815 Lupascu, A...... P1220 Manfredi, A...... 1512 Liu, K...... P903 Lusis, A...... 1018 Mangavite, L...... 1471 Liu, L.P173, P174, P178, P204, P720, P1158 Lutjohann, D...... 536, 539, 580 Mangili, L...... P1382 Liu, M-L...... 540, P1159 Luyendyk, J...... P1162 Maniero, F...... P426, P427 Liu, P-L...... P221 Lyakishev, A...... P807 Manini, R...... P971 Liu, P-Y...... P266, P791 Lydia, G...... P364 Mannarino, E...... 1089, P1190 Liu, S...... P1390 Lynch, S...... P1249 Mannarino, M...... P1190 Liu, X...... P1146 Lynum, S...... P902 Manoharan, M...... 1461 Liu, X-H...... P983, P1125, P1126, P1132, Lytvyak, E...... 1519, P349 Manolopoulos, V...... 579 P1135, P1142, P1143 Müller, M...... P467 Manousakis, S...... P481 Liu, Y...... P234, P253, P260, P284, Mündlein, A...... P886, P887 Manson, J...... 1053 P323, P697 Maaijen, R...... 1477 Mansouri, B...... P1236 Livingstone, C...... P805 Maas, A...... P980 Mantilla, T...... P335 Liyanage, K...... P846 Mabuchi, H...... 18, 66, 99, 532, P851, P852, Manzoni, C...... 600, P1413 Ljunggren, Ö...... 524 P859, P860, P919, P979 Mar, G...... P310 Lloyd, M...... P763 Macedo, A...... P341 Marín, A...... P955 Lloyd-Jones, D...... P903 Macedo, M...... P1410 Maranhão, R...... 1015, P426, P427, P468, Lo Prete, A...... P426 Macfarlane, R...... P790, P798 P476, P946, P1397, P1394 Lobo, S...... P635 Machado, R...... 57 Marano, G...... P304 Lobo, S...... P675, P676 Machado-Lima, A...... P1133, P1139 Marchioli, R...... 503 Locsey, L...... P804, P1193 MacIntosh, G...... P1134 Marcovina, S...... 1019 Loffredo, L...... P1350 Mack, P...... 558 Marcoyannopoulou Fojas, H...... P324 Loft, S...... P894 Madani, H...... P633 Maree, R...... 1113 Logvinenko, A...... P1309 Madaric, A...... P1344 Marenzi, G...... P316 Lombardo, E...... P158 Madden, S...... 60 Mari, A...... P409 Lomsky, M...... P900 Madonna, R...... P646, P1140 Mariano, M...... P688 Loncar, S...... P344 Madrigal, A...... P167 Mariko, S...... P932 Long, G...... P697, P1206, P1345 Madrigal-Matute, J...... P678 Marin, C...... P930 Lookene, A...... 556 Maebuchi, D...... P1225 Marino, A...... 564 Lopes, J...... P688 Maeda, S...... P768, P1217, P1258, P1357, Markaki, I...... P680 Lopes, N...... P871 P1361, P1362 Marniemi, J...... P869 Lopez Miranda, J...... P839 Maeda, T...... P417 Marott, J...... P787 Lopez-Marure, R...... P747 Maegawa, H...... P660 Marotta, G...... P1253 Lopez-Miranda, J...... 555, P930, P931 Maejima, T...... P193 Marrero-Rodriguez, F...... P303 Lorenzo, A...... P335 Maekawa, M...... P367 Marschang, P...... 1105 Lorkowski, S...... P1389 Maekawa, T...... P210 Martín-Barallat, J...... P1290 Lottenberg, AM...... 57 Maffioli, .P ...... P783, P1266 Martínez de Lizarrondo, S...... P748 Loued, S...... P1160 Maghroon, M...... P350, P1296 Martínez González, J...... P748 Lovati, M...... 600, P1413 Maghzal, G...... 81 Martín-Ventura, JL...... P678 Lovegrove, J...... 1476 Magliaro, A...... P1524 Marte, A...... P1382 Lowe, R...... 582, P947, P948, P949, Magnolo, L...... 528 Marte, T...... P855, P1271, P1285, P1339 P966, P967 Mahley, R...... 566 Martelli, E...... 564, P1181, P1182 Lu, H...... 994 Mahzoni, P...... P633 Martinet, W...... 1092, P203 Lu, Y...... P1442 Maier, M...... 1461 Martinez, A...... 531, P858 Lu, Z-L...... 27 Majumdar, V...... P880 Martinez, L...... 1501, P793, P1212, P1385, Luaces, P...... P821 Mak, V...... 36, P486, P487 P1397, Lucas, A...... P460 Makarewicz-Wujec, M...... P1170 Martinez, T...... P806, P1252, P1282 Lucero, D...... P936 Maki, K...... P950 Martin-Fortea, P...... P360 Luchoomun, J...... P443, P1438, P1442 Makino, T...... P660 Martin-Moreno, J...... P364

P=Poster 198 Martino, F...... P1350 McEneny, J...... 602, P1161, P1176, P1395, Micuda, S...... P181, P1419 Maruyama, K...... P1191 P1426 Midwinter, R...... 81 Marziali, L...... P957, P1177 McGinty, A...... P1161 Miettinen, T...... 534, 537, 583, 1082 Mas, E...... P272 McGovern, M...... 569, 1004 Mihas, C...... P827 Masaki, H...... P261 McGrath, K...... 1066, 1510, P655 Mihulka, K...... 562 Masana, L...... 1089, P924, P927 McGregor, J...... P714, P950 Mikhailidis, D...... P827 Mascaro, O...... 129 McManus, B...... 1497 Milincic, Z...... P342 Maschi, O...... P1416 McMaster, C...... P1395 Milioni, V...... P382 Masciangelo, S...... P1277 McNeal, C...... P790, P798 Milionis, H...... P322, P383 Masenko, V...... P970 McNulty, M...... P190 Miltiadous, G...... P834, P835 Maseri, A...... 1512 McPherson, D...... P282 Minagawa, Y...... P320 Masoura, C...... 132, P359 McPherson, P...... P1161, P1395 Miname, M...... P1212, P1382, P1385, P1397 Masoura, K...... P361 McPherson, R...... 500 Minardi, F...... P795 Masson, D...... 1464 McRobb, L...... P168 Minetti, M...... P217 Masson, W...... P325, P918, P1284, P1368 Meagher, E...... 103 Minihane, A...... P935, P1274 Massy, Z...... P218 Mechirova, V...... 604 Minushkina, L...... P881 Masuda, D...... P410, P416, P430, P749, Medeiros, A...... P829 Miragoli, L...... P913 P862, P1378 Medina, A...... P1436 Mirdamadi, H...... P1439 Masuda, M...... P261 Medina, M...... 1471 Mirel, D...... 115 Masuo, K...... P1377 Medina-Urrutia, A...... P434 Mirkovic, I...... P1219 Mata, P...... 530, 575 Meijer, R...... P953 Mistrík, E...... P1226, 1096, P849, Mata Lopez, P...... P839 Meijers, J...... 1113 P951, P1227 Matchin, Y...... P807 Meikle, P...... P1134 Mitchel, Y...... P1390 Mateo, R...... 46, P842 Meitinger, T...... 546 Mitchenko, O...... P296, P627, P1309 Mateo-Gallego, R...... P360, P1372 Melamed, S...... P760 Mitlak, B...... 1057 Mathew, O...... P241 Melander, O...... 34, P777 Mitsios, J...... P276 Matikainen, N...... P922 Melguizo, E...... P1179 Mitsumata, M...... P238, P733 Matoba, T...... 65 Melino, G...... 564 Mitsuoka, H...... 521 Matsinkou, R...... P1116 Mello, E...... P653 Mitsutake, R...... 1036 Matsuda, H...... P741 Melnikov, M...... P327 Mittal, A...... P745 Matsuda, M...... 1097, P1280 Melo, I...... P1402 Miura, S-I...... 1036 Matsui, J...... P428, P1144, P1269 Melo, M...... P635 Miyamori, I...... 1045, 1104 Matsui, S...... 516 Memmos, D...... P1425 Miyana, R...... 1097 Matsuki, J...... P861, P428, P861, P1144, Mendivil, C...... 1472 Miyano, R...... P1280 P1269 Mendoza, E...... P1436 Miyata, M...... P166 Matsumoto, S...... 1046 Mendoza-Pérez, E...... P434 Miyauchi, K...... P392 Matsumoto, T...... P238, P733, 624, P719, Meneses-Lorente, G...... 1063 Miyazaki, A...... P292 P721, P981 Meng, Y...... 1069 Miyazaki, O...... P919 Matsuo, T...... P420 Menghini, R...... 564, P1181 Miyazaki, T...... 1071, P392, P1183 Matsuoka, H...... P1388 Mensink, R...... 539, 1032, 1085, 1087 Miyoshi, T...... P376, P657 Matsushita, K...... P1328 Mentaverri, R...... P218 Mizrahi, J...... 1061 Matsuzaki, M...... 504, 510, P301 Mereu, R...... P1266 Mizuguchi, K...... P494 Matsuzawa, Y...... 13, 516, P336 Merhige, M...... P879 Mizuno, K...... 30, P393 Mattei, J...... P366, P877 Merikanto, K...... 529, P1138 Mizuno, T...... P192, P244 Matthan, N...... 47, 139, 535 Merkel, M...... 1504, P928 Mizutani, T...... P733 Mattiello, A...... 1074, P1253 Meroño, T...... P957, P1177 Mo, Z-C...... P983, P1125, P1126, P1132, Matzouranis, G...... P1189, P1302, P1303 Meshkov, A...... P271, P847 P1135, P1142, P1143 Mauad, T...... P189, P652, P653, P693 Mesloub, D...... P898, P1236, P1363 Mocan, T...... P212 Maubaret, C...... P794, 1061 Messig, M...... 574, 589, P492 Modéer, T...... P648 Mauriello, A...... P1181 Meta, M...... 1050 Modena, MC...... P784, P808 Maurissen, L...... P1365 Metaxa, V...... P359 Moghadasian, M...... P192 Mavroidis, N...... P1400 Methe, H...... 1094, P681 Mogylnytska, L...... P1192 Mavrommatis, Y...... 1029 Methot, J...... 554, 1017, P848 Mohammadifard, N...... P350 Mayer, Jr., O...... P1329 Metso, J...... 1056, P435, P637 Mohammed, H...... P1442 Mayi, T...... P724 Metspalu, A...... P868 Mohan, V...... P816 Mazon, S...... P738 Meurs, I...... 620, 622, 1101, 1502, P1122 Mohebbi, Z...... P796, P850 Mazor-Aronovitch, K...... P832 Meuwese, M...... P215 Mohebi Nobandegani, Z...... P488 Mazzone, T...... 991 Meyer, B...... P463, P464 Molema, F...... P810 McBride, P...... 1070 Meyer, K...... P1418 Mollaki, V...... P1400 McCallum, J...... P1367 Meyer, Z...... P1365 Molyneux, S...... P497 McCarthy, C...... P235 Mezo, I...... P414 Mombelli, G...... 105, P1305 McCormick, S...... 1480, P185 Miah, S...... P705 Momiyama, Y...... P797, P1225, P1405 McCrindle, B...... 1070 Micallef, M...... 1086 Momo, CE...... P1268 Miche, E...... P758 Monello, A...... 1512

P=Poster 199 Monroy, A...... 1016 Munroe, P...... 996 Nakamura, Y...... P789, P962, P1180, Monsonis-Artero, J...... P1290 Muntendam, P...... P799 P1295, P1325 Monte, J...... P743, P1221, P1222, P1231 Murakami, H...... P428, P861, P1144, P1269 Nakandakare, E...... 57, 509, P686, P713, Montebello, E...... P646 Murakami, J...... 508 P1133, P1139 Monteiro, A...... P1210, P1211 Murakami, K...... 603, P695, P717, P722, Nakanishi, C...... 532, P851, P852, P860 Monteiro, C...... P751, P1244 P1403, P1406, P1427, P1429, Nakano, A...... P960 Montgomery, H...... P794 P1431, P1432, P1433, P1434 Nakano, H...... P910 Monti, M...... P343 Murakami, Y...... P660 Nakano, K...... P182 Montiel-Davalos, A...... P747 Murata, K...... P417 Nakano, M...... P682 Mooij, H...... P215, P406, P929 Murohara, T...... 79, 97, P176, P280, P730 Nakano, T...... 551, P407, P429, P859, P929 Moon, HD...... P407, P429 Murphy, A...... 1042 Nakatani, K...... P410, P416, P430, P749, Mooney, P...... P916 Murray, E...... P780 P862, P1378 Moore, D...... P798 Murray, P...... P935, P1274 Nakaya, K...... P228, P418, P440, P802, 1306, P1407 Moore, K...... 1504 Murri, M...... P923 Nakou, E...... P956, P1243 Mora, S...... 1470 Musi, N...... 1016 Nam, M...... P878 Moraes, R...... P1382 Musliner, T...... 581, P972 Nampoothiri, S...... P1373 Morales, M...... P793 Mustafa, F...... P293 Namura, M...... P458 Morato, T...... P341, P399 Mustafina, O...... P893 Nanjee, N...... 597 Morazzoni, P...... 600 Mustufa, F...... P1250 Narciso, R...... P1222 Moreira Monteiro, A...... P189 Musunuru, K...... 34 Naruszewicz, M...... P351, P380, P477, Moreno-Iribas, C...... P1293 Mutch, W...... P1435 P1170, P1420 Morgan, R...... P493 Myasoedova, V...... P387, P904 Narverud, I...... P683 Mori, A...... P919 Mylaswamy, M...... P490 Nascimento, H...... P806 Mori, M...... 532, P725 Myllyharju, J...... 64 Nasibullin, T...... P893 Mori, T...... P272 Myoishi, M...... 76 Nasiff, A...... P821 Mori, Y...... P179 Mysliwiec, M...... P1229, P1230 Nathan, D...... 989 Moriarty, P...... 50, P1162 Nørskov, M...... P894 Nathanson, G...... P1297 Morihara, N...... P258, P1165 Na, JO...... 1038 Naukkarinen, J...... P1138 Morikawa, A...... P946 Naba, H...... P494 Naumann, A...... P928 Morimoto, H...... P420 Nachtigal, P...... P181, P1419 Naumovski, N...... 1488 Morimoto, Y...... P176 Nadeem, N...... 602, P1426 Navarro, M...... P478 Morino, K...... P660 Naderi, G...... P800, P1118, P1398 Nawawi, H...... P273, P684, P1316 Morioka, N...... P1326 Nagafi, S...... P850 Nayeri, H...... P800 Morishita, R...... P261 Nagai, M...... 603, P695, P717, P722, Nazari, B...... P449 Morita, N...... P394 P1403, P1406, P1427, P1429, Nechev, L...... 1461 Morita, T...... P180 P1431, P1432, P1433, P1434 Nechevska, E...... P1270 Morita, Y...... 1097, P1280 Nagai, R...... 510, 618, 1046, P197, Nechevska, L...... P1270 Moriyama, T...... P926 P301, P650 Nechevski, M...... P1270 Morrisett, J...... P252 Nagaki, A...... P166 Nedeljkovic, S...... P342 Morrissey, J...... 522 Nagamine, T...... P406, P407, P429, P929 Nederveen, A...... 104, 608 Mortensen, A...... 1088 Nagano, M...... P1381 Nedog, V...... P319 Mosca, L...... 1057 Nagao, K...... P367 Neil, A...... P753 Moscatelli, B...... P343 Nagao, M...... P932 Nelson, A...... 607 Moshtaghian, J...... P1118, P1398 Nagaraja, D...... P880 Nematbakhsh, M...... P227 Mota, E...... P1294, P1334 Nagasaki, H...... P1346 Nemoto, N...... P245 Mota, M...... P1294, P1334 Nagata, D...... P197 Nenseter, M...... P683 Motoyama, A...... P1171 Nagata, T...... P411, P920 Neskudla, T...... P882 Mourelle, M...... P478 Nahrendorf, M...... 611 Nestel, P...... 988 Movva, R...... P471 Naito, M...... P752 Nesto, R...... 125 Muñoz-Garcia, B...... P678 Najafi, S...... P796 Netea, M...... P731 Muendlein, A...... P1256 Najafi Doulatabad, .S ...... P488 Neto, A...... P1211 Mugellini, A...... P783 Najafian, .J ...... P1175 Neto, W...... P942 Mugishima, H...... P921 Naji, A...... 591, P326 Neville, C...... 602 Muid, S...... P273, P684, P1316 Naji, F...... P319 Newcombe, P...... P813 Mukae, H...... P768, P1217, P1357, Nakagawa-Toyama, Y...... P410, P749, Newens, K...... P459 P1361, P1362 P862, P1378 Newman, J...... P755 Mukhamedova, N...... 1042, 1061, 1480 Nakajima, K...... 551, 1466, P406, P407, P408, P429, P461, P859, Neyer, U...... 1494 Mukhtar, R...... P1409 P929, P1228 Neykova, A...... P321 Mukose, A...... P660 Nakajima, T...... P210 Ng, M...... P825 Mulder, U...... P377 Nakajima, Y...... P408, P932 Ng, T...... 94, P412 Mulders, T...... P1364, P1365 Nakamichi, R...... P635 Ngondi, J...... P1116 Muller, J...... 60 Nakamura, H...... 30, P393 Niagolov, Y...... P452 Mulvihill, E...... 136 Nakamura, K...... P280 Nicholls, P...... P1395 Munhoz, D...... P341, P399 Nakamura, R...... 547, 1058, P738 P=Poster 200 Nicholls, S...... 89, 992, 1111, 1493, 1495, Nunes, C...... P738 Oliveira, M...... P1222 1496, P964, P965, P1154, P1386 Nunes, V...... 57 Oliveira, S...... P184 Nicholson, B...... P801 Nunes de Paiva, V...... P199 Oliveira, T...... P426, P427 Nicolaides, A...... 546 Nunez, I...... P842 Olkkonen, V...... 529, P711, P1138 Nicolle, C...... 1089 Nunziata, M...... 1074 Ollila, S...... 617 Niculescu, L...... 1022 Nwosu, Z...... P297 Olofsson, K...... P638 Nielsen, J...... P1121 O’Brien, E...... P190 Olofsson, S-O...... 625, P727 Nielsen, L...... P185, P186, P404, P1121 O’Brien, R...... 998 Olsen, JO...... P164 Nielsen, LB...... P419 O’Leary, D...... 542, P952, P953 Olson, F...... P288, P289, P735, P1254 Nielsen, P...... P1330 O’Malley, B...... P935, P1274 Olsson, A...... 1463, P824 Niesor, E...... 1061 Oba, J...... P1394 Olukman, M...... 998 Nieswandt, B...... 563 Oba, K...... P910 Onat, A...... P1247, P1359 Nieto, F...... P812, P1353 Obana, Y...... P245 Oncken, C...... 1515 Nieto, FJ...... P822 Obel, T...... P448, P450, P465 Ono, A...... P400 Nieuwdorp, M...... P215 Oben, J...... P1116, P1268 Ono, M...... P411, P920 Nieuwland, R...... P242 Oberdanner, J...... 1105 Ono, T...... P1225 Nijpels, G...... P409, P409 Obikane, H...... P238 Ooi, E...... 72, 139, P403, P412, P419, P432 Nikaidoh, A...... P394 Obregón, A...... P821 Opolski, G...... P1420 Nikitin, A...... P881, P897 Oda, M...... 1457 Oram, J...... 1457 Nikkari, S...... P1275 Odeyemi, K...... P938 Orbe, J...... P291, P748 Nikola, A...... P1400 Odgerel, T...... P367 Ordovas, J...... 1475, 1479, 1481, 1489, Nikolaishvili, N...... P939, P1215 Ödünc, N...... P391 P370, P857, P896, P931 Nikolaou, V...... P361 Offerman, E...... P201 Ordovas, JM...... P366, P877 Nikolic, D...... P342, P1237 Ogawa, A...... P466 Ordovas Muñoz, J...... P839 Nikopensius, T...... P868 Ogawa, H...... 29, 1037, P237, P336, P729 Orekhov, A...... P387, P904, P1136 Nilsson, J...... P636, P638, P699, P706, P777 Ogihara, T...... P1377 Orho-Melander, M...... 34 Nilsson, L...... P744 Ogura, M...... P418, P440, P802, Orillaza, M...... P1245 Nilsson, P...... 120, 592, P371 P1306, P1407 Orlando, G...... P784, P808 Nilsson, S...... 556 Oh, BH...... P457 Ornish, D...... 588, P781 Nimoityn, P...... 27 Oh, B-H...... P1437 Ortíz-Muñóz, G...... P679 Nishida, M...... P410, P416, P430, P749, Oh, DJ...... 1038 Ortega, H...... P364, P1312 P862, P926, P1378 Oh, GT...... P685 Ortega-Azorin, C...... P1322 Nishikawa, T...... 624, P719, P721, P981 Oh, H...... P424, P1374 Osada, J...... P478 Nishimichi, N...... P741 Oh, J-S...... 545 Osaka, M...... P654, P704 Nishio, Y...... P660 Ohama, T...... 1508, P410, P416, P430, Osborne, J...... P1383 Nisiwaki, Y...... P960 P749, P862, P1378 Oscarsson, J...... P482 Nissen, S...... 1495, P1386 Ohashi, R...... P752 Ose, L...... 102, P683, P853 Nissinen, M...... 583 Ohishi, M...... P892 Oshima, S...... 508 Nitschke, Y...... P183 Ohlsson, C...... 524, P159 Oshita, A...... P1388 Noakes, M...... 95 Öhman, J...... P638 Oslakovic, C...... 614 Noera, G...... P346 Ohmori, R...... P797, P1405 Osman, E...... P287 Noffsinger, V...... P1157 Ohni, M...... P461, P1228 Osman, M...... P1316 Noguchi, T...... 532, P851, P852, P860 Ohnishi, H...... P1217, P1258, P1361, P1362 Østerud, B...... P164 Nohara, A...... 66, 532, P851, P852, P859, Ohnishih, H...... P768 Ostli, L...... P840 P860, P919, P979 Ohnsorg, P...... P431 Oto, A...... P818, P819 Noji, Y...... 66 Ohsuzu, F...... P228, P418, P440, P797, Otokozawa, S...... 1466, P413, P1357, P1361 Nomura, M...... 584 P1405, P1407 Otsui, K...... P741 Nomura, S...... P236 Ohta, M...... P494, P1281 Ott, M...... P202 Nondahl, D...... P1353 Ohta, T...... P1346 Ottenhoff, R...... P158, P444 Nordestgaard, B...... 119, 1081, P894 Ohwaki, K...... P216, P394 Otterdal, K...... P683 Nordin Fredrikson, G...... P636 Okabayashi, I...... P902 Otvos, J...... P357 Nordzell, M...... 1091 Okada, T...... P458, P921 Ouadahi, N...... P1236, P1363 Nosikov, V...... P881, P897 Okajima, F...... P932 Ouchi, M...... P910 Notarbartolo, A...... 1089 Okamoto, N...... P394 Ouchi, N...... 97 Notsu, T...... P494 Okayama, H...... P1326 Out, R...... 518, 620, 622, 1502, P1122 Novakova, L...... P951 Okeahialam, B...... 134 Ouwehand, W...... P213 Novakovic, A...... P1404 Okita, K...... P1327 Ovchinnikova, O...... 64, 560 Novakovic, I...... P342 Okuda, L...... 509, P686 Overvad, K...... P455 Novelli, G...... 564 Okumura, K...... 79, P280 Oyama, P...... P652, P653 Novotny, D...... P820 Okutucu, S...... P818, P819 Ozasa, H...... P440, P802 Nowak, M...... P460 Olivecrona, G...... 556 Ozgur, G...... 96, P973 Nozaki, T...... P237 Oliveira, C...... 1015, P653 Ozkutlu, H...... P818, P819 Nuñez, I...... 544 Oliveira, H...... P274, P278, P279, P1396 Páramo, J...... P748 Nucci da Silva, L...... P1331 Oliveira, J...... P1205, P1318 Pütz, G...... P391

P=Poster 201 Packard, C...... 24, 35, P780 Park, M...... P424, P1374 Perman, J...... 625, P727, P308, P651, Padley, R...... 1009, P333, P1444 Park, S...... P424, P1374 P1184, P1199 Padmapriya, P...... 563 Park, S-M...... 545 Perret, B...... 1501 Padoveze, A...... P426, P427 Park, S-U...... P395 Perri, L...... P318 Pagácová, L...... P1213 Park, YB...... P457 Perron, P...... 1017 Paganoni, A...... 1512 Park, Y-B...... P1437 Persson, J...... 1068 Paglialunga, S...... 74, 146 Parnell, L...... 1479, 1481, 1489, P366, P370, Perttila, J...... P1138 Pagoni, S...... P769 P857, P877 Perunicic-Pekovic, G...... P1232 Paigen, B...... 122, 144 Parolini, C...... P913 Pesic, M...... P1320 Paik, JK...... P1428 Parris, M...... 103, P470, P471 Peter, I...... 35 Paim, B...... P274, P278, P1139 Parsa Mahjoob, M...... P311 Petersen, M...... P767 Pajukanta, P...... 49 Parving, H...... 582, P947, P966, P967, P1308 Peterson, K...... P480 Pal, R...... 148 Parving, H-H...... 31 Petit, L...... P218 Palacios, L...... 531 Parzonko, A...... P477 Petlichovski, A...... P1169 Palacios, L...... P858 Paschalidou, E...... P382 Petraki, M...... P441, P956 Palazhy, S...... 56 Pasparakis, M...... P187 Pettersson, K...... 1091, P779 Palella, F...... P784, P808 Passarelli, M...... 509, P686, P713, P1133, Pfeufer, A...... 546 Paletas, K...... P726 P1139 Pfister, .P ...... P223, P715 Palini, A...... 1512 Pasterkamp, G...... P483 Phatak, H...... P759 Pallas, J...... 527 Patel, P...... P640 Phelan, M...... 1063 Palma, I...... P1205, P1318 Patel, R...... P156 Phelan, N...... P1176 Palmen, J...... 527, 1078 Patellongi, I...... P811 Phillips, M...... 1041, P436 Palmer, M...... P952, P953, P964, P965 Patricio, P...... P1396 Phivthong-Ngam, L...... P1399 Palomo, M...... 1016 Patsch, J...... 1105 Phornchirasilp, S...... P1399 Palsauskaite, R...... P498 Pattou, F...... P724 Piaha, J...... P1213 Pam, S...... 134 Patvardhan, E...... P338, P339, P943 Piantadosi, C...... 607 Pan, W-H...... 1073 Pauciullo, P...... P1253 Picca, M...... P298 Panagiotakos, D...... 55, 58, P337, P803, Paul, J-L...... P422 Pichardo-Almarza, C...... P935 P1168 Paulsson Berne, G...... 1068, 1077, P631 Piegas, L...... P1408 Panagopoulos, P...... P1303 Pavão, ML...... P331 Pierre, J...... P1418 Panayiotou, A...... 546 Pavlidou, S...... P382 Pieterman, E...... P201, P980, P984 Panico, S...... 1074 Pawlak, D...... P1229, P1230 Pietraforte, D...... P217 Panico, S...... P1253 Pawlak, K...... P1229, P1230 Pignatelli, P...... P687, P1350 Panisello, J...... P1195 Paximadas, S...... P769 Pihlajamäki, J...... 537 Pankow, J...... P822, P1353 Pearson, T...... P739 Pilegaard, K...... 1088 Papadaki, H...... P231, P247 Pedersen, T...... 19, 28, P185, P186, P755 Pilios, J...... P769 Papadimitriou, L...... P359, P361 Pedragosa, A...... 129 Pille, J...... P1421 Papagianni, A...... P1425 Pedrelli, M...... 1456, P446 Pillois, X...... P867 Papathanasiou, A...... P1189 Pedrosa, A...... P708 Pimentel, I...... P1408 Paradise, E...... 538 Peinado-Onsurbe, J...... P1251 Pingsuthiwong, S...... P896 Paragh, G P239, P804, P1137, P1193, ‘ Pelikanova, T...... P882 Pinhas-Hamiel, O...... P832 P1198, P1439 Pella, D...... 604, P396 Pinheiro, L...... P1244 Paragh, Jr., G...... P239 Peloso, G...... 115 Pinna, C...... 1055 Paramo, J...... P291 Peltonen, L...... 529, P1138 Pinto, R...... 509, P1133, P1139 Paramsothy, P...... P1272, P1273 Peng, J...... P174, P198 Pinto, X...... 129 Pardina, E...... P1251 Peng, X...... P1158 Pinto-Blazquez, J...... P1290 Parga, J...... P1385 Pengal, S...... P328 Pinto-Sietsma, S...... P1364 Pargalava, N...... P669 Pengal, S...... P1241 Pinto-Sietsma, S-J...... P774, P1365 Parhofer, K...... 1067 Pengiran Burut, DF...... P805 Piotrowski, W...... P299, P340, P352 Parikh, S...... P694 Penko, M...... P319 Pirro, M...... P1190 Park, C...... P1186 Pensionerova, ...... P1238 Pirro, MR...... P343 Park, CG...... 1038 Peppes, V...... P868 Piskorz, D...... P1261 Park, CS...... P348 Peracino, A...... P1239 Pistea, A...... P638 Park, H...... P348 Perazolo, T...... P420 Pitha, J...... 590, P882 Park, HY...... P1248 Pereira, A...... P806, P871, P1252, P1282 Pithova, P...... P882 Park, J...... P232 Pereira, V...... P743 Pitsavos, C...... 55, 58, 132, P337, P359, Park, JE...... P154, P626, P1152 Perez, J...... P1195 P361, P803, P1168 Park, JG...... P685 Perez Jimenez, F...... P839 Piwonska, A...... P340, P352, P353, P354 Park, JH...... 1038 Perez Martinez, P...... P839 Piwonski, J...... P340, P352, P353, P354 Park, J-M...... 545, P395 Perez Ontiveros, JA...... P170 Pl, C 49 Park, JY...... P1428 Perez Perez, LM...... P1332, P1333, P1379 Place, K...... P1442 Park, K-H...... P1291, P1423 Perez-Jimenez, F...... P930, P931 Placido, A...... P341, P355 Park, K-Y...... P1384 Perez-Martinez, P...... 555, 1476, P930, P931 Plana, N...... P924, P927

P=Poster 202 Plat, J...... 539, 1085, 1087 Qu, S...... P153, P211, P226, P240, P1148 Reimers, G...... P290 Pleteneva, O...... P1173 Qu, S-L...... P229 Rein, P...... 1494, P855, P886, P887, P906, Plomgaard, P...... P419 Quax, P...... 1091 P945, P1255, P1256, P1285, P1311, Plotena, M...... P837 Queipo-Ortuño, MI...... P923 P1337, P1339 Ploug, T...... P1121 Queiroz, K...... P1221 Reinheimer, A...... P497 Plutzky, J...... 124, 511, P640 Queiroz, P...... P793 Reitz, R...... 34 Pocoví, M...... P838 Quevedo-Aguado, L...... P1290 Relvas, W...... P169, P688 Pocovi, M...... 531, P421, P842 Quiles, J...... P1167 Remaley, A..... 1065, 1100, 1458, 1465, P437 Poggi, L...... P913 Quinaglia e Silva, J...... P341, P398, P399, Ren, Z...... P153 Pokrovsky, S...... 362, P807, P1283 P400 Renner, J...... P938 Polak, J...... P903 Quinn, C...... 622, P732 Rensen, P...... 533, 1455, P444, P479, P700, Polakowska, M...... P299 Quintão, E...... 57, 509, 553 P980, P982 Polanski, S...... P1155 Quinto, B...... P635, P675, P676, P743, Rensen, PCN...... 142 Poledne, R...... 590, P175, P433, P1130 P1221, P1222, P1231 Rensing, K...... 1090 Polimeni, L...... P318 Röther, J...... 1067 Rentero, C...... 623 Polis, A...... 31, P1443 Racek, J...... P961, P1414 Restighini, N...... 535 Polisecki, E...... 35 Racie, T...... 1461 Retterstøl, K...... 102, P683, P1366 Poltorak, V...... P1187, P1188 Radenkovic, N...... P917 Reuwer, A...... P242 Polykratis, A...... P187 Radenkovic, S...... P917 Reuwer, A...... P810 Pomaro, D...... P169, P688 Rader, D...... 103, 612, 1060, P469, P470, Reyna, S...... 1016 Pongrapeeporn, K...... P1399 P471, P1297 Reyna-Asuncion, B...... P312 Poon, E...... P486, P487 Radhika, A...... P728 Reynaud, A...... P867 Poormoghadas, M...... P746 Radi, R...... P279 Rha, S-W...... 1038 Popa, S...... P1294, P1334 Radukhina, N...... P188 Rhodes, T...... P409 Poredoš, P...... P1223 Radzewitz, A...... P758 Rhomberg, S...... P1256 Porta, M...... 997 Rafecas, M...... P1430 Ribalta, J...... P924 Portoles, O...... P1322 Rafiei, .M ...... P1118 Ribeiro, A...... P675, P676 Porzio, O...... P1181, P1182 Rafnsson, A...... P651, P1184 Riccioni, G...... P1218 Posadas, C...... P1436 Raggi, P...... P784, P808 Richards, C...... P643 Posadas, R...... P1436 Rahim, P...... P633 Richards, M...... 143 Posadas-Romero, C...... P434 Rahmani, M...... 1497 Rickards, J...... P290 Posadas-Sanchez, R...... P434 Raichlen, J...... P952, P953 Ricketts, M-L...... 1482 Potì, F...... P446 Raicu, M...... 1103 Ridgway, E...... 1463 Potempa, L...... P701 Raitakari, O...... P869 Ridker, P...... 90, 1071 Pozniak, A...... P714 Rakugi, H...... P892, P1377 Riestra, P...... P364, P368, P1312 Prager, S...... P1272, P1273 Rallidis, L...... P884 Rigamonti, E...... P913 Prahl, U...... P905 Ramakrishnan, G...... P1401, 1504 Riganò, R...... P217, P639 Prahl-Abrahamsson, U...... P1254 Ramdani, B...... P843 Rijkelijkhuizen, J...... P409 Prasad, J...... P745 Ramires, J...... P1259, P1260 Rikitake, Y...... P243, P248 Praveen Kumar, S...... 616 Ramos Sanchez, E...... P189 Rimm, E...... 599, 1472 Prawitt, J...... P656 Ramos-Mozo, P...... P678 Rinninger, F...... 1504 Preti, P...... P783 Ranganna, K...... P241 Rios, F...... P1402 Price, C...... P470 Rani, U...... P191 Risch, L...... 1494 Price, J...... P866 Raposo, H...... P1396 Ritsatos, C...... P1352 Princen, H...... 533, P201, P202, P479, P482, Rasic-Markovic, A...... P163 Rizos, C...... P383 P980, P982, P984 Rasic-Milutinovic, Z...... P1232 Rizza, S...... P1181, P1182 Profumo, E...... P217, P639 Raslova, K...... P1371 Roach, P...... 1488 Province, M...... 1479 Rasmussen, L...... P455 Robaye, B...... 1501 Prusa, R...... P883 Rateri, D...... 1108 Robciuc, M...... P1335 Prusikova, M...... P358 Rato, Q...... P830 Robenek, H...... P1389 Pryjma, J...... P742 Ratto, R...... P1249 Roberston, M...... P780 Pu, X-Q...... P785 Ravani, A...... P901, P1307 Roberts, B...... 515 Puddey, I...... P272 Rayner, K...... P190 Robertson, A-K...... 64, P664 Puepet, F...... 134 Razuvaev, A...... 1077, P629 Robertson, M...... 35, 535 Pueyo, M...... P838 Reardon, C...... 1507, P628 Robertsson, P...... 131 Pullinger, C...... 37 Rebelo, I...... P1410 Robins, S...... 512 Punzi, H...... P1444 Reber, M...... P972 Robinson, J...... 31, 103, 582, P332, P947, Purnell, D...... 588, P781 Reckless, J...... P1409 P966, P967, P1308 Purroy, A...... P291 Reddy, K...... 40, P750, P756, P809 Rocco, D...... 509, P686 Pussinen, P...... P659, P1209 Reedy, M...... P763 Rocha, G...... P1205, P1318 Qin, J...... P1349 Reenu, ...... P191 Roche, H...... 555, 1476, P930 Qin, S...... P1194, P1440 Reiber, I...... P414 Rochitte, C...... P1382, P1385 Qiu, J...... P205, P254, P323 Reid, J...... P1409 Rodgers, K...... P290

P=Poster 203 Rodríguez, A...... P955 1112, 1510, P1151, 1008, 1111, Sang, H...... P1194, P1440 Rodríguez, C...... P748 1458, P290, P1154, P1202 Sangalli, L...... 1512 Rodríguez, J...... P748 Ryndel, M...... P289, P1254 Sangle, G...... P244, P275 Rodriguez, A...... 1099 Rzeszutko, M...... P1155 Sanguigni, V...... P687 Rodriguez, J...... P291, P1195 Söderlund, S...... 69, P922 Sano, M...... P245 Rodriguez Acuña, MI...... P1249 Saïle, R...... P843, P1336 Santas, J...... P1430 Rodriguez Ferreira Rivero, D...... P189 Saad, N...... P443 Santiago, F...... 81, 547 Rodriguez-Porcel, M...... P480 Saarela, J...... P435 Santoliquido, A...... P1220 Rodstein, S...... P470 Saava, M...... P1347 Santoro, L...... P1220 Roebroek, A...... 1102 Saavedra, N...... P885, P888 Santos, A...... P751 Roediger, A...... P759 Saberi, S...... P449 Santos, A...... P1244 Roelleke, E...... P758 Šabovic, M...... P1223 Santos, B...... P743 Rogowski, O...... P691, P754 Sacks, F...... 1071, 1472, P937 Santos, O...... P743, P1221, P1222, P1231 Rogus, J...... 1509 Sadeghi, M...... P800 Santos, R...... 5, 574, 589, 1034, P1212, Rohrer, L...... 1013, P431 Saeki, T...... P969 P1252, P1259, P1260, P1382, Roman, M...... 1050 Saely, C...... 1494, P855, P886, P887, P906, P1385, P1397, P1410 Romanov, V...... P296, P627, P1309 P945, P1255, P1256, P1271, Santos, S...... P398 Romeo, F...... P1181, P1182 P1285, P1310, P1311, P1337, Santos, T...... P830 Romijn, J...... 533, P479, P700, P982 P1338, P1339 Sanvarinta, Y...... P1399 Ronda, N...... P716 Saenz, P...... 575 Sapre, A...... P972 Roozme, S...... P314 Safranek, R...... P951 Sarecka-Hujar, B...... P889 Ros, E.....544, 606, P462, P842, P927, P1293 Sagara, M...... 1071 Sarg, B...... 1105 Rosas Lezama, MA...... P170 Saheb, S...... 106 Sarigianni, M...... P726 Roseboom, T...... 1024 SaiBabu, R...... P864 Sarrafzadegan, N...... P449, P915, P1296 Rosen, J...... 31, 582, P947, P966, P967, Saikku, P...... P659 Sartika, C...... P811 P1308 Saita, E...... 603, P695, P717, P722, Sasaki, C...... P725 Rosen, M...... 103 P1403, P1406,P1427, P1429, Sasaki, J...... 23 Rossebø, A...... 28 P1431, P1432, P1433, P1434, Sasaki, M...... P418, P1306, P1407 P921, P436 Rossi, L...... P304 Sasaki, T...... 79, P280 Saito, Y...... 504, 516, P216, P246, P718 Rossi, R...... P784, P808 Sasiela, W...... 103, P469, P470, P471 Saiz, C...... P1278 Rotllan, N...... P1441 Sata, M...... P197 Saja, K...... P1163 Rousseau-Ralliard, D...... P451 Satish Ramana, K...... P490 Saji, B...... P180 Rousset, X...... 1465, 37 Sato, I...... P411 Sajjadi, F...... P350 Rowney, M...... 601 Sato, K...... 63, 65 Sakai, T...... P1257 Roy, C...... 46 Sato, N...... 1486, P454, P1145 Sakamoto, M...... P1225 Roy, J...... 077, P629 Sato, R...... 33, P1171 Sakamoto, T...... 29 Roy Chowdhury, S...... P275 Satoh, K...... P428, P682 Sakashita, N...... P1131 Roytberg, G...... P854 Savchenko, A...... P752 Saku, K...... 1036, P1257 Rozman, F...... P1219 Savic, M...... P1237 Sakuma, I...... P968, P1327 Ruíz, G...... P955 Sawabe, M...... 63 Sakuma, N...... P969 Ruaño, G...... 37 Sawamura, T...... P741 Sakurabayashi, I...... P406 Ruan, C...... P484 Sawanobori, K...... P193, P292 Sakurabayshi, I...... P367 Ruan, J...... P338 Sawayama, Y...... 587, P768, P1217, P1258, Sakurai, Y...... P228 Ruan, R...... P262 P1357, P1361, P1362 Salah, S...... 1089 Rubal, B...... P764 Sawyer, J...... 145 Sala-Vila, A...... 544, P462 Rubba, F...... 1074 Sayegrih, K...... P460 Salazar, L...... P885, P888 Rubba, P...... 1074, P1253 Sayyedah, N...... P1316 Saldiva, P...... P652, P653 Rubino, F...... 91, 596 Sazonov, V...... P759, P1262 Salehzadeh, F...... P1199 Rubino, J...... P1390 Sberna, AL...... 1464 Salgado, W...... P1385 Rubinstein, J...... P156 Schäfer, A...... 563 Salminen, I...... P659 Rubio, ME...... P196 Schaap, M...... P242 Salomaa, V...... P1275 Rudd, J...... 61 Schaefer, E ...... 1468 Salpea, K...... P794, P874 Rudel, L...... 53, 145 Schaefer, EJ...... 33, 35, 47, 115, 139, 535, Salvadeo, S...... P782, P783, P1266 Rudnicki, M...... P630, P707 1003, 1466,1517, P369, P413, Salzmann, K...... 1105 P1357, P1361 Ruetti, S...... 1013 Samimi-Fard, S...... P302, P303 Schaefer, J...... 577 Ruggiero, L...... P316 Samovilova, N...... P709 Schaffer, L...... 540 Ruiz, A...... 575 Sanada, F...... P261 Scharf, R...... P317 Russo, G...... P369 Sanclemente, C...... 129 Scheffer, P...... 525, P409, P817 Rutkevich, P...... P188 Sandberg, W...... P692 Scheja, L...... P1196 Rutsch, F...... P183 Sanders, J...... P794 Schewe, T...... P391 Rybar, R...... 604, P396 Sandhu, M...... P895 Schiavone, D...... P1140 Rye, K-A...... 82, 1043, 1066, 1095, 1110, Sandoval, J...... P416, P430, P862 Schillaci, G...... P1190

P=Poster 204 Schilling, S...... P642, P689 Shapiro, R...... P397 Sihlbom, C...... P288 Schindler, T...... 1468 Shargorodsky, M...... P814 Silander, K...... P1275 Schmidt, C...... P345, P905, P1254 Sharkhun, O...... P854 Silosi, I...... P1341 Schmidt, E...... P447, P448, P450, P455, Sharma, A...... P490, P495 Silva, C...... P1408 P465, P767 Sharma, M...... P495 Silva, J...... P946 Schmidt, K...... 1518 Sharma, S...... P191, P694 Silva, L...... P398, P652, P653 Schneider, M...... P758 Shaw, G...... 1509 Silva, R...... 80 Schneider, W...... P216, P435 Shearer, G...... P755 Silvani, G...... P971 Schoenhagen, P...... P1386 Sheather, S...... P790 Silveira, L...... P1436 Scholz, M...... 1080, P776 Shell-Steven, A...... 1468 Sima, A...... 1022, 1103, P1141 Schoppen, S...... P364, P368, P1312 Shemyakin, A...... P1184, P1199 Simard, T...... P190 Schou, J...... 1081 Shen, G...... P192, P244, P275 Simes, J...... P496 Schrøder, M...... 1088 Shen, J...... 1479, 1489, P370, P877 Simeunovic, D...... P342 Schröttle, A...... 563 Shen, J-L...... P255 Simeunovic, S...... P342 Schreier, L...... 67, P936, P1177 Shen, L...... P453 Simionescu, M...... 1103, P1141 Schubert, C...... P812, P822 Shepherd, J...... 20, 26, 35, 535 Simon, J...... P1329 Schueller, O...... 538 Shi, G-P...... 561, P280 Simone, J...... P1331 Schuler, G...... 1080 Shibata, H...... P193, P292 Simonen, P...... 537, 583 Schuler, G...... P776 Shibata, R...... 97, P176 Simons, J...... P1367 Schwandt, P...... P1313, P1340, P1358, P1359 Shibuya, K...... P292 Simons, L...... P1367 Schwartz, S...... 515 Shiga, Y...... 1036 Simpson, W...... P1435 Schwentek, A...... P1373 Shigemi, S...... P1388 Sinclair, A...... P463, P464 Schwertfeger, M...... 1067 Shiina, Y...... 1097, P1280 Singh, M...... P750, P756, P809 Schwocho, L...... P863 Shimada, K...... P392, P1183 Singh, R...... P293, P1250 Scordo, W...... P325, P918, P1284, P1368 Shimizu, K...... 611 Singh, S...... 130 Scott, R...... P497 Shimizu, T...... P458 Siniawski, D...... P325, P918, P1284, P1368 Šebeštjen, M...... P1174, P1197 Shimokado, K...... P654, P666 Sirtori, C...... 105, 120, P371, P901, P913, Sedova, M...... P372 Shimokawa, H...... 39, 77, P682 P1305 Seed, M...... P753 Shimooki, O...... P320 Sitnikova, M...... P230 Segretto, H...... P688 Shimoyama, T...... P246 Sivapalaratnam, S...... 1024, P213, P378 Seidman, J...... 121 Shin, B-S...... P890 Sjoquist, P-O...... P308 Seino, Y...... P962 Shin, D-G...... P1291 Skouma, A...... P856 Seip, R...... 37 Shin, E...... P424, P1374 Skouma, A...... P1400 Šejda, T...... P1213 Shin, HH...... 523, P1172 Skoumas, I...... 58, 132, P359, P1168 Sekine, K...... P458 Shin, J-H...... P1186 Skoumas, J...... P361 Sekine, O...... P660 Shin, M-J...... 1001 Skoumas, Y...... P337 Selathurai, A...... P690 Shingu, T...... P236 Skrbic, R...... P344 Seljeflot, .I...... 1030, P1380 Shinichi, O...... P932 Skurnik, M...... P637 Sellers, D...... P667 Shinozuka, K...... P269 Slanarova, M...... P1419 Semenova, A...... P970 Shintani, S...... P176 Sleep, D...... 517, 1014 Seo, HS...... 1038 Shiomi, M...... P194, P195 Slim, A...... P764 Serafinovich, .I...... P313, P907 Shirasawa, T...... P166 Smedbakken, L...... P692 Serebryakova, O...... P854 Shirassu, M...... P793 Smeeth, L...... 1078 Seres, I...... P239, P804, P1137, P1193, Shirokov, R...... P271 Smeeth, L...... P813 P1198, P1439 Shiroto, T...... 39 Smelt, A...... 1477 Serfinovich, .I...... P309 Shishkina, V...... P188 Smirnov, A...... P1136 Sergeeva, ...... P1238 Shiu, S...... P439, P1203 Smit, A...... P377 Sergeeva, E...... P265 Shlyakhto, E...... 64, P230 Smit, J...... 533 Sergeeva, M...... P265 Shoelson, S...... 10110, P700 Smith, A...... P935, P1274 Sergienko, I...... P970 Shojaie, M...... P311, P314 Smith, C...... P366, P370, P857, P877 Serpytis, P...... P356, P498 Shouda, M...... P1328 Smith, J...... 1079 Sethi, A...... P437 Shrikanth, T...... P490 Smith, S...... 1 Setze, C...... 517, 1014 Shry, E...... P764 Smyth, I...... 1042 Sever, P...... 1514 Shurin, S...... 11 Snyder, J...... P397 Shafeh, R...... P1233 Shuvalova, J...... P271 Soares, S...... P652, P653, P693 Shah, A...... 582, 1006, P823, P947, P948, Si, S ...... P438, P445, 472 Sobenin, I...... P387, P904, P1136 P966, P967, P1308 Siadat, Z...... P915, P1175, P1296 Sobotka, L...... P1226 Shah, S...... 527, P397, P1390 Sidorenko, B...... P897 Sofat, R...... 1064 Shah, T...... 527, P813 Siebelink, E...... 51 54 Sohn, DW...... P457 Shamoun, F...... P156 Siegel, E...... P391 Sohn, D-W...... P1437 Shao, B...... 1457 Siest, G...... P1153 Solanas, M...... P421, P838, P1372 Shao, M...... P1386 Sievenpiper, J...... 1026, P1411 Solich, P...... P951 Shapira, I...... P691, P754 Sigurdsson, S...... 114 Solichova, D...... P181, P849, P951

P=Poster 205 Solini, A...... P1181 Stehouwer, C...... 525, P817, 1365 Suzuki, J...... 1045, 1104 Sonderegger, G...... P886, P887, P1256 Stein, E...... P950 Suzuki, K...... 603, P695, P717, P722, Sone, H...... P722 Steinberg, D...... 1114 P910, P1403, P1406, P1427, P1429, Song, H...... P280 Steinerova, A...... P961, 1414 P1431, P1432, P1433, P1434 Song, J...... 1057 Stella, A...... P1216 Suzuki, S...... P969 Song, J-N...... P815 Stender, S...... P770 Suzuki, T...... P902, P910 Song, Y...... P959 Stentarelli, C...... P784 Suzuki, Y...... P466, P1225 Sonmez, A...... 96, P973 Stepanavage, M...... P1390 Svedlund, S...... 131 Soria, E...... P196 Stephens, J...... P874 Svetlikov, A...... P327 Sorice, M...... P639 Stewart, A...... 500 Sviridov, D...... 1042, 1061, 1480 Sorli, J...... P1322 Stfanadis, C...... P803 Svobodova, H...... P372 Sorroche, P...... P325, P918, P1284, P1368 Stienstra, R...... P731 Swedenborg, J...... P631 Soska, V...... P1276 Stocker, R...... 81 Sweetnam, P...... 538 Sosland, R...... 50 Stof, L...... P1236 Swirski, F...... 611 Soto, Y...... P821 Stojsic, D...... P1200 Sygnowska, E...... P354 Sotoodah, A...... P314 Stojsic, J...... P1200 Sylvänne, T...... P1164 Sotoodeh Jahromi, A...... P311 Stoldt, V...... P317 Syrigos, D...... P769 Sourides, V...... P884 Stolzenbach, J...... 517 Szabo, L...... P804 Sourij, H...... P1338 Stomeo, G...... P446 Szczeklik, A...... P1155 Sousa, T...... P184 Stone, N...... 2, 571 Szlanka, B...... P1193 Souza, H...... P630 Stone, P...... P285, P286, P1115 Szpunar, S...... P737 Souza, R...... P1180, P1295, P1325 Stonick, J...... 1065 Sztanek, F...... P804, P1193, P1198, P1439 Spagnoli, L...... P1181 Stonik, J...... 1465, P437 Szucs, T...... P759 Sparkes, C...... P463, P464 Stozicky, F...... P961, P1414 Szymanowski, A...... P757 Sparwasser, T...... 150 Straka, R...... 1479 Tabas, I...... 619 Spasic, N...... P1369 Stritecka, H...... P1298, P1370 Tabet, F...... 1043, 1458, P1202 Spasic, S...... P786, P1369 Strodthoff, D...... 150 Tabeta, K...... P210 Spencer, H...... P761 Stroes, E...... 104, 541, 608, P215, P365, Tada, H...... 532, P851, P852, P859, P860 Spiroglou, S...... P231, P247 P423, P475 Tada, N...... 1486, P415, P454, P1145 Spiroski, M...... P1169 Strunk, M...... P838 Tada, Y...... P269 Spisak, L...... P961 Stulc, T...... P358 Taggart, W...... 581, P972 Spisakova, M...... P961 Su, J ...... P648, P649 Taguchi, C...... 603, P695, P722, P1403, Sposito, A...... P341, P355, P398, P399, Su, S-L...... P891 P1406, P1427, P1433, P1434 P400, P806, P1259, P1260 Su, T ...... 1072 Taguchi, M...... P926 Sprecher, D...... 72, 139, P432 Suchanek, P...... P433 Taheri, S...... P1342 Spustova, V...... P1344 Suda, T...... P428, P861, P1144, P1269 Taib, R...... P1316 Squellerio, I...... P795, P1307 Sudhakaran, P...... P728, P1163 Taira, C...... P936 Srinivasan, A...... 616 Sudhop, T...... P972 Taira, T...... P1279 Sritara, P...... P896 Sueyoshi, S...... P733 Takada, M...... 532 Srivastava, B...... P816, P745 Sugamura, K...... P682, P729 Takagi, A...... 1478, P1381 Srivastava, RA...... P694 Sugihara, N...... 603, P695, P717, P722, Takahashi, H...... P261 Srojidinova, N...... P1314 P1403, P1406, P1427, P1429, Takahashi, J...... 39 Ståhlman, M...... 70, P1164 P1431, P1432, P1433, P1434 Takahashi, K...... P658 Staels, B...... 72, 513, P724 Sugimoto, T...... P1378 Takahashi, N...... P210, P652, P653 Stakos, D...... P481 Sugimoto, Y...... P960 Takahashi, S...... 1045, 1104 Stalenhoef, A...... 47, 577, P731 Sugisawa, T...... P388, P389 Takai, Y...... P243, P248 Stamatelatou, M...... P827 Sugiura, T...... P658 Takano, A...... P725 Stambolsky, D...... P847 Sugiyama, S...... 1037, P237, P336, P729 Takano, T...... P725 Stanciulescu, C...... P1294, P1334 Suh, J-W...... 1462, P160 Takase, M...... P458 Stancu, C...... 1103, P1141 Suh, S-H...... P161 Takata, K...... P415, P1346 Stanek, V...... 590 Sullivan, D...... P496 Takata, M...... P851, P852, P859, P860 Stanhope, K...... 1025, P407 Sumiyoshi, K...... P392, P1183 Takata, Y...... P1326 Stanko, U...... P908 Sun, J...... P190 Takeichi, S...... P408 Stanojlovic, O...... P163 Sundh, V...... P1304 Takemoto, M...... P246 Stark, J...... P443 Suneja, S...... P1201 Takemura, Y...... P892 Stavek, P...... 590 Sung, F...... 1072 Takenaka, K...... 603, P695, P717, P722, Stef, M...... 531, P858 Sung, J...... P1186 P1403, P1406, P1427, P1429, P1431, Stefanadis, C...... 55, 58, 132, 337, P359, Sunitha, V...... P1373 P1432, P1433, P1434 P361, P1168 Sura, T...... P896 Takeoka, Y...... P417 Stefansson...... 506 Susic, V...... P163 Takeshita, K...... P730 Steg, G...... 1067 Sutherland, B...... 136 Taketa, K...... 624, P719, P721, P981 Stegger, J...... P465 Suwa, J...... P1315 Takeuchi, H...... P466 Stegmayr, B...... P1235 Suzuki, H...... P944 Takeya, M...... P1131

P=Poster 206 Taki, H...... P1336 Tentes, I...... P481 Toyama, Y...... P416, P430 Takiguchi, S...... P802, P1306, P1407 Terada, E...... P180 Toyozaki, M...... 603, P695, P717, P722, Takiguchi, S-I...... P418, P440 Teramoto, T...... 4, 613, P417 P1403, P1406, P1427, P1429, Takikawa, M...... P394 Terao, Y...... P228, P418, P440, P802, P1431, 1432, P1433, P1434 Takikawa, Y...... P394 P1306, P1407 Trøseid, M...... 1030, P1380 Tall, A...... 1445 Tereshina, E...... P1173 Trabattoni, D...... P315 Talmud, P...... 527, 1078, P874 Terrinoni, A...... 564 Tracey, K...... P677 Tam, X...... P1203 Terry, J...... 610 Tran, P-K...... P219 Tamaki, T...... P718 Tershakovec, A...... 31, 573, 582, 1006, Tran-Lundmark, K...... P219 Tamasawa, N...... P428, P861, P1144, P1269 1007, P773, P823, P947, P948, Trave, P...... P1195 Tamhane, U...... P156 P949, P966, P967, P1308, P1443 Tremblay, G...... P848 Tamsma, J...... P700 Tesche, C...... 1511 Tremoli, E...... 112, 543, P263, P315, P316, Tan, J...... 1510, P168, P655 Teupser, D...... 1080, 1093, 1503, P467, P775, P795, P899, P901, P1307 Tan, K...... P439, P1203 P776, P928 Trento, M...... 997 Tanabe, J...... P428, P861, P1144, P1269 Thakkar, R...... 1009, P333, P1444, P864 Tribble, D...... 104 Tanabe, S...... P193, P292 Theodoraki, E...... P868 Trigatti, B...... P165, P643 Tanaka, A...... P413, P1279 Therond, P...... 82 Trimarco, B...... 1487 Tanaka, K...... P197, P962 Theuwissen, E...... 539 Trip, M...... 577, P213, P378, P895 Tanaka, M...... 521, P436 Thiery, J...... 1080, 1093, 1503, P467, P776 Tripathy, D...... 1016 Tanaka, T...... 1098 Thies, F...... P1435 Trombetta, I...... P940, P941 Tandy, S...... 601, 1031 Thomaidi, A...... P481 Tromsdorf, U...... 140 Tang, C...... P204, P205, P253, P284, P723, Thomas, G...... P1342 Tsai, C-H...... P255 P1128, P1148 Thomas, W...... P162 Tsai, H-Y...... P155, P696 Tang, C-K...... P983, P1125, P1126, P1132, Thompson, A...... P459 Tsai, M...... 1479, P370, P812, P857 P1135, P1142, P1143 Thompson, G...... 101 Tsaih, S-W...... 122 Tang, M...... P215 Thompson, P...... 37, 100 Tsao, F...... P1418 Tang, S...... P723 Thorlacius, H...... P638 Tsapas, A...... P726 Tang, Z...... P174, P198, P720, P1158 Thorsby, P...... P683 Tselepis, A...... P276, P322, P441, P674, Tani, M...... 603, P695, P717, P722, P1403, Thorsson, B...... 114 P933, P956 P1406, P1427, P1429, P1431, Thurison Sørensen, T...... P289 Tseng, C-H...... P1343 P1432, P1433, P1434 Thymiakou, E...... 1081, 1500 Tseng, C-N...... P249 Tanigaki, T...... 1097, P1280 Tian, M...... P333 Tseng, W...... 558 Taniguchi, A...... P962 Tichy, L...... P837 Tsiklauri, P...... P669 Taniguchi, H...... P797, P1405 Tierney, AC...... 555 Tsimihodimos, V...... P933 Tanimura, K...... P932 Tighe, P...... P1435 Tsinajinnie, D...... P628 Taniyama, Y...... P261 Tikkanen, M...... 1056 Tsiros, G...... P1303 Tapan, S...... 96, P973 Timasheva, Y...... P893 Tsokanis, A...... P361 Tararak, E...... P188, P200, P251, P709 Timinouni, M...... P843 Tsoutsou, E...... P1400 Tarasenko, L...... 574, 589 Tinahones, F...... P923 Tsubakio-Yamamoto, K...... 1508, P410, Tarasov, K...... 105, 585 Tivesten, Å...... 524, P159 P749, P862, P1378 Tardif, J...... 1492 Tjonneland, A...... P455 Tsuburaya, R...... 39 Tardivel, S...... P460 Tobias, P...... 143 Tsuchida, M...... P851, P852, P860 Tartaglia, A...... P971 Todorova, B...... P374 Tsuda, K...... P962 Tartagni, E...... P1300 Toedter, K...... P1196 Tsui, T...... P486, P487 Tarugi, P...... 120, 528, P371 Toet, K...... 142 Tsuji, S...... P411, P920 Tasci, I...... 96, P973 Toh, B-H...... P690 Tsukamoto, O...... 76 Taskinen, M-R...... 69, 70, P922, P1138 Tokgözoglu, L...... 9, P818, P819 Tsukie, N...... P182 Tateishi, S...... P411 Toma, L...... P1141 Tsushima, M...... P909 Tateishi, S...... P920 Tomassini, J...... 31, 573, 582, 1006, 1007, Tuchida, M...... 532 Tavasoli, A...... P746 P1308, P1443 Tuck, M...... P1377 Tavridou, A...... 579 Tome, A...... P1180, P1295, P1325 Tucker, K...... 1489, P366, P877, P1351 Tawa, H...... P248 Tomlinson, B...... 36, P486, P487 Tulemisov, E...... P1147 Taylor, G...... P1409 Tomoike, H...... 76, 1478, P388, P389 Tulumen, E...... P818, P819 Tchaiko, L...... P1347 Tomono, S...... 508 Tuo, Q...... P277 Tchoua, U...... 1061 Tondi, P...... P1220 Tuomainen, A...... P659 Teeffelen, J...... P1364 Tong, W...... 538 Turnbull, L...... 1063 Teeling, P...... P644, P645 Tonini, G...... P199 Turner, S...... P437, P443, P1438, P1442 Teerlink, T...... 525, P409, P817 Toren, A...... P386 Turnock, D...... P491 Tei, C...... P166 Tormo, M...... P1293 Tutihashi, E...... P1259, P1260 Tejedor, D...... 531, P838, P842, P858 Torrejon, C...... 1028 Tuzcu, E...... 1495, P1386 Telle-Hansen, V...... P683 Torti, F...... P223 Tweed, T...... P822 Tellis, N...... P1352 Tosheska Trajkovska, K...... P373, P374 Twickler, M...... P242, P810, P863 Tengku Ismail, TS...... P1316 Totani, N...... P411, P920 Twickler, T...... 1090

P=Poster 207 Tybjærg-Hansen, A...... 117, 119, 1081, P894 van Wijk, D...... P483 Vissers, M...... 48, 536, 576, 580, 1024, P841 Tyllis, T...... 546 van Wissen, S...... P863 Visvikis-Siest, S...... P1153 Tzallas, C...... P933 VanBavel, E...... 608 Vita, J...... 128 Tzeng, Y-W...... P1422 Vandenput, L...... 524 Vitek, L...... P1419 Tziakas, D...... P481 Varakis, J...... P231, P247 Vithiavathi, S...... P490 Tzvetkov, B...... P321 Varga, E...... P1198 Vitorio, T...... P476 Ubaldi, S...... P1253 Vargas, V...... P1251 Vitulano, N...... P1218 Uchida, M...... P250 Varounis, C...... P884 Vives, G...... P924 Udartseva, O...... P200, P251 Vasco, M...... P1244 Vlachopoulos, C...... 132 Udristioiu, A...... P1204 Vasiliadis, I...... P827 Vlachopoulou, M...... P382 Ueda, K...... P367, P1387 Vasovic, O...... P401, P1317 Vladica, M...... 1022 Uehara, K...... P733 Vasudevan, M...... 56, P1323 Vodolagina, N...... P1173 Ueland, T...... P683 Vaughan, N...... P1435 Vogt, J...... P448, P465 Ueno, H...... P162, P238 Vaverkova, H...... P820 Vohnout, B...... P1371 Ueno, M...... 1045 Vaz, D...... P1205, P1318 Vojdani, A...... P778 Ueno, T...... P245, P733 Vazquez, A...... P821 Volger, O...... P483 Underhill, H...... 610 Vecchio, V...... 1512 Volkmann, R...... 131 Uren, N...... 1512 Vecerova, L...... P181 Volpe, R...... P1421 Ushakova, T...... P854 Vedie, B...... P422 Volpe, S...... P1297 Utermann, G...... 1518 Vedre, A...... P156 von Bergmann, K...... 581, P972 Utino, F...... P279 Vega, G...... 573 von der Thüsen, J...... 1090 Uto-Kondo, H...... P418, P440, P1407 Vega, J...... P842 von Eckardstein, A...1013, P268, P281, P431 Völker, W...... P183 Veglia, F...... P795 Vonbank, A...... 1494, P855, P886, P887, Vaidyanathan, K...... 56 Velazco, M...... P1265 P906, P945, P1255, P1256, P1271, Vainstein, N...... 1000, P1178, P1261 Veltri, E...... 536, 580 P1285, P1311, P1337, P1339 Vaisman, B...... 1465 Vemu, L...... P634 Voogt, J...... P437, P443, P1438, P1442 Vakhtangadze, T...... P632 Vendarame, C...... P1124 Vorobiova, E...... P632 Valachovicova, M...... P1344 Vendramin, C...... P304 Voshol, P...... P700 Valbusa, G...... P913 Verberne, H...... P215 Voskuilen, M...... P482 Valduga, C...... P468 Vercesi, A...... P274, P278, P279, P1139 Voss, B...... 1511 van ‘t Klooster, G...... P202 Verdejo, J...... 574, 589 Vossen, M...... P1196 Van Berkel, T...... 73, 518, 620, 622, 1101, Vergès, B...... 71 Voyatzidis, C...... P1352 1455, 1502, P1122 Vergeer, M...... 1101, P863, P895 Vozovikov, I...... P200, P251 van Bochove, K...... P934 Verhoeven, G...... P159, 576 Vrablik, M...... P358, P372 van Bockxmeer, F...... P846 Verlan, N...... P265, P1238 Vrins, C...... P444 van den Hoek, A...... P201, P202 Verma, A...... 585, P1164 Vrints, C...... 1092, P203 van den Hoogen, C...... P201, P984 Verreschi, I...... P1252 Vrionis, S...... P769 van der Donk, C...... P1365 Vezeridis, A...... 1498, P442 Vrolix, R...... 1032 van der Graaf, A...... 48, 1024 Vianello, D...... 615 Vukadinovic, N...... P1289 van der Greef, J...... P934 Vicario, A...... 1000, P1178, P1261 Vukotic, M...... P342 van der Hoorn, J...... 533, P201, P479, P482, Vicca, S...... P460 Vuletic, M...... P172 P980, P984 Vickers, K...... 1100, P252 Vulic, D...... P344 van der Loos, C...... 1090, P483, P644, P645 Viegas, M...... 531 Wågsäter, D...... 64 van der Wal, A...... P483, P644, P645 Vieira, C...... P1212 Wähälä, K...... 1056 Van Der Westhuvzen, D...... 1108 Vieira, L...... P1282 Wade, L...... P1161 van der Zwan, L...... 525, P817 Viereck, J...... P167 Wael, N...... P832 van Deventer, S...... 554, P475 Vihervaara, T...... P711 Wagner, G...... 1453 van Diepen, J...... P700 Viikari, J...... P869 Wagner, H...... P1199 van Doormaal, J...... P377 Vikström, M...... P872, P873 Wagner, J...... P1392 Van Eck, M...... 518, 620, 622, 1101, 1455, Villa, D...... P315 Wahle, K...... P1435 1502, P444, P1122 Villar, J...... 530 Wahrborg, P...... P345 Van Herck, J...... 1092, P203 Villarreal Jr., G...... 558 Wait, R...... P263 van Heyningen, C...... P491 Villaverde, C...... P1195 Wajchenberg, B...... 1015 Van Himbergen, T...... 35, 47 Villegas, D...... P1442 Wakame, K...... 603, P1432, P1434 van Hinsbergh, V...... 1090 Vinagre, C...... P946 Wakiguchi, H...... P658 van Leuven, S...... P483 Vincentelli, GM...... P343 Wald, N...... 572 van Loendersloot, L...... P378 Vink, H...... P215, P1364 Walden, C...... P935 van Nieuwkoop, A...... P201 Violi, F...... P318, P687, P687, P1350 Wallenius, V...... P735 van Ommen, B...... P934 Virgil, D...... P357 Walsh, K...... 97 Van Roomen, C...... P158 Virmani, R...... 62 Wan, M...... P649 van Schalkwijk, D...... P934 Virtanen, I...... P1138 Wanders, A...... 51, 54 van Tits, L...... P731 Vis, K...... P870 Wang, G...... P204, P205, P206, P207, P208, Van Tol, A...... 1062, P895 Visser, M...... 104 P253, P254, P294, P323, P484, P697, P1206, P1345 van Vliet, J...... P845 Visseren, F...... 577

P=Poster 208 Wang, H...... P985 Williams, M...... 1480 Yakuschko, L...... P627 Wang, H-H...... P255 Williamson, D...... 622 Yakushiji, E...... P228, P418, P440, P802, Wang, J...... 1069, P485, P1440 Wilson, M...... 145 P1306, P1407 Wang, L...... P472 Wilson, P...... 109, 519 Yamada, S...... P194, P195 Wang, R...... P1129 Windemuth, A...... 37 Yamada, T...... P245, P733, P909 Wang, S...... P698 Winder, T...... P1256 Yamagishi, M...... 532, P851, P852, P859, Wang, S-C...... P831 Winkler, K...... P391 P860, P979 Wang, X...... 515 Wittert, G...... 607 Yamaguchi, H...... 1097, P1280 Wang, Y...... P479, P484 Wittfeldt, A...... P911 Yamaguchi, N...... P725 Wang, Z...... P204, P209, P257, P474, P661, Woess, M...... P1255 Yamaguchi, S...... P741 P662, P959, P1129 Wojnoonski, K...... P1392 Yamamoto, A...... P388, P389 Wang, Z-Q...... P256, P974, P975, P976 Woldseth, B...... 102 Yamamoto, K...... P416, P430 Wann, S...... P310 Wolfe, M...... P1297 Yamamoto, M...... P411 Wareham, N...... P810, P895 Wolski, K...... 1495, P1386 Yamamoto, T...... P962, P926 Warnick, GR...... P407 Won, B...... P424 Yamanaka, Y...... P960 Warodomwichit, D...... P896 Wong, B...... P732 Yamane, K...... P660 Warodowichit, D...... 1489 Wong, J...... 1026, 1461, P1411 Yamasaki, J...... P180 Wascher, T...... P1338 Wong, K-L...... P222 Yamashiro-Kanashiro, E...... P1124 Wasserman, B...... P903 Wong, M...... P700 Yamashita, M...... P428, P861, P1144, P1269 Wat, E...... 601, 1031 Wong, M-C...... P479 Yamashita, S...... 516, 1508, P410, P416, Watanabe, K...... P910 Wong, N...... 1453 P430, P749, P862, P926, P1378 Waterman, P...... 611 Wong, Y...... P439, P1203 Yamazaki, H...... P193, P734 Waters, D...... 574, 589 Wood, D...... 6, 110 Yamazaki, K...... P210 Waters, L...... P714 Wood, S...... 1029 Yamazaki, T...... P771, P772 Watkins, N...... P213 Woodman, R...... P272 Yamwong, S...... P896 Watson, K...... 8 Woodroofe, M...... P667 Yan, L...... 1008 Watts, G...... 72, 94, 138, 514, P403, P412, Woodside, J...... 602, P1426 Yanai, H...... 1486, P454, P1145 P419, P432, P954, P986 Worthley, M...... 607 Yang, F...... P207 Waye, M...... P825 Worthley, S...... 607 Yang, H...... P677, P703 Webb, N...... 621, 1108 Wroblewski, J...... 1108, P1157 Yang, H-C...... 609 Weber, C...... 559 Wsolova, S...... P1371 Yang, L...... P1345 Wegner, M...... P756. P809 Wu, A...... 37 Yang, Q...... P173, P178 Wei, D...... P204 Wu, B...... 81, 1008 Yang, S-Y...... 609 Wei, H...... P209, P257 Wu, C...... P173 Yang, T-L...... P696 Wei, X...... P240, P1148 Wu, C-C...... 609 Yang, X-Y...... P256, P974, P975, P976 Weidner, G...... 588, P781 Wu, D-M...... P831 Yang, Y...... P204, P445, P472, P1393 Weih, F...... 1093 Wu, T-C...... P220, P379 Yang, Y-Z...... P698, P975 Weijers, E...... 1090 Wu, X...... P253 Yannarelli, G...... P957 Weill, P...... P451 Wu, Y...... P701 Yano, M...... 624, P981 Weinstein, M...... 141 Wu, Y-F...... 27 Yanovskaya, K...... P627 Weisgraber, K...... 566 Wu, Z...... P259 Yao, Z...... 528 Weiss, N...... P258, P1165 Wung, B-S...... P702 Yasuda, D...... P417 Weiss, T...... P1380 Wycherley, T...... 95 Yasuda, G...... P1328 Weissleder, R...... 561, 611, P640 Xanthoulea, S...... P187 Yasuda, O...... P892 Wenger, N...... 26, P773 Xavier, C...... P713 Yasuda, S...... 39 Werba, P...... P1307 Xenophontos, S...... P834, P835 Yatsu, F...... P241 West, N...... 1019 Xia, C...... P723 Yazawa, K...... P1433 Westerbacka, J...... P922 Xia, M...... P1393 Ye, D...... 1455, P1122 White, C...... 1466 Xiao, G...... P209, P257 Ye, L ...... P206, P208 Whittaker, J...... 527 Xiao, J...... P983, P1125, P1126, P1132, Widschwendter, P...... 1105 P1135, P1142, P1143 Ye, P ...... P985 Wiegman, A...... 48 Xiao, L...... P253 Ye, S ...... P872 Wigren, M...... P636, P699 Xiao, Q...... P224 Yeap, B...... P732 Wijaya, A...... P811 Xie, G...... P294 Yeh, H-I...... P255 Wikinski, R...... P936 Xie, M...... P720 Yeh, W-T...... 1073 Wildgruber, M...... 611 Xie, W...... P307 Yeo, HY...... P1428 Wildhirt, S...... 1511 Xie, X...... P275 Yesilaltay, A...... 148 Wilhelmson, A...... P159 Xie, Z...... P438 Yi, G ...... P257 Willems van Dijk, K...... 1477 Xiong, W...... P225 Yilmaz, S...... P714 Willerson, J...... 999 Xiong, X...... P1156 Yin, H...... P977 Williams, C...... P459, P935, P1274 Xu, F...... P260 Yin, T...... P323, P484 Williams, K...... P1159 Xu, Q...... P224 Yin, W...... P209, P211, P257, P723, P1148 Williams, KJ...... 540 Xu, Y...... P438, P703 Yingchoncharoen, T...... P896

P=Poster 209 Yndestad, A...... P692 Zeymer, U...... 1067 Yokoi, T...... P261 Zhan, W...... P1353 Yokote, K...... P246 Zhang, C...... 1069, P211, P226, P1148 Yokoyama, M...... 504 Zhang, H...... 1454, P205 Yokoyama, S...... P388, P389 Zhang, L...... 1002, P152, P723 Yong, HS...... 1038 Zhang, Q...... P1207 Yoo, B...... 545 Zhang, WS...... P1342 Yoo, J-Y...... P685 Zhang, X...... P474, P661, P662, P959 Yoon, J...... P381 Zhang, Y...... 558, P1440 Yoshida, H...... 1486, P454, P1145 Zhang, Z...... P438 Yoshida, M...... 584, P654, P666, P695, Zhang, Z-Y...... P256, P974, P975, P976 P704, P1434 Zhao, M...... P706 Yoshida, T...... P1346 Zhao, R...... P192 Yoshika, M...... P261 Zhao, R...... P244 Yoshimasa, Y...... P388, P389 Zhao, S-P...... 1059, P171, P978, P1299 Yoshimura, N...... P417 Zhao, W...... P171, P978, P1299 Yoshinaka, Y...... P193, P292 Zhao, Y...... 620, P151 Young, I...... 602, P1161, P1176, P1395, Zhao, Y-C...... 27 P1426 Zhao, Z...... P284, P307, P1128, P1158 Young, J...... P497 Zheng, C...... P937 Young, S...... 141 Zheng, X-L...... P977 Yu, D...... P1159 Zhong, S...... 528 Yu, J ...... P209, P257, P262 Zhong, W...... P822 Yu, P ...... P1212 Zhou, H...... P439 Yu, S-C...... P876 Zhou, M...... P294 Yu, W...... P151 Zhou, X...... P474, P661, P662, P663, P664 Yu, X-H...... 27 Zhou, Y...... P673, P1207 Yu, Y-M...... P641, P1422 Zhu, B...... P723 Yuan, C...... 610 Zhu, H...... P240 Yuan, X-M...... P233, P287, P672, P705 Zhu, J...... 41, P205 Yuan, Z...... P1146 Zhu, W...... P1208 Yuan, Z-H...... P975 Zieve, F...... P773 Yubero-Serrano, E...... P931 Zilberman, J...... 1000, P1178, P1261 Yue, D...... P484 Zimmerman, T...... 1461 Yuksel, H...... P1247 Zimolova, M...... P175, P1130 Yun, J...... P1248 Zivkovic, V...... P172 Yuri, K...... P658 Zlatohlavek, L...... P358 Yusoff, K...... P684, P1316 Zo, JH...... P457 Zack, M...... 621 Zo, J-H...... P1437 Zadelaar, S...... 142 Zocco, MA...... P1220 Zago, V...... P936 Zoladl, M...... P796 Zaheer, M...... P750, P756, P809 Zoller, B...... P758 Zairis, M...... 593, P300 Zona, S...... P784, P808 Zak, I...... P889 Zou, J...... P234 Zakopoulos, N...... P868 Zvarova, J...... P372 Zambón, D...... P462 Zweiker, R...... P1338 Zambon, A...... 615 Zambon, D...... 530, 544, P842 Zanaboni, A...... P1305 Zanasi, A...... P1218 Zanella, M...... P675, P676 Zannis, V...... 119, 1498, P442, P925, P1123 Zanotti, I...... 1456, P446 Zapletalova, P...... P837 Zarantonello, G...... 615 Zarfeshani, S...... P915, P1175 Zaslavkaya, R...... P1147 Zateyshchikov, D...... P881, P897 Zatonski, W...... 42 Zatz, H...... P1180, P1295, P1325 Zelinsky, V...... P327 Zenimaru, Y...... 1045, 1104 Zerrad-Saadi, A...... 82 Zetterqvist, A...... P638

P=Poster 210 Notes

______

211 Notes

______

212 Notes

______

213 Notes

______

214 Notes

______

215 Notes

______

216 Notes

______

217 Notes

______

218 Notes

______

219 Notes

______

220 Notes

______

221 Notes

______

222 Notes

______

223 Notes

______

224 Convention Center Map Hynes Convention Center • 900 Boylston Street • Boston, Massachusetts 02115 ph: 617.954.2800 fx: 617.954.3326

Level 2

Level 3 International Atherosclerosis Society

Offices

Emanuela Folco, Ph.D. Ann Stephens Jackson, M.B.A. Executive Director Executive Director Administration, Education, and Scientific Affairs Fellowship, Finance, and Legal Affairs

International Atherosclerosis Society International Atherosclerosis Society Via Appiani 7 6535 Fannin, M.S. A-601 20121 Milan, Italy Houston, TX 77030 USA Tel: +39 02 29 06 18 79 Tel: +1 713 797-9620 Fax: +39 02 29 06 35 81 Fax: +1 713 797 9507 E-mail: [email protected] E-mail: [email protected]